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Abstract
Ab s t r a c t
The interaction between myxoma virus and the European rabbit is one of the best 
documented natural models of host/ virus co-evolution. Although there were many 
studies which documented the development of this co-evolution, the cellular and 
molecular mechanisms behind the co-evolution are not clear. This thesis examined the 
role of lymphocytes in resistance of rabbits to myxomatosis and in attenuation of 
myxoma virus strains. Primary lymphoid cells were isolated from susceptible 
(laboratory) and resistant (wild) rabbits and infected in vitro with the virulent SLS or 
attenuated Ur strain of myxoma virus. The effect of lymphocyte activation on the 
interaction between the lymphoid cells and myxoma virus was examined by the addition 
of the T-cell mitogen, concanavalin A (Con A) to the primary cultures.
The permissivity of lymphoid cells to myxoma virus replication significantly increased 
with the addition of Con A. When this was observation was examined at a cellular level 
it was found that myxoma virus preferentially replicated in lymphocytes that were 
activated or in the G2/M stage of the cell cycle. However, once lymphocytes were 
infected myxoma virus completely abrogated T-cell activation processes, such as the 
increase in cell size and CD25 expression. Myxoma virus also down-regulated MHC-I 
and CD4 expression on the surface of activated primary lymphocytes and RL-5 cells. 
These results suggested that activated cell signaling pathways may play a critical role 
during myxoma virus pathogenesis.
The increase in SLS titres with T-cell activation was due to an increase in virus 
production in every infected cell. For Ur infection, however, the increase in titres with 
T-cell activation, which was only detected in lymphoid cell cultures from laboratory
XX
Abstract
rabbits, was due to an increase in the number of infected cells. Ur did not replicate in 
activated lymphoid cells from wild rabbits.
It was also observed that in Ur infections there was a reduction in lymphocyte viability 
late in infection. This was presumably due to the failure of Ur to inhibit cell death 
pathways that are initiated on cell cycle arrest. In contrast, SLS was able to maintain 
lymphocyte viability late in infection. Genetic analysis identified a lesion in the M005 
ORF in Ur where there was an insertion of a cytosine relative to the M005 ORF in SLS. 
The insertion of this cytosine induces a frameshift, potentially resulting in production of 
a truncated M005 protein. M005 has been previously implicated in lymphocyte survival, 
so this lesion may interfere with the biological function of this protein ieading to the 
inability of Ur to maintain lymphocyte viability at late time points. This may then lead 
to a reduction in viral titres and viral dissemination in vivo compared to SLS and is the 
first identified potential attenuation mechanism for myxoma virus.
This thesis is also the first to show a potential mechanism for resistance of rabbits to 
myxoma virus. There was a small but statistically significant reduction in the 
permissivity of lymphocytes from resistant rabbits for myxoma virus replication 
compared to lymphocytes from susceptible rabbits. Unstimulated mock-infected 
lymphocytes from wild rabbits also had greater cell surface expression of CD4 and 
CD43 and stimulated lymphocytes had greater expression of MHC-I than lymphocytes 
from laboratory rabbits which may enhance the early immune response against the 
virus. Taken together, a lower ability of myxoma virus to replicate in lymphoid cells 
from wild rabbits in addition to a potentially more efficient and effective early innate 
immune response in wild rabbits compared to laboratory rabbits, may be responsible for 
resistance of rabbits to myxomatosis.
XXI
Abstract
A secondary part of this thesis was the production and characterisation of antibodies 
specific for rabbit IL-2 and IFNy, as representative Th I cytokines, and rabbit IL-4, IL-6 
and IL-10, as representative Th2 cytokines. Synthetic peptides corresponding to 
potential epitopes on these cytokines were designed conjugated to the immunogenic 
carrier protein and injected into rats (and chickens for the IL-2 synthetic peptides).
Antibodies to IL-4, IL-6, IL-10 and IFNy were generated after immunization of rats 
with synthetic peptide/conjugate. These antibodies worked to differing extents in 
immunofluorescence, Western blot assays, flow cytometry and tissue sections. 
Production of anti-peptide sera to rabbit IL-2 was attempted but was unsuccessful. The 
ability of the antibodies produced to recognize native forms of rabbit cytokines will 
enable future investigation of the role of cytokine expression in the attenuation of 
myxoma virus and genetic resistance to myxoma virus. However, their most useful role 
is likely to be in immunostaining in tissue sections rather than in immunostaining of 
infected cultures as this will enable clarification of the immune response elicited by the 
host rabbit on infection with myxoma virus.
In conclusion, this thesis showed that the interaction between myxoma virus and T-cells 
may be critical for determining the outcome of infection and postulated that it is this 
interaction that ultimately determines resistance of rabbits to myxomatosis and 
attenuation of the virus. This thesis also presented a model for resistance of rabbits to 
myxomatosis and a model for attenuation of myxoma virus.
XXII
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1.1 Introduction
1.1 In t r od u ct io n
Perhaps the most studied and documented natural model of host/virus co-evolution in 
mammals is that of myxoma virus and the European rabbit, Oryctolagus cuniculus. 
Myxoma virus is the causative agent of myxomatosis and was released in Australia in 
the summer of 1950-51 in order to control the wild European rabbit population, which 
was immunologically and evolutionarily naive with respect to myxoma virus. The initial 
epidemic of myxoma virus was estimated to have killed greater than 99% of infected 
wild rabbits. However in the years following, there was rapid selection for attenuated 
strains of myxoma virus and for rabbits resistant to myxomatosis (reviewed in Fenner 
and Fantini 1999).
Leukocytes are one of the key players during myxoma virus pathogenesis. Fenner and 
Woodroofe (1953) first identified leukocytes as important for in vivo amplification, 
dissemination and pathology of myxoma virus. More recently it has been shown that 
lymphocytes, in particular T-cells, are critical for myxoma virus pathogenesis as 
myxoma virus localizes to the T-cell zones in lymph nodes from infected rabbits (Best 
and Kerr 2000) and replicates in the rabbit CD4+ T-cell line, RL-5 (Barry et al., 1995; 
Macen et ah, 1996; Barry et ah, 1997). It has also been postulated that T-cells are one of 
the key cell types that disseminate myxoma virus systemically (Kerr and Best 1998). 
This is supported by studies using recombinant myxoma viruses with genes essential for 
replication in T-cells deleted, which show virus strains that are unable to replicate in T- 
cells are attenuated in vivo (Opgenorth et ah, 1992a; Macen et ah, 1996).
This thesis investigates the role of T-cells in co-evolution of myxoma virus with the 
European rabbit by examining infection of lymphoid cells from susceptible and resistant 
rabbits with virulent and attenuated strains of myxoma virus. The original virulent strain
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of myxoma virus, the ‘standard laboratory strain’ (SLS), released in the field in 1950 is 
available, as well as an attenuated strain, Uriarra (Ur), isolated from the field in 1953. In 
addition, laboratory rabbits that are susceptible to myxomatosis and wild rabbits 
selected in the field for resistance to myxomatosis are also available. The accessibility 
of these resources puts our laboratory in a unique position to study host/virus co-
evolution in this natural model.
The introduction to this thesis will firstly detail the characteristics of myxoma virus and 
the historical development of myxoma virus attenuation and wild rabbit resistance. 
Following from this, the cellular responses to virus infection and the importance of T- 
cells and T-cell activation and replication in these responses will be described. Then, the 
immunomodulatory mechanisms used by myxoma virus to overcome the rabbit immune 
response will be discussed and finally, the aims of this thesis set out.
1.2 My x o ma  Vi r u s
1.2.1 Myxoma Virus
Myxoma virus is the causative agent of myxomatosis, a systemic lethal disease of 
European rabbits, Oryctolagus cuniculus. Myxoma virus is one of six members of the 
Leporipoxvirus genus (Fenner 1979). All six of the Leporipoxvirus species cause a 
benign, cutaneous fibroma in their respective natural host, but they cause differing 
extents of disease in O. cuniculus (Fenner and Ratcliffe, 1965; Fenner and Ross, 1994). 
The natural host of each of these virus species and the general disease each causes in O. 
cuniculus are listed in Table 1.1. The use of ‘myxoma virus’ in this thesis refers to the 
South American myxoma virus species.
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Ta b l e  1 .1 .  Na t u r a l  Ho s t  a n d  Di s e a s e  Ph e n o t y pe  
In d u c e d  b y  L e p o r i p o x i v r u s  Spe c i e s
IN O r y c t o l a g u s  c u n i c u l u s
L ep o r ip o x v iru s N atu ra l H ost* D isease  in
S p ecies O rycto lagu s cu n icu lu s
S o u t h  A m e r ic a n Sylv ilagus b ras iliens is generalized lethal disease,
M y x o m a  V ir u s gross external pathology
C a lif o r n ia n  M y x o m a S ylv ilagus b achm an i generalized lethal disease,
V ir u s few external signs
S h o p e  F ib r o m a  V ir u s S ylv ilagus flo ridanus benign, cutaneous fibroma
S q u ir r e l  F ib r o m a Sciu rus ca ro linens is benign, cutaneous fibroma
V ir u s
W e s t e r n  S q u ir r e l Sciu rus g riseus not determined
F ib r o m a  V ir u s griseus
H a r e  F ib r o m a  V ir u s Lepus europaeus benign, cutaneous fibroma
* All virus species cause a benign cutaneous fibroma in their natural host
The Leporipoxvirus genus is part of the Poxviridae family. Poxviruses have linear, 
double-stranded DNA genomes. The genome of myxoma virus is 161.8 kilobases (kb) 
(Cameron et al., 1999). Each end of the genome is composed of a covalently closed 
single stranded hairpin loop and 11.5 kb terminal inverted repeat (TIRs), which is 
typical of poxviruses (Cameron et al., 1999). The TIRs and adjacent regions of the 
genome typically encode ‘virulence’ genes (Cameron et al., 1999; Moss 2001). 
Virulence genes encode proteins that disrupt and circumvent the host anti-viral immune 
response and that block apoptosis of infected cells. The genes in this region are variable 
between members of the Poxviridae family and tend to be specific to particular virus 
species or virus genera. The central region of the genome encodes structural and house-
keeping genes (e.g. genes encoding mRNA transcription and translation factors, virion 
morphogenesis factors). Many of these genes are essential for the production of
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infectious virus progeny and are highly conserved among the Poxviridae family. Figure
£
1.1A shows a schematic of the myxoma virus genome.
Sequencing of the genome from the Lausanne (Lu) strain of myxoma virus identified 
425 potential open reading frames (ORFs) with a minimum length of 50 amino acids 
(Cameron et al., 1999). Of these, 159 are predicted to be co-linear expressed genes 
based on homology to known poxvirus genes and by comparison to predicted ORFs in 
Shope fibroma virus (SFV). One of these ORFs, M037L, encodes a 32 amino acid 
protein, but has been identified based on comparisons with genomes from other 
poxviruses. The 159 ORFs were numbered sequentially starting from the left end of the 
genome, based on the nomenclature of Melanoplus sanguinipes and Molluscum 
contagiosum (as shown in Cameron et ah, 1999). A diagrammatic representation of the 
159 assigned ORFs of myxoma virus is shown in Figure 1 .IB. The ORF names used in 
this thesis are defined as in Cameron et al. (1999) without the direction of transcription
Figure  1.1. Th e  Myxom a  Virus  Genome
(A) Schematic of the myxoma virus genome. The genome is linear double-stranded DNA and 
contains a covalently closed single-stranded hairpin loop and terminal inverted repeats (TIR) at 
each end. The central region of the genome encodes structural and house-keeping genes, which 
tend to be conserved among the Poxviridae family. The genes encoding proteins with putative 
immunomodulatory functions are generally situated at the ends of the genome and vary between 
members of the Poxviridae family. (B) Linear map of myxoma virus genome (adapted from 
Cameron et al, 1999). The genome is 161.8 kb (161.4 kb excluding the TIR) and contains 159 
assigned ORF. ORFs are numbered sequentially, starting at the left end of the genome. The ‘R’ 
and ‘L’ designate the direction of gene transcription. Genes with predicted immunomodulatory 
functions are shown in red, those predicted to encode proteins related host range or anti- 
apoptotic activity are coloured blue. The conserved genes (genes encoding house-keeping and 
structural proteins) are shown in . The TIR (purple) encodes genes MOO 1 to M008.1.
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stated, and will be described as genes (e.g. M001 gene). For this thesis, the putative 
proteins translated from these genes will share the gene name (e.g. M001).
1.2.2 Myxoma Virus Morphology
The myxoma virus virion appears brick-shaped when viewed by electron microscopy 
and morphologically is indistinguishable from the prototype poxvirus, vaccinia virus 
(Orthopoxvirus genus) (Fenner 1996). Studies of vaccinia virus have identified two 
infectious forms, the intracellular mature virion (IMV) and extracellular enveloped 
virion (EEV). The IMV consists of a biconcave nuclear core, containing the DNA 
genome and core membrane, and two lateral bodies surrounded by a lipoprotein 
membrane. An additional membrane derived from the Golgi encloses the IMV to form 
the EEV. Myxoma virus infection also generates IMV and EEV (Padgett et al., 1964). 
Figure 1.2 shows an electron micrograph of a myxoma virus IMV and a schematic of a 
poxvirus virion.
In vaccinia virus, IMV forms 80-95% of the total virus produced by the cell with the 
remainder being EEV (Moss 2001). However, EEV is considered the primary infectious 
form of virus for in vivo and in vitro dissemination. This is because the EEV does not 
rely on the loss of cell membrane integrity (e.g. cell lysis), which is required for release 
of IMV from the cell (Vanderplasschen et al., 1998).
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A
Lateral Body
Outer ____
membrane
B
L ateral body Envelope 
S u r f a c e \  I X  „ O u ter
tu b u les m em b ran e
N u c le o s o m e  
C ore  m e m b ra n e
Figure  1.2. Myxom a  Viru s  Vir io n
(A) An electron micrograph of the intracellular mature myxoma virus virion (IMV) (Fenner, 
personal communication) and (B) schematic of a typical poxvirus virion (taken from Fenner, 
1996). A poxvirus virion is made up of the nucleosome, containing the DNA genome, and is 
surrounded by the core membrane. An additional lipoprotein membrane (outer membrane) 
surrounds this core and the two lateral bodies. This is the IMV form of the virus. A Golgi- 
derived membrane envelopes the virions in the EEV form.
1.2.3 Poxvirus Replication Cycle
Poxvirus replication has been elucidated by studying that of vaccinia virus and is 
outlined in this section and in Figure 1.3 (reviewed in Moss 2001).
9
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The first steps in the poxvirus replication cycle are attachment of a virion to the cell 
membrane, fusion with the cell membrane and entry of the viral core into the cell 
cytoplasm (Step 1, Figure 1.3). Attachment to and fusion of a virion with the cell 
membrane will be discussed in more detail in Section 1.2.3.1. Once the virion has 
entered the cell, replication of the virus begins. Replication of poxviruses occurs 
exclusively in the cytoplasm in defined areas called virosomes. The machinery required 
to transcribe early genes is packaged within the viral core and transcription of these 
genes is initiated from early promoters after partial uncoating of the core (Step 2, Figure 
1.3). These early transcripts encode immunomodulatory proteins, host-range proteins, 
intermediate transcription factors and proteins involved in replication of the viral 
genome, in addition to proteins that complete uncoating of the viral core. Once the core 
is uncoated (Step 3, Figure 1.3), replication of the viral genome can begin (Step 4, 
Figure 1.3). At this time, gene transcription from intermediate and late promoters is 
initiated.
Replication of the poxvirus genome results in the formation of concatemeric DNA, 
which is cleaved into unit genomes and packaged, along with early transcription factors 
required during the next replication cycle (Step 5, Figure 1.3), and assembled at the late 
stage of infection into an immature virion. Maturation of the virion occurs leading to 
formation of IMV (Step 6, Figure 1.3) (Beaud 1995; (Moss 2001). Virions destined for 
the extracellular environment acquire an additional membrane from the Golgi and are 
transported to the cell surface via actin tail polymerization (Step 7, Figure 1.3) 
(Frischknecht et al., 1999). At the cell surface, the virion fuses with the cellular 
membrane and either EEV is released or the virion stays adhered to the cell surface 
forming a cell-associated enveloped virion (Step 8, Figure 1.3) (reviewed in Moss 
2001).
10
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Step 1:
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and entry of virion
Step 6:
virion maturation
cell membrane
Step 3: 
Uncoating of 
viral core
/ /*Step 2:
transcription and 
translation of 
early genes
M \ /
trans-Golgi
network
Step 4:
Replication of viral 
genome and 
intermediate and late 
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packaging genome 
and early transcription 
factors into immature virions
Step 7:
wrapping IMV with 
Golgi-derived 
membrane
Step 8:
release of virions 
from the cell
EEV
F i g u r e  1.3. T h e  R e p l i c a t i o n  Cy c l e  o f  Po x v i r u s e s
Step 1: Poxvirus virions attach and fuse to the cell membrane, releasing viral cores into the 
cytoplasm. Step 2: Early genes are transcribed and translated. Step 3: The viral core is uncoated 
and replication of the viral genome begins (Step 4). Step 5: The DNA genome and early 
transcription factors required for the next poxvirus cycle are packaged into immature virions. Late 
gene expression follows, and assembly of the virus particle occurs. Step 6: The virion matures to 
an IMV. The IMV may be wrapped in a second, Golgi-derived membrane (Step 7), transported to 
the cell membrane and released from the cell as EEV (Step 8). Figure adapted from Moss (2001).
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1.2.3.1 Virion Attachment, Fusion and Entry
Attachment to, and fusion with the cell membrane differs between the two infectious 
forms of virion, as there are additional viral-encoded proteins associated with EEV that 
are not present in IMV (Payne 1979; Payne 1980). The differences between vaccinia 
virus IMV and EEV in cell membrane attachment and fusion have been illustrated 
experimentally (Vanderplasschen and Smith 1997; Vanderplasschen et ah, 1998). The 
cell surface receptors responsible for vaccinia virus attachment have not been elucidated 
(Vanderplasschen and Smith, 1997). However, it has been shown that entry of vaccinia 
virus IMV is dependent on temperature, pH (Dorns et al., 1990) and cell signaling 
cascades (Locker et al., 2000). In contrast, EEV entry does not require cell signaling 
cascades (Locker et al., 2000) even though it is also dependent on pH. The fact that 
signaling cascades are not required for EEV entry into a cell may explain why cell entry 
of EEV is more rapid than that of IMV (Payne and Norrby 1978; Dorns et al., 1990).
A number of proteins putatively involved in myxoma virus virion attachment and fusion 
have been identified based on homology to other poxvirus proteins. The products of the 
M035, M041, M055, M071, M088, M098, M102, M103, M107 and Ml 15 ORFs are 
predicted to be associated with the IMV membrane (Cameron et al., 1999) and may be 
implicated in IMV attachment and fusion. For EEV, the products of M022, M l21, 
M l22 and M l26 ORFs are associated with the EEV envelope and are putatively 
implicated in EEV attachment and fusion (Cameron et al., 1999). The putative 
properties of each of these IMV and EEV-associated proteins, in addition to their 
poxvirus homolog and relative conservation among the Poxviridae family, are shown in 
Table 1.2.
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Ta b l e  1.2. Pu t a t i v e  Pr o pe r t i e s  o f  IMV- a n d  EEV-As s o c i a t e d  Pr o t e i n s
ENCODED BY MYXOMA VIRUS
M y x o m a  V i r u s  
O R F *
V a c c i n i a  V i r u s  
H o r n  o l o g
P u t a t i v e  P r o p e r t i e s C o n s e r v a t i o n
a m o n g
P o x v i r u s e s +
1 M V -
a s s o c i a t e d
p r o t e i n s
M 03 5 E10R • hydrophobic N-terminus
• t ransmembrane domain
• redox function
conserved
M 041 15L • hydrophobic
• basic
• structural protein
• transmembrane
semi-conserved
M 055 L1R • myristylated
• hydrophobic N-terminus
conserved
M 07 1 H3L • hydrophobic
• heparin binding
• immunodominant
semi-conserved
M 088 D13L • rifampicin resistance conserved
M098 A9L • putative signal peptide
• t ransmembrane domain
conserved
M 102 A 13L • predicted secreted
• hydrophobic N-terminus
semi-conserved
M 103 A 14L • phosphorylated
• myristoylated
• associated with 
A17L/M 107
conserved
M 107 A 17L • associated with A27L and semi-conserved
A14L/M 103
• morphogenesis factor
• neutralizing antibody
E E V -  M 115
a s s o c i a t e d
p r o t e i n s
A27L • fusion protein
• neutralizing antibody
• heparin binding
• EEV formation
semi-conserved
M 022 F13L • non-glycosylated
• palmitylated
• envelope protein
• EEV antigen
conserved
M 121 A33R • lectin-like glycoprotein
• transmembrane
semi-conserved
M 122 A34R • hydrophobic N-terminus
• C-type lectin domain
• transmembrane
• NK cell receptor homolog
• N-glycosylated
semi-conserved
M 126 A37R • unknown semi-conserved
* Information in this table was taken directly from Cameron et al. (1999) and Moss (2001) 
Proteins with conservation classified as ‘semi-conserved’ share 20% to 50% amino acid 
identity and those classified as ‘conserved’ proteins share greater than 50% amino acid 
identity, with at least one gene outside the Leporipoxvirus genus but within the poxvirus 
family.
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The discrete entry mechanisms of myxoma virus IMV and EEV particles have not been 
investigated. In fact, there are very few studies on myxoma virus in the early stages of 
infection. One study that has examined myxoma virus infection, showed that infection is 
dependent on tyrosine phosphorylation signaling pathways, as infection was blocked by 
herbimycin A (tyrosine kinase inhibitor) and tyrophostin AG490 (Jak 2 inhibitor) 
(Lalani et al., 1999b; Masters et al., 2001). Although not stated, it is probable that the 
virus used in these studies consisted predominantly of the IMV form of myxoma virus 
because of the method of preparing virus stocks. This suggests that myxoma virus IMV 
also requires signaling cascades to enter a cell, and suggests that myxoma virus IMV 
enters the cell by a similar mechanism to vaccinia virus IMV.
Lalani et al. (1999b) also found pre-treatment of cells permissive for infection with 
either the growth factor RANTES (Regulated-upon Activation, Normal T-cell 
Expressed and Secreted) or an anti-CC chemokine receptor-5 antibody that blocks HIV 
infection, also blocked infection of myxoma virus. Pretreatment of cells with other 
chemokines, such as macrophage inhibitory protein (MlP)-la or MIP-lß or with other 
signal cascade inhibitors, such as pertussis toxin (G-protein inhibitor) or PP2 (4-amino- 
5-(4-chlorophenyl)-7-(r-butyl)pyrazolo[3,4-<i] pyrimidine, generalized phosphatase 
inhibitor) did not block infection (Lalani et al., 1999). These results suggest that some 
aspects of HIV entry may be similar to that of myxoma virus and that signaling 
pathways involving tyrosine phosphorylation and that are linked to RANTES or CC- 
chemokine receptors may be critical for myxoma virus infection.
1.3 My x o m a t o s is
Infection of naive European rabbits with virulent strains of myxoma virus causes the 
lethal, systemic disease, myxomatosis. Myxomatosis is characterized by multiple
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internal and external lesions, both at the site of virus inoculation and in tissues 
throughout the infected rabbit. Clinical signs of myxomatosis include swelling of the 
eyelids, conjunctival inflammation, anogenital edema and respiratory difficulties (Best 
and Kerr 2000). In contrast, in its natural host, S. brasiliensis, myxoma virus infection is 
generally not fatal and is characterized by mucoid cutaneous tumors localized to the site 
of infection (reviewed in Kerr and McFadden 2002; Zuniga 2002).
Myxoma virus is transmitted by arthropod vectors, such as mosquitoes and fleas. 
Transmission is passive, meaning myxoma vims does not replicate in the arthropod 
vector; rather myxoma vims virions adhere to the mouthparts of the arthropod, which 
transfers the virions to the epidermis or dermis of another rabbit during the arthropod’s 
next feeding (Aragao, 1943). In Australia, epidemics of myxomatosis usually occur 
annually in the spring and summer, but can occur at any time depending on the 
availability of vectors and susceptible rabbits (Fenner and Ratcliffe 1965; Fenner and 
Ross 1994).
A model for myxoma virus pathogenesis has been postulated by Best et al. (Best 1998; 
Best et al., 2000; Best and Kerr 2000). This model is outlined in Figure 1.4 and is 
described below. Myxoma virus enters the dermis of the host from the mouthpart of a 
biting arthropod. In the dermis, the vims infects MHC-II+ dendritic-like cells that 
transport the vims to the lymph node draining the site of infection. Once at the lymph 
node the vims can infect other cells, but most importantly lymphocytes and monocytes, 
which disseminate it systemically to other tissues. Lymphocytes and monocytes also 
transport myxoma virus back to the dermis/epidermis where the vims can be picked up 
by the next biting arthropod.
15
Chapter 1- Introduction
Fig u re  1.4. Model  fo r  the  Pa th o g e n es is  of  My xo ma  Vir u s  
■" Myxoma virus enters the dermis of the host from the mouthpart of a biting arthropod. The virus 
infects MHC-lT dendritic-like cells which transport it to the lymph node. At the lymph node the 
virus can infect lymphocytes and monocytes which disseminate the virus systemically to other 
tissues and also transport myxoma virus back to the dermis/epidermis where it can be picked up by 
the next biting arthropod and transmitted to another rabbit. Figure adapted from Kerr and Best 
(1998).
An inflammatory and immune response against myxoma virus is initiated at the skin 
and lymph node. The interaction between the rabbit immune response and myxoma 
virus determines subsequent pathogenesis and ultimately determines the outcome of 
myxoma virus infection. This interaction will be influenced by the virulence of the virus 
and the degree of resistance of the rabbit. These factors will be discussed in detail in 
Section 1.6.
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Infection of European rabbits, that are immunologically naive with respect to myxoma 
virus, with virulent strains of this virus typically ends with the death of the infected 
rabbit. The mechanism of death is obscure, but can be is associated with opportunistic 
infection of the upper respiratory tract with Gram-negative bacteria. Death from virulent 
South American strains of myxoma virus has been previously attributed to respiratory 
obstructions (Hobbs 1928; Strayer and Sell 1983). The lethality of myxoma virus in 
naive O. cuniculus made it an attractive candidate as a biological control agent for the 
wild European rabbit population of Australia.
1.4 My x o ma  V ir us  as  a  Bio l o g ic a l  Co nt r o l  Ag ent  fo r  the  
W il d Eur o pea n  Ra bb it
Wild European rabbits (wild rabbits) were deliberately introduced into Australia in 1859 
and spread across the continent at an estimated rate of 100-300 km per year. The 
clearing of land, introduction of domestic livestock, and control of predators by settlers 
and pioneers all assisted the establishment and spread of the wild rabbit population 
(reviewed in Myers et al., 1994).
Initial trials of the effectiveness of myxoma virus as a biological control agent were 
undertaken in the 1930s using Moses’ strain of South American myxoma virus (referred 
to in subsequent years as the ‘standard laboratory strain’ or ‘SLS’) (Moses 1911; Martin 
1936; Bull and Mules 1944). These trials were unsuccessful, with the virus failing to 
become established in the wild rabbit population and not spreading beyond the sites of 
its introduction (Myers et ah, 1954). Further field trials with myxoma virus were 
performed after World War II and, in the summer of 1950-1951, there was an explosive 
epidemic of myxomatosis, initiated from experimental release sites in southeastern 
Australia. During this time, Culex annulirostris mosquitoes were in plague proportions
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and were probably the chief vectors for the myxomatosis epidemic as the incidence of 
disease closely followed waterways infested with these mosquitoes (Ratcliffe et al.,
1952; Myers et al., 1994). The spread of myxoma virus at this time was augmented by 
extensive wild rabbit inoculation campaigns throughout southern Australia (Ratcliffe et 
al., 1952; Fenner et al., 1953). By 1954, myxomatosis had extended throughout the 
entire geographic range of the wild rabbit (Fenner and Ratcliffe 1965).
The myxomatosis epidemic in the summer of 1950-51 was estimated to have killed 
greater than 99% of infected wild rabbits. However, this level of effectiveness of 
myxoma virus as a biological control agent was short-lived, with the rapid emergence of 
both attenuated myxoma virus strains and rabbits resistant to myxomatosis (Myers et 
al., 1954; Marshall and Fenner 1958). The attenuated strains were selected for in the 
field as they allowed the infected rabbit to survive for a longer period, thereby giving 
the virus a longer time for transmission. As these strains were less virulent, they also 
enabled the survival of occasional rabbits with some degree of inherent resistance to 
myxomatosis. Thus, the emergence of attenuated virus strains and resistant rabbits was
the result of interactions between the virus and host. This co-evolution of.myxama_virus__ ___
and wild O. cuniculus provided an exciting opportunity to study a natural model of 
host/virus co-evolution, which had followed the introduction of a novel pathogen into a 
completely naive species. As a result, long-term studies monitoring virus virulence and 
resistance of wild rabbits were initiated. These studies are described in the following 
section.
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1.5 Co -e v o l ut io n  o f  Ho s t  a nd  Vir us
1.5.1 Development of Attenuated Strains of Myxoma Virus
To study the changing virulence of myxoma virus, field isolates collected during 
sequential annual epizootics were assigned a virulence grade, from grade I through to 
grade V, depending on the mortality rate and mean survival time of inoculated naive 
laboratory rabbits (Table 1.3) (Fenner and Marshall 1957). Grade I strains were the 
most virulent (least attenuated), killing 100% of inoculated laboratory rabbits with an 
average survival time of less than 13 days. Grade V strains were the least virulent (most 
attenuated) with less than 50% mortality and prolonged survival time for inoculated 
laboratory rabbits. Grade II-IV strains were intermediate between the two. For example 
grade III strains had a mortality rate of 70-95% and a mean survival time for inoculated 
laboratory rabbits of 17-28 days (Fenner and Marshall 1957).
Tab l e  1.3. Me a n  Surv ival  Time  an d  Mort al it y  Rate  of  Naiv e  Labor at or y  
Ra bb it s  Ino cul ate d  with  Myxom a  Vir u s  Strai ns  of  Diff ere nt  Virulenc e  
Grades
Virulence Grade* 
of Myxoma Virus
Mean Rabbit Survival 
Time
Rabbit Mortality 
Rate (%)
I < 13 days 100
II 13-16 days 95-99
III 17-28 days 70-95
IV 29-50 days 50-70
V not relevant <50
* Table taken from Kerr and Best (1998) from data in Fenner and Marshall (1957).
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SLS, the original strain of myxoma virus introduced into the wild rabbit population in 
1950, is a grade I strain. Although SLS was not the only strain of myxoma virus 
released in Australia in an attempt to control the wild rabbit population, experimental 
evidence indicates that all myxoma virus strains isolated from the field are derived 
genetically from SLS (Saint et al., 2001). By 1952-53, the proportion of virus field 
isolates of grade I virulence had fallen from 100% to approximately 13%, and only 
comprised 1-2% of the field isolates between 1975 and 1981 (Figure 1.5) (Marshall and 
Fenner 1960). Grade III and IV strains became dominant in the field and comprised 
greater than 60% of the virus isolated between 1952 and 1954, and greater than 90% 
between 1975 and 1981 (Figure 1.5) (Marshall and Fenner 1960). Virus strains of grade 
II and V virulence only constituted a small proportion of strains isolated from the field 
between 1952 and 1981. In recent years, virus strains of grade I virulence have been 
regularly isolated from the field (Saint et al., 2001; Kerr et al., 2003). This will be 
discussed further in Section 1.5.3.
The reason strains of grade III and IV virulence initially became dominant in the field 
between 1952 and 1981 was due to the enhanced transmission of strains with this 
virulence at this time. As previously described, myxoma virus is transmitted passively 
by blood-feeding arthropod vectors. Thus, the probability that myxoma virus would be 
transmitted to an uninfected rabbit depends on virus attached to the mouthparts of the 
arthropod vector. This in turn would depend on the titre of virus in the skin of the 
infected rabbit that initially probed for a blood meal (Fenner et al., 1952; Day et al., 
1956; Fenner et al., 1956).
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Fig ure  1.5. Attenua tion  of  Myxoma  Vir u s
The proportion of myxoma virus strains of each grade isolated from Australian wild rabbits 
between 1952 and 1981 are shown. Grades are defined in Table 1.3. The numbers of isolates 
tested during each period is indicated above each group of columns. Figure from Kerr and Best 
(1998) from data in Marshall and Fenner (1960).
7Experimentally it was shown that a virus titre in the skin of greater than 10 pock-
forming units per gram of skin (pfu/g) was required for effective transmission by 
arthropod vectors (Day et al., 1956; Fenner et ah, 1956). The skin titre in inoculated 
rabbits, of myxoma virus strains of different virulence grades over time is shown in 
Figure 1.6. If the virus was highly virulent (grade I) then it would kill its rabbit host 
within a few days of reaching skin titres required for effective transmission. However, if 
it was too attenuated (grade V), then the host would control replication of the virus, 
thereby rapidly reducing skin titres and the period of time those titres are over the 
transmission threshold. It must be noted that strains of grade V were able to reach titres 
sufficient for transmission for a limited time. Infection with virus strains of grade III or
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Fig ure  1.6. Tra ns mi ss ibi li ty  of  Stra in s  of  Myxoma  Vir u s  of  Dif fe re nt  
Virulence  Gr ad es
The titre o f myxoma virus strains o f grade I, III, IV and V virulence in the skin o f inoculated 
rabbits over time is shown. A skin titre o f 107 has been shown experimentally to be the threshold 
for effective transmission by arthropod vectors. Figure from Kerr and Best (1998) from data in 
Fenner et al. (1956) for grade I, III and IV data, and Best and Kerr (2000) for grade V data.
grade IV virulence enabled the virus to reach transmissible titres in the skin and allowed 
the infected rabbit to survive for longer periods. Together these increased the chances of 
successful transmission. Thus, virus strains of grades III and IV virulence would have 
had the highest probability for transmission by arthropod vectors and, over time, were 
more likely to out-compete strains of other grades.
1.5.2 Development of Rabbit Resistance to Myxomatosis
As previously stated, the emergence of attenuated strains of myxoma virus allowed the 
survival of rabbits with some inherent resistance to myxomatosis. Environmental
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factors, such as ambient temperature, may have augmented the development of 
resistance in wild rabbit populations as, experimentally, naive laboratory rabbits had a 
greater survival rate after challenge with myxoma virus if housed at high temperatures 
(Marshall 1959). Thus the hot Australian summer, especially in inland regions, may 
well have aided the survival of naturally infected wild rabbits with some degree of 
inherent resistance to myxomatosis (Marshall 1959; Marshall and Douglas 1961).
Studies during the 1950s illustrated the rapid development of genetic resistance of wild 
rabbits to myxomatosis. In one of these studies, rabbit kittens were taken from the Lake 
Urana (NSW) area each year prior to the seasonal epidemic of myxomatosis (Marshall 
and Fenner 1958). Kittens were not challenged until at least 4 months of age. Only 
kittens that were seronegative with respect to myxoma virus were used in resistance 
experiments as these animals had presumably not previously been exposed to myxoma 
virus. The kittens were challenged with myxoma virus and the clinical signs of disease 
recorded. The strain of myxoma virus used, KM 13, was of grade III virulence and killed 
90% of inoculated wild rabbit kittens at the beginning of the study (Figure 1.7). After 
the fourth epidemic in the Lake Urana area, the mortality rate of challenged kittens had 
fallen to approximately 50%, and further decreased to approximately 26% by the 
seventh epidemic (Figure 1.7).
The development of resistance was also illustrated by the changes in the severity of 
clinical disease, with the proportion of infected rabbits exhibiting mild clinical 
symptoms increasing from 0-2% to 30% over the seven epidemics (Marshall and Fenner 
1958; Marshall and Douglas 1961; Fenner and Ratcliffe 1965). The decrease in severity 
of clinical signs as rabbits became increasingly resistant to myxomatosis was an 
important factor in the field, as rabbits with mild clinical signs were more likely to
23
Chapter 1- Introduction
90 , «
Number of epidemics
Figu re  1.7. Dev el op me nt  of  Resi sta nce  of  Wil d  Ra bb it s  t o  Myxoma to sis
The mortality rate of wild rabbit kittens from the Lake Urana area challenged with the KM 13 
strain of myxoma virus (grade III virulence) was determined. The mortality rate is expressed as 
a percentage of total number of rabbits tested (numbers above each column). Rabbits were 
caught and challenged after 2, 3, 4, 5 or 7 epidemics. Graph from Kerr and Best (1998) from 
data in Marshall and Fenner (1958) and Marshall and Douglas (1961).
avoid predator attack and less likely to succumb to dietary pressures during the 
progression of the disease, compared to rabbits with severe clinical signs, which may 
have survived in cage trials (reviewed in Kerr and Best 1998).
1.5.3 Co-evolution in Recent Years
Co-evolution between myxoma virus and the Australian wild rabbit is still occurring. 
Rabbit resistance has developed to the point where strains of myxoma virus with 
intermediate virulence, as judged in laboratory rabbit assays, are quickly controlled by 
the wild rabbit host. The mortality rate of the present day wild rabbits infected with 
grade I strains of myxoma virus, such as SLS, is often less than 50% (Kerr et al., 2003).
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For titres of myxoma virus to be maintained over the threshold for effective 
transmission in the skin of these rabbits, the virus has had to become increasingly 
virulent. This has been observed in recent years with the re-emergence in the field of 
myxoma virus strains of grade I virulence, as measured in naive laboratory rabbits 
(Saint et ah, 2001).
1.6 Int e r a c t io n s  Bet w een  t he  Eu r o pe a n  Ra b b it  a nd  My x o ma  
V ir us
The inherent resistance of an infected rabbit to myxomatosis combined with the 
virulence of the infecting myxoma virus strain, intercurrent disease and the environment 
will determine whether the rabbit restricts virus replication, clears the virus from its 
system and recovers from disease, or whether virus replication is unrestrained, the rabbit 
develops severe myxomatosis, fails to clear the virus and eventually dies. The outcome 
of this dynamic interaction is ultimately determined by the interaction of the host and 
pathogen at the cellular and molecular level.
1.6.1 Cell Permissivity for Virus Replication
All viruses require cellular resources for replication. If a virus cannot replicate in a cell 
then it will not survive in that host and subsequently will not be propagated to a new 
host. The ability of a virus to replicate in a cell, or the ability of the cell to allow virus 
replication, defines the permissivity of that cell to virus replication. The permissivity of 
a cell to virus replication is critical for virus propagation and for host-virus interactions. 
Differences in cell permissivity for virus replication are hypothesized as the mechanism 
for attenuation of some viruses and for host resistance to some viruses (Brinton et al., 
1998). Mechanisms of virus attenuation and of host resistance can affect one or more
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stages in the virus replication cycle. These stages include attachment of the virion to the 
cell membrane, entry of the virion into the cell, transcription of early and late viral 
genes, replication of the viral genome, virion assembly and maturation, and virion 
egress. If the virus cannot interact appropriately with cellular proteins and maintain the 
viability of the cell, then virus replication will be severely limited.
1.6.1.1 Cell Permissivity for Virus Replication: Considerations for 
Myxoma Virus Attenuation
A reduced ability of the virus to infect a host cell, due to changes in the envelope 
proteins of the virion, has been shown as the mechanism of attenuation for some 
viruses, including Japanese encephalitis virus (Ni and Barrett 1998), yellow fever virus 
(Dunster et ah, 1999), vaccinia virus (Dallo and Esteban 1987; Engelstad and Smith 
1993; McIntosh and Smith 1996; Mathew et ah, 1998) and tick-bourne encephalitis 
virus (Labuda et ah, 1994). Other attenuated viruses, such as attenuated avian-human 
influenza A virus, are able to gain entry into the cell but cannot effectively interact with 
the host cellular machinery (Snyder et ah, 1987) or, like Sendai virus, cannot prevent 
induction of cell death (apoptosis) on infection (Itoh et ah, 1998).
The ability of some Leporipoxviruses to replicate in infected rabbit lymphocytes in vitro 
has been shown to correlate with virus virulence in rabbits. Shope fibroma virus (SFV), 
which is highly attenuated in rabbits, does not replicate in rabbit lymphocytes in vitro as 
it cannot effectively inhibit virus-induced cellular apoptosis (Strayer et ah, 1985; Macen 
et ah, 1996). Additionally, recombinant myxoma viruses with one of MO 11 (M11L, 
Opgenorth et ah, 1992a; Macen et ah, 1996), M002 (MT2, Macen et ah, 1996), M004 
(MT4, Barry et ah, 1997) or M005 (MT5, Mossman et ah, 1996) ORFs deleted are all 
unable to replicate in rabbit lymphocytes; of these modified viruses all result in
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apoptosis in infected lymphocytes in vitro and are all highly attenuated in rabbits. 
Interestingly, all of these deletion mutants are able to replicate to similar levels to wild 
type virus in fibroblast cell lines and, for the M005 deletion virus, in monocytic cell 
lineages (Mossman et al., 1996). This suggests that it is the ability of Leporipoxviruses 
to replicate in lymphocytes that is critical for pathogenesis.
Investigation of replication of the virulent and attenuated strains of myxoma virus in 
vitro has been limited. Preliminary work has shown that both the virulent SLS and 
attenuated Ur strains of myxoma virus are able to infect and replicate in the rabbit CD4+ 
T-cell line, RL-5 (Dr P. Kerr, personal communication) and in primary rabbit 
lymphocytes (Best and Kerr 2000). However, significant differences between the two 
virus strains in their ability to replicate in these cells were not observed. These 
preliminary studies suggest that attenuation of the Ur strain of myxoma virus is not due 
to differences in replication. The details of these studies will be considered in more 
detail in Section 1.7 and in chapter 3. Thus, it is not known whether natural attenuation 
of myxoma virus is related to changes in the ability of the virus to infect and replicate in 
primary rabbit cells. - —
1.6.1.2 Cell Permissivity for Virus Replication: Considerations for 
Resistance to Myxomatosis
A change in cell permissivity to virus replication has also been postulated as a 
mechanism of host resistance to a virus (e.g. mice resistant to flavivirus infection, 
reviewed in Brinton and Nathanson 1981). Investigation of the permissivity of primary 
rabbit cells to myxoma virus replication in vitro is also limited. One study showed no 
difference in replication of the SLS strain of myxoma virus in primary fibroblast or 
lymphocytes from laboratory (susceptible) or wild (resistant) rabbits (Best and Kerr
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2000). However, differences in cell permissivity to virus replication may not have been 
detected because the cells were not stimulated with mitogen, which may increase 
permissivity. This will be further discussed in chapter 3 of this thesis. Any difference in 
the permissivity of a cell for virus replication may be sufficient for reduced virus 
replication and reduced expression of immunomodulatory proteins, which may help the 
host mount an effective anti-viral immune response and quickly control and clear the 
virus.
The current hypothesis for resistance of rabbits to myxomatosis is that the rabbit 
controls systemic spread of myxoma virus and reduces virus replication in distal tissues. 
This is hypothesized to be due to an enhanced effective, early innate immune response, 
controlling virus replication enough to allow development of an effective adaptive 
cellular immune response (Kerr and McFadden 2002). Any changes in the virus or in 
the permissivity of rabbit lymphocytes that decreases the ability of the virus to replicate 
may aid control of the virus by the rabbit and thereby contribute to resistance.
1.6.2 Host Response to Virus Infection
The mammalian immune response is made up of two interconnected systems; the innate 
and the adaptive immune responses. Both of these systems are activated on virus 
infection. The innate immune response can alter the permissivity of a cell to virus 
replication by production of interferon, whereas the adaptive immune response is, 
responsible for generating immunological memory. Both these responses aid the control 
and clearance of the virus by the host. The activities of the innate and adaptive immune 
responses require interaction and co-operation.
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1.6.2.1 The Innate Immune Response
The innate immune response is the first line of defense against pathogens and includes 
the physical barrier of the skin and mucous membranes as well as having a cellular 
component. Although the innate immune response is non-specific, its activity ultimately 
determines the specific, adaptive immune response (reviewed in Medzhitov and 
Janeway 1997). The innate immune response involves effector cells, such as natural 
killer (NK) cells, macrophages, neutrophils and the complement proteins (reviewed in 
Parkin and Cohen 2001).
The innate immune response has a variety of ways to combat virus infections. In the 
extracellular environment, complement proteins can opsonise virions thereby inducing 
their phagocytosis by macrophages and neutrophils (reviewed in Greenberg and 
Grinstein 2002; Uthaisangsook et al., 2002). If a virus is inside a cell, interferon (IFN) - 
y and tumor necrosis factor (TNF) can inhibit viral replication and TNF can directly kill 
some virus-infected cells (reviewed in Benedict et al., 2003). In addition, the type II 
interferons (IFNa and IFNß) are also key components of the anti-viral innate immune 
response and are secreted by fibroblasts and leukocytes.
Natural killer cells and macrophages are also able to directly kill virus-infected cells. 
The activity of these cells is regulated by a balance between stimulatory and inhibitory 
signals. The inhibitory signals are given by major histocompatibility complex (MHC) -I 
expression on the surface of cells (reviewed in Raulet et al., 2001; French and 
Yokoyama 2003). If a cell expresses abnormally low MF1C-I levels, which is common 
in virus infection, then NK cells will induce lysis of that cell. Natural killer cells induce 
apoptosis in their target cells by either formation of a pore in the target cell membrane 
and release of granzyme B into the cell or by signaling through the Fas receptor
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(reviewed in Parkin and Cohen 2001). Natural killer cells are activated by IFNa and 
IFNß, which are secreted by virus-infected cells (reviewed in Decker et al., 2002). 
Interferon-a and IFNß can also induce a non-permissive state in cells for virus 
replication (reviewed in Decker et al., 2002). Other cytokines also play roles in this 
response. On activation, NK cells secrete IFNy and interleukin (IL) -2. Interferon-y 
secretion by NK cells is increased by TNF and IL-12 (reviewed in Trinchieri 2003). 
Tumor necrosis factor also induces expression of the IL-2 receptor a-chain, which then 
enables IL-2 to stimulate NK cell proliferation and activation (reviewed in Parkin and -4 
Cohen 2001). The actions of the innate immune response result in a non-specific 
defense against the virus and, because of the general nature of the response, are often 
not sufficient to resolve virus infection. To provide a specific immune response against 
the virus, an adaptive immune response is activated. The activation of the adaptive 
immune response is aided by expression of cytokines during the innate immune 
response.
1.6.2.2 The Adaptive Immune Response
The adaptive immune response is a specific response against the invading pathogen and 
involves T- and B-cells. T-cells are activated by antigen presenting cells (APCs). Cells 
able to present antigen to effector cells include activated B-cells, dendritic cells and 
macrophages. APCs present antigen in association with MHC-I (expressed on all 
nucleated cells) or MHC-II (expressed on APCs cells). MHC-I presents peptides from 
processed antigen derived from the intracellular environment such as viral antigen, 
whereas MHC-II presents peptides from processed antigen derived from the 
extracellular environment, such as B-cell processed antigen or soluble toxins.
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Two major types of T-cells, cytotoxic T-lymphocytes (CTLs, CD8+ Tc-cells) and helper 
T-cells (CD4+ Th cells) have been identified in mice and similar subsets have been 
identified in other species, such as human. Cytotoxic T-lymphocytes recognize 
intracellular-derived antigen associated with MHC-I and respond by killing virus- 
infected cells, whereas Th cells recognize and respond to antigen in association with 
MHC-II and are involved in mediating interactions between cells of the immune system 
during an immune response (Santana and Rosenstein 2003). Activation of murine CD4+ 
T-cells leads to generation of TH1 or TH2 T-cell subsets (reviewed in Asnagli and 
Murphy 2001). The induction of a TH1 or TH2 immune response, by Th I and Th2 CD4+ 
T-cell subsets respectively, can determine the outcome of the virus/host interaction. 
Classification of Th cells into these subsets originated in mouse models and is a useful 
tool for categorizing immune responses. CD8+ T-cells have also been shown to 
differentiate into Tel and Tc2 sub-types based on cytokine secretion (reviewed in 
Parkin and Cohen 2001). The role of these subsets is still the subject of research.
Th cell subsets identified in mice are defined in Table 1.4. The immune response 
mediated by TH1 CD4+ T-cells is classified as the anti-viral cell-mediated immune 
response and is characterized by production of IFNy and IL-2 by activated Th I-cells 
(Santana and Rosenstein 2003). Interleukin-2 stimulates proliferation of T-cells and 
proliferation and functioning of NK cells (reviewed in Karupiah et al., 1990; Kuby 
1997). Interleukin-2 also promotes the differentiation of CD8+ T-cells into CTLs 
(reviewed in Parkin and Cohen 2001). As previously described, IFNy can inhibit virus 
replication in infected cells. IFNy can also enhance macrophage activity, increase MHC- 
I and MHC-II expression, thereby enhancing antigen presentation. IFNy inhibits the 
development of Th2 cells and the Th2 immune response.
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1.6 Interactions Between the European Rabbit and Myxoma Virus
The Th2 immune response primarily involves events leading to the production of 
antigen-specific antibodies (reviewed in Parkin and Cohen 2001). Activation of CD4+ 
Th2 cells leads to the production of IL-4, IL-5, IL-6, and IL-10 (Table 1.4) (reviewed in 
(Asnagli and Murphy 2001). IL-4, IL-5 and IL-6 stimulate the differentiation and 
proliferation of B-cells and, for IL-5, eosinophils (Parkin and Cohen 2001). Eosinophils 
are involved in protection against parasites. IL-4 also increases MHC-II expression on 
B-cells, enhances phagocytic activity and inhibits the Th I immune response. IL-10 
antagonizes the effects of TH1 cytokines such as IL-2 and IFNy and decreases MHC-II 
expression and cytokine production.
There is also evidence of a Th3 cytokine pattern produced by murine CD4+ T-cells 
(reviewed in Coffman and Romagnani 1999; Mosmann and Sad 1996). The Th3 
response has not been well documented, but is characterized by the secretion of 
transforming growth factor (TGF) -ß. TGFß has an anti-proliferative effect and inhibits 
leukocyte activation. CD4+ Th3 cells do not secrete IL-2, IFNy, IL-4 or IL-10 and 
inhibit both the Th I and Th2 immune responses (reviewed in Coffman and Romagnani 
1999; Mosmann and Sad 1996).
For viral infections, the overall aim of the adaptive immune response is to activate a 
response that is specific for the invading virus and that ultimately controls and clears the 
virus. The adaptive immune response also generates immunological memory so that 
subsequent infections will be more quickly controlled.
1.6.2.3 The Rabbit Immune System
Although the rabbit has been extensively used in immunology for production of anti-
sera, it has not been the animal of choice for delineation of immunological concepts
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with the majority of the data regarding the host immune response delineated using mice 
or in vitro assays. The ability to extensively examine the rabbit immune system and 
thereby determine the applicability of the murine and in vitro work to the rabbit, is 
severely hindered by the paucity of rabbit-specific reagents and the fact that inbred 
rabbits are not routinely available. However, it has been shown that the rabbit immune 
system is functionally similar to that of other mammals (reviewed in Mage 1998). The 
rabbit has a complement system and array of MHC antigens and leukocyte markers that 
are similar to those identified in mice and humans (reviewed in Mage 1998). The rabbit 
T-cell population has been shown to contain CD8+ and CD4+ T-cells. However, 
different to the mouse, rabbit peripheral blood leukocytes contain a population of cells 
that express both f- and B-cell markers. For example, both activated T-cells and B-cells 
express MHC-II (reviewed in Mage 1998). The importance of this for the rabbit 
immune system is not clear. However, generally it can be concluded that the rabbit 
immune response will involved similar activities to those described in Sections 1.6.2.1 
and 1.6.2.2.
1.6.2.4 T-cell Activation and Proliferation
Presentation of viral antigen by APCs to T-cells initiates interactions between a variety 
of immune cells and accessory molecules, leading to activation of multiple T-cell 
signaling pathways and transcription of genes involved in T-cell differentiation, 
proliferation and clonal expansion (Hollsberg 1999). The interaction of IL-2 with the 
IL-2 receptor is a key event in T-cell proliferation. The IL-2 receptor has three subunits 
that are not all continuously expressed. Expression of the a-subunit (CD25) is regulated 
by T-cell activation signals. Removal of these signals stops expression of CD25, thereby 
curtailing subsequent IL-2 signaling and cell proliferation (Cantrell and Smith 1984).
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Cell proliferation involves the progression of cells through the cell cycle. Figure 1.8 
shows the stages of the eukaryotic cell cycle, which have been elucidated by studying 
proliferation of yeast (reviewed in Bartek and Lukas 2001; Stewart and Pietenpol 2001). 
Quiescent cells are in GO phase of the cell cycle. If these cells are activated, they move 
into G1 phase where the cell prepares for DNA replication. The G1 checkpoint ensures 
there is no damaged DNA and that the environment is favorable for the cell to divide 
before the cell enters S phase (Stewart and Pietenpol, 2001). After DNA replication, 
which occurs in S phase, the cells enter G2 phase. G2 is the gap between DNA 
replication and mitosis (M). The G2 checkpoint ensures that all DNA has replicated 
successfully prior to cell division.
G2 Checkpoint
Is all DNA replicated?
Is cell large enough?
•Is environment favourable?
G1 Checkpoint
•Is cell large enough? 
•Is environment
favourable?
•Is DNA damaged?
Figur e  1.8. Th e  Euka ry o t ic  Cell  Cycle
The stages of the eukaryote cell cycle. Cell activation stimulates cells in GO to enter G1 phase. 
After the cells pass through the G1 checkpoint, S phase is entered. DNA replication occurs and 
then the cell enters G2. Passage through the G2 checkpoint leads to M phase (mitosis) and cell 
division. Figure adapted from Alberts et al. (1994).
35
Chapter 1- Introduction
Both the G1 and G2 checkpoints ensure that the cell is large enough to continue through 
the cell cycle. The role of cell size checkpoints in cell cycle progression of mammalian 
cells is unclear.
A recent study showed that Schwann cells (adherent neural cells) did not co-ordinate 
their growth with cell cycle progression (Conlon and Raff 2003). However, this finding 
may not apply to lymphocytes and other cells that can proliferate in suspension, 
coordinating cell growth with cell cycle progression as just described for yeast.
1.6.2.5 Apoptosis
Cell cycle progression is inextricably linked to programmed cell death (apoptosis) as 
failure of a cell to pass a checkpoint induces apoptosis (Kerr et al., 1972; Wyllie et al., 
1980). Apoptosis is also an essential part of the immune response through death of 
infected or unhealthy cells and by regulation of the immune system. There are three 
main phases of apoptosis: induction, effector and degradation. These are presented in 
Figure 1.9. Apoptosis can be induced through a ‘death receptor’, such as Fas or TNFR1, 
through CTL or NK cell activity or external stimuli such as cellular stress. Apoptosis is 
effected through proteolytic cascades involving caspases (cysteine proteases), 
cytochrome c and other death substrates (e.g. poly(ADP-ribose) polymerase, lamins, 
and cell cycle regulators). The effector stage commits the cell to apoptosis. Once the 
cell is committed to apoptosis, the degradation phase begins. This last phase leads to the 
morphological features of apoptosis, which are characterized by nucleolysis, 
chromatinolysis, proteolysis and cytolysis.
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Fig ur e  1.9. Apo pto s is
The three main phases of apoptosis- induction, effector and degradation, and the major factors 
involved in each is depicted. Induction of apoptosis can be through either interaction with a 
death receptor, cytotoxic (CTL) killing or external stimuli, such as virus infection. Apoptotic 
signals are transduced via caspases during the effector phase, leading to the degradation phase 
where the morphological changes of the cell are observed. Figure is adapted from Turner and 
Moyer (1998) and Everett and McFadden (2001).
The stage of the cell cycle that a cell is in determines its susceptibility to apoptosis 
(Buttyan et al., 1988; Colotta et al., 1992; Marti et al., 1994; Nishioka and Welsh 1994). 
Activation of various cyclins and cyclin-dependent kinases, which are proteins involved
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in cell cycle regulation and progression, have been shown to correlate with the onset of 
apoptosis (Shi et al., 1994; Meikrantz and Schlegel 1996; Yao et ah, 1996; Evan and 
Littlewood 1998; Guo and Hay 1999). There has recently been a report that the Fas- 
associated death domain protein (FADD) has an additional domain that is involved in 
cell proliferation. When this domain is altered it abolishes the cell’s ability to progress 
through the cell cycle but does not alter the cell’s ability to undergo apoptosis (Hua et 
al., 2003).
The previous experiences of the lymphocyte also appear to determine susceptibility to 
apoptosis. In one study, IL-2 stimulation of lymphocytes prior to activation through the 
T-cell receptor (i.e. naive T-cells) led to cell death, whereas IL-2 stimulation after 
activation through the T-cell receptor led to cell proliferation (Lenardo 1991).
1.6.2.6 Summary of Host Response to Virus Infection
An overview of the immune response generated by virus infection is shown in Figure 
1.10. Virus infection initiates both innate and adaptive immune responses. The innate 
response helps control virus replication by killing of virus-infected cells by NK cells 
and by production of factors, such as IFNa and IFNß, which induce an anti-viral state in 
cells. Infected cells can also undergo programmed cell death (apoptosis). The innate 
response ultimately determines the adaptive immune response as it is the first response 
the host initiates against the invading pathogen. The adaptive immune response against 
a virus involves activation of CD8+ T-cells, which directly kill infected cells and CD4+ 
T-cells, which differentiate into Th I or Th2 cell subsets. The Th I response activates NK 
cells and CD8+ T-cells and stimulates IFNy production. The Th2 response helps 
mediate the activity of B-cells and other APCs. Activation of these cells in turn helps
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anti-viral state
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from leukocytes and fibroblasts
Figur e  1.10. Host  Immu ne  Res po ns e  t o  Vir u s  Infection
On virus infection, the host responds through both the innate (red arrows) and adaptive (black 
arrows) immune responses. The innate response is non-specific and includes natural killer (NK) 
cells and cytokines, particularly interferons (IFNs), and acts to control virus infection prior to 
activation of the specific adaptive immune response. Induction of antigen-specific CD4+ T-cells 
during the adaptive immune response leads to generation of a TH1 or TH2 response. TH1 
response activates CD8+ T-cells. CD8" T-cells and NK cells non-specifically kill virus-infected 
cells. Virus-infected cells may also undergo apoptosis without CD8 T-cell or NK cell help. The 
Th2 response activates antigen presentation by antigen presenting cells (APC). APCs present 
extracellular and intracellular-derived viral antigen to T-cells. Activation of B-cells leads to 
production of virus-specific antibody, which can neutralise virus particles and generate 
immunological memory.
activate more T-cells through antigen presentation, and leads to antibody production and 
immunological memory.
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1.6.3 Specific Action of a Virus Against the Host Immune 
Response
The outcome of a vims infection is determined by the interaction between the vims and 
the cells of the host immune system. For poxvims infections, CD8+ T-cells, CD4+ T- 
cells, IFNy, nitric oxide and TNF are all involved in control of poxvims replication 
(Ruby and Ramshaw 1991; Sambhi et al., 1991; Kampiah et al., 1998) and in poxvirus 
clearance from the host (Spriggs et al., 1992; Karupiah et al., 1996; Karupiah 1998). 
The production of antigen-specific antibodies is not cmcial for control of poxvims 
infection but may be essential for complete clearance of the virus (Karupiah 1998).
An effective host anti-viral immune response has been postulated to be the mechanism 
of host resistance to some poxvimses. For example, various studies have postulated that 
resistance of inbred mouse strains to ectromelia vims infection is associated with an 
increased CTL-mediated immune response (O'Neill and Brenan 1987), early enhanced 
non-specific host defenses, such as NK cells and IFNa/ß (Jacoby et al., 1989) and 
induction of a Th I cytokine response as opposed to a Th2 cytokine response (Kampiah 
1998). Genetic analyses of mice resistant to ectromelia vims infection have determined 
that the main genetic component is in gene(s) within the natural killer gene complex 
(Delano and Brownstein 1995). In studies of other vimses early IFN production has 
been implicated in resistance of mice to encephalomyocarditis virus infection (Pozzetto 
and Gresser 1985) and herpes simplex vims type 2 infection (Pedersen et al., 1983).
Many viruses have evolved mechanisms to mediate, modify or survive the host anti-
viral immune response by directly interfering with the activity of the cells of the host 
immune system. For example, inhibition or inappropriate activation of T-cell 
proliferation or cellular apoptosis may have a drastic effect on the outcome of vims
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infection as these functions are central to the host anti-viral immune response. Some of 
the mechanisms developed by viruses to interfere with T-cell proliferation and cellular 
apoptosis will be described in the following sections.
1.6.3.1 T-cell Proliferation and Virus Infection
Inhibition of T-cell proliferation leads to improper T-cell functioning and 
immunosuppression. Viruses can abrogate cell proliferation by arresting the cell cycle. 
For example, herpes simplex virus type I arrests cells at the Gl/S boundary in growing 
cells and entry to G1 in quiescent cells, by degrading a component of human 
kinetochores (Lomonte and Everett 1999) and by inhibiting the increase in cyclin D1 
and D3, which are involved in progression through G1 (Ehmann et al., 2000; Song et 
al., 2000). Measles virus (Schnorr et al., 1997; Engelking et al., 1999), bovine 
herpesvirus type 1 (Hanon et al., 1997) and human papilloma virus (Wiman 1993; Lee 
and Cho 2002) arrest cells in the G1 or GO stage of the cell cycle.
Other viruses have been shown to alter T-cell function by stimulating cell cycle 
progression. For example, productive HIV-I replication requires T-cell proliferation 
(Forsdyke 1991), as non-dividing (GO) T-cells restrict virus replication at a stage prior 
to import of viral DNA into the nucleus (Stevenson et al., 1995). Adenovirus, 
herpesviruses and human papillomavirus have also been shown to stimulate cell cycle 
progression by either inhibiting the activity of negative cell cycle regulators or by 
enhancing the activity of positive cell cycle regulators (reviewed in Swanton and Jones 
2001).
Poxviruses have been shown to alter T-cell function by either stimulating or inhibiting 
T-cell proliferation. For example, inactivated parapox virus stimulates proliferation of
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CD4+ T-cells leading to increased production of the Th I anti-viral cytokines IL-2, TNF 
and IFNy (Fachinger et al., 2000). Malignant rabbit fibroma virus (MRV), a 
recombinant between SFV and myxoma virus, suppresses T-cell proliferation (Strayer 
et al., 1983; Strayer et al., 1986a; Strayer et al., 1986b; Strayer and Leibowitz 1986; 
Heard et al., 1990). This suppression has been postulated to be due to a T-cell derived 
factor that stimulates T-cell suppression mechanisms. The MRV-induced suppression of 
lymphocyte proliferation is postulated to be directly related to the ability of MRV to 
replicate in lymphocytes (Strayer et al., 1985; Stern et al., 1997; Heard et al., 1990).
Other poxviruses can inhibit or stimulate lymphoid cell proliferation depending on the 
system studied. Vaccinia virus has been shown to transiently inhibit proliferation of 
peripheral blood mononuclear cells (Mathew et al., 2000) and stimulate proliferation of 
human leukocytes (McFarland et al., 1980) and rabbit B- and T-cells (Elfenbein and 
Rosenberg 1973). Fowlpoxvirus can also stimulate proliferation of epithelial cell lines 
(Tanizaki et al., 1989), whereas variola virus inhibits proliferation of epithelial cell lines 
(Ono and Kato 1968).
1.6.3.2 Apoptosis and Virus Infection
Apoptosis can be initiated by an infected cell (i.e. cell suicide), or can be induced in 
virus-infected cells by CTLs or NK cells. Many viruses have evolved mechanisms to 
either inhibit or stimulate apoptosis. By inhibiting apoptosis, and therefore keeping the 
host cell alive, a virus will prolong the period it has to replicate and produce infectous 
progeny. On the other hand, induction of apoptosis by a virus may assist disseminaion 
of the virus, by freeing intracellular virions (reviewed in McFadden and Barry 1°98; 
Everett and McFadden 1999). Apoptosis may also aid suppression of the antiviral 
immune response, as phagocytic cells are induced to secrete immunosuppressive
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factors, such as IL-10, on engulfment of apoptotic cells (Voll et al., 1997) and apoptotic 
cells themselves secrete TGF-ß which inhibits Th I and Th2 responses (Chen et al., 
2001).
There are a number of different viral mechanisms to mediate apoptosis. Homologs of 
the apoptosis inhibitor, Bcl-2, are encoded by Epstein Barr virus (BHRF-1) (Henderson 
et al., 1993), adenovirus (E1B-19K) (Rao et al., 1992) and African swine fever virus 
(A179L/5-HL) (Brun et al., 1996). Inhibitors of caspase activity are encoded by African 
swine fever virus (A224L/4CL) (Nogal et al., 2001) and baculoviruses (p35, IAP) 
(Bertin et al., 1996; Zoog et al., 1999). Poxviruses also encode a variety of anti- 
apoptotic factors, such as serpins and caspase inhibitors. Those encoded by myxoma 
virus will be described in Section 1.6.4.1. Extensive reviews of other virus-encoded 
anti-apoptotic factors can be found in Collins (1995), Razvi and Welsh (1995), Everett 
and McFadden (1999) and Roulston et al. (1999).
1,6.4 Immunomodulation by Myxoma Virus
Myxoma virus encodes proteins that interfere with the innate and adaptive immune _ 
responses, cell proliferation and apoptosis. Table 1.5 summarizes the putative 
immunomodulatory, anti-apoptotic or host-range proteins identified by Cameron et al. 
(1999), their promotor type (early, intermediate or late), conservation between different 
poxviruses and predicted cellular localization. These characteristics determine when and 
where virus-encoded proteins act and suggest potential roles during myxoma virus 
pathogenesis. Myxoma virus immunomodulatory proteins include growth factors as 
well as proteins that interfere with antigen presentation, recognition and co-stimulation. 
These have been recently reviewed by Kerr and McFadden (2002), Zuniga (2002) and 
Everett and McFadden (2002).
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T a b l e  1 .5 .  I m m u n o m o d u l a t o r y , 
E n c o d e d  b y  M y x o m a  V i r u s
A n t i - a p o p t o t i c a n d  H o s t - R a n g e  P r o t e i n s
o r f * P r o m o t o r
T y p e
C o n s e r v a t io n  
w it h in  p o x v ir u s e s
P r e d ic t e d
L o c a l iz a t io n
P u t a t iv e  F u n c t io n /  S tr u c t u r e  
o f  P r o t e in
M 001 E arly se m i-co n se rv e d ex trace llu la r c h em o k in e  b in d in g  p ro te in
M 0 0 2 E arly se m i-co n se rv e d e x trace llu la r  /  
in tra ce llu la r
T N F  re cep to r  h o m o lo g  
a p o p to s is  reg u la to r
M 0 0 4
7 ,
E arly se m i-co n se rv e d e n d o p la sm ic
re ticu lu m
a p o p to s is  reg u la to r  
R D E L  m o tif
M 0 0 5 E arly se m i-co n se rv e d c y to p la sm ic ap o p to s is  reg u la to r  
an k y rin -lik e , h o st-ran g e  
R N ase3  do m ain
M 0 0 7 E arly se m i-co n se rv e d e x trace llu la r IFN y recep to r  h o m o lo g , a -c h a in
M 0 0 8 .1 L ate un iq u e ex trace llu la r an ti- in f lam m ato ry  se rp in
M 0 1 0 E arly se m i-co n se rv e d ex trace llu la r E G F -lik e  g ro w th  fac to r
M 011 E arly se m i-co n se rv e d in teg ra l m em b ran e  
p ro te in
ap o p to s is  reg u la to r
M 0 2 9 E arly se m i-co n se rv e d cy to p la sm ic IF N -re s is tan ce  
P K R  in h ib ito r 
h o st-ran g e
M 0 6 2 E arly se m i-co n se rv e d cy to p la sm ic v iru le n ce  fac to r, h o s t-ran g e
M 0 6 3 E arly se m i-co n se rv e d u n k n o w n a p o p to s is  reg u la to r, h o s t-ran g e  
D A X X -lik e  m o tif
M 0 6 4 E arly se m i-co n se rv e d cy to p la sm ic h o st-ran g e , v iru le n ce  fac to r
M l  04 L ate se m i-co n se rv e d tran sm em b ran e recep to r-lik e  f rag m en t
M 121 E arly se m i-co n se rv e d tran sm em b ran e
(E E V ?)
N K  cell re cep to r  h o m o lo g  
E E V  g ly co p ro te in  
C -ty p e  lec tin
M l  22 L ate se m i-co n se rv e d tran sm em b ran e
(E E V ?)
N K  cell re cep to r  h o m o lo g  
E E V  g ly co p ro te in  
C -ty p e  lec tin  d o m ain
M l  28 E arly ? u n ique tran sm em b ran e C D 4 7  h o m o lo g  ( in te g rin -a sso c ia ted  p ro te in )
M l  35 E arly se m i-co n se rv e d tra n sm e m b ra n e /
e x trace llu la r
I L - l / IL -6  recep to r-lik e
M 141 E arly u n iq u e tra n sm e m b ra n e O X -2  h o m o lo g  
im m u n o g lo b u lin  d o m ain
M l  43 L ate se m i-co n se rv e d cy to p la sm ic a p o p to s is  reg u la to r  
z in c  r in g  fin g e r p ro te in
M l  44 E arly ? se m i-co n se rv e d tra n sm e m b ra n e c o m p lem en t co n tro l p ro te in  h o m o lo g  
C D 4 6  h o m o lo g
M l  46 E arly ? se m i-co n se rv e d c y to p la sm ic? n o n essen tia l v iru le n ce  fac to r
M 1 4 8 E arly se m i-co n se rv e d cy to p la sm ic? a n k y rin -lik e , h o st-ran g e
M l  49 E arly u n ique cy to p la sm ic a n k y rin -lik e , h o st-ran g e
M l  50 E arly un iq u e cy to p la sm ic an k y rin -lik e , h o st-ran g e
M 151 E arly se m i-co n se rv e d cy to p la sm ic se rp in
ap o p to s is  reg u la to r
M l  52 E arly ? u n ique cy to p la sm ic Z in c  finger 
R N A  b in d in g  
se rp  in-1 ike
M l  56 L ate se m i-co n se rv e d cy to p la sm ic in te rfe ro n  re s is tan ce  
S I  R N A  b in d in g  
e - IF 2 a  h o m o lo g
* Open reading frames (ORFs) encoding proteins with putative immunomodulatory function are 
shown in red. ORFs encoding proteins with putative functions designated as anti-apoptotic or 
host-range are shown in blue. Host-range proteins mediate the interaction between viral and 
cellular proteins. Information in table taken from Cameron et al. (1999).
Figure 1.11 shows the steps in the host immune response with which some of these 
virus-encoded proteins interfere. Examples of these factors include NK cell receptor
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M005 -apoptosis regulator 
M011 -apoptosis regulator 
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of virus-infected 
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029 -IFN resistance to
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F i g u r e  1.11. In t e r a c t i o n s  b e t w e e n  t h e  H o s t  Im m u n e  Re s po n s e  a n d  My x o m a  
V i r u s
The cells involved in the host immune response, as described in Figure 1.10, are shown. Myxoma 
virus encodes factors that interfere with many of these pathways. In particular myxoma virus 
putatively encodes NK cell receptor homologs and proteins involved in IFN resistance. This 
disrupts the innate immune response. Myxoma virus also encodes homologs to receptors for 
cytokines, which help inhibit both TH1 and TH2 responses. In addition, myxoma virus interferes 
with antigen presentation by down-regulating MHC-I and CD4 on the surface of infected cells. 
Myxoma virus interferes with apoptosis by encoding a variety of anti-apoptotic factors.
homologs, cytokine and chemokine receptor homologs, anti-inflammatory and anti- 
apoptotic proteins, such as serine proteinase inhibitors (serpins) and caspase inhibitors. 
Relevant to this thesis are the anti-apoptotic and host-range proteins and the down- 
regulation of host proteins, which are described in the next section.
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1.6.4.1 Anti-Apoptotic and Host-Range Factors
The list of anti-apoptotic factors identified in the myxoma virus genome by Cameron et 
al. (1999) includes so called ‘host-range’ proteins. Host-range proteins are postulated to 
mediate the interaction between viral and cellular proteins and, therefore, determine cell 
permissivity for viral replication or cell-type able to be infected, rather than species 
specificity. If the interactions between virus and host proteins fail, due to a defective 
gene for example, apoptosis may be induced. It is for this reason that they are included 
with anti-apoptotic factors. Some putative myxoma virus host-range proteins have been 
identified based on homology to host-range proteins from other species, although none 
of these has been extensively studied. The following sections describe the current 
knowledge of myxoma virus-encoded proteins with anti-apoptotic or host-range 
function.
1.6.4.1.1 M002
The M002 (MT-2) gene encodes a TNF receptor homolog in addition to having an anti- 
apoptotic domain. Truncated versions of M002 that are unable to bind TNFa are still 
able to prevent apoptosis, suggesting that these functions are distinct and spatially 
separated in the native protein (Schreiber et al., 1997). M002 acts intracellularly to 
block apoptosis. In vitro, the M002 deletion virus induced apoptosis of infected RL-5 
cells and non-adherent leukocytes, but not adherent leukocytes, such as monocytes and 
macrophages (Macen et al., 1996). This suggests that M002 plays a role in maintaining 
the viability of infected monocytes and macrophages.
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1.6.4.1.2 M004
The myxoma virus M004 (M-T4) gene is encoded under the control of an early 
promotor and its protein product localizes to the endoplasmic reticulum (ER) (Cameron 
et al., 1999). The ER retention-like sequence -RDEL (Arg, Asp, Glut, Leu) in M004 is 
not essential for ER retention, but its presence increases the biological half-life of M004 
(Hnatiuk et ah, 1999). Infection of the RL-5 cell line or primary rabbit peripheral blood 
lymphocytes with the M004 deletion virus results in the rapid induction of apoptosis 
when compared to wild type virus (Barry et al., 1997). Apoptosis of rabbit peripheral 
blood mononuclear cells will limit spread of myxoma virus as these cells are involved in 
virus dissemination. This may account for failure of the M004 deletion virus to produce 
secondary lesions in vivo (Barry et al., 1997).
1.6.4.1.3 M005
M005 (M-T5) acts early in infection to prevent apoptosis. This protein contains seven 
ankyrin repeat domains. Ankyrin domains are involved in protein-protein interactions 
and protein folding (Lambert et al., 1990). Infection of RL-5 cells with recombinant 
virus in which both copies of the M005 gene have been disrupted, abrogates host and 
viral protein synthesis, leading to apoptosis of these cells (Mossman et al., 1996). 
Apoptosis did not occur in adherent monocyte or primary rabbit fibroblast cell cultures 
infected with M005 deletion virus suggesting that M005 is critical for infection of 
lymphocytes. In vivo studies with the M005 deletion virus showed a greatly reduced 
formation of secondary lesions, suggesting the M005 deletion virus was not capable of 
systemic dissemination (Mossman et al., 1996). This was postulated to be due to the 
rapid induction of apoptosis of infected lymphocytes and an effective immune response 
at the inoculation site (Mossman et al., 1996).
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1.6.4.1.4 M011
The MO 11 gene product, M11L, is a type II transmembrane protein that is targeted to 
the mitochondria (Everett et al., 2000). It is expressed early in infection and has 
important anti-apoptotic and anti-inflammatory activity (Opgenorth et al., 1992a; 
Cameron et al., 1999). In vitro, infection of RL-5 cells and cells of the 
monocyte/macrophage lineage with the M011 deletion virus resulted in apoptosis with 
extensive DNA fragmentation (Macen et al., 1996; Everett et al., 2000). Further studies 
revealed the M011 protein blocks staurosporine-induced apoptosis by preventing 
mitochondrial permeability transition (Everett et al., 2000). In vivo, the M011 deletion 
virus decreased cellular proliferation and hemorrhage in primary lesions, but increased 
edema and leukocyte infiltration compared to wild type virus (Opgenorth et al., 1992). 
The M011 deletion virus is highly attenuated in vivo. These results suggest that M011 
helps to inhibit the pro-inflammatory response by inhibiting apoptosis of infected 
leukocytes.
1.6.4.1.5 M151
M l51 (SERP-2), the second of three putative serpins encoded by myxoma virus, is 
expressed intracellularly, early in infection (Petit et al., 1996). The M l51 deletion virus 
is attenuated in vivo compared to wild type virus (Messud-Petit et al., 1998). Elevated 
levels of apoptosis in lymph nodes draining the inoculation site and a greater 
inflammatory response were also observed in rabbits infected with the M l51 deletion 
virus. This protein binds human interleukin-1 ß converting enzyme (ICE), tlereby 
preventing the processing of pro-IL-lß to IL-lß in vitro. M l51 also inhibits grarzyme 
B (Turner and Moyer 1998). However, biochemical studies have shown that
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Ml 51 is only a weak inhibitor of ICE and granzyme B in vitro (Turner et al., 1999). A 
recombinant cowpox virus with the myxoma virus M l51 gene does not block apoptosis 
in cowpox virus-infected cells (Turner et al., 1999), indicating M l51 activity is specific 
to myxoma virus infection.
1.6.4.2 Additional Immunomodulatory Functions
Myxoma virus also circumvents the rabbit immune response by down-regulating key 
proteins involved in antigen presentation and co-stimulation. For example, CD4 
expression was down-regulated from the surface of RL-5 cells infected with myxoma 
virus (Barry et al., 1995). During infection, CD4 is targeted to lysosomes by the 
myxoma virus-encoded ubiquitin ligase, MV-LAP, where it is subsequently degraded 
(Mansouri et al., 2003). The MV-LAP ORF was identified in the T1 strain of myxoma 
virus by Guerin et al. (2002), 621 bp downstream of M l52. It is a combination of the 
M l53 and M l53.1 ORF identified in Lu by Cameron et al. (1999). This latter group 
subsequently re-sequenced this area of the Lu genome and found that the complete MV- 
LAP ORF was also present in Lu (Mansouri et al., 2003). Down-regulation of CD4 on 
infected Th cells potentially inhibits both the cell-mediated and antibody-mediated 
immune responses as CD4 is not available for appropriate CD4+ Th cell functioning. 
This may potentially cause T-cells and B-cells to become anergic, due to the lack of co-
stimulation, and would drastically disrupt the anti-viral immune response (Mueller and 
Jenkins 1995; Schwartz 1997).
Myxoma virus also induces the endosomal/lysosomal degradation of MHC-I (Zuniga et 
al., 1999). This viral-induced degradation is not only of cell surface MHC-I, but also of 
intracellular post-Golgi MHC-I associated with ß2-microglobulin. Even though MHC-I 
down-regulation is not observed until late in infection (Zuniga et al., 1999), it is
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mediated by MV-LAP (Guerin et al., 2002). The degradation of MHC-I has been 
postulated to provide myxoma virus with a means of reducing MHC-I molecules that 
are associated with processed viral proteins (Zuniga et al., 1999), and thus inhibiting 
recognition of virus-infected cells by CD8+ T-cells.
The action of MV-LAP has been proposed to help protect the infected cells from 
immune surveillance (Guerin et al., 2002). The MV-LAP deletion virus induces fewer 
secondary lesions, indicating decreased virus dissemination, and milder respiratory 
complications compared to infection with wild type virus. In addition, the inoculation 
site of infected rabbits had a predominantly monocytic immune response compared to a 
predominately polymorph response in wild type virus infections. MV-LAP also down- 
regulated CD95 (Fas) molecules in vitro (Guerin et al., 2002) but a change in 
lymphocyte apoptosis, as measured by the TUNEL assay, was not observed during in 
vivo infections of the MV-LAP deletion virus (Guerin et al., 2002).
1.6.4.3 Summary
Myxoma virus encodes 27 predicted immunomodulatory, anti-apoptotic or host-range 
proteins, examples of those with anti-apoptotic or host-range functions are described 
above. These experiments show that deletion of only a single gene can dramatically 
alter myxoma virus virulence, indicating the complexity of the interactions between host 
and virus. However, entire genes do not have to be deleted to alter the outcome of 
infection. Small changes in immunomodulatory proteins, or the regulation of their 
products, rendering them non-functional or semi-functional, may also have drastic 
consequences on the outcome of infection.
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Ultimately the interaction between myxoma virus and the host rabbit leads to either 
myxoma virus producing enough infectious progeny and immunomodulatory factors to 
overcome the host immune response, or the host immune response controlling the extent 
of virus replication leading to virus control and clearance. These factors are determined 
by both the characteristics of the virus and the ability of the host rabbit’s cells to sustain 
virus replication.
1.7 Ly mpho id  Ce l l s  in My xo ma  V ir us  Pa t h o g e n e s is
Lymphoid cells are the key effectors of the immune system and are central to effective 
functioning of the anti-viral immune response, as they are involved in cytotoxic killing 
of virus-infected cells and are involved in regulating the immune response through 
production of cytokines and other molecules (Section 1.6.2). Leukocytes and lymphoid 
tissues have been identified as important for in vivo amplification and dissemination 
(Fenner and Woodroofe 1953; Best and Kerr 2000) and are one of the major sites of 
pathology during myxoma virus infection (Hurst 1937; Best et al., 2000). Additionally, 
it has also been shown that myxoma virus is able to infect and replicate in the rabbit 
CD4+ T-cell line, RL-5 (Barry et ah, 1995; Macen et ah, 1996; Barry et ah, 1997), and 
that myxoma virus localizes to the T-cell zones of rabbit lymph nodes during in vivo 
infection (Best et ah, 2000). These results suggest an important role for T-cells in 
myxoma virus pathogenesis.
Myxoma virus inhibits T-cell action by encoding immunomodulatory factors that 
compromise cytokine and chemokine networks and other lymphocyte effector functions 
(Section 1.6.4). Best (1998) has also shown that lymphoid cells isolated from 
susceptible rabbits infected with virulent myxoma virus did not proliferate in response 
to the T-cell specific mitogens Concanavalin A (Con A) and phytohaemagglutinin
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(PHA). However, response to the B-cell mitogen, lipopolysaccharide (LPS), was 
unchanged. Infection of laboratory rabbits with the attenuated Ur strain of myxoma 
virus did not affect the response of lymphoid cells to stimulation in vitro with T-cell 
mitogens. It is unknown whether a similar effect on T-cell responsiveness is observed in 
rabbits resistant to myxomatosis. The mechanism of suppression of T-cell 
responsiveness is also unknown but may involve one of the many immunomodulatory 
proteins encoded by this virus, or, similarly to MRV, may involve a T-cell-derived 
suppressive factor (Section 1.6.3.1).
Activity of the lymphoid cells may also contribute to myxoma virus attenuation. In vivo 
dissemination of the attenuated Ur strain of myxoma virus from the lymph node 
draining the inoculation site to distal tissues is delayed compared to virulent SLS (Best 
and Kerr 2000). Systemic dissemination has been postulated to involve T-cells as well 
as monocytes and macrophages (Best et al., 2000; Best and Kerr 2000). In addition, 
Best et al. (2000) showed differences in the pathology of the draining lymph node 
between SLS and Ur infection of laboratory rabbits. In SLS-infections, apoptosis of 
uninfected lymphocytes was observed 4-6 days post infection and there was a failure to 
repopulate the node, whereas in Ur infections of laboratory rabbits, the node was 
repopulated and apoptosis was only prominent from 6 days post infection. The reduced 
dissemination of Ur may be hypothesized to be due to Ur being unable to replicate as 
efficiently in lymphocytes and therefore unable to control the host anti-viral immune 
response.
Lymphoid cells may also be involved in resistance to myxomatosis as control of 
myxoma virus replication by wild rabbits is first evident at the lymph node draining the 
inoculation site. Infection of resistant rabbits with the virulent SLS strain of myxoma
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virus has been shown to result in a significantly reduced viral titre in the lymph node 
draining the inoculation site when compared to susceptible laboratory rabbits, even 
though virus reached the draining lymph node at similar times (Best and Kerr 2000). A 
decrease in dissemination of virus to distal tissues, as measured by virus titre, was also 
observed in wild rabbits compared to laboratory rabbits. In this case lymphocytes from 
wild rabbits may effectively control virus replication leading to the host being able to 
mount an effective immune response against the virus.
1.8 Summa r y  an d  A ims o f  th is  St u d y
The mechanisms for attenuation of myxoma virus and resistance to myxoma virus are 
still unclear but recent studies have implicated a major role for lymphoid cells. 
Extensive study of the effects of myxoma virus infection on primary lymphoid cells 
from resistant rabbits has not previously been undertaken. The goal of this thesis is to 
investigate the role of lymphoid cells in attenuation of myxoma virus and resistance to 
myxomatosis. This was carried out by isolating lymphoid cells from susceptible 
(laboratory) and resistant (wild) rabbits and infecting the cell cultures in vitro with the 
virulent SLS or attenuated Ur strains of myxoma virus and examining the subsequent 
interactions.
Firstly, lymphoid cell permissivity for myxoma virus replication was examined to 
determine whether this is a critical factor in resistance of wild rabbits to myxoma virus 
or in attenuation of the Ur strain of myxoma virus. The requirement for cell activation 
for cellular permissivity for virus replication was analyzed by addition of a T-cell 
mitogen to the cell cultures. These results are described in chapter 3.
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As apoptosis was a major feature of all infections from the Best et al. (2000) study and 
has been postulated to play a role in attenuation and resistance, the cell cycle was 
examined in infected cell cultures (chapter 4). The genetic basic for the cell death that 
was observed in Ur infections from examination of the cell cycle was investigated by 
sequencing viral genes with putative anti-apoptotic functions and looking for mutations 
that may be responsible for changes in apoptosis.
The role of activation of lymphoid cells in myxoma virus pathogenesis was revisited in 
chapter 5, by analysis of expression of cell surface proteins critical for the immune 
response.
Chapter 6 details production and characterization of anti-rabbit cytokine antibodies. The 
early innate immune response has been postulated as important for resistance to 
myxoma virus. The ability to undertake immunological studies in rabbits is limited due 
to the paucity of rabbit specific reagents and the fact that inbred rabbits are not 
available. The antibodies produced in chapter 6 were used to characterize the cytokine 
production during myxoma virus infection. ...
The results obtained in this thesis will help clarify the cellular and molecular 
mechanisms of host/virus co-evolution.
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Chapter 2- Materials and Methods
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2.1 Ce l l s  a nd  The ir  Cult ure
2.1.1 Cells and Cell Lines
The rabbit kidney cell line, RK.13 (ATCC- CCL-37) was used to produce working 
stocks of the Standard Laboratory Strain (SLS) and Uriarra (Ur) strain of myxoma virus. 
The African green monkey kidney cell line, Vero (ATCC- CCL-81) was used to titre 
virus stocks and during analysis of myxoma virus replication.
Primary rabbit lymphoid cells, prepared from rabbit lymph node, and the rabbit T-cell 
line, RL-5 (obtained from Dr I. Ramshaw, JCSMR, Canberra, Australia) (Kaschka- 
Dierich et al., 1982; Wilkinson et al., 1992), were used to examine the effects of 
myxoma virus infection on rabbit lymphoid cells.
COS-7 cells (green monkey kidney cell line) (ATCC- CRL-1651) were used for 
expression of proteins from plasmid DNA.
2.1.2 Cell Culture Media
RK13 and Vero cells were cultured in minimal essential medium (MEM, Life 
Technologies) supplemented with 10% fetal calf serum (FSC) (CSL, Melbourne 
Australia), 2 mM L-glutamine (Invitrogen), 0.225% NaHC03  (Merck), 60 pg/ml 
penicillin G (CSL), 100 pg/ml streptomycin (ICN) and 250 ng/ml amphotericin 
(GibcoBRL). In this thesis, MEM containing all supplements is referred to as ‘complete 
MEM’.
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RL-5 cells and primary rabbit lymphoid cells were cultured in RPMI 1640 medium 
(JCSMR Media Facilities, Canberra, Australia) supplemented with 10% FCS, 2 mM L- 
glutamine, 0.17% ß-mercaptoethanol (Sigma), 60 pg/ml penicillin, 100 pg/ml 
streptomycin and 250 ng/ml amphotericin. Supplemented RPMI 1640 is referred to in 
this thesis as complete RPMI 1640.
COS-7 cells were grown in DMEM media (JCSMR Media Facilities, ANU) 
supplemented with 10% FCS, 2 mM L-glutamine, 10 mM HEPES (Sigma), 0.17% ß- 
mercaptoethanol, 60 pg/ml penicillin, 100 pg/ml streptomycin and 250 ng/ml 
amphotericin. In this thesis, DMEM with all these supplements is referred to as 
complete DMEM.
2.1.3 Reconstitution of Cell Lines
Aliquots of RK13, Vero, RL-5 and COS-7 cells, stored in 20% dimethyl sulphoxide 
(DMSO) (Sigma)/ 80% FCS in liquid nitrogen, were thawed at 37°C for 1-2 min, after 
which 1 ml of complete MEM (RK13, Vero), complete RPMI 1640 (RL-5), or complete 
DMEM (COS-7), warmed to 37°C, was added to the cell suspension. The cells were 
then transferred to a 15 ml tube and an additional 10 ml of warm media was gradually 
added over 5 min to each tube. The cells were centrifuged at 270xg for 5 min, and 
washed once with 10 ml of warm media. After a final resuspension in warm media, the 
cells were transferred to a tissue culture flask which was incubated overnight in a 
humidified incubator at 37°C and 5% CO2 in air. Cell cultures were checked every day 
and sub-cultured when confluent as described in Section 2.1.4 (RK13, Vero and COS-7 
cells) or Section 2.1.5 (RL-5 cells).
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2.1.4 Sub-culturing of RK13, Vero and COS-7 Cell Lines
RK13, Vero and COS-7 cells are adherent cell lines. For sub-culturing, the cell 
monolayers were washed twice with trypsin diluent (140mM NaCl (BDFI), 5 mM KC1 
(Ajax Chemicals), 0.4 mM Na2HP0 4  (BDH), 0.4 mM KH2PO4 (Ajax Chemicals), 0.3 
mM K2EDTA (Ajax Chemicals), 6 mM NaHC0 3 , pH 7.3). After washing, the cell 
monolayers were covered with a thin layer of 0.04% trypsin (Sigma) in trypsin diluent 
and incubated for 5-10 min at 37°C to detach the cells from the flask. The resulting cell 
suspension was transferred to a 50 ml tube containing 10 ml of complete MEM (RK13 
and Vero) or complete DMEM (COS-7) and centrifuged at 270xg for 5 min. The cell 
pellet was resuspended in complete MEM (RK13 and Vero) or complete DMEM (COS- 
7). The concentration of the cells was determined using a haemocytometer. An 
appropriate number of cells, depending on the size of the flask required, were seeded 
into a new flask and the cells incubated in a humidified incubator at 37°C and 5% CO2 
in air.
2.1.5 Sub-culturinq RL-5 Cells
RL-5 cells are suspension cells, but cell cultures have a significant proportion of cells 
adhering to the bottom of tissue culture flasks. For this reason, flasks containing RL-5 
cells were first incubated at 4°C for approximately 30 min prior to harvesting in order to 
detach the adherent cells. Cell cultures were then decanted and centrifuged at 270xg for 
5 min and the cell pellet resuspended in complete RPMI 1640. An appropriate volume 
of cells, depending on the size of the tissue culture flask required, was then transferred 
to a new flask and the cells incubated in a humidified incubator at 37°C and 5% CO2 in 
air. RL-5 cells were sub-cultured the day before they were used for an experiment to
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ensure that actively replicating cells were used in experiments. This also helped to 
prevent inconsistencies in results due to cells in different stages of growth.
2.1.6 Preparation of Primary Lymphoid Cell Culture from Rabbit 
Lymph Nodes
2.1.6.1 Rabbit Breeds and Housing
Laboratory European rabbits (Oryctolagus cuniculus) and Australian wild rabbits 
{Oryctolagus cuniculus) were bred and housed at the CSIRO Gungahlin animal house 
facility. The wild rabbits used as breeding stock were captured from the field and 
confirmed as naive to myxoma virus. All wild rabbits used in this thesis were three 
generations removed from the field and, as such, neither the experimental rabbits nor 
their direct parents had been exposed to myxoma virus. Details of housing and care are 
given elsewhere (Best and Kerr 2000). All animal work followed ANU and 
CSIRO/NHMRC guidelines for animal usage and was approved by the CSIRO 
Sustainable Ecosystems Animal Ethics Committee. In this thesis, ‘susceptible rabbits’ 
are laboratory rabbits and ‘resistant rabbits’ are wild rabbits.
2.1.6.2 Preparation of Rabbit Lymphoid Cell Cultures
Lymphoid cell preparations were made from the popliteal lymph nodes o f laboratory
and wild rabbits (Kruisbeck 1993). Lymph nodes were dissected from the rabbit and 
any adherent, non-lymphoid tissue was removed. Each lymph node was cut into small 
pieces and passed through a 50 pm steel mesh using a glass pestle, in order to break up 
clumps ol cells. The steel mesh had been pre-wet with RPMI 1640. To optimize the 
number of cells obtained from the lymph nodes, 50 ml o f  RPMI 1640 was poured 
through the mesh. The
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cell suspension obtained after this process was centrifuged at 270xg for 5 min, 
resuspended in 10 ml of RPMI 1640 and centrifuged again at 270xg for 5 min. The cells 
were washed twice with RPMI 1640 after which they were resuspended in 5 ml of 
complete RPMI 1640 and transferred to a T25 tissue culture flask (Life Technologies). 
The rabbit lymphoid cell cultures were incubated overnight in a humidified incubator at 
37°C and 5% CO2 in air. The following day the cells in suspension were removed and 
the viability of the lymphoid cells was determined by trypan blue exclusion (Section 
2.1.6.3). Only preparations with viability greater than 95% were used for further 
experiments. The cells adherent to the tissue culture flask were discarded.
2.1.6 3 Trypan Blue Exclusion
Trypan blue exclusion gives a measure of cell viability; cells take up trypan blue when 
their membranes are leaky, which occurs during cell death. An equal volume of 0.4% 
trypan blue (GibcoBRL) and rabbit lymphoid cells were mixed and the percentage of 
viable (clear) and non-viable (blue) cells was calculated after counting the cells using a 
haemocytometer. Approximately 200 cells were counted each time.
2.2 V ir uses  a nd  t he ir  Cul t u r e
2.2.1 Derivation of Viruses
SLS was the original strain of myxoma virus released in Australia in the summer of 
1950-51. SLS is of grade I virulence and is 100% lethal for laboratory rabbits. The SLS 
stock used in this study was derived from a rabbit tissue stock freeze-dried by Professor 
Frank Fenner in 1953. It has since been passaged twice through RK13 cells and once
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through laboratory rabbits. The virulence of SLS derived from this seed stock has been 
recently confirmed (Robinson et al., 1999).
Ur is of grade V virulence and infected laboratory rabbits have a survival rate greater 
than 95%. All infected laboratory rabbits develop clinical myxomatosis (Fountain et al., 
1997; Kerr, unpublished data). The Ur stock used in this thesis was derived from 
plaque-purified stocks produced in 1989 (Russell and Robbins 1989), which in turn 
were derived from Uriarra/2/53-1, a strain isolated from the field in 1953 (Mykytowycz 
1953). The Ur stock was subsequently passaged through tissue culture (CV-1 cells, 
RK13 cells) and laboratory rabbits. The virulence of the Ur stocks has been recently 
confirmed by inoculation of laboratory rabbits (Fountain et al., 1997; Kerr et al., 1999).
The Lausanne (Lu) strain of myxoma virus was released in France in 1952, it has since 
spread across the entire European continent (Fenner and Ross 1994). Similarly, to the 
co-evolution in Australia, attenuated strains of virus and resistant rabbits emerged in 
Europe (Fenner and Chappie 1965; Ross and Sanders 1977; Ross and Sanders 1984; 
Ross and Sanders 1987; Fenner and Ross 1994). Lu is highly lethal in laboratory rabbits 
and is more virulent in Australian wild rabbits than SLS (reviewed in Kerr and Best 
1998).
2.2.2 Preparation of Seed and Working Stocks of Myxoma 
Virus
SLS, Ur and Lu virus stocks were obtained from Ms B. Inglis (School of Biochemistry 
and Molecular Biology, ANU). To prepare seed and working stocks of virus, RK13 
cells were grown to confluency in a T75 tissue culture flask (Life Technologies). Media 
was removed from the flask leaving approximately 2 ml behind. Virus stock (0.5 ml),
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was added to the flask. The RK13 cells were then incubated at 37°C for 1 h with 
frequent agitation, after which an additional 15 ml of complete MEM was added to the 
flask. The cells were incubated in a humidified incubator at 37°C and 5% CO2 in air for 
48h. After this time, the monolayers were checked for cytopathic effects (CPE). If CPE 
was observed, the flasks were frozen at -70°C. If CPE was not observed, flasks were left 
overnight and checked for CPE the following day. This was continued until CPE was 
observed, at which point the flasks were frozen at -70°C. The frozen flasks were 
freeze/thawed twice and 5ml aliquots were frozen at -70°C. This virus preparation 
became the seed stock.
To obtain a working stock of virus, RK13 cells were grown to confluency in a T180 
tissue culture flask (Nalge Nunc International) and infected as described above using 5 
ml of seed stock. Once CPE was observed, the cells and media were freeze/thawed 
twice and transferred to Oak Ridge tubes. The cell/virus suspension was then 
centrifuged for 2 h in a Sorvall SS-34 rotor at 12,000 rpm and 4°C. The supernatant was 
decanted and the cell/virus pellet resuspended gently and slowly in 1 ml of complete 
MEM. All suspensions were pooled and the Oak Ridge tubes washed with an additional 
1 ml of complete MEM, which was added to the pooled suspensions. The pooled 
suspensions were sonicated using a MSE 100 Watt Ultrasonic Disintegrator, (3 cycles 
of 15 sec sonication then 45 sec rest) at 4°C, to release virus from the cells. Aliquots of 
1 ml of the cell/virus suspension were stored at -70°C.
2.2.3 Plaque Assay for Determining Virus Concentration
Vero cells were seeded at 0.8x106 cells per well in 6-well plates (Life Technologies) 
and incubated overnight in a humidified incubator at 37°C and 5% CO2 in air. Each
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virus sample was then titrated with a minimum of three dilutions, plated in duplicate. 
Thus, one 6-well plate was the minimum requirement for each virus sample. Media was 
aspirated from each well, leaving approximately 100 pi behind. Serial dilutions of 100 
pi of the virus samples were set up (10"3, 10‘4 and 10'5 for titration of working virus 
stocks) and added to the corresponding well in the 6-well plate. The plates were 
incubated at 37°C for 1 h with frequent agitation. After this time, an additional 3 ml of 
complete MEM was added and the plates incubated in a humidified incubator at 37°C 
and 5% CO2 in air, for 5 to 7 days, depending on the time taken for virus plaques to 
appear.
When plaques were detected, the media was removed and 1 ml of 10% formalin 
(Merck) was added to each well to fix the cell monolayers. The plates were incubated 
for 1 h at room temperature (RT) after which the formalin was removed and 1 ml of 
0.1% crystal violet (Sigma) was added to each well to enhance plaque visualization. 
After a further 1 h, the monolayers were washed with tap water, left to dry and the 
number of plaques counted. Titres were expressed as plaque forming units (pfu)/ml and 
were the mean of duplicate titrations.
2.3 Inf ec t io n  of  Ra bb it  Ly mph o id  Cell  Cu l t u r e s  a nd  RL-5 
Cells  w it h  SLS a n d  Ur
2.3.1 Infection of Rabbit Lymphoid Cell Cultures Prior to 
Mitogen-Stimulation
For analysis of myxoma virus infection prior to mitogen stimulation, primary lymphoid 
cells isolated from laboratory or wild rabbits were either mock infected (media without
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virus) or infected with SLS or Ur at a multiplicity of infection (moi) of 3 or 0.1. Cells 
were infected for 1 h at 37°C with frequent agitation in a total volume less than 500 pi. 
The appropriate number of cells, depending on the experiment undertaken, was added to 
wells in a 24-well plate (Life Technologies). Complete RPMI 1640 was added to give a 
total volume of 1 ml per well and Concanavalin A (Con A) (Sigma) was added at this 
point to the required samples to a final concentration of 5 pg/ml. This concentration has 
been previously shown to be optimal for stimulation of primary lymphoid cells 
(Cartledge 1995).
2.3.2 Infection of Mitogen-Stimulated Rabbit Lymphoid Ceil 
Cultures
To analyze the effects of myxoma virus infection on rabbit lymphoid cells that were 
infected after mitogen stimulation, cells were isolated as described in Section 2.1.6.2, 
and seeded at lx l0 6 cells per well in 24-well plates. Complete RPMI 1640 was added to 
give a final volume of 1 ml per well and Con A was added to give a final concentration 
of 5 pg/ml. Cell cultures were incubated with Con A for 4, 24, 48 or 72 h, after which 
the cells were harvested, counted and either mock-infected with media or infected with 
SLS or Ur at a moi of 3 for 1 h at 37°C with frequent agitation, in a total volume less 
than 500 pi. The cells were then re-plated in 24-well plates with 1 ml of complete RPMI 
1640 containing 5 pg/ml of Con A.
2.3.3 Infection of RL-5 Cells
RL-5 cells were mock-infected with media or infected with SLS or Ur at a moi of 3 or 
0.1 as described for primary lymphoid cells (Section 2.3.1). Con A was not used for the 
experiments involving myxoma virus infection as RL-5 cells are already actively
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proliferating. Con A stimulation of RL-5 cell cultures was tested during amlysis of 
IFNy expression (Section 2.13) and was added to cell cultures to a final concentation of 
5 pg/ml.
2.4 Fl o w  Cy t o me t r ic  An a l y s is  o f  My x o ma  V ir us  Inf ec t ic n a nd  
Ce l l u l a r  DNA Co nt ent
2.4.1 Myxoma Virus Infection and DNA Content of Frimary 
Rabbit Lymphocytes
Myxoma virus infection and DNA content were measured concurrently using uc same 
samples. In cell cultures stimulated with Con A after infection with myxona virus 
(Section 2.3.1), cells were seeded at 2xl06 cells per well in a 24-well plate and>ne well 
from each infection was harvested at 4, 12, 24, 36, 48 and 72 h. In cell culturesinfected 
after stimulation (Section 2.3.2), cells were stimulated for 4, 24, 48 or 7> h and 
harvested after infection for an additional 12 or 24 h.
The harvested cells were centrifuged at 3,000 rpm in a microfuge and resuspnded in 
100 pi PBS (137 mM NaCl, 2.7 mM KC1, 4 mM Na2HP04, 0.18 mM KH2PO). To fix 
and permeabilise the cells, 400 pi of methanol (Merck):acetone (Merck) (1:1 //v) was 
added. After a 10 min incubation at RT, the cells were washed twice with 'BS and 
resuspended in 100 ul of anti-myxoma virus monoclonal antibody (3b6e4; Fcintain et 
al., 1997) diluted 1:800 in 0.1% bovine serum albumin (BSA) (Amersham P.armacia 
Biotech) in PBS. To examine non-specific binding, 100 pi of mouse ascites Hud diluted 
1:800 in 0.1% BS A/PBS, was used in place of the 3b6e4 antibody. The ells were 
incubated at 37°C for 1 h, then washed twice with 0.1% BS A/PBS befee being
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content
resuspended in 100 pi of anti-mouse IgG-FITC conjugate (1:40 dilution, in 0.1% w/v 
BSA/PBS) (Silenus). After incubation for 30 min at RT in the dark, 500 pi of 10 pg/ml 
of propidum iodide (PI) (Sigma) in PBS was added and the cells were incubated on ice 
in the dark for a further 30 min. PI binds DNA and was used to analyse cell viability 
and stage of cell cycle. The proportion of cells infected with myxoma virus and PI 
staining of DNA were analyzed on a Becton Dickinson FACSort; forward scatter 
(FSC)- Voltage E-l, AmpGain 9.17, Mode Lin; side scatter (SSC)- Voltage 203, 
AmpGain 1.00, Mode Log; FL1-H- Voltage 381, AmpGain 1.00, Mode Log; FL3-H- 
Voltage 319, AmpGain 1.00, Mode Log. The experiment was repeated using lymphoid 
cell cultures from three laboratory and three wild rabbits.
2.4.2 DNA Content of Infected RL-5 Cells
Myxoma virus infection was not examined in RL-5 cells as this has previously been 
done (Barry et al., 1995; Macen et al., 1996; Barry et ah, 1997). To examine DNA 
content, RL-5 cells were mock-infected with media or infected with SLS or Ur at a moi 
of 3 or 0.1 for 1 h as previously described (Section 2.3.3), and seeded at lxlO6 
cells/well in a 24-well plate. Cells were harvested at 4, 24, 48 and 72 h post infection 
and resuspended in 100 pi PBS. To fix and permeabilise the cells, 400 pi of 
methanol:acetone (1:1 v/v) was added. After 10 min incubation at RT, the cells were 
washed twice with PBS and resuspended in 500 pi of 10 pg/ml PI diluted in PBS. The 
cells were incubated on ice in the dark for 30 min. PI staining of DNA was analyzed on 
a Becton Dickinson FACSort using the settings previously described (Section 2.4.1). 
This experiment was repeated on three separate occasions.
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2.4.3 Data Analysis of Myxoma Virus Infection
The proportion of cells infected with myxoma virus was determined by analysis of 
density plots of side scatter (SSC) (cell granularity) versus FL1-H using CelQuest 
software (Becton Dickinson Immunocytometry Systems). FL1-H detects FITC 
fluorescence and therefore correlates to binding of the 3b6e4 antibody. Graphs were 
generated of the proportion of infected cells versus time. These results are descriled in 
chapter 3. Samples were also gated based on cell size and those gated sub-popuhtions 
were analyzed separately for myxoma virus infection as just described. These resuts are 
also described in chapter 3.
2.4.4 Data Analysis of Cellular DNA Content
2.4.4.1 Cell Viability
The proportions of viable primary lymphoid cells, as measured by trypan blue excusion 
(Section 2.1.6.3), was used to confirm the gating used in flow cytometry to separate 
non-viable from viable cells. Viability was examined on the flow cytometer usingFL-3, 
which detects PI fluorescence. The gate used was set up such that the major popilation 
of viable cells (G1/G0 stage of the cell cycle) had a fluorescence intensity of PI shining 
greater than 10 units. Therefore, non-viable cells were defined as those event; with
1 9fluorescence intensity between 10 and 10 units and viable cells were defined as those 
events with fluorescence intensity greater than 10 units. It must be noted that the gating 
o f ‘non-viable cells’ includes cell fragments in addition to apoptotic and necrotic cells. 
Cell debris had a fluorescence intensity <101 units and as such was not includedin the 
gatings. These results are described in chapter 4.
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Viability of RL-5 cells is presented as histogram plots of FL3-H and tables of the 
proportion of non-viable cells as calculated using CellQuest software.
2.4.4.2 Stage of Cell Cycle
Staining with PI identified cells in G1/G0 (single copy of DNA), G2/M (two copies of 
DNA) and Sub G1 (non-viable cells) sub-populations. Histograms of DNA content were 
gated with respect to events classified as G1/G0, G2/M or Sub Gl, and the proportion of 
events in each sub-population was calculated using CellQuest software. Additional two- 
color analysis was performed to determine stages of the cell cycle where viral antigen 
was detected to examine the permissivity of cells in different stages of the cell cycle to 
myxoma virus replication. To investigate this, FL1-H (myxoma virus infection) and 
FL3-H (DNA content) were examined concurrently. The results are described in chapter 
4.
2.5 Vir u s  Re pli c at io n
Rabbit lymphoid cell cultures were infected with SLS or Ur at a moi of 3 or 0.1, and 
stimulated with Con A (5 pg/ml final concentration) as described in Section 2.3.1. Cells 
were harvested at 4, 12, 24, 36, 48 and 72 h post infection, freeze/thawed twice and 
sonicated using a MSE lOOWatt Ultrasonic Disintegrator (3 cycles of 15 sec sonication 
and 45 sec rest) at 4°C. These cell/virus suspensions were stored at -70°C. Virus titres 
were measured by duplicate plaque assay on Vero cell monolayers as previously 
described (Section 2.2.3).
Titres were expressed as pfu/input cell and graphed as pfu/input cell versus time. Data 
was also converted to pfu/infected cell using the mean proportion of infected cells as
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determined in Section 2.4.3. Virus replication was examined in infected lymphoid cell 
cultures from three laboratory and three wild rabbits. Results of virus replication are 
described in chapter 3.
2.6 Pr o l if e r a t io n  of  Ra b b it  Ly mph o c y t e s  a nd  RL-5 Cell s
Rabbit lymphoid cells and RL-5 cells were mock-infected with media or infected with 
SLS or Ur at a moi of 3 or 0.1 and stimulated with Con A as described in Section 2.3.1 
for primary cell cultures and Section 2.3.3 for RL-5 cell cultures. Cells were plated in 
triplicate in a 96-well plate at a concentration of 3x10^ cells/well for primary lymphoid
o p l lo  rvv 1 \/ 1 o o l l o /  1 -Tor P  T o a I I o  i n  o f t  n q !  trrvlii m  o  f  1 Hfl i i 1 Tl^ p  n l o f o o  t i / p r a
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incubated for 0, 24, 48 or 72 h. At each time point, cell proliferation was analyzed by 
tritiated thymidine (3H-T) incorporation (Section 2.6.1) or CellTitre 96® AQue0Us One 
Solution Assay (Section 2.6.2). Proliferation assays were performed in lymphoid cell 
cultures from three laboratory and three wild rabbits, and in RL-5 cell cultures on three 
separate occasions.
2,6.1 3H-T Incorporation
In this assay, JH-T is incorporated into cellular DNA during its replication. Therefore, 
this assay measures actively replicating cells. At each time point (0, 24, 48 and 72 h) 50 
pi of media containing 10 pCi of H-T was added to each well. Primary cell cultures 
were then incubated for 18 h in a humidified incubator at 37°C and 5% CO2 in air. RL-5 
cells were incubated for 4 h. At the end of the incubation, the plates of cells were 
frozen. The plates were freeze/thawed twice prior to harvesting of the cells using a 
Packard Filtermate 196 Cell Harvester and analysis on a Packard Top-Count Microplate 
Scintillation Counter (Packard Instrument Co.) as per the manufacturer’s instructions.
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2.6.2 CellTitre 96® AQ„pn,,<; One Solution Assay
The CellTitre 96® AQue0us One Solution assay (Promega) is a colorimetric assay in 
which absorbance at 490 nm is directly proportional to the number of live cells in a 
culture. Metabolically active cells reduce MTS tetrazolium compound to a colored 
formazan product, the absorbance of which can be read at 490 nm. Cells that are not 
metabolically active will not cause a color change.
Rabbit lymphoid cells and RL-5 cells were set up as described above. At each time 
point (0, 24, 48 and 72 h) 20 pi of CellTitre 96® AQue0us One Solution Reagent was 
added to each well and the plates incubated in the dark at 37°C. After 4 h, the 
absorbance at 490 nm was read on a microplate reader. This incubation period was 
previously shown to produce an optimal signal: noise ratio for primary lymphocytes (Dr 
P. Kerr, unpublished data).
2.6.3 Presentation of Cell Proliferation Data
Results from the H-T incorporation assay and CellTitre assay were scaled such that H- 
T incorporation (as measured as counts per minute), or absorbance at 490 nm, of mock- 
infected cell cultures at the 4 h time point was equal to 1 unit. Proliferation data was 
plotted as relative 3H-T incorporation, or relative absorbance at 490 nm versus time.
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2.7 Ana l ys is  of  Cel l  Sur f a c e  Pr o t e in  Ex pr es s io n
2.7.1 Cell Surface Protein Expression in Rabbit Lymphoid Cell 
Culture Infected with Myxoma Virus Prior to Mitogen 
Stimulation
Rabbit lymphoid cell cultures and RL-5 cells were mock-infected with media or 
infected with SLS or Ur at a moi of 3 or 0.1 as described previously (Section 2.3.1 and 
Section 2.3.3), seeded at a concentration of 2xl06 cells/well (primary cell cultures) or 
0.5x106 cells/well (RL-5 cells) and incubated in a humidified incubator at 37°C and 5% 
CO2 in air. Cell cultures were incubated with or without 5 pg/ml Con A, which was 
added after an initial 1 h infection. Preliminary experiments using 24 and 48 h time 
points demonstrated that the greatest level of cell surface marker expression was after 
48 h incubation. Therefore, cell cultures were harvested and analyzed for expression of 
proteins on the cell surface after 48 h.
After harvesting, the cells were washed twice with PBS and resuspended in 100 pi of a 
specific monoclonal antibody (1:20 diluted in 0.1% BSA/PBS). The antibodies tested 
were specific for rabbit CD25, CD4, CD43, CD45, KEN-5, MHC-I or MHC-II 
(Serotec). Mouse ascites fluid, at a dilution of 1:20 in 0.1% BS A/PBS, was used instead 
of the primary antibody to measure non-specific binding of the monoclonal antibodies 
to the cells. Cells were incubated for 1 h at 37°C after which they were washed twice 
with 0.1% BSA/PBS. Next, the cells were resuspended in 100 pi of anti-mouse IgG- 
FITC (1:40 dilution in 0.1% BSA/PBS) and incubated at RT in the dark for 30 min. 
Prior to analysis, 500 pi of 0.1% BSA/PBS was added to each sample. Samples were 
analyzed for expression of the specific marker on a Becton Dickinson FACSort flow 
cytometer. Flow cytometer instrument settings for primary cell cultures were FSC-
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Voltage E-l, AmpGain 9.17, Mode Lin; SSC- Voltage 203, AmpGain 1.00, Mode Log, 
with the following FL1-H settings;- for analysis using CD25, CD4, CD43, MHC-I and 
MHC-II monoclonal antibodies, FL1-H voltage was set at 450; for the monoclonal 
antibody specific for CD45 FL1-H voltage was 350; and for the KEN-5 monoclonal 
antibody FL1-H voltage was 390. For RL-5 cells, instrument settings were identical to 
those used for primary cell cultures for the respective cell surface marker, with the 
exception of CD25, where the FL1-H voltage was 400, and MHC-I, where the FL1-H 
voltage was 380. The expression of cell surface markers was examined on three separate 
occasions using lymphoid cells prepared from three laboratory, three wild rabbits and 
three different cell cultures of RL-5 cells.
2.7.2 Cell Surface Protein Expression in Rabbit Lymphoid Cell 
Cultures Stimulated Prior to Infection with Myxoma Virus
Rabbit lymphoid cells were stimulated with Con A and infected with myxoma virus as 
described in Section 2.3.2. After the cells were infected, they were incubated for 24 or 
48 h, at which time they were harvested and analyzed for expression of CD25 or MHC-I 
as described in Section 2.7.1. Experiments were repeated in lymphoid cell cultures from 
three laboratory and three wild rabbits.
2.7.3 Data Analysis
Cell surface marker expression was presented as histogram overlays of protein
expression and density plots of cell size versus protein expression generated using
2CellQuest software. Plots were divided into Tow’ (fluorescence intensity less than 10 
units) and ‘high’ (fluorescence intensity greater than 10 units) expression levels. The 
median fluorescence intensity of cell surface marker expression in cell cultures infected
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with myxoma virus was also determined and the mean of three replicate samples was 
calculated.
Cell cultures were also gated based on cell size into large and small cells (Section 2.8). 
The mean median fluorescence intensity corresponding to cell surface marker 
expression in each of these sub-populations was determined using CellQuest software.
2.8 Ana l ys is  o f  Cel l  Size  a nd  G r a n u l a r it y  in Pr ima r y  
Ly mph o c y t e s  a nd  RL-5 Cells
Mitogen stimulation of cells is not only associated with proliferation, but also with 
changes in cell morphology, for example cell size and granularity (Webster et al., 1995). 
Cell size and granularity were analyzed as FSC (forward scatter- cell size) and SSC 
(side scatter- cell granularity) and are collected by the flow cytometer automatically 
with every sample. Cell size data was presented as histogram overlays of cell size and 
density plots of cell granularity versus cell size. The proportion of large and small cells 
was calculated. The data used in this analysis was that from Section 2.7. Instrument 
settings for FSC and SSC for primary cells and RL-5 cells were as listed in Section 
2.7.1.
The size of cells in cell cultures infected with myxoma virus after stimulation with Con 
A were examined as density plots of myxoma virus infection versus cell size. These 
plots were divided into quadrants. The proportion of cells in each quadrant was 
calculated using CellQuest software. Large and small cell sub-populations were also 
examined for myxoma virus infection (Section 2.4.3) and cell surface protein expression 
(Section 2.7.3).
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Cell granularity was examined as density plots of cell size versus cell granularity and 
histogram overlays of cell granularity. These results are described in chapter 3.
2.9 St a t is t ic a l  Ana l ys is
Statistical analysis of virus replication, the proportion of cells infected and cell 
proliferation were undertaken. All data expressed as a percentage were logit 
transformed, the remainder being log transformed. Statistical analysis was by analysis 
of variance (ANOVA) with components of variance between and within rabbits. All 
main effects and interactions were tested for significance. A p  value <0.05 was deemed 
significant. Analyses were done using S-Plus (Insightful Corporation, 2001). These 
statistical analyses were performed by Mr J. Wood and Ms J. Searle at the Statistical 
Consulting Unit, ANU.
ANOVA analysis was performed on the proportions of cells in Sub Gl, G1/G0 and 
G2/M. Infection regimes were compared at each time point and data from the one 
infection regime was compared over the 72 h time course. ANOVA analysis was also 
performed on the expression of cell surface proteins. Mock-infected and SLS- and Ur- 
infected cultures were compared to each other. A p  value of <0.05 was deemed 
significant. Discussion of the expression of cell surface markers was not restricted to 
only significant differences. The levels of expression of some proteins, although not 
significant, were discussed as it was considered that the changes may have some 
biological significance.
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2.10 Ana l ys is  o f  An t i-Apo pt o t ic , Ho s t -Ra n g e  and 
Immu n o mo d u l a t o r y  V ir a l  Gen es
2.10.1 Preparation of Viral DNA
Total DNA (cellular and viral) was purified from working stocks of Lu, SLS and Ur 
strains of myxoma virus prepared as described in Section 2.2.2. For each virus strain, a 
100 pi volume of working stock was added to 100 pi of 2x lysis buffer (100 mM This 
(Progen) pH 7.5, 5 mM K2EDTA pH 8.0, 200 mM NaCl, 0.2% SDS (BDH), 0.1 mg/ml 
proteinase K (Sigma)) and incubated at 58°C for 2 h. The samples were centrifuged at 
14,000 rpm in a microfuge for 15 min. The supernatant was removed (approximazely 
200 pi) from each sample and added to an equal volume of phenol 
(Amresco):chloroform (Ajax Chemicals) (1:1 v:v), then incubated at RT for 20 ihn 
with frequent inverting. The samples were centrifuged again at 14,000 rpm for 5 ihn 
and the aqueous supernatant (top layer) transferred to fresh tubes. An equal volume of 
isopropanol (Merck) and a 1/10 volume of 3 M Na acetate (Merck) were added to each 
tube and mixed with the contents of the tube. The samples were incubated at RT fir a 
minimum of 1 h and centrifuged at 14,000 rpm for 15 min to pellet the DNA. The pellet 
was rinsed with 1 ml 70% ethanol (Merck) and dried in a Speed Vac SC 100 (Sa\ant) 
(~5min). The DNA was resuspended in 50 pi of MilliQ water.
2.10.2 Primers for Amplification of Myxoma Virus Open 
Reading Frames
Primers for M002, M004, M005, M062, M063, M064, M128, M151, M152 and M 56 
open reading frames (ORFs) were designed from the published Lu gene sequeices 
(Cameron et al., 1999). The primers used to sequence the above ORFs are showi in
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Table 2.1, and were synthesized by Proligos (formerly Genset Oligos, Lismore, 
Australia). Primers were diluted to 5 pM stocks and stored at -20°C.
2.10.3 PCR Amplification of Myxoma Virus ORFs
A 1 pi volume of each primer (5 pM stock) from a pair was added to 1 pi of 1 Ox buffer 
(Fisher Biotech), 1 pi of Mg2+ (Fisher Biotech), 1 pi of dNTPs (Fisher Biotech), 0.2 pi 
of Taq polymerase (Fisher Biotech), 3.3 pi of ddF^O and 1 pi of viral DNA (prepared 
in Section 2.10.1). The ORFs were amplified using a capillary thermal cycler (Corbett 
Research).
The following PCR cycle was used for amplification; 
lx J95°C for 3 min 
95 °C for 15 sec
35 x ^ 53°C, 55°C or 57°C (depending on the Tm of the primer pairs) for 15 sec 
J2°C for 90 sec repeated 
lx A 72°C for 3 min and 25°C for 1 min.
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Tabl e  2.1. Prime rs  used  fo r  Sequen cin g  Viru s  ORFs
O R F P r im e r s E x p e c te d  P C R O R F  S iz e M e lt in g  T e m p e r a tu r e
P r o d u c t  S iz e  (b p ) (b p ) (T m )
M 0 0 2 * 5' external primer
C T A A T T G G C A C C T T C T A C G T C 5 ’ fragment-
57°C
3' external primer
C G C G A A T A A T A C A C A C A G G C
730bp
1064bp 55°C
5' internal primer 3 ’ fragm ent-
53°C
C T G C A C A A A A T G T C C T C G G 65 3 bp
3' internal primer
G C T C G T T C C G T A G T A T T C C G 57°C
M 0 0 4 5 ’ p r i mer
GAAG^GTTCCTGGrTTGGG 809bp 714bp
53°C
3 ’ p r  i mer
GCXAACIAACAGTXXXAGTG 59°C
M 0 0 5 * 5' external primer
G T T G A T A T A A C C C C G G A C G A G 5 ’ fragm ent-
59°C
3' external primer
C A A A T  C G A T A G G A T A G G A C C
727bp
1428bp 57°C
5' internal primer 3 ’ fragm ent-
53°C
G T T G G A A C G T A A G A T C A G C C 850bp
3' internal primer
C A A C A C C T T T C G A T T A A A G A C G 57°C
M 0 6 2 5’ p r  i mer
CAGOGACCTCTAGGACGrC
57°C
3 ’ p r  i mer
aXACGCTCGTAATGCTCAG
543bp 477bp 59°C
M 0 6 3 5 ’ p r  i mer
TCTCAGCATTACGACKGrGG
59°C
3 ’ p r  i mer
c x a x x A T G r r r A c x x x  a a ( x ;
732bp 648bp 57°C
M 0 6 4 5 ’ p r  i mer
AGCGACGATTAT ACCAGCAG
55°C
3 ’ p r  i mer
TGTGXATAGATACXXJGrTCC
785bp 612bp 55°C
M 1 2 8 * 5' external primer
C G T T C T A C T A C G T A C G A C G T External fragm ent-
58°C
3' external primer
G C A T T C T T G A A G A A C T T G C C
900bp
846bp 58°C
3' internal primer Internal fragm ent-
59°C
G C T T T G C C C A G C A G A T A G T G C 679bp
M 1 5 1 * 5' external primer
5 ’ fragm ent-
43°C
T A A G T G C G A T T A T G G A G
3' external primer
C T A A C G G A T A C A G G A G A G
999bp
49°C
5' internal primer 3 ’ fragm ent- lOOlbp
53°C
C G A C A G C G T C G G A C G T C 1044bp
3' internal primer
G A A G T G A C T C T A C C C A G 47°C
M 1 5 2 5 ’ p r  i mer
GGTAGAGIX A C riX  TCXX
51°C
3 ’ p r  i mer
GGCTACTGaTGT AAACATGG
889bp 801 bp 53°C
M 1 5 6 5 ’ p r  i mer
OGTAGCGTATACATAATGOCG
57°C
3 ’ p r  i mer
CGAOGrTAAACATAAGACGAGG
376bp 309bp 59°C
* M002, M005 and M l 51 were amplified in two overlapping sections, 5’ and 3’ ends 
M l 28 was amplified over the entire gene sequence and from an internal primer
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2.10.4 Cloning of PCR Product
Each PCR product was purified (described in Section 2.10.4.1), cloned into a vector 
(described in Section 2.10.4.2) and amplified in competent DH5a E. coli cells 
(described in Section 2.10.4.4). The vector containing the amplicon was purified from 
the bacterial cells (described in Section 2.10.4.5) and the amplicon sequenced 
(described in Section 2.10.5).
2.10.4.1 Purification of the PCR Product
The PCR product was separated from the primers on a 1% agarose gel in TAE buffer 
(40 mM Tris, 1% acetic acid (Merck), 1 mM K2EDTA) at 90 V for approximately 1 h. 
To visualize the DNA, the gel was stained in 1 pg/ml of ethidium bromide (Sigma) for 
30 min before destaining in ddLLO for an additional 30 min. If an amplicon of 
appropriate size was visible when the gel was viewed on a UV transluminator, the DNA 
band was excised and the DNA extracted from the gel matrix using the UltraClean DNA 
Purification Kit (Mo Bio Laboratories Inc) as per the manufacturer’s instructions. 
Components in the solutions were not defined by the manufacturer. Briefly, the gel slice 
was weighed and 3 equivalent volumes of ULTRA SALT were added. The gel slice was 
melted at 55°C and 5 pi of BRESA-BIND glass beads were added. The solution was 
mixed on a turntable for 10 min at RT and centrifuged at 14,000 rpm in a microfuge for 
1 min. The pellet was then washed three times with BRESA-WASH solution. The 
resulting pellet was resuspended in 10 ul of ddLLO and incubated at 55°C for 5 min. The 
solution was centrifuged again as above and the 10 pi supernatant containing the eluted 
PCR product was removed and stored at -20°C.
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2.10.4.2 Ligation of PCR Product into the Plasmid Vector
To ligate the PCR product into a plasmid vector, 7 pi of the PCR product was added to 
l pi of pGEM-T Easy vector (Promega), l pi of T4 DNA ligase (Promega) and 1 pi of 
lOx ligase buffer (Promega) and incubated overnight at 16°C.
2.10.4.3 Preparation of Competent DH5a E. coli Cells
Competent DH5a E. coli cells were used to amplify the cloned PCR product. To 
prepare the competent cells, one loop of DH5a E. coli cells from a glycerol stock 
(obtained from Ms B. Inglis) was streaked onto a LB plate and incubated overnight at 
37°C. A single bacterial colony was picked and used to inoculate 20 ml of LB broth, 
which was incubated overnight at 37°C in a shaking incubator. The following morning, 
two flasks containing 1 L of LB broth were inoculated with 10 ml of culture and 
incubated at 37°C and 200 rpm until the ODeoo was between 0.5 and 0.6 units (—2-3h). 
Once this OD was reached, the cultures were equilibrated on ice water and all following 
procedures were carried out gently at 2-4°C.
The cultures were divided equally between six pre-chilled 500 ml bottles and 
centrifuged in a G5-3 rotor (Sorvall) at 4,500 rpm, 4°C for 15 min. The supernatant was 
drained quickly and the pellet gently resuspended in 5 ml of ice-cold sterile MilliQ 
water. After addition of extra ice-cold MilliQ water to a final volume of 500 ml, the 
suspensions were centrifuged at 4,500 rpm and 4°C for 15 min. At the end of the 15 
min, the pellets were resuspended in 5 ml ice-cold MilliQ water. Suspensions were 
combined into two bottles and MilliQ water was added again to a final volume of 500 
ml. The suspensions were centrifuged at 4,500 rpm and 4°C for 15 min. The 
supernatants were discarded and the pellets resuspended in 5 ml of ice-cold 10%
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glycerol in ddFfO. At this point, the suspensions were transferred to two pre-chilled 30 
ml Oak Ridge tubes and ice-cold 10% glycerol in ddLLO was added to give a final 
volume of 25 ml. The samples were centrifuged in a Sorvall SS-34 rotor at 5,000 rpm, 
4°C for 15 min. The supernatants were drained and the pellets resuspended in 1 ml of 
ice-cold 10% glycerol in ddLLO. Cells were aliquoted (40 pi) into pre-chilled eppendorf 
tubes on ice, which were then stored at -70°C.
2.1G.4.4 Transformation of DH5a E. coli Cells
For transformation, 1 pi of ligation mix was added to 40 pi of competent DH5a E. coli 
cells that had been thawed on ice. The ceils were electroporated at 2.5 kV after which 
400 pi of LB broth was added and the cells incubated for 1 h at 37°C. A 100 pi aliquot 
of the cell suspension was plated on a LB plate supplemented with 10 pg/ml of 
ampicillin (Sigma), 10 pg/ml of X-gal (Progen) and 10 pg/ml of IPTG (Progen). 
Ampicillin selected for colonies that had taken up the plasmid during transformation. X- 
gal and IPTG were used in color selection of vector containing the amplicon. In this 
assay, white colonies contain vector with the inserted PCR product and blue colonies 
contain vector without the PCR product inserted. The plates were incubated overnight at 
37°C. Three white colonies were picked from each plate and grown overnight at 37°C in 
a shaking incubator in 3 ml of LB broth containing 10 pg/ml of ampicillin.
2.10.4.5 Isolation of Plasmid DNA
Plasmid DNA was isolated using a DNA plasmid miniprep kit (Qiagen) as per the 
manufacturer’s instructions. Components in the solutions were not defined by the 
manufacturer. Briefly, 3 ml of culture was spun down and the cells resuspended in 250 
pi of resuspension solution (PI). P2 lysing solution (250 pi) was added and the tubes
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inverted 6 times. After this, 350 pi of neutralizing solution (P3) was added and again the 
tubes were inverted 6 times. The suspensions were centrifuged at 14,000 rpm for 10 min 
in a microfuge, after which the supernatants were transferred to a miniprep filter. The 
filters were centrifuged at 14,000 rpm for 1 min and washed with 500 pi of PB solution. 
The filters were centrifuged again in a microfuge at 14,000 rpm for 1 min and washed 
with 750 pi of PE buffer. After this wash, the filters were centrifuged at 14,000 rpm for 
30 sec to remove all traces of PE buffer. To elute the plasmid DNA from the filter, 50 pi 
of ddEEO was added to the filter and incubated at RT for 1 min. The filters were 
centrifuged at 14,000 rpm for 1 min and the 50 pi containing the plasmid DNA was 
removed. The absorbance at 260 nm and 280 nm of a diluted aliquot of the plasmid 
DNA solution was determined. The DNA concentration was calculated by multiplying 
the 260 nm absorbance reading by 50 pg DNA/ml and by the dilution factor. The 260 
nm/280 nm ratio was also calculated to estimate the purity of the DNA samples. The 
samples were stored at -20°C.
2.10.5 Nucleotide Sequencing Reactions
The plasmid DNA containing the gene of interest, produced in Section 2.10.4, was used 
as the template for sequencing reactions. Plasmid DNA (200 pg) was added to 4 pi of 
Big Dye reaction mix (Applied Biosystems) and 2 pi of M l3 forward or M l3 reverse 
primer (Biomolecular Resource Facility, JCSMR, Canberra, Australia). The sequencing 
reaction mix was made up to a final volume of 10 pi with ddTEO.
Sequencing reactions were done using a capillary thermal cycler (Corbett Research) 
with the following steps;
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1 x -4 96°C for 30 sec 
50°C for 15 sec 
60°C for 4 min
25x
lx < 25°C for 1 min
After sequencing, 25 pi of 100% ethanol and 1 pi of 3 M Na acetate was added to each 
sample, which was then incubated on ice for 10 min. The samples were centrifuged in a 
microfuge at 14,000 rpm for 20 min before being washed twice with 70% ethanol and 
left to air dry. The samples were processed by the Biomolecular Resource Facility 
(JCSMR, Canberra, Australia) using an Applied Biosystems gel system.
2.10.6 Analysis of Nucleotide Sequences
Initially, only ORFs from the Ur strain of myxoma virus were sequenced and compared 
with the published Lu strain of myxoma virus. If these sequences differed, then the ORF 
from SLS and Lu were sequenced independently and compared. To check for 
differences between the nucleotide sequences obtained, an alignment of the nucleotide 
sequences was done using ClustalW (alignment- full, matrix- iub, gap open- 10, gap 
extension- 0.05, gap distance- 8) (http://ebi.ac.uk). For genes that were different 
between sequence obtained in this thesis and the published Lu sequence, all six ORFs of 
the virus gene were translated using MacVector (Oxford Molecular Inc). The resulting 
protein sequences were aligned using the above programs. Analysis of molecular 
weight, pi, amino acid composition and hydrophilicity (Kyte and Doolittle scale) was 
undertaken using MacVector. Analysis of putative protein transmembrane domains was 
done using the Dense Alignment Surface (DAS) Transmembrane Prediction Server 
(http://www.sbc.su.se/~miklos/DAS/) (Cserzo et ah, 1997). Putative protein domains
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were identified using PROSITE (all patterns, profiles and rules scanned, patterns with a 
high probability of occurring were included) (http://au.expasv.org/cgi-bin/scanprosite). 
These results are described in chapter 4.
2.11 Pr o duc t io n  o f  An t ibo d ie s  Spec if ic  f o r  Ra b b it  Cy t o k ines
2.11.1 Synthetic Peptides Derived from Rabbit Cytokine
Two synthetic peptides for each of rabbit IL-2, IL-4, IL-6, IL-10 and IFNy were 
designed with assistance from Dr H. Perkins (School of Biochemistry and Molecular 
Biology, ANU) and Dr P. Kerr (CSIRO Sustainable Ecosystems). Peptides were 
synthesized by the Biomolecular Resource Facility (JCSMR, Canberra, Australia). The 
names of each peptide are as follows; IL-2 helix B, IL-2 C/D loop, IL-4 helix A, IL-4 
helix C, IL-6 helix E, IL-6 tail, IL-10 C/D-hD, IL-10 Nterm, IFNy helix D, IFNy hb- 
B/C. Each peptide was modeled on the cytokine from which it was derived, using the 
3D structure viewer, Cn3D 4.0, available from the National Centre for Biotechnology 
Information (NCBI) (http://www.ncbi.nlm. nih.gov:80/Structure/CN3D/cn3d. shtml). 
Alignments of rabbit, rat, human and chicken sequences, where available, for each 
cytokine were aligned using ClustalW (http://ebi.ac.uk) using the settings listed in 
Section 2.10.6.
2.11.2 Immunization of Rats with Synthetic Peptides
2.11.2.1 Conjugation of Synthetic Peptides to mcKLH
Each synthetic peptide was conjugated to mariculture keyhole limpet hemocyanin 
(mcKLH) using the Imject® Maleimide Activated mcKLH kit (Pierce) as per the 
manufacturer’s instructions. Components in the solutions were not defined by the
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manufacturer. Briefly, 2 mg of each peptide was dissolved in a 300 pi volume of 
conjugation buffer. The IL-2 helix B, IL-2 C/D loop, IL-4 helix A, IL-4 helix C, IL-6 
helix E and IFNy hb-B/C synthetic peptides were not soluble in conjugation buffer so 
were dissolved in guanidine (Sigma) or DMSO, as listed in Table 2.2. For each 
synthetic peptide, 2 mg of carrier protein was dissolved in 200 pi ddEEO and added to 
the dissolved synthetic peptide. The carrier protein and synthetic peptide were mixed for 
2 h at RT on a rocker.
Tab l e  2.2. Solub ilit y  of  Synthe tic  Pep ti des
S y n th etic
P ep tid e
S o lu b ility
IL -2  h elix  B Soluble in 10% 7 M guanidine
IL -2  C /D  loop Partially soluble in 7 M guanidine
IL -4  h elix  A 5 M guanidine
IL -4  h elix  C 20% DMSO
IL -6  h elix  E Partially soluble in 7 M guanidine
IL -6  ta il Imject® Conjugation buffer (Pierce)
IL -1 0  C /D -h D Imject® Conjugation buffer (Pierce)
IL -1 0  N term Imject® Conjugation buffer (Pierce)
IF N y  h elix  D Imject® Conjugation buffer (Pierce)
IF N y  h b -B /C Soluble in 10% 7 M guanidine
Conjugated synthetic peptides were separated from unconjugated synthetic peptides and 
carrier proteins by column chromatography. Each D-Salt Desalting column was washed 
with 5 column volumes of Imject® purification buffer (Pierce) prior to addition of 500 
pi of the synthetic peptide/carrier protein mixture. A separate column was used for each 
synthetic peptide. Aliquots of 500 pi of Imject® purification buffer were added to the 
column to elute the conjugated peptides. Fractions of 500 pi were collected and the 
absorbance at 280 nm of each fraction was determined. The fractions with the conjugate
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(as shown by increased absorbance) were pooled. The pooled fractions were; passed 
through a 0.22 pm filter and stored at -20°C. The columns were reconstituted by 
washing with five column volumes of ddFfoO and were stored at 4°C.
2.11.2.2 Rat Breeds and Housing
Female Wistar rats older than 6 weeks were obtained from the JCSMR Specific 
Pathogen Free Animal Facility (Canberra, Australia) and housed and cared for at the 
School of Biochemistry and Molecular Biology, ANU, using standard housing and care 
practices. All animal work followed ANU guidelines for animal usage md was 
approved by the ANU Animal Experimentation Ethics Committee.
2.11.2.3 Inoculation Protocol
Each peptide-conjugate was thawed at 37°C. An equal volume of peptide-conjigate and 
Freunds incomplete adjuvant (GibcoBRL) was mixed by pipetting and vorte>ing until 
an emulsion was formed. The peptide-conjugate emulsion (100 pi) was injected 
subcutaneously into each rat behind each shoulder; thus, each rat was injected with a 
total of 200 pi. Two rats were used for each peptide-conjugate. Rats were boosed twice 
with the same volume of peptide-conjugate emulsion at fortnightly intervals. Eich boost 
was accompanied by a tail bleed (~50 pi of blood was collected) and the collected sera 
were analyzed for the presence of antibodies specific for the particular cytokne from 
which the peptide was derived. Two weeks after the last boost, the rits were 
anaesthetized using chloroform and blood collected by cardiac puncture. Di P. Ken- 
assisted with blood collection. The blood was left to clot at 4°C overnight afer which 
the samples were centrifuged at 14,000 rpm in a micro fuge and the sera remcved. The 
sera were stored at -20°C.
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2.11.3 Analysis of Rat Sera for Recognition of Rabbit 
Cytokines
2.11.3.1 Preparation of Plasmid DNA Expressing Rabbit Cytokines
Glycerol stocks of DH5a E. coli cells transformed with plasmids expressing rabbit IL-2, 
IL-4, IL-6, IL-IO or IFNy were obtained from Dr H. Perkins and Ms B. Inglis. Each 
cytokine gene had been cloned into pcDNA3.1 vector under the control of the 
immediate early cytomegalovirus promotor and with signal sequences for expression in 
mammalian tissue culture systems. Each gene was cloned such that it was in frame with 
a six-Histidine tag. Glycerol stocks of the transformed DH5a E. coli cells were thawed 
slowly on ice. One loop of cells was transferred to 20 ml of LB broth and grown 
overnight at 37°C in a shaking incubator. A larger culture volume was used than that in 
Section 2.10.4.5 to enable greater replication of E. coli, and thus the plasmid. Plasmid 
DNA was isolated from the culture using the DNA plasmid miniprep kit (Qiagen) as per 
the manufacturer’s instructions. Details of this protocol are outlined in Section 2.10.4.5. 
The concentration of plasmid DNA was determined by measuring absorbance at 260 nm 
as described in Section 2.10.4.5 and the DNA was stored at -20°C.
2.11.3.2 Transfection of Vero Cells
Vero cells were seeded at 0.8x106 cells per well in a 24-well plate. Plates were 
incubated overnight in a humidified incubator at 37°C and 5% CO2 in air. Vero cells 
were transfected with plasmid DNA produced in Section 2.11.3.1. For each well 
transfected, the volume of DNA stock containing 2 pg of plasmid DNA was made up to 
50 pi with MEM. In a separate tube, 3 pi of Lipofectamine 2000 (Invitrogen) per well 
was added to MEM to a final volume of 50 pi per well. The plasmid DNA/MEM and
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Lipofectamine/MEM solutions were incubated separately at RT for 5 min. The plasmid 
DNA/MEM solution was then added to the Lipofectamine/MEM solution and these 
solutions were incubated together for 20 min at RT. The Vero cell monolayers were 
washed twice with MEM, after which 100 pi of plasmid DNA/Lipofectamine solution 
was added to each well. An additional 200 pi of MEM supplemented with 10% FCS 
was added per well and the cells incubated in a humidified incubator at 37°C and 5% 
CO2 in air, for 24 h.
2.11.3.3 Detection of Rabbit Cytokines by Immunofluorescence
Vero cell monolayers transfected with plasmid-expressing rabbit cytokines (Section 
2.11.3.2) were washed twice with PBS and incubated at RT for 10min in 200 pi of 
methanol .-acetone (1:1). The cells were then washed twice with PBS and incubated with 
200 pi of the primary antibody. Primary antibody was either the rat serum specific for 
the cytokine the cells had been transfected with (test samples) or sera from rats’ not 
immunized (negative control). The primary antibodies were diluted 1:20 in 3% 
BSA/PBS. The anti-His (C term) antibody (Invitrogen) diluted 1:500 in 3% BSA/PBS 
was used as the positive control. The plates were incubated at RT for 2 h on a platfomi 
rocker after which the monolayers were washed three times with 3% BSA/PBS. 
Secondary antibody, diluted 1:40 in 3% BSA/PBS, in a volume of 200 pi was added to 
each well. For the rat sera the secondary antibody was anti-rat Ig-FITC (Silenus) and for 
the anti-His C-term antibody, the secondary antibody was anti-mouse Ig-FITC 
(Silenus). The plates were incubated in the dark for a further 1 h before being washed 
three times with 3% BSA/PBS. Fluorescence of the monolayers was examined using a 
Fluorvert FS (Leica) fluorescence microscope. Photographs were taken of the cell 
monolayers using a Wild MPS 46/52 Leica camera.
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To determine if antibodies specific for murine IL-2 and IL-10 cross-reacted with rabbit 
cytokines, a 1:20 dilution of anti-mouse IL-2, anti-mouse IgG IL-10 or anti-mouse IgM 
IL-10 (obtained from Dr A. Ramsay, JCSMR, Canberra, Australia) in 3% BSA/PBS 
was used as the primary antibody in place of the rat sera. The negative control was 
mouse ascites fluid (1:20 dilution in 3% BSA/PBS) and the secondary antibody was 
anti-mouse Ig-FITC. The anti-His C-term antibody was used, as described in the 
previous paragraph, as the positive control.
2.11.4 Immunization of Chickens with Synthetic IL-2 Peptides
As no positive staining of rat sera was detected for synthetic peptides derived from IL-2, 
production of anti-rabbit IL-2 antibodies was attempted in chickens.
2.11.4.1 Chicken Breeds and Housing
Chickens were obtained from Bellchamber Produce, Fyshwick (ACT). Chickens were 
housed at the Research School of Biological Sciences Animal Facility (ANU) using 
standard housing and care practices. All animal work followed ANU guidelines for 
animal usage and was approved by the ANU Animal Experimentation Ethics 
Committee.
2.11.4.2 Inoculation Protocol
Approximately 3 ml of blood was collected from the superficial vein under the wing of 
each chicken prior to inoculation. Chickens were inoculated at two sites in the thigh 
muscle with 100 pi of either IL-2 helix B or IL-2 C/D loop conjugated to mcKLH, 
emulsified with Freund’s incomplete adjuvant, prepared as for the rat inoculations 
(Section 2.11.2.3). Therefore, each chicken was inoculated with a total of 200 pi of
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emulsion. The chickens were boosted with the peptide-conjugate emulsion after four 
weeks and again two weeks later. To test the progress of the immunization protocol, the 
chickens were bled (~1 ml) from the superficial vein on the underside of the wing, prior 
to the second boost. Two chickens were inoculated with each synthetic peptide.
2.11.4.3 Infection of Vero Cells with SLS-IL2 and Examination for 
Antibodies to IL-2
Infection of cells with a recombinant myxoma virus (SLS) that expressed rabbit IL-2 
(Junankar 1999) was used as a source of rabbit IL-2 to test for the presence of specific 
antibodies in the chicken sera. Vero cells were seeded in 24-well plates, at a 
concentration of 2x1 O'1 cells/well and incubated overnight in a humidified incubator at 
37°C and 5% CO2 in air. Media was aspirated from each well. A moi of 1 of 
recombinant SLS-expressing rabbit IL-2 was added to each well in a total volume of 
100 pi of complete MEM. The plates were incubated at 37°C for 1 h with frequent 
agitation. After this time, an additional 1ml of complete MEM was added and the plates 
incubated for 24 h in a humidified incubator at 37°C and 5% CO2 in air.
Monolayers were examined for IL-2-specific antibodies as described in Section 
2.11.3.3. The primary antibodies used for immunofluorescence were either the anti-
myxoma virus monoclonal antibody (3b6e4) diluted 1:800 in 3% BSA/PBS as the 
positive control, or the chicken sera diluted 1:20 in 3% BSA/PBS as the test samples. 
The negative control was the sera taken from each chicken prior to immunization. 
Primary antibody binding was detected using anti-mouse-FITC or anti-chicken-FITC 
(Sigma) at a dilution of 1:40 in 3% BSA/PBS. Fluorescence was analyzed using a 
Fluorvert FS (Leica) fluorescence microscope and photographs were taken of the cells 
using a Wild MPS 46/52 Leica camera.
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2,11,5 DNA Immunization of Rats
Due to the lack of success in producing anti-rabbit IL-2 antibodies using synthetic 
peptide-conjugates, DNA immunization of rats using a plasmid containing the rabbit IL- 
2 gene was performed.
2.11.5.1 Preparation of Plasmid DNA for Immunisation
The plasmid expressing rabbit IL-2 under the CMV promoter, pMagicIL-2, was 
obtained from Mr M. Adams (School of Biochemistry and Molecular Biology, ANU). 
The concentration of the plasmid stock was determined by measuring the OD260- A 400 
pi aliquot of the plasmid stock was taken and added to l ml of 100% ethanol and 40 pi 
of 3 M Na acetate. The mixed sample was incubated on ice for 10 min and centrifuged 
at 14,000 rpm in a microfuge for 15 min. The DNA pellet was washed twice with 70% 
ethanol and resuspended in sterile saline such that 100 pi of solution contained 50 pg of 
DNA.
2.11.5.2 Inoculation Protocol
Female Wistar rats were obtained and housed as previously described (Section 
2.11.2.2). A 100 pi solution of saline containing 50 pg of plasmid DNA was injected 
intramuscularly into two sites on each of two rats. Rats were bled after two weeks and 
boosted twice at two-week intervals using the peptide-conjugate emulsion as described 
in Section 2.11.2.3. The boost in this case was similar to previous inoculations of 
peptide-conjugates except that both IL-2 conjugates were added in the same emulsion. 
Therefore, each rat had a total of 100 pi of Freund’s incomplete adjuvant and 50 pi of 
each IL-2 peptide-conjugate. Rats were then tail bled (Section 2.11.2.3) and the sera 
tested for antibodies specific for rabbit IL-2 as described in Section 2.11.3.
91
Chapter 2- Materials and Methods
2.12 Ch a r a c t e r iz a t io n  o f  Rat  Sera
Only rat sera positive for rabbit cytokines were characterized. Sera were titrated on 
transfected Vero cell monolayers to determine optimal working dilutions for 
immunofluorescence. Immunoblot analysis and flow cytometric analysis of the sera 
were also performed. The results for antibody characterization are presented in chapter 
6.
2.12.1 Titration of Rat Sera
Vero cell monolayers were transfected and analyzed as described in Section 2.11.3.2 
and Section 2.11.3.3. Rat sera were used as the primary antibody and were diluted 1:20, 
1:40, 1:100 or 1:500 in 3% BSA/PBS. The secondary antibody (anti-rat lg FITC) was 
used at a 1:40 dilution. Photographs were taken of the monolayers to analyse 
fluorescence using a Fluorvert FS fluorescence microscope and Wild MPS 46/52 Leica 
camera.
2.12.2 Immunoblot Analysis of Rat Sera
Western analysis of the rat sera was performed. Samples for analysis were prepared 
from either cells infected with recombinant myxoma virus-expressing rabbit cytokines 
(described in Section 2.12.2.1) or from cells transfected with plasmid DNA-expressing 
rabbit cytokines (described in Section 2.12.2.2).
2.12.2.1 Preparation of Samples from Virus-Infected Cells
RK13 cells were seeded at 0.8x106 cells/well in 6-well plates and grown overnight in a 
humidified incubator at 37°C and 5% CO2 in air. Monolayers were washed three times
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with MEM. Cells were infected with a moi of 1 of recombinant myxoma viruses 
expressing one of IL-4, IL-6, IL-10 or IFNy (obtained from Dr H. Perkins and Ms B. 
Inglis) for 1 h at 37°C with frequent agitation. After this initial infection, the unbound 
virus was removed from the cells, by washing three times with MEM. MEM (1 ml) was 
added to each well and the cells incubated for 48 h in a humidified incubator at 37°C 
and 5% CO2 in air. After this time the supernatants were collected and the monolayers 
were frozen. Processing of supernatants and monolayers are described in the following 
sections.
2.12.2.1.1 Processing ,of Supernatants from Virus-Infected Cells
Five volumes of cold acetone were added to each supernatant sample to precipitate the 
protein. The samples were incubated at -20°C for 10 min, then centrifuged at 10,000 
rpm at 4°C for 5 min in a Sorvall SS-34 rotor. The supernatants were discarded and the 
precipitate washed again with cold acetone and centrifuged as above. The supernatants 
were again removed and the precipitate left to air dry, then resuspended in 100 pi of 2x 
sample loading buffer (62.5 mM Tris, 10% glycerol, 2% SDS, 0.04% bromophenol blue 
(Sigma)) and stored at -20°C.
2.12.2.1.2 Processing Cell Monolayers from Virus-Infected Cells
The cell monolayers were thawed and 200 pi of 2x sample loading buffer was added to 
each well. The bottom of each well was scraped and the cell extracts removed and 
boiled for 5 min to denature the cellular DNA. The cell extracts were stored at -20°C.
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2.12.2.2 Preparation of Samples from Transfected Cells
Rat anti-rabbit antibodies specific for IL-6 and IFNy could not be detected when virus- 
infected cells were used as the source of antigen. As an alternative source of antigen, 
COS-7 cells were transfected with pcDNA3.l containing IL-6 or IFNy as detailed in 
Section 2.11.3.2 for Vero cells, except complete DMEM was used as the media. 
Transfected COS-7 cells were incubated for 48 h, after which the supernatants were 
removed and processed as described in Section 2.12.2.1.1. The monolayers were 
processed as described in Section 2.12.2.1.2. One well from each transfection was 
analyzed for transfection efficiency as described in Section 2.11.3.3 using rat sera 
previously shown, by immunofluorescence to contain antibodies specific for rabbit IL-6 
or IFNy.
2.12.2.3 Fractionation of Supernatants and Cell Extracts by SDS- 
PAGE
Protein extracted from supernatants and cell extracts were fractionated by SDS- 
polyacrylamide gel electrophoresis (SDS-PAGE) in non-reducing and reducing 
conditions. A 9% resolving gel was made from 2.5 ml of resolving gel buffer (0.4% 
SDS, 1.5 M Tris), 3 ml of 30% bis/acrylamide (Amresco), 4.5 ml of ddFLO, 50 pi of 
10% ammonium persulphate (APS) (Bio-Rad) and 5 pi of Temed (Bio-Rad). The 
resolving gel was poured into a mini-gel former (Bio-Rad) and ddHEO was layered on 
top. Once the gel was set, the water was removed and a 3.6% stacking gel poured on 
top. The stacking gel consisted of 1.25 ml of stacking gel buffer (0.4% SDS, 0.5 M 
Tris), 600 pi of 30% bis/acrylamide, 3.25 ml of ddFEO, 50 pi of 10% APS and 5 pi of 
Temed. A 10 well comb was placed in the stacking gel, which was left to set.
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For non-reduced samples, 20 pi of protein samples at RT, were loaded onto the gel. For 
reduced samples, 2 pi of 1M dithiothreitol (DTT) (Sigma) was added to 20 pi of 
sample, which was then boiled for 5 min prior to loading on the gel. Pre-stained 
Benchmark protein ladder (Invitrogen), 5 pi, was also loaded onto a lane of each gel. 
The SDS-PAGE gels were run with Tris-glycine running buffer (12 mM Tris, 96 mM 
glycine (Merck), 1.7 mM SDS) at 100 V for approximately 60 min using the Mini- 
Protean II system (Bio-Rad). The gels were either stained as described in Section
2.12.2.4 or transferred to a PDVF membrane as described in Section 2.12.2.5.
2.12.2.4 Protein Detection by Staining SDS-PAGE Gels
The protein gels were initially stained with Coomassie brilliant blue stain (l g of 
brilliant blue dye (Progen) in 550 ml of methanol:acetic acid: ddffO 5:1:5 v:v:v) 
overnight on a rocker and subsequently destained with destaining solution (25% ethanol 
(Merck), 10% acetic acid in ddFfO). The gels were then silver stained using the Bio- 
Rad silver stain kit according to the manufacturer’s instructions. Components of each 
solution in the kit were not specified. Briefly, the gels were fixed in 200 ml of 40% 
methanol/10% acetic acid for 60 min, then twice in 200 ml of 10% ethanol/5% acetic 
acid for 30min. The oxidizer solution was prepared according to manufacturer’s 
instructions. The gels were incubated for 10 min in 100 ml of oxidizer before being 
washed three times, each in 200 ml of ddFfO for 10 min. The silver reagent was also 
prepared as per the manufacturer’s instructions and the gels incubated in 100 ml of 
silver reagent for 30 min. After this time the gels were washed once in 200 ml of ddFfO 
for 2 min. To visualize the protein bands, 100 ml of developer solution was added and 
the gels incubated for approximately 2 min at RT, at which point the developer solution 
was discarded and 100 ml of fresh developer solution was added. The gels were
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incubated for a further 5 min at RT and the developer solution again changed. To stop 
development, 200 ml of 5% acetic acid solution was added.
2.12.2.5 Electroblotting of Protein to a PDVF Membrane
Proteins were transferred to a PDVF membrane (Millipore) using a Hoefer TE 70 semi-
dry transfer unit according to the manufacturer’s instructions. The transfer stack was 
assembled containing 9 sheets of 3MM paper soaked in transfer buffer (25 mM Tris, 
192 mM glycine, 20% methanol, pH 8.3), PDVF membrane (prewet with methanol and 
then with transfer buffer), the protein gel and an additional 9 sheets of 3 MM paper 
soaked in transfer buffer. The transfer was run for 1 h at 40 mA with the voltage capped 
at 50 V. After 1 h, the membrane was stained with 0.5% Ponceau S solution (Gelman 
Sciences) for 5 min and subsequently destained with dd^O  to check for transfer of 
protein.
2.12.2.6 Immunodetection of Cytokines
Membranes were incubated in 10% (w/v) skim milk in TBS buffer (137 mM NaCl, 2.7 
mM KC1, 25 mM Tris) overnight at 4°C. The membranes were washed at RT three 
times with TTBS buffer (100 pi of Tween 20 in 100 ml TBS) for 5 min and once with 
TBS for 5 min. Membranes were then incubated with primary antibody in antibody-
binding buffer (1% skim milk and 50 pi Tween 20 in 100 ml TBS). Rat sera that had 
tested positive in Section 2.11.3.3 were used as the primary antibody and were diluted 
1:200 in 10 ml of antibody binding buffer. As a positive control for samples from virus- 
infected cells, polyclonal anti-myxoma virus rabbit serum was used, diluted 1:5,000 in 
10 ml of antibody binding buffer. For samples prepared from transfected cells, anti-His 
C-term antibody was used diluted 1:5,000 in 10 ml of antibody binding buffer. After the
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addition of the primary antibody, membranes were incubated at RT on a platform rocker 
for 2 h. Next, the membranes were washed once for 10 min with TTBS then three times 
for 5 min with TTBS and finally, once for 5 min with TBS. All washes were done at RT 
with agitation. Secondary antibody was prepared (1:1,000 dilution in 10 ml of antibody 
binding buffer). For the rat sera this was anti-rat-HRP (Silenus), for the polyclonal anti-
myxoma virus rabbit serum this was anti-rabbit-HRP and for anti-His C-term antibody 
this was anti-mouse-HRP (Silenus). Membranes were incubated in 10 ml of secondary 
antibody solution for 1 h at RT on a platform rocker, before being washed once with 
TTBS for 10 min then three times for 5 min with TTBS. The final wash was for 5 min 
in TBS. Detection of the bound FIRP antibody was done using either enhanced 
chemiluminescence (ECL, Amersham Pharmacia Biotech) (described in Section 
2.12.2.8.1) or SigmaFast (3,3’-diaminobenzidine (DAB) peroxidase substrate) (Sigma) 
(described in Section 2.12.2.8.2).
2.12.2.7 Stripping and Re-probing Membranes
Membranes were stripped in 100 mM ß-mercaptoethanol, 2% SDS and 62.5 mM Tris at 
50°C for 30 min with agitation. The membranes were then washed twice for 10 min 
each with TTBS and blocked in 10% skim milk in TBS for 1 h at RT on a platform 
rocker. The membranes were washed once more with TTBS and once with TBS before 
detection using ECL (as described in Section 2.12.2.7.1) to confirm stripping success.
If no binding was evident on the membranes, they were re-probed with a different 
primary antibody and processed as detailed in Section 2.12.2.6.
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2.12.2.8 Visualization of Rabbit Cytokines
2.12.2.8.1 ECL Detection
ECL is a non-radioactive method for detection of proteins conjugated directly or 
indirectly with horseradish peroxidase-labeled (HRP-labeled) antibodies. Briefly, an 
equal volume of detection solution 1 (Amersham Pharmacia Biotech) and detection 
solution 2 (Amersham Pharmacia Biotech) were mixed, poured onto the protein-bound 
side of the membrane and incubated for precisely 1 min at RT. The excess detection 
reagent was then drained and the membrane wrapped in cling wrap and placed in a film 
cassette. Under a safelight in a dark room, a piece of autoradiography film was placed 
on top of the membrane and the cassette closed. Initial exposure was for 15 sec and the 
film was developed immediately in an automatic film processor (Kodak). Once the film 
had been developed other exposure times were used depending on the signal strength.
2.12.2.8.2 SigmaFast Detection
Bound secondary antibody conjugated to HRP was also detected using the SigmaFast 
kit. After washing the unbound secondary antibody from the membrane as described in 
Section 2.12.2.6, membranes were incubated in 10 ml of SigmaFast solution for 10-30 
min until protein bands were visualized. SigmaFast solution was made according to the 
manufacturer’s instructions; one of each 3,3’diaminobenzidine tablet set was dissolved 
in 5 ml of ddHfO. The reaction was stopped by the addition of 10 ml of ddfUO.
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2.13 Flo w  Ana l ys is  of  Ra bb it  Cy t o k in e s
Flow cytometric analysis was undertaken to investigate whether the rabbit cytokine 
anti-sera could be used as a tool for examining the response of lymphoid cells to 
myxoma virus infection. The results from this section are described in chapter 6.
2.13.1 Optimization of IFNy Detection in RL-5 Cells Using Flow 
Cytometry
RL-5 cells constitutively express IFNy (Seto et al., 1997) and so were used to optimize 
experimental conditions for detection of cytokines in rabbit lymphocytes by flow 
cytometry. RL-5 cells, 2xl06 per well, were seeded in a 24-well plate and incubated 
overnight with and without 5 pg/ml Brefeldin A (Bref A) (Sigma). Bref A reduces 
secretion of proteins from the cell by inhibiting their movement from the Golgi 
apparatus. As cytokines are secreted proteins, Bref A was used to sequester cytokines 
for intracellular detection. RL-5 cells were also incubated with and without 5 pg/ml Con 
A to determine whether stimulation with Con A activated signaling pathways involved 
in IFNy expression that were potentially not constitutively activated.
RL-5 cells were harvested and centrifuged at 270xg and resuspended in 100 pi of PBS. 
To permeabilise the cells, 400 pi of methanol:acetone (1:1) was added and the cells 
incubated for 10 min at RT. The cells were then washed twice with PBS and 
resuspended in 100 pi of primary antibody. The primary antibody, either normal rat 
serum or serum from rats inoculated with IFNy hb-B/C was diluted 1:20 in 0.1% 
BSA/PBS. As controls, two additional RL-5 cell samples were resuspended in 100 pi of 
0.1% BSA/PBS without either serum. Cells were incubated at 37°C for 1 h, after which
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they were washed twice with 0.1% BSA/PBS. Samples with either normal rat serum or 
IFNy hb-B/C rat serum and one of the control samples were resuspended in 1:40 
dilution of anti-rat-FITC (Silenus) in 0.1% BSA/PBS. The second control sample was 
resuspended in 100 pi of 0.1% BSA/PBS without secondary antibody. Cells were 
incubated at RT in the dark for 30 min. Prior to analysis on a Becton Dickinson 
FACSort flow cytometer, 500 pi of PBS was added to each sample. Instrument settings 
for the flow cytometer were FSC- voltage E-l, AmpGain 9.17, Mode Lin; SSC- voltage 
203, AmpGain 1, Mode Log; FL1-PI- voltage 443, AmpGain 1, Mode Log. IFNy 
expression was analyzed as histogram overlays of FL1-H (IFNy expression), which 
were generated using the CellQuest software.
2.13.2 Analysis of IFNy in RL-5 Cells Infected with SLS or Ur
To determine whether IFNy could be detected in cells infected with myxoma virus, 
2xl06 RL-5 cells were infected with SLS or Ur at a moi of 3 as described in Section 
2.3.3, and incubated for 24 h with or without 5 pg/ml Bref A in a humidified incubator 
at 37°C and 5% CO2 in air. IFNy expression was examined as described in Section 
2.13.1.
The results showed that normal rat serum non-specifically bound to cells when cell 
cultures had been infected with SLS or Ur. To try to reduce this non-specific binding, 
different permeabilisation and blocking techniques were tried.
2.13.2.1 Examination of Different Permeabilising Solutions
In all earlier experiments methanol:acetone had been used to permeabilise cells. To 
examine the effects of other permeabilisation techniques, RL-5 cells were infected with
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SLS at a moi of 3 (Section 2.3.3) and either methanol:acetone, 70% ethanol or buffered 
formaldehyde acetone (BFA) (0.05 mM Na2HPC>4, 0.7 mM KH2PO4, 45% acetone, 25% 
formalin, pH6.8) was used for permeabilisation. Samples were analyzed for IFNy 
expression as described in Section 2.13.1.
2.13.2.2 Blocking Non-Specific Binding With Fetal Calf Serum or High 
Concentrations of BSA
RL-5 cells were infected and permeabilised with methanohacetone, 70% ethanol or 
BFA. After permeabilisation, samples were incubated with 1:10 dilution of fetal calf 
serum (FCS) in PBS for 1 h at 37°C. The samples were washed twice with 0.1% 
BSA/PBS before being resuspended in primary antibody and analyzed for IFNy 
expression by flow cytometry as described in Section 2.13.1. This experiment was also 
repeated two more times using 1% BSA/PBS and 3% BSA/PBS instead of 0.1% 
BSA/PBS for antibody dilutions and for washing cells.
2.14 Immu n o f l u o r e s c e n c e  of  T issue  Se c t io ns  From  Ra bb it s  
Inf ec t ed  w it h  My x o ma  V irus
To analyze the immune response to myxoma virus in vivo, the expression of IFNy and 
IL-4 in lymph node sections from laboratory and wild rabbits infected with SLS or Ur 
four days post infection were examined.
2.14.1 Sectioning Tissues for Analysis
Lymph nodes from laboratory and wild rabbits infected with SLS or Ur were used for 
analysis. Rabbit lymph nodes draining the virus inoculation site and contralateral lymph
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nodes held at -70°C in Tissue-Tek (Sakura) blocks were obtained from Dr P. Kerr. 
Sections of 5-7 jam were cut using a cryostat and placed on microscope slides that had 
been coated with 0.01% poly-L-lysine (Merck) (v/v in ddlT^O) and air dried. Slides were 
labeled and fixed by immersing in formyl-calcium (10% formaldehyde (40%) (Merck), 
10% 1 M CaCb (Merck) in ddFfO) for 5 min, dipping in cold acetone, immersing in 
chloroform: acetone (1:1) for 5 min at -20°C, dipping in cold acetone and washing twice 
in PBS. The slides were air dried and stored at -70°C.
2.14.2 Immunodetection of Rabbit Cytokines
Prior to immunodetection of rabbit cytokines, tissue sections were blocked overnight in 
3% BSA/PBS, washed once with 1% BSA/PBS then three times with 0.01% Tween 
20/PBS. Slides were placed in a humidified chamber and 100 pi of primary antibody 
diluted in 1% BS A/PBS was added. The primary antibodies used in these experiments 
were normal rat serum (negative control), anti-rabbit IL-4 helix A rat serum and anti-
rabbit IFNy hb-B/C rat serum (test samples) and the monoclonal antibody specific for 
anti-rabbit CD43 (positive control). The rat sera vveic diluted 1.40 m 1% BSA/rBS 
whereas the CD43 monoclonal antibody was diluted 1:200 in 1% BSA/PBS. Slides 
were incubated in a humidified chamber at 37°C for 2h. Sections were washed with 1% 
BSA/PBS and three times with 0.01% Tween 20/PBS. The secondary antibody (anti-rat- 
FITC or anti-mouse-FITC) was diluted 1:100 in 1% BSA/PBS, and 100 pi was added to 
each tissue section. The sections were then incubated in a humidified chamber at 37°C 
in the dark for 1 h. The slides were again washed once with 1% BSA/PBS and three 
times with 0.01% Tween 20/PBS before being mounted with FluoroGuard anti-fade 
(Bio-Rad) under a coverslip and examined using a confocal microscope. The results are 
presented in chapter 6.
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p values for chapter 3
Proportion o f Cells Infected
Con A significantly increased the proportion of cells infected, p values for this are 
shown in the table below.
Time (h) p value
4 <0.02
12 <0.00001
24 <0.0003
36 <0.00001
48 <0.00001
72 <0.002
The proportion of Ur-infected cells dropped significantly at 72 h, with a p value <0.02
The proportion of cells infected with SLS or Ur when lymphoid cell cultures from 
laboratory and wild rabbits were stimulated with Con A for 4 h prior to infection was 
significantly lower compared to cell cultures stimulated for longer periods prior to 
infection, with a p value <0.001
Viral Replication
Con A significantly increased the titre of SLS. The p values for this are shown in the 
table below. The increase in Ur titres as a result of Con A activation was only 
significant in domestic rabbits (p<0.03).
Time (h) p value
4 n o t s ig n ific a n t
12 n o t s ig n ific a n t
24 <0.003
36 <0.00001
48 <0.00001
72 <0.00001
Viral titres in wild rabbit lymphoid cell cultures were significantly lower than those in 
domestic rabbit lymphoid cell cultures. The p values for this are shown in the table 
below.
Time (h) p value
4 <0.0004
12 <0.0006
24 <0.03
36 <0.00001
48 <0.0003
72 <0.00001
3.1 Introduction
3.1 In t r o d u c t i o n
Following the introduction of myxoma virus into the Australian wild rabbit population 
in the 1950s there was a rapid selection for rabbits that were genetically resistant to 
myxomatosis. The development of this resistance in rabbits has been well described 
(Fenner et al., 1953; Myers et al., 1954; Marshall and Fenner 1958; Marshall and 
Douglas 1961). More recently, the pathogenesis of myxoma virus in resistant rabbits has 
been experimentally examined and compared to that in susceptible rabbits (Best et al., 
2000; Best and Kerr 2000). Although these studies put forward a model for resistance of 
rabbits to myxomatosis, no mechanism for resistance has been experimentally 
identified. Because of the major role of lymphocytes play in the pathogenesis of 
myxomatosis, it may be postulated that any decrease in the permissivity of lymphocytes 
for myxoma virus replication diminishes the severity of clinical disease (Fenner and 
Woodroofe 1953; Best and Kerr 2000). This is supported by other studies which have 
shown that myxoma viruses that are unable to replicate in lymphocytes, due to the 
insertional inactivation of genes that are essential for virus replication, have an 
attenuated phenotype in susceptible European rabbits (reviewed in Kerr and McFadden 
2002; Zuniga 2002). The permissivity of lymphocytes from resistant wild rabbits to 
myxoma virus replication has been examined in unstimulated cells (Best and Ken- 
2000). The aim of this chapter is to further investigate the relationship between 
lymphocyte permissivity and resistance of rabbits to myxomatosis.
Outside the skin, T-cells have been proposed to be the primary cell for myxoma virus 
replication and dissemination in vivo (Best and Ken 2000). This is because myxoma 
virus antigen is detected in T-cell zones of the lymph node of infected rabbits (Best et 
al., 2000) and myxoma virus replicates in the rabbit CD4+ T-cell line, RL-5 (Barry et 
al., 1995; Macen et al., 1996; Bany and McFadden 1997).
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Additionally, MRV, a laboratory recombinant between myxoma virus and a small 
component of Shope fibroma virus (SFV), replicates in T-cells in vitro and is able to 
disseminate in O. cuniculus, whereas SFV does not replicate in T-cells and does not 
disseminate in O. cuniculus (Strayer et al., 1985). These studies indicate an association 
between replication in lymphocytes and dissemination in vivo.
T-cell permissivity for myxoma virus replication may be controlled at several stages of 
infection: attachment of the virion to the cell surface, entry of the virion into the cell, 
early and late viral gene transcription and translation, virion assembly and maturation 
and virion egress. Differences in permissivity between lymphocytes from susceptible 
and resistant rabbits to virus replication could be due to obstruction at any one of these 
stages. Best and Kerr (2000) have previously examined the permissivity of lymphocytes 
from resistant rabbits to myxoma virus replication. This study did not detect any in vitro 
difference in either virus replication (measured by plaque assay) or in the proportion of 
cells expressing a late viral protein (measured by immunofluorescence) in primary 
fibroblast and lymphocyte cultures from laboratory and wild rabbits (Best and Kerr 
2000).
However, in hindsight and in the light of other evidence discussed below, a more 
extensive investigation is warranted to examine differences between lymphocytes from 
laboratory and wild rabbits in their permissivity for myxoma virus replication. Firstly, 
lymphoid cells in the Best and Kerr (2000) study were not stimulated with mitogen. 
Mitogen stimulation activates multiple cell signaling pathways, and has been shown to 
increase cell permissivity to myxoma virus infection (Lalani et al., 1999). Activation of 
cells in this way may enhance in vitro differences between lymphoid cells from 
susceptible and resistant rabbits that are too small to be detected in the absence of
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activation. Activation of T-cells is an important part of the anti-viral immune response 
(reviewed in Sloan-Lancaster and Allen 1996; Hollsberg 1999; Bi and Altman 2001; 
Sims and Dustin 2002). Hence, any differences between activated lymphocytes from 
susceptible and resistant rabbits in permissivity for virus replication may considerably 
affect the outcome of myxoma virus infection.
Secondly, Best and Kerr (2000) only tested the virulent SLS strain of myxoma virus. 
The use of an attenuated strain of myxoma virus may increase the sensitivity of the 
assay for detecting small differences in permissivity between lymphocytes from 
susceptible and resistant rabbits. Finally, the proportion of lymphoid cells infected with 
myxoma virus was estimated by microscopic examination of cells for
immunofluorescence staining for a late viral protein. A more sensitive quantitative 
analysis, for example, by using flow cytometry, may enhance the detection of 
differences in virus replication in infected lymphocytes from susceptible and resistant 
rabbits. Therefore, the hypothesis that lymphocytes from genetically resistant rabbits are 
less permissive for myxoma virus replication than lymphocytes from susceptible 
rabbits, would be more comprehensively tested in experiments incorporating these 
parameters.
To test this hypothesis, the following questions were addressed;
1) Can resistance of rabbits to myxomatosis be attributed to differences between 
lymphoid cells from susceptible and resistant rabbits in their permissivity to 
myxoma virus replication?
2) Does mitogen stimulation affect the permissivity of lymphoid cells to myxoma 
virus replication?
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In these experiments, primary lymphoid cells isolated from lymph nodes of susceptible 
(laboratory) and resistant (wild) rabbits were infected in vitro with either the virulent 
SLS or attenuated Ur strain of myxoma virus. Cell cultures were prepared from rabbit 
lymph nodes as described in chapter 2 (Section 2.1.6), and left overnight to remove 
adherent cells, such as monocytes and macrophages, which are known to be permissive 
for myxoma virus infection (Macen et ah, 1996; Mossman et ah, 1996; Everett et ah, 
2000). It has been estimated that -57% of cells in rabbit lymph nodes are T-cells and 
-37% are B-cells (Mage 1998). Thus, the lymphoid cell cultures prepared for this thesis 
would have consisted predominantly of T- and B-cells, but would also include small 
populations of other non-adherent cells, such as NK cells. Because T-cells are 
considered the main target of myxoma virus outside of the skin (Best and Kerr 2000), 
the effect of activation of lymphocyte signaling pathways on SLS or Ur infection was 
analysed by addition of the T-cell specific mitogen, Con A, to the lymphoid cell cultures 
from resistant and susceptible rabbits.
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3.2 Resu lt s
3.2.1 Permissivity of Rabbit Lymphoid Cells for Myxoma Virus 
Replication
The ability of the virulent SLS and attenuated Ur strains of myxoma virus to replicate in 
lymphoid cell cultures from laboratory (susceptible) and wild (resistant) rabbits was 
examined by measuring the titre of virus produced by the cultures and the proportion of 
lymphoid cells infected. Virus titre was determined by plaque assay on Vero cell 
monolayers. The proportion of cells infected was determined by flow cytometric 
analysis of cells immunofluorescently stained for a myxoma virus late protein using the 
monoclonal antibody, 3b6e4. To examine the effects of low and high moi, rabbit 
lymphoid cell cultures were infected with SLS or Ur at a multiplicity of infection (moi) 
of 0.1 or 3 plaque-forming units (pfu)/input cell. If all cells are equally permissive for 
infection, then a moi of 3 theoretically leads to approximately 95% of cells being 
infected with at least one pfu of virus, and a moi of 0.1 results in a low proportion of 
cells initially infected, with the virus able to spread from initially-infected cells to 
uninfected cells.
3.2.1.1 Replication of Myxoma Virus in Rabbit Lymphoid Cell 
Cultures
Lymphoid cells were infected with either SLS or Ur at a moi of 0.1 or 3 and analyzed 
for virus replication by plaque assay, 4, 12, 24, 36, 48 and 72 h post infection. Cultures 
were incubated with or without the T-cell mitogen, Con A. All experiments were 
replicated using lymphoid cell cultures prepared from three laboratory and three wild 
rabbits. Virus replication was expressed as mean pfu/input cell for each infection and
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data are presented as pfu/input cell over time. Statistical analysis of virus replication 
was by ANOVA with ap value <0.05 deemed significant.
3.2.1.1.1 SLS Titres in Unstimulated and Con A-Stimulated Lymphoid Cell 
Cultures from Laboratory and Wild Rabbits
Unstimulated lymphoid cell cultures from laboratory rabbits produced low titres (mean 
<5 pfu/input cell) of SLS regardless of moi (Figure 3.1 A and 3. IB, open squares, dotted 
line). In these infections, SLS titres remained negligible (<2 pfu/input cell) until 36 h 
post infection after which they increased to a mean of 5 pfu/input cell by 72 h (Figure
3.1 A and 3.IB). Unstimulated lymphoid cell cultures from wild rabbits appeared to be 
less permissive for SLS replication than those from laboratory rabbits, with the mean 
titre remaining less than 2 pfu/input cell for all time points for both moi (Figure 3.IE 
and 3.IF).
Con A stimulation significantly increased the titres of SLS produced by rabbit lymphoid 
cell cultures (p<0.05) (Figure 3.1 A, 3.IB, 3.IE and 3.IF filled square/circles, solid line). 
When lymphoid cell cultures from either laboratory or wild rabbits were infected with 
SLS at a moi of 0.1, titres increased after 24 h to reach a mean of 11 pfu/input cell by 72 
h (Figure 3.1 A and 3.IE). When a moi of 3 was used for the initial infection, SLS titres 
increased after the 12 h time point and plateaued at 36-48 h. By 72 h, there were 19 
pfu/input cell and 9 pfu/input cell for lymphoid cell cultures from laboratory and wild 
rabbits respectively (Figure 3.IB and 3.IF).
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Figure  3.1. Titre s  of  SLS and  Ur  in  Lymp ho id  Ce ll  Cul t ur es  f r o m 
Lab o ra tor y  an d  Wil d  Rab b it s
Primary lymphoid cells isolated from (A-D) laboratory or (E-H) wild rabbits were infected with 
either SLS, at a moi of 0.1 (A, E) or 3 (B, F), or Ur at a moi of 0.1 (C, G) or 3 (D, H). Samples 
were harvested 4, 12, 24, 36, 48 or 72 h post infection. The time course was undertaken in the 
presence (solid) or absence (open) of 5pg/ml Con A. Virus was released from the cells by 
freeze/thawing and sonication and titres determined by plaque assay on Vero cell monolayers. 
Graphs show results from lymphoid cell cultures prepared from three laboratory and three wild 
rabbits, with each point representing a different rabbit. Solid lines indicate the mean titre in Con 
A-stimulated lymphoid cell cultures, whereas dotted lines indicate the mean titre in unstimulated 
lymphoid cell cultures.
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3.2.1.1.2 Ur Titres in Unstimulated and Con A-Stimulated Lymphoid Cell 
Cultures from Laboratory and Wild Rabbits
In unstimulated lymphoid cell cultures from laboratory rabbits infected with Ur at a moi 
of 0.1 or a moi of 3, a mean titre of 2 and 6 pfu/input cell respectively, was reached 72 h 
post infection (Figure 3.1C and 3. ID). Infection of unstimulated lymphoid cell cultures 
from wild rabbits with Ur at a moi of 0.1 did not produce infectious virus particles to 
any extent over the 72 h time course (mean <1 pfu/input cell) (Figure 3.1G). Infection 
of unstimulated cell cultures from wild rabbits, with a moi of 3, produced a mean of 5 
pfu/input cell by 72 h (Figure 3.1H).
Con A significantly increased Ur titres only in lymphoid cell cultures from laboratory 
rabbits (p<0.05). In these cultures, Ur titres increased after 24 h to 20 pfu/input cell by 
72 h, when a moi of 0.1 was used (Figure 3.1C). In cultures infected with Ur at a moi of 
3, titres increased after 12 h and plateaued at 36 h with 18 pfu/input cell produced by 72 
h (Figure 3.ID). A similar increase in Ur titres was not observed in lymphoid cell 
cultures from wild rabbits as Ur titres remained less than 5 pfu/input cell for all 
infections at all time points (p<0.05) (Figure 3.1G and 3.1H). However, in the low moi, 
Con A stimulation tended to increase Ur titres when compared to unstimulated 
lymphoid cell cultures from wild rabbits, but this was not significant at the 95% 
confidence interval (Cl) (Figure 3.1G).
3.2.1.1.3 Summary of Myxoma Virus Replication
Using plaque assays to measure viral titre in Con A-activated lymphoid cell cultures 
from different rabbits gave varied results, as illustrated by the scattered data points. In 
spite of this variation, statistical analysis of the plaque assay results showed that Con A 
activation significantly increased SLS titres in cultures from both rabbit types. However
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for Ur infections, Con A activation only significantly increased viral titres in lymphoid 
cell cultures from laboratory rabbits. The lack of Ur replication in Con A-stimulated 
lymphoid cell cultures from wild rabbits clearly differentiated between the two rabbit 
types. In addition, the replication of myxoma virus was significantly less efficient 
overall in stimulated lymphoid cell cultures from wild rabbits than in lymphoid cell 
cultures from laboratory rabbits (p<0.05). These results suggest that the use of the 
virulent SLS strain in unstimulated cultures in previous studies (Best and Kerr, 2000) 
has masked potential differences in lymphocyte permissivity for myxoma virus 
replication between the two rabbit types. This will be discussed in more detail in 
Section 3.3.1.
Infection of cultures with the low moi resulted in a low proportion of cells initially 
infected compared to a moi of 3, where approximately 95% of cells would be infected 
with at least one pfu. Therefore, in cultures infected at the low moi, virus would have to 
spread from cell to cell. This would explain why viral titres were increased with Con A 
stimulation after 12 h in cultures infected with a moi of 3 and after 24 h in cultures 
infected with a moi of 0.1.
Lymphoid cell cultures from resistant rabbits were statistically significantly less 
permissive for virus replication than cell cultures from susceptible rabbits. This may 
have important implications for resistance to myxomatosis and will be considered 
further in the discussion to this chapter.
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3.2.1.2 Proportion of Rabbit Lymphoid Cells Infected with Myxoma 
Virus
The proportion of cells infected with myxoma virus was determined, using flow 
cytometry, by immunostaining infected lymphoid cells with a monoclonal antibody 
(3b6e4) specific for an intracellular myxoma virus protein expressed late in infection. 
Lymphoid cell cultures from laboratory and wild rabbits were mock-infected with 
medium or infected with SLS or Ur at a moi of 0.1 or 3. Cells were examined 4, 12, 24, 
36, 48 and 72 h post infection. Lymphoid cell cultures were incubated in the presence or 
absence of Con A.
Lymphoid cell cultures were mock-infected or infected with myxoma virus and the 
binding of either mouse ascites fluid or the 3b6e4 monoclonal antibody. Figure 3.2A 
shows that the binding of the 3b6e4 antibody is specific for myxoma virus infection, as 
a shift of the peak to the right was observed in samples incubated with the 3b6e4 
antibody, compared to the mouse ascites fluid control (Figure 3.2A). Figure 3.2B and 
3.2C show density plots of cell granularity (SSC) versus 3b6e4 antibody binding (FL1- 
H) and histogram plots of 3b6e4 antibody binding respectively in mock-infected and 
myxoma virus-infected lymphoid cell cultures. It was assumed that all cells in the gated 
sub-population staining for the myxoma virus protein (Figure 3.2- blue ovals and 
brackets) were infected because mock-infected lymphoid cell cultures did not fluoresce 
at these intensities.
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Figu r e  3.2. Fl o w  Cy to m et ri c  An a l y s is  o f  Myx o m a  V irus  Infecti on  o f  
Ra bb it  Lymp ho id  Ce l l s
Myxoma virus infection of rabbit lymphoid cells was analysed by flow cytometry. (A) To 
determine non-specific binding, rabbit lymphoid cells were infected with myxoma virus and 
stained using mouse ascites fluid. This was compared to staining of infected cells using the anti-
myxoma monoclonal antibody, 3b6e4, which is specific for an intracellular myxoma virus 
protein. (B) Density plots of cell granularity versus myxoma virus protein expression and (C) 
histogram plots of protein expression versus number of cells (counts) were generated using 
CellQuest software. Blue circles and brackets are those sub-populations of cells expressing the 
viral protein.
The sub-population of infected cells was gated as shown in Figure 3.2 and the 
proportion of events in this gate was calculated using CellQuest software. All 
experiments were replicated by using lymphoid cell cultures prepared from three 
individual laboratory and three individual wild rabbits. Samples of these cultures were 
used in the analysis of virus replication. Statistical analysis of the proportion of infected 
cells was by ANOVA with a p value less than 0.05, significant.
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3.2.1.2.1 Proportion of Rabbit Lymphoid Cells Infected with SLS 
In lymphoid cell cultures from both laboratory and wild rabbits, incubated in the 
absence of Con A, the proportion of SLS-infected lymphocytes increased steadily after 
24 h to reach 13% by 72 h when a moi of 0.1 was used (open squares and circles Figure 
3.3A and 3.3E). However, when a moi of 3 was used, differences in the proportion of 
infected cells were observed between unstimulated lymphoid cell cultures from 
laboratory and wild rabbits. In cultures from laboratory rabbits, 21% of cells were 
infected by 12 h and 40% by 72 h post infection (Figure 3.3B). In contrast, in cell 
cultures from wild rabbits infected with SLS at a moi of 3, the proportion of infected 
cells rose steadily from 24 h to reach 30% at 72 h (Figure 3.3F). These cultures also had 
similar proportions of infected cells at 4 and 12 h post infection to lymphoid cell 
cultures from laboratory rabbits but lower proportions of infected cells at 24 h post 
infection (4%) and all subsequent time points. This may indicate events occurring 
within the first 24 h are important for resistance in unstimulated lymphoid cells from 
wild rabbits.
Con A significantly increased the proportion of cells infected with SLS in lymphoid cell 
cultures from both laboratory and wild rabbits (p<0.05). The increase in proportion of 
rabbit lymphoid cells infected for both moi was similar, reaching approximately 70%, 
but occurred around 24 h with the higher moi, compared to 36 h with the low moi (solid 
squares and circles Figure 3.3A, 3.3B, 3.3E and 3.3F). In all SLS infections, the 
proportion of cells infected was slightly less towards the end of the time course with 
approximately 60% of cells infected at 72 h in all cultures. The exception to this was 
SLS in lymphoid cell cultures from wild rabbits.
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Figure  3.3. Pro po r ti o n  of  Cells  in  Ra bb it  Lym ph oid  Cell  Cul tu res  Inf ect ed  
with  SLS or  Ur
Rabbit lymphoid cells isolated from (A-D) laboratory or (E-H) wild rabbits were infected with 
either SLS, at a moi of 0.1 (A, E) or 3 (B, F), or Ur, at a moi of 0.1 (C, G) or 3 (D, H). Cells 
were harvested 4, 12, 24, 36, 48 or 72 h post infection. The time course was undertaken in the 
presence (solid squares) or absence (open squares) of 5pg/ml Con A. The proportion of cells 
infected was determined by immunostaining for an intracellular late viral protein and analysis on 
a Becton Dickinson FACSort using the associated CellQuest software, as shown in Figure 3.2. 
Graphs show data points for lymphoid cell cultures prepared from three laboratory and three 
wild rabbits. Grey data points indicate mock-infected controls (solid and open diamonds indicate 
with and without Con A respectively). Solid lines indicate the mean proportion of infected cells 
in Con A-stimulated cultures, whereas dotted lines indicate the mean proportion of infected cells 
in unstimulated cultures.
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3 . 2 . 1 . 2.2  Proportion of Rabbit Lymphoid Cells Infected with Ur
The proportion of Ur-infected cells was similar over the 72 h time course between 
lymphoid cell cultures from both rabbit types regardless of moi. In unstimulated 
cultures from laboratory rabbits, the proportion of Ur-infected cells reached 24% and 
27% by 72 h, when infected with a moi of 0.1 or 3 respectively (Figure 3.3C and 3.3D). 
In unstimulated cultures from wild rabbits the proportion of cells infected increased to 
13% and 22% by 72 h post infection when a moi of 0.1 and 3 were used respectively 
(Figure 3.3G and 3.3H).
Con A stimulation significantly increased the proportion of cells infected with Ur in 
lymphoid cell cultures from both laboratory and wild rabbits (p<0.05). In infections 
with a moi of 0.1, the proportion of infected cells reached 66% and 71% by 48 h in 
lymphoid cell cultures from laboratory and wild rabbits respectively (Figure 3.3C and 
3.3G). In lymphoid cell cultures from laboratory rabbits, the proportion of infected cells 
did not change during the remainder of the experiment. The proportion of infected cells 
fell to 60% by 72 h in lymphoid cell cultures from wild rabbits.
When a moi of 3 was used in lymphoid cell cultures from laboratory rabbits, the 
proportion of cells infected with Ur increased significantly with Con A stimulation to 
69% at 48 h (p<0.05). After this time point, the proportion of cells infected dropped 
significantly to 18% at 72h (p<0.05) (Figure 3.3D). A similar result was observed in 
wild rabbits lymphoid cell cultures infected with Ur. In these cultures, the proportion of 
cells infected rose to 58% by 36 h (Figure 3.3H), after which it dropped to 22% at 72 h. 
This significant decrease was not observed in cultures infected with Ur at a low moi or 
in cultures infected with SLS.
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3.2.1.2.3 Summary of the Proportion of Infected Lymphoid Cells 
Con A stimulation had a significant effect on the proportion of cells infected with 
myxoma virus in rabbit lymphoid cell cultures (p<0.05). The maximum proportion of 
lymphocytes infected with SLS was similar to that infected with Ur when cultures were 
stimulated. This was regardless of type of rabbit from which the lymphocytes were 
derived, and directly contrasts to virus replication, where Ur did not replicate in 
stimulated lymphoid cell cultures from wild rabbits, but did replicate in stimulated 
cultures from laboratory rabbits.
Although approximately 70-80% of cells were infected when either a high or low moi 
was used, there was a lag in reaching the 70-80% in cell cultures infected with a moi of 
0.1 compared to infections with a moi of 3. For example, 70-80% of cells were infected 
with SLS 36-48 h after Con A stimulation, when a moi of 0.1 was used compared to 24- 
36 h for infections when a moi of 3 was used. Supporting this, the proportion of cells 
infected was significantly different between the two moi only until 36 h (p<0.05).
The significant drop in the proportion of cells infected with Ur in Con A-stimulated 
lymphoid cell cultures at late time points contrasts to SLS infections, where no large 
decrease was apparent. This decrease was observed in cell cultures from both laboratory 
and wild rabbits after infection with Ur at a moi of 3. This indicates that there was a 
difference between the virulent and attenuated myxoma virus strains in their replication 
in primary rabbit lymphocytes. The difference was not due to the properties of the 
lymphocytes since the same effect was observed in infected lymphoid cell cultures from 
both laboratory and wild rabbits. Therefore, there must be a difference between SLS and 
Ur that becomes apparent during in vitro infection of lymphocytes.
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3.2.1.3 Proportion of Cells Infected in Rabbit Lymphoid Cell Cultures 
Stimulated with Con A Prior to Infection
Stimulation of lymphoid cells significantly increased both viral titre (Section 3.2.1.1) 
and proportion of infected cells (Section 3.2.1.2). However, the cells were stimulated 
after an initial 1 h infection. Therefore, stimulation would not be affecting attachment to 
the cell surface, but rather, would be acting on processes after this point, such as entry 
of the virion into the cell, early and late gene transcription and translation, virion 
assembly and maturation or virion egress. Stimulation of specific cell signal pathways 
has already been shown to be critical for myxoma virus infection (Lalani et al., 1999; 
Masters et al., 2001). However, those experiments were undertaken on cell lines that 
were permanently activated. To examine myxoma virus infection of primary lymphoid 
cell cultures that were activated prior to infection, cell cultures were stimulated with 
Con A for 4, 24, 48 and 72 h before infection with SLS or Ur at a moi of 3 for an 
additional 12 or 24 h. Myxoma virus infection was examined by flow cytometric 
analysis of 3b6e4 binding as described in Section 3.2.1.2.
The proportion of cells infected when cultures were stimulated with Con A prior to 
infection are tabulated in Table 3.1. For comparison, the mean and range of proportion 
of cells infected when cell cultures were stimulated with Con A after infection, as 
described in Section 3.2.1.2, is also included.
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3.2.1.3.1 Infection of Con A-Stimulated Lymphoid Cell Cultures from 
Laboratory and Wild Rabbits
The proportion of cells infected with SLS or Ur when lymphoid cell cultures from 
laboratory and wild rabbits were stimulated with Con A for 4 h prior to infection was 
significantly lower compared to cell cultures stimulated for longer periods prior to 
infection (p<0.05) (Table 3.1). This was also significantly less than those in cell cultures 
that were stimulated after infection. For example, lymphoid cells from laboratory 
rabbits, infected with SLS for 24 h after stimulation with Con A for 4 h had 21% of cell 
infected compared to 59% when Con A stimulation followed infection. This was also 
lower than in cultures stimulated for longer periods prior to infection. Comparing this 
with previous results, where cultures were stimulated with Con A after infection, shows 
that the proportion of cells infected in cultures stimulated for 4 h with Con A prior to 
infection, was less than half that in cultures that were infected prior to stimulation. 
These results raise some interesting questions, as they suggest that a short period of 
lymphocyte activation prior to infection makes the cells refractory to productive 
infection. Alternatively, a longer period of Con A stimulation resulted in a greater 
proportion of lymphocytes infected, suggesting that events occurring late in lymphocyte 
activation have either less effect on or increase the permissivity of lymphocytes for 
myxoma virus replication.
Lymphoid cell cultures from wild rabbits that were stimulated with Con A for 48 h prior 
to infection for 24 h with either SLS or Ur at a moi of 3, had a lower proportion (not 
statistically significant at the 95% Cl) of cells infected than if cultures were stimulated 
for 24 or 72 h prior to infection. For example, 32% of lymphocytes were infected with 
SLS in cultures that were stimulated for 48 h prior to infection for 24 h, compared to
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46% and 63% if cultures were first stimulated for 24 or 72 h (Table 3.1). This effect was 
not observed in cultures from laboratory rabbits. The reason for this is not clear.
Experiments in Section 3.2.1.2 and 3.2.1.3 indicate that there is an upper limit of 60- 
80% of cells in rabbit lymphoid cell cultures susceptible to myxoma virus infection. 
This limit was reached in cell cultures stimulated with Con A after infection for 24-48 h 
and in cultures stimulated with Con A for 72 h prior to infection for 24 h. This, taken 
together with the increase in virus replication in Con A-stimulated cell cultures, implied 
that either mitogen stimulation produced more target cells for the virus, or Con A- 
stimulated cells were more permissive for infection and that only a small proportion of 
cells were appropriately activated in unstimulated cell cultures. To address these issues, 
proliferation assays (Section 3.2.2) and a more comprehensive analysis of viral titre per 
infected cell (Section 3.2.3) and cell activation, as measured by cell size (Section 3.2.4), 
were undertaken.
3.2.2 Con A-lnduced Proliferation of Rabbit Lymphoid Cells
Proliferation of rabbit lymphoid cells was measured by two methods. The first of these 
was tritiated thymidine (JH-T) incorporation, which measures DNA replication. The 
second, the CellTitre 96® AQue0Us One Solution Cell Proliferation Assay, is a 
colorimetric assay where the mitochondrial activity in metabolically active cells causes 
the reduction of a MTS tetrazolium compound to a colored formazan product, the 
absorbance of which can be read at 490 nm. Cells that are not viable are not 
metabolically active and, therefore, will not cause a color change. Hence, the 
absorbance at 490nm is directly proportional to the number of live cells.
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The use of these two proliferation assays enabled examination of somewhat different 
time points because the primary lymphoid cell cultures were incubated for 18 h with 3H- 
T prior to harvest, whereas in the CellTitre Proliferation Assay, samples were measured 
after a 4 h incubation with the MTS reagent. Thus, the H-T assay measured whether 
cells were actively replicating their DNA for a period after each time point whereas the 
CellTitre assay provided a snapshot of the number of metabolically active cells at each 
time point.
All infections were analysed in triplicate and repeated in primary lymphoid cell cultures 
prepared from three different laboratory and three different wild rabbits. Because 
similar results were obtained for all rabbit lymphoid cell cultures, only results from one 
rabbit of each type is shown here, with the replicates for H-T and CellTitre 
Proliferation Assay in Appendix 1 and 2 respectively. The ability of infected RL-5 cells 
to proliferate was also examined. Results are presented as column graphs with values 
adjusted such that H-T incorporation or absorbance at 490 nm of unstimulated mock- 
infected cell cultures at the 0 h time point was equal to 1 unit.
3.2.2.1 3H-T Incorporation as a Measure of Proliferation of Rabbit 
Lymphoid Cells Infected with SLS or Ur
H-T incorporation into mock-infected cell cultures was first detectable at the 24 h time 
point (24 h mock-infection and 18 h incubation with H-T) and peaked at the 48 h time 
point (48 h mock-infection and 18 h incubation with H-T) (Figure 3.4), with the 
exception of one wild rabbit sample where the peak in H-T incorporation was at the 72 
h time point (72 h mock-infection and 18 h incubation with H-T) (see Appendix 1).
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Fig u re  3.4. 3H-T incorporation  in  Prim ar y  Lym ph oid  Cells  Is o la t ed  fro m  
Labo ra to ry  or  Wi l d  Rab b it s  an d  Inf ect ed  w it h  SLS or  Ur  
The proliferation of lymphoid cells from (A) laboratory and (B) wild rabbits was measured 
using tritiated thymidine (°H-T) incorporation. Lymphoid cells were mock-infected (MI) or 
infected with SLS or Ur at a moi of 0.1 or 3 pfu/input cell, for one hour prior to the 0 h time 
point. Con A was added at 0 h. JH-T was added at 0*, 24^, 48 and 72 h* post infection. 
Pulsing was for 18h prior to analysis on a Top Count Microplate Scintillation Counter. Values 
were adjusted such that 3H-T incorporation of MI cultures at 0 h (0 h incubation and 18 h 
incubation with JH-T) was equal to 1 unit. Reactions were done in triplicate and repeated on 
cultures prepared from three laboratory and three wild rabbits (a representative result is shown 
here, see Appendix 1 for replicates). Error bars represent standard errors.
Infection with SLS or Ur completely abrogated Con A-induced proliferation of 
lymphoid cells from both laboratory and wild rabbits, as measured by H-T 
incorporation (Figure 3.4). This occurred even at low moi. Unstimulated rabbit
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lymphoid cells did not proliferate in the absence of mitogen, nor did they proliferate in 
response to myxoma virus infection in unstimulated cell cultures (Figure 3.4).
3.2.2.2 MTS Assay as a Measure of Proliferation of Rabbit Lymphoid 
Cells Infected with SLS or Ur
Total abrogation of Con A-induced proliferation of primary lymphoid cells by SLS and 
Ur was also observed using the CellTitre 96® AQue0us One Solution Cell Proliferation 
Assay (Figure 3.5). In most cases, the peak absorbance due to Con A stimulation of 
mock-infected cell cultures was observed 72 h post infection (Figure 3.5, Appendix 2). 
The reason this differs from the peak in H-T incorporation is most probably due to the 
different times required for analysis. JH-T incorporation is measured over an 18 h 
period whereas the CellTitre assay is a colorimetric assay that measures live cell 
numbers at each time point. The optimal time for incubation with the MTS reagent to 
maximize the signal to noise ratio for primary rabbit lymphocytes was previously 
determined to be 4 h (Dr P. Kerr, personal communication).
The absorbance at 490 nm was lower in virus-infected cell cultures than in mock- 
infected cell cultures. As the CellTitre assay measures the number of live cells, this 
suggests that both SLS and Ur may induce cell death in infected lymphocytes. 
Mitochondrial activity, as measured in the CellTitre assay, in unstimulated primary 
rabbit lymphoid cells did not change substantially over the time course and was not 
altered by myxoma virus infection (Figure 3.5).
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Laboratory Rabbit Lymphoid Cell Cultures
B Wild Rabbit Lymphoid Cell Cultures
0.5 -
Figure  3.5. Proli fe rat io n  of  Pri mar y  Lymp ho id  Cell s  Isolated  fr om  
Labo ra to ry  or  Wi l d  Ra bb it s  and  Inf ect ed  w it h  SLS or  Ur
The proliferation of lymphoid cells from (A) laboratory and (B) wild rabbits was measured 
using the CellTitre 96® AQue0Us One Solution Cell Proliferation Assay. Lymphoid cells were 
mock-infected (MI) or infected with SLS or Ur at a moi of 0.1 or 3 pfu/input cell, for one hour 
prior to the 0 h time point. Con A was added at 0 h. The MTS reagent was added at 0*, 24 S, 
48 and 72 h® post infection. Absorbance was read at 490 nm after a 4 h incubation with the 
MTS reagent. Values were adjusted such that the absorbance of MI samples at 0 h was equal to 
1 unit. Reactions were done in triplicate and repeated using cultures from three laboratory and 
three wild rabbits. A representative result is shown here, with replicates in Appendix 2. Error 
bars represent standard errors.
3.2.2.3 Proliferation of RL-5 Cells Infected with SLS or Ur
Since most studies analyzing myxoma vims infection have utilized the RL-5 rabbit T- 
cell line, H-T and CellTitre proliferation assays were undertaken on infected RL-5 cells 
to determine whether infection with myxoma virus could also inhibit proliferation of 
these cells. As RL-5 cells are continuously proliferating, they incorporated H-T at 0 h
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and did not require Con A activation. This contrasted with primary lymphoid cell 
cultures, which only proliferated once Con A was added.
As with primary lymphoid cells, infection of RL-5 cells with SLS or Ur at either moi 
totally abrogated proliferation measured by both the JH-T incorporation and CellTitre 
assay (Figure 3.6). This experiment was repeated three times with different RL-5 cells. 
Results shown in Figure 3.6 are from one set of experiments, with results from the other 
two sets of experiments in Appendix 3. The absorbance in cultures infected with 
myxoma virus was lower than that in mock-infected cultures (Figure 3.6B), suggesting 
that myxoma virus induced cell death in some infected cells.
3.2.2.4 Summary of Cell Proliferation
Myxoma virus infection totally abrogated proliferation of primary rabbit lymphoid cells 
and RL-5 cells. Thus, it can be concluded that the increase in proportion of cells 
infected and increase in viral titres in primary rabbit lymphoid cell cultures observed 
when cultures were stimulated with Con A was not due to an increase in the number of 
target cells. In fact, infection with myxoma virus even at a low moi prevented cell 
proliferation, suggesting that inhibition of lymphocyte proliferation may be a critical 
immunosuppressive mechanism during myxoma virus infection.
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Figure  3.6. Pro l i fe r a t io n  o f  th e  Ra b b i t  T-ce l l  li n e , RL-5, In f e c t e d  with  
SLS or  Ur
Proliferation of RL-5 cells was measured using (A) tritiated thymidine (3H-T) incorporation or 
(B) CellTitre 96® AQue0Us One Solution Cell Proliferation Assay. RL-5 cells were mock-infected 
(MI) or infected with SLS or Ur at a moi of 0.1 or 3 pfu/input cell for one hour prior to beginning 
of time course. 3H-T or MTS reagent was added at 0*, 24*, 48 and 72 h^ post infection. 
Samples were pulsed for 4 h with 3H-T or MTS reagent. Values were adjusted such that the 3H-T 
incorporation or absorbance at 490 nm of MI samples at 0 h was equal to 1. Reactions were done 
in triplicate and the experiments repeated three times. Result from one of the sets of experiments is 
shown. Error bars represent standard errors.
129
Chapter 3- Lymphocyte Permissivity to Myxoma Virus Replication
3.2.3 Titre of Myxoma Virus per Infected Cell
The previous section showed that the increase in viral titre and proportion of cells 
infected observed after Con A stimulation was not due to increased cell numbers. To 
examine whether the increase in viral titre and proportion of cells infected could be 
attributed to individual infected cells producing higher titres of virus, analysis was 
undertaken by adjusting virus titre per input cell to virus titre per infected cell. This 
conversion was performed by taking the mean proportion of cells infected from Figure 
3.3, and, using the mean virus titre from Figure 3.1, calculating pfu/infected cell.
3.2.3.1 SLS Titre per Infected Cell
Infected lymphoid cells from laboratory rabbits stimulated with Con A produced up to 4 
fold more infectious SLS virus particles than unstimulated lymphoid cells (Table 3.2). 
The difference between unstimulated and Con A-stimulated cultures was greatest 24 
and 48 h post infection. For example, 48 h post infection there were 5.7 and 22.5 
pfu/infected cell in unstimulated and Con A-stimulated lymphoid cell cultures from 
laboratory rabbits, infected with SLS respectively.
Tab l e  3.2. Me a n  Ti t r e * per  Inf ect ed  Ce ll
SLS Ur
Ti
m
e P
os
t 
In
fe
ct
io
n Laboratory Rabbit Cell Cultures
Wild Rabbit Cell 
Cultures
Laboratory Rabbit 
Cell Cultures
Wild Rabbit Cell 
Cultures
- Con A + Con A Con A + Con A - Con A + Con A - Con A + Con A
12 h 6.9 7.4 5.6 13.4 36.0 10.0 15.5 2.8
24 h 5.5 19.5 19.2 5.7 66.7 23.4 16.5 3.8
48 h 5.7 22.5 6.2 17.5 32.3 25.9 11.2 9.1
72 h 12.8 31.6 6.2 15.2 24.1 94.1 21.2 11.3
* Mean virus titres were analyzed with respect to mean number of infected cells to obtain mean titre 
(pfu)/infected cell, pfu/infected cell was calculated at 12, 24, 48 and 72 h after infection with SLS or 
Ur at a moi o f 3.
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Infected lymphoid cells from wild rabbits stimulated with Con A produced 2 to 3 fold 
more infectious SLS particles than their unstimulated counterparts. For example, 48 h 
post infection there was 6.2 pfu/infected cell in unstimulated lymphoid cell cultures 
from wild rabbits compared to 17.5 pfu/infected cell in stimulated lymphoid cell 
cultures from wild rabbits. The exception to this was the 24 h time point. At this time 
point, SLS-infected unstimulated lymphoid cells from wild rabbits produced 19.2 
pfu/infected cell, whereas SLS-infected stimulated cells produced 5.7 pfu/infected cell 
(Table 3.2). In addition, there were a lower proportion of lymphocytes infected in 
unstimulated cell cultures compared to stimulated cell cultures from wild rabbits, but 
similar viral titres. This resulted in the 3 to 4 fold decrease in pfu/infected cell observed 
when cultures were stimulated.
Overall, these results show that in SLS infections, Con A stimulation increased virus 
replication in individual infected cells.
3.2.3.2 Ur Titre per Infected Cell
Con A did not increase the pfu/infected cell in rabbit lymphoid cell cultures infected 
with Ur (Table 3.2). For example, in unstimulated lymphoid cells, from laboratory 
rabbits, infected with Ur there were 32.3 pfu/infected cell 48 h post infection, compared 
to 25.9 pfu/infected cell in cultures stimulated with Con A. Similar results were 
observed in lymphoid cells from wild rabbits. The one exception to this result was 72 h 
after Ur infection of stimulated lymphoid cells from laboratory rabbits. In this infection 
there was 94.1 pfu/infected cell in Con A-stimulated cells compared to 24.1 pfu/infected 
cell in unstimulated cells. This result is most likely skewed by the large decrease in 
proportion of cells infected (Figure 3.3), but similar viral titres at this time point (Figure 
3.1). The reason for this decrease in proportion of infected cells is postulated to be due
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to an increase in cell death and will be discussed in Section 3.3.5 and examined in 
chapter 4.
Thus, for Ur, the increase in viral titres observed with Con A stimulation appeared to be 
due to an increase in the number of cells infected and not due to an increase in 
replication in individual infected cells as shown for SLS.
3.2.4 Analysis of Myxoma Virus Infection and Con A-lnduced 
Changes in Cell Morphology
Con A stimulation of lymphoid cells is not only associated with cell division but also 
with an increase in cell size and granularity. It was postulated in Section 3.2.1.3. that 
activation of cultures with Con A either produced more target cells for the virus, or 
made the cells more permissive for infection. Section 3.2.2 examined the first 
possibility and demonstrated that more target cells for myxoma virus infection were not 
produced when cultures were stimulated with Con A, as myxoma virus completely 
abrogated lymphocyte proliferation. This section investigates the second possibility; that 
activated lymphoid cells are more permissive for myxoma virus replication. One 
method of identifying activated cells is by an increase in their size, which can be 
measured by flow cytometry (Tsao et al., 1993; Webster et al., 1995). Experiments in 
this section will firstly examine the effects of myxoma virus infection on cell size 
(Section 3.2.4.1), and then investigate whether stimulated cells are more permissive for 
myxoma virus replication by gating large and small cells and examining 3b6e4 binding 
in these sub-populations (Section 3.2.4.2). The cultures used in these experiments were 
those used to examine the expression of cell surface proteins (chapter 5). Cultures 
previously used in this chapter to examine myxoma virus infection were not used for
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examining cell size as permeabilisation, which was essential for the 3b6e4 monoclonal 
antibody binding may have affected cell size results.
3.2.4.1 Con A-Induced Changes in Lymphocyte Size
3.2.4.1.1 Cell Size in Rabbit Lymphoid Cell Cultures Infected with 
Myxoma Virus Prior to Stimulation with Con A
Lymphoid cell cultures from laboratory and wild rabbits were infected with SLS or Ur 
at a moi of 0.1 or 3 and incubated for 48 h in the presence or absence of Con A. Cell 
size was analysed as forward scatter (FSC) using flow cytometry. Data was presented as 
density plots of cell granularity versus cell size and histogram overlays of cell size. The 
proportion of large and small cells was calculated using CellQuest software.
Two sub-populations based on cell size (forward scatter- FSC) were gated in mock- 
infected rabbit lymphoid cell cultures as shown in Figure 3.7A. The proportion of cells 
in each sub-population, Targe’ and ‘small’, was calculated using CellQuest software. 
The gates used were identical for all infections and tried to encompass discrete large and 
small sub-populations of every infection. As a result they do not include the entire cell 
culture and proportions will not add up to 100%.
Con A increased the proportion of large cells from 7% to 50% and from 4% to 60% 
over the 48 h in mock-infected lymphoid cell cultures from laboratory and wild rabbits 
respectively (Figure 3.7B). There was a corresponding decrease in the proportion of 
small cells in these cultures.
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A B
tt Unstimulated Cultures
t t  Stimulated Cultures
C
Mean proportion of unstimulated and Con A- 
stimulated MI cells in each sub-population, as 
defined by cell size (FSC), 48 h post-infection.
M I M I  +  C o n  A
L a b o r a t o r y
R a b b i t
S m a l l
c e l l s
71% 27%
L y m p h o i d  C e l l
C u l t u r e s L a r g e
c e l l s
7% 50%
W i l d  R a b b i t  
L y m p h o i d  C e l l
S m a l l
c e l l s
83% 24%
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c e l l s
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Fig ure  3.7. Th e  Effe ct s  of  Con  A St im ul a ti o n  o n  t he  Siz e  of  Mo c k -Inf ec te d  
Lym ph ocy te s  fr om  La bo ra to ry  and  Wil d  Rab b it s
The size of mock-infected (MI) lymphocytes from laboratory and wild rabbits was analysed 
with or without Con A stimulation, 48 h post infection. Lymphocyte size was examined as 
forward scatter (FSC) by flow cytometry. (A) A representative density plot of MI cultures 
showing the large and small cell sub-populations. (B) The proportion of cells in the large and 
small sub-population was calculated using CellQuest software. Numbers are mean proportions 
from infections of cultures from three different rabbits. (C) A histogram overlay showing the 
increase in cell size in stimulated mock-infected cell cultures compared to unstimulated mock- 
infected cultures. The shaded region represents cell size in unstimulated cell cultures and the 
black line represents cell size in Con A-stimulated cultures. Plots were generated using the 
CellQuest software.
Infection of lymphoid cell cultures with either SLS or Ur abrogated the Con A-induced 
increase in proportion of large cells (Figure 3.8). This appeared to be somewhat 
proportional to moi as both SLS and Ur at a moi of 0.1 did not inhibit the increase in
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Laboratory Rabbit Wild Rabbit Lymphoid 
Lymphoid Cell Cultures Cell Cultures
Unstimulated
cultures
Unstimulated
cultures
Stimulated
cultures
Stimulated
cultures
Cell Size
L a b o r a to r y  R a b b it  
L y m p h o id  C e ll C u ltu re s
W ild  R a b b it  L y m p h o id  C eli 
C u ltu res
unstimulated Con A- 
stimulated
unstimulated Con A- 
stimulated
S m a ll
ce lls
Mock-
infected
71% 27% 83% 24%
SLS (0.1) 70% 55% 84% 50%
SLS (3) 70% 60% 83% 69%
Ur (0.1) 72% 56% 83% 44%
Ur (3) 76% 53% 81% 63%
L a rg e
ce lls
Mock-
infected
7% 50% 4% 60%
SLS (0.1) 7% 19% 5% 25%
SLS (3) 7% 13% 4% 9%
Ur (0.1) 10% 23% 4% 32%
Ur (3) 6% 17% 7% 13%
Figure  3.8. The  Effe c ts  of  Co n  A Sti mu la tio n  o n  the  Siz e  of  Lymp ho cyt es  
Infect ed  with  SLS or  Ur
(A) Data is presented as histogram overlays of cell size. Lymphocytes from laboratory and wild 
rabbits were mock-infected (black) or infected with either SLS at a moi of 0.1 (red) or 3 (green), 
or Ur at a moi of 0.1 (pink) or 3 (blue). Cell size was analysed 48 h post-infection in 
lymphocytes isolated from three laboratory and three wild rabbits (a representative sample is 
shown). Cultures were infected with and without Con A stimulation. (B) Mean proportion of 
rabbit lymphoid cell cultures in each size sub-population. The large and small cell sub-
populations were gated on density plots, as shown in Figure 3.7, and the mean percentage of 
cells comprising each population, was calculated using CellQuest software.
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proportion of large cells to as great an extent as the same virus at a moi of 3, although 
proportions were not greatly different from each other. For example, as seen in Figme 
3.8B, lymphoid cell cultures from laboratory rabbits, infected with SLS at a moi of 0.1, 
had 19% of cells classified as large but only 13% were classified as large under tie 
same conditions when a moi of 3 was used. In Ur-infected lymphoid cell cultures fron 
laboratory rabbits, 23% of cells were classified as large in infections with a moi of 01 
and 17% of cells were classified as large in infections with a moi of 3. Similar resuls 
were observed in lymphoid cell cultures from wild rabbits (Figure 3.8). Concurrent wih 
the abrogation of cell size in SLS- and Ur-infected cell cultures stimulated with Con A, 
there was an increase, relative to mock-infected cell cultures, in the proportion of cells 
classified as small.
SLS and Ur infection at either moi did not affect cell size in unstimulated lymphoid cell 
cultures from laboratory and wild rabbits, as similar proportions of cells in the large ar.d 
small sub-populations to those in the corresponding unstimulated mock-infected cell 
cultures were observed (Figure 3.8B).
3.2.4.1.2 Cell Size in Rabbit Lymphoid Cell Cultures Stimulated with Ccn 
A Prior to Infection
Investigation of whether myxoma virus could alter cell size if cells were activated prior 
to infection was undertaken. Cultures were stimulated for 4, 24 or 48 h before moclc- 
infection or infection with SLS or Ur at a moi of 3, for 24 or 48 h. Results are presented 
as histogram overlays of cell size and proportions of large and small cells, calculated as 
shown in Figure 3.7. Cell cultures stimulated with Con A for 4 h prior to infection will 
be described in Section 3.2.4.1.2.1, followed by cell size in cell cultures stimulated for 
24 and 48 h prior to infection (Section 3.2.4.1.2.2).
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3.2.4.1.2.1 Cell Size in Rabbit Lymphoid Cell Cultures Stimulated with Con A 
for 4 h Prior to Infection with SLS or Ur
In lymphoid cell cultures from laboratory rabbits, the proportion of cells in the large 
sub-population when cultures were stimulated for 4 h prior to mock-infection was 42% 
at 24 h post infection and rose to 61% at 48 h (Figure 3.9). Concurrent with this, there 
was a decrease in cells classified as small in mock-infected lymphoid cell cultures.
Infection with either SLS or Ur prevented the increase in proportion of large cells in 
cultures that had been stimulated with Con A for 4 h prior to infection (Figure 3.9). For 
instance, in lymphoid cell cultures from laboratory rabbits infected with SLS or Ur, the 
mean proportion of large cells remained between 32-38% during the 48 h period of 
infection. The reason for the sizeable population of large cells in infected cell cultures is 
presumably due to an increase in cell size during the 4 h of Con A stimulation prior to 
infection. The mean proportion of small cells in myxoma virus-infected cell cultures 
remained between 62-68% in infected lymphoid cell cultures from laboratory rabbits 
(Figure 3.9B).
Infection of lymphoid cell cultures from wild rabbits with either SLS or Ur also 
inhibited the increase in proportion of large cells induced by Con A. For example, 48 h 
after infection, 60% of mock-infected cells were in the large cell sub-population, 
whereas 27% and 34% of cells were large in SLS- and Ur-infected cell cultures 
respectively (Figure 3.9B).
These results show that myxoma virus either abrogates the increase in cell size 
associated with activation if infection occurs 4 h after stimulation or may induce death 
in large cells. This will be examined in chapter 4.
137
Chapter 3- Lymphocyte Permissivity to Myxoma Virus Replication
A
4 h Con A
a#o
«2c
JS
T t
24 h Con A 48 h Con A
Cell Size-
B
Laboratory Rabbit Lymphoid Cell Cultures Wild Rabbit Lymphoid Cell Cultures
M I SLS U r MI SLS U r
Small
cells
Large
cells
Small
cells
Large
cells
Small
cells
Large
cells
Small
cells
Large
cells
Small
cells
Large
cells
Small
cells
Large
cells
4 h Con A 
Stimulation
24 h
Infection
58% 42% 63% 37% 62% 38% 44% 56% 56% 44% 51% 49%
48 h
Infection
39% 61% 68% 32% 68% 32% 40% 60% 73% 27% 66% 34%
24 h Con A 
Stimulation
24 h
Infection
43% 57% 52% 48% 48% 52% 29% 71% 41% 59% 27% 63%
48 h
Infection
40% 60% 63% 37% 63% 37% 21% 79% 44% 56% 42% 58%
48 h Con A 
Stimulation
24 h
Infection
41% 59% 56% 44% 52% 48% 21% 79% 31% 69% 27% 73%
48 h
Infection
36% 64% 48% 52% 56% 44% 22% 78% 39% 61% 36% 64%
Figur e  3.9. Mean  Pr o po r t io n  of  La r g e  an d  Sma l l  Ra bb it  Ly m ph o id  Cel ls  in  
Cu lt ur es  Sti mu la ted  w it h  Co n  A Pr io r  t o  Inf ec ti o n  w it h  SLS or  Ur
Lymphoid cells from (A) laboratory and wild rabbits that had been stimulated with Con A for 4, 
24 or 48 h prior to mock-infection (MI) (black) or infection with SLS (green) or Ur (blue) at a 
moi of 3, were analysed for cell size, 24 and 48 h post-infection. Data is presented as histogram 
overlays of cell size of a representative result. (B) The Targe’ and ‘small’ populations were 
gated on density plots, as shown in Figure 3.7, and the mean proportion of cells comprising each 
sub-population was calculated. The experiment was undertaken using lymphoid cell cultures 
prepared from three laboratory and three wild rabbits and the mean calculated.
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3.2.4.1.2.2 Cell Size in Rabbit Lymphoid Cell Cultures Stimulated with Con A 
for 24 or 48 h Prior to Infection with SLS or Ur
Cells were stimulated with Con A for 24 and 48 h prior to mock-infection or infection 
with SLS or Ur for an additional 24 or 48 h. The proportion of cells classified as large 
was calculated and mean value for each group of three rabbits presented as shown in 
Figure 3.7.
In mock-infected lymphoid cell cultures prepared from laboratory rabbits and stimulated 
with Con A for 24 or 48 h, the proportion of large cells was 57% and 59% respectively 
after 24 h mock-infection and 60% and 64% respectively after 48 h mock-infection 
(Figure 3.9B). If lymphoid cell cultures from laboratory rabbits, stimulated for 24 were 
infected with SLS then 48% and 37% of cells were large after 24 h and 48 h infection 
respectively. For comparison, 33% of lymphoid cells from laboratory rabbits were large 
after 24 h of Con A stimulation prior to infection (data not shown). If the period of 
stimulation prior to SLS infection was 48 h then 44% of cells were large after infection 
for 24 h and 52% of cells were large after infection for 48 h (Figure 3.9). Similar results 
were observed in Ur-infected cell cultures.
These results suggest that the size of stimulated cells is maintained after infection with 
SLS or Ur and that the longer stimulation occurs prior to infection, the lower the ability 
of myxoma virus to alter cell activation. Similar results were observed in lymphoid cell 
cultures from wild rabbits, although the proportions of large cells in the majority of 
infections were greater than the corresponding infection in cell cultures from laboratory 
rabbits. This indicates that any difference between rabbit types in the ability of 
lymphoid cells to be activated after infection with myxoma virus is small.
139
Chapter 3- Lymphocyte Permissivity to Myxoma Virus Replication
3.2.4.2 Permissivity of Large and Small Sub-Populations of 
Laboratory and Wild Rabbit Lymphoid Cells to Infection with SLS or 
Ur
3.2.4.2.1 Lymphoid Cell Cultures Infected Prior to Con A Stimulation
To determine whether large cells are more permissive for myxoma virus replication, 
further analysis of large and small cell sub-populations in data collected from Section
3.2.1 was undertaken. The method used for this analysis is shown in Figure 3.10A. The 
flow cytometric data from unstimulated and Con A-stimulated lymphoid cells from 
laboratory and wild rabbits that had been mock-infected or infected with SLS or Ur at a 
moi of 3 were analysed for virus infection, 48 h post infection. The mean median 
fluorescence intensity of virus infection was determined for each rabbit, from the 
histogram plot of granularity versus fluorescence intensity of anti-myxoma virus 
antibody (3b6e4) binding. The mean median fluorescence intensity of anti-myxoma 
antibody binding was then calculated for large and small cell sub-populations in cultures 
prepared from each group of three laboratory or three wild rabbits. The mean median 
fluorescence intensity is a quantitative measure of protein expression and is less likely 
to be skewed by very high or low antibody binding in a minor cell sub-population. 
Analysis in this way would be important for examining virus infection in large and 
small cell sub-populations as Section 3.2.4.1 showed that myxoma virus infection 
inhibited the increase in cell size associated with Con A activation, resulting in a low 
proportion of large cells. The difference between the mean median fluorescence 
intensity in SLS- or Ur-infected and mock-infected cell cultures was calculated. These 
numbers are tabulated in Figure 3.1 OB.
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Figur e  3.10. Mean  Medi an  Fluo re sc enc e  Int e ns it y  of  An t i -My x o m a  Viru s  
An t ib o d y  Sta in in g  in  Large  and  Small  Cell  Sub -Pop u la ti o ns
Unstimulated and Con A-stimulated lymphoid cells from laboratory and wild rabbits that had been 
mock-infected or infected with SLS or Ur at a moi of 3 were analysed for virus infection 48 h 
post-infection. (A) The method used for the analysis. The sub-populations were gated on density 
plots of cell size versus granularity and plotted on density plots of granularity versus virus 
infection (3b6e4 antibody binding) and histogram plots of virus infection (inset). The median 
fluorescence intensity corresponding to 3b6e4 antibody binding was determined (indicated by 
numbers). The example shown here is Con A-stimulated lymphoid cell cultures from a laboratory 
rabbit infected with Ur. (B) Mean median fluorescence intensity of anti-myxoma virus antibody 
staining in large and small cell sub-populations. The mean net difference in fluorescence intensity 
of large and small populations between mock-infected and virus-infected cell cultures was 
calculated by subtracting values in mock-infected cell cultures from those in virus-infected cell 
cultures. Means are for each group of three rabbits.
The mean median fluorescence intensity of anti-myxoma virus staining in the small cell 
sub-population of either Con A-stimulated or unstimulated cell cultures infected with
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either SLS or Ur, was 0 to 22 fluorescence units above mock-infected controls (Figure 
3.1 OB). In contrast, the fluorescence intensity of anti-myxoma virus staining in large 
cells from cell cultures infected with SLS or Ur ranged from 55 to 191 fluorescence 
units above mock-infected cell cultures in the absence of Con A, and ranged from 195 
to 592 fluorescence units above mock-infected cell cultures in the presence of Con A. 
Greater expression of viral protein was observed in the large cell sub-population 
compared to the small cell sub-population from lymphoid cell cultures from both 
laboratory and wild rabbits (Figure 3.1 OB). The expression of greater amounts of viral 
protein in the large cell sub-population compared to the small cell sub-population is 
hypothesized to be associated with increased virus replication in large cells. This is 
supported by the Con A-induced increase in mean median fluorescence, which, as 
previously shown, is associated with an increase in viral titre. The fact that stimulation 
of Ur-infected lymphoid cell cultures from wild rabbits had a mean median fluorescence 
intensity of 438 units (compared with 592 units for cultures infected with SLS), but 
infectious progeny were not produced will be discussed in Section 3.3.5.
3.2.4.2.2 Lymphoid Cell Cultures Stimulated with Con A Prior to Infection
The previous sections showed expression of a late myxoma virus protein was higher in 
large cells. Although this suggests myxoma virus preferentially replicated in large cells, 
the experiments are not able to show whether myxoma virus preferentially infects large 
cells as cultures were infected prior to stimulation. To investigate whether myxoma 
virus preferentially infected large cells, cultures were Con A-stimulated for 48 h prior to 
infection with SLS or Ur at a moi of 3, for an additional 48 h. Con A stimulation of 
mock-infected cell cultures for 48 h would lead to 50-60% of lymphoid cells being 
activated. Hence, it can be assumed that half of the cells in the culture will be activated 
prior to infection.
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Results were similar between lymphoid cell cultures from three laboratory and three 
wild rabbits, hence only one sample is shown in Figure 3.11 (laboratory rabbit). Density 
plots of myxoma virus infection versus cell size were divided into quadrants. The 
proportion of cells in each quadrant was calculated using CellQuest software. 
Fluorescence intensity above 10 was taken to correspond to infection of cells with 
myxoma virus.
MI T SLS ^ Ur
Fig u re  3.11. Po pu la ti o n  of  Lym ph oid  Cells  In f ec te d  with  Myx om a  Vir u s  
Lymphoid cells from laboratory and wild rabbits were stimulated with Con A for 48 h prior to 
mock-infection (MI) (black) or infection with SLS (green) or LIr (blue) at a moi of 3, for an 
additional 48 h. Density plots of myxoma virus infection versus cell size were generated using 
CellQuest software. Results were similar between lymphoid cell cultures from different rabbits, 
hence only one sample is shown here (laboratory rabbit). The percentages are the proportion of 
cells in each quadrant- large/high fluorescence of anti-myxoma virus antibody (3b6e4) binding 
(upper right quadrant), large/low fluorescence of 3b6e4 antibody binding (lower right 
quadrant), small/high fluorescence of 3b6e4 antibody binding (upper left quadrant), small/low 
fluorescence of 3b6e4 antibody binding (lower left quadrant).
Figure 3.11 shows that myxoma virus preferentially infected large cells. For example, of 
the 65% of lymphoid cells that had a fluorescence intensity of 3b6e4 binding greater 
than 10 , 59% were classified as large and the other 6% were small. Similar results were 
obtained with Ur infections where, of the 60% of lymphoid cells with a fluorescence 
intensity of 3b6e4 binding greater than 102, 56% of them were classified as large and 
the other 4% as small. This is compared to mock-infected cell cultures, which show a 
total background staining of 8% of cells with a fluorescence intensity greater than 102 
(Figure 3.11). As Con A is a T-cell specific mitogen and approximately 57% of cells in
143
rabbit lymph nodes are T-cells (Mage 1998), these results suggest that activated T-cells
are the sub-population permissive for myxoma virus replication.
3.2.4.3 Con A-Induced Changes in Lymphocyte Granularity
Granularity was examined 48 h post infection in lymphoid cell cultures that were either 
mock-infected or infected with SLS or Ur at a moi of 0.1 or 3. Granularity of a cell can 
change in response to activation and may be altered by myxoma virus infection. 
Granularity (side scatter- SSC) is collected automatically by the flow cytometer at the 
same time as FSC. Side scatter detects light scattered by a particle 90° from the incident 
laser beam and is related to the internal structure and granularity of that cell.
Figure 3.12 shows Con A-stimulation increased granularity of mock-infected rabbit 
lymphoid cell cultures. Myxoma virus infection did not alter cell granularity in 
unstimulated cell cultures or in cell cultures stimulated with Con A after infection 
(Figure 3.13).
The presence of viral replication factories might be expected to deflect the incidence 
laser beam. However, myxoma virus did not substantially alter granularity in cell 
cultures that were stimulated with Con A prior to infection (Figure 3.14). Those cell 
cultures that did have a slight change in granularity following myxoma virus infection 
were lymphoid cells from wild rabbits infected for 48 h after stimulation for 48 h. As 
this increase was not seen in all panels, the increase in granularity was not due to viral 
replication factories.
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Fig u re  3.12. The  Effe ct s  of  Co n  A Sti mu la tio n  on  the  Gra n u l a r it y  o f  
Lym ph o cy te s  fr om  La bo ra to ry  an d  Wil d  Ra bb it s
The granularity of mock-infected lymphocytes from laboratory and wild rabbits was analysed with 
and without Con A stimulation, 48 h post infection. Granularity was detected as side scatter by 
flow cytometry (horizontal axes). Plots shown are representative (A) density and (B) histogram 
plots of all samples. The histogram overlay shows the increase in cell granularity when Con A was 
added to the cultures. The shaded region represents mock-infected cell cultures and black line 
represents Con A-stimulated cultures. A line has been drawn at a fluorescence intensity of 101 to 
aid visual analysis of the histogram plots. Plots were generated using the CellQuest software.
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Figure  3.13. Ch a n g e s  in  Cell  Gr an ul ar it y  in  In f ec te d  Ly m ph o c y t e s  fro m  
Labo ra to ry  an d  Wil d  Ra bb it s
Lymphocytes from laboratory and wild rabbits were mock-infected (black) or infected with 
either SLS, at a moi of 0.1 (red) or 3 (green), or Ur, at a moi of 0.1 (pink) or 3 (blue). 
Granularity was analysed in lymphoid cell cultures isolated from three laboratory and three wild 
rabbits (a representative sample is shown) with and without Con A stimulation. Data is presented 
as histogram overlays of cell granularity.
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F i g u r e  3.14. Ch a n g e s  i n  C e l l  Gr a n u l a r i t y  i n  Ra b b i t  Ly m p h o c y t e s  
St i m u l a t e d  w i t h  Co n  A Pr i o r  t o  In f e c t i o n  w i t h  M y x o m a  V i r u s  
Lymphoid cells from (A) laboratory and (B) wild rabbits that had been stimulated with Con A 
for 4, 24 or 48 h prior to mock-infection (black) or infection with SLS (green) or Ur (blue) at a 
moi o f 3, were analysed for cell granularity 24 and 48 h post infection. The experiment was 
undertaken using lymphocytes isolated from three laboratory and three wild rabbits. A 
representative sample is shown here. Data is presented as histogram overlays o f cell granularity.
3.2.4.4 RL-5 Cell Size and Granularity
The size and granularity of RL-5 cells mock-infected or infected with SLS or Ur at a 
moi of 3 was also examined 48 h post infection. Figure 3.15 shows that infection with 
myxoma virus did not alter the size of RL-5 cells. However, granularity was increased 
after infection with either strain of myxoma virus. These results are different to those 
obtained for primary cultures, as granularity in primary lymphoid cell cultures was not 
altered by myxoma virus infection, and may be related to RL-5 cells being 
immortalized.
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Figur e  3.15. Siz e  and  Gr an ul ar it y  of  RL-5 Cells  In f ec te d  w it h  SLS or  Ur
The size and granularity of RL-5 cells mock-infected (black) or infected with SLS (green) or Ur 
(blue) at a moi of 3 were analysed 48 h post infection. Cell size was detected as forward scatter 
and granularity as side scatter by flow cytometry. The above histogram overlays were generated 
using the associated CellQuest software. The experiment was repeated three times, a 
representative sample is shown here.
3.2.5 Summary
Table 3.3 shows a comparison of the results from this chapter between infection with 
the virulent SLS and attenuated Ur strains of myxoma virus and between lymphoid cell 
cultures from susceptible laboratory and resistant wild rabbits. Differences between SLS 
and Ur may reflect a cellular basis for attenuation of the virus. Difference between 
laboratory and wild rabbits may reflect a cellular basis for resistance.
V
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Table  3.3. Sum ma ry  of  SLS an d  Ur  Infe cti on  of  Lym ph o id  Cell  Cul tures  
Fr o m Labo ra to ry  and  Wil d  Ra bb it s
SLS v ersu s  U r L abo ra to ry  R abb its  
versus
W ild  R abbits
Virus • Ur did not replicate in Con • Con A did not increase Ur
R eplication* A-stimulated lymphoid cell replication in lymphoid cell
cultures from wild rabbits cultures from wild rabbits, but 
did in infected cultures from 
laboratory rabbits
• Myxoma virus has a
significantly reduced ability to 
replicate in lymphoid cell 
cultures from wild rabbits 
compared to cultures from 
laboratory rabbits
Proportion • Proportion of cells infected • SLS infected a greater
o f  Cells with Ur dropped proportion of cells at early time
Infected+ significantly 72 h post points (<48 h) in unstimulatedinfection compared to the lymphoid cell cultures from
proportion of cells infected laboratory rabbits compared to
with SLS wild rabbits
Titre per • Con A increased SLS • No difference in titre per
infected c e ll6 replication in infected cells infected cell was observed
• The Con A-indvvced 
increase in Ur titre was 
predominantly due to 
increase in proportion of 
cells infected
between rabbit types
* Analysis of virus replication was by plaque assay and is shown in Figure 3.1 
Analysis of proportion of cells infected was by detection of a late viral protein by flow 
cytometry and is shown in Figure 3.3.
9 Titre per infected cell was calculated from the mean virus titres and mean proportion of 
cells infected and is listed in Table 3.2.
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3.3 Dis c u s s io n
This chapter investigated if the genetic resistance of wild rabbits to myxoma virus could 
be attributed to differences in the permissivity of lymphocytes from susceptible and 
resistant rabbits for virus replication. The results showed:
1. Lymphoid cell cultures from resistant rabbits were statistically significantly less 
permissive for virus replication (as measured by plaque assay) than cell cultures 
from susceptible rabbits.
2. Con A activation significantly increased SLS titres and the proportion of cells 
infected with SLS in cultures from both rabbit types. Con A activation also 
increased the proportion of Ur-infected cells in lymphoid cell cultures from both 
rabbit types. However, Con A stimulation did not increase Ur titres in lymphoid 
cell cultures from wild rabbits significantly above that of unstimulated cultures.
3. The increase in SLS titres observed with Con A stimulation of rabbit lymphoid 
cell cultures was due to increased virus production in every infected cell. For Ur 
infection, however, the increase in titres observed with Con A stimulation was 
due to the increased number of infected cells.
4. Both strains of myxoma virus, although preferentially replicating in stimulated 
lymphocytes, completely abrogated T-cell activation (measured by lymphocyte 
proliferation and cell size).
5. A key difference between SLS and Ur identified in this chapter was the dramatic 
drop in proportion of cells infected with Ur 48-72 h post infection compared to 
cultures infected with SLS.
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3.3.1 Differences in Permissivitv of Lymphoid Cells from 
Susceptible and Resistant Rabbits to Virus Replication
Lymphoid cell cultures from resistant rabbits were significantly less permissive for 
mxyoma virus replication than lymphoid cell cultures from susceptible rabbits. This was 
highlighted in Con A-stimulated wild rabbit lymphoid cell cultures infected with Ur, 
where the mean titre of three replicates did not rise above 5 pfu/ input cell over the 72 h. 
In contrast, the mean Ur titre reached 17 pfu/input cell in lymphoid cell cultures from 
laboratory rabbits. The small but statistically significant reduction in titre of myxoma 
virus in lymphoid cell cultures from resistant rabbits indicated that there is a measurable 
difference in vitro between lymphocytes from laboratory and wild rabbits. Viral titres 
were measured by plaque assay on Vero cell monolayers and, as such, actually 
measured production of infectious viral progeny, which is the end stage of the virus life 
cycle.
There are many stages when the permissivity of the lymphocyte to myxoma virus 
replication have been impeded, including virus entry, viral DNA and protein synthesis, 
virion assembly and maturation and virion egress. The mechanism for the reduced 
permissivity of lymphocytes from wild rabbits for myxoma virus replication is most 
probably related to virion assembly and maturation. This is because experiments in this 
chapter examined myxoma virus infection by staining for a 42 kDa late virus protein. 
As similar proportions of cells expressing this protein in lymphoid cell cultures from 
laboratory and wild rabbits were detected, this suggests that resistance is operating after 
expression of this protein. This could include events late in the virus life cycle, such as 
virion assembly and maturation or egress. However, any problems in virion egress 
would not have been detected in these experiments as the cells were sonicated to release 
virions prior to determination of titres by plaque assay. Further experiments examining
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viral morphogenesis will be needed to determine which step(s) in the virion assembly 
and maturation pathway is hindered in lymphocytes from wild rabbits. Alternatively, 
resistance may involve increased cell death in cell cultures from wild rabbits which is 
initiated after late protein expression. This would lead to reduced titres because cells are 
killed before infectious virus progeny are produced. Cell death during myxoma virus 
infection is examined in chapter 4.
A reduced ability of myxoma virus to replicate in vivo in lymphocytes during infection 
of resistant rabbits compared to infection of laboratory rabbits, may aid control of virus 
replication and dissemination by the wild rabbit immune response. If virus replication is 
reduced, it may be expected that the overall transcription and translation of viral genes 
and proteins would also be reduced (some early gene products would be present as these 
are packaged in the virion). Lower expression levels of any immunomodulatory viral 
proteins may diminish the extent to which myxoma virus can suppress the immune 
response leading to the development of an effective adaptive immune response by the 
host. Lower expression of proteins involved in virus replication may reduce the 
numbers of infectious progeny, which will also diminish the extent to which myxoma 
virus can suppress the immune response.
In the model presented by Best and Kerr (2000) resistance is postulated as due to an 
effective innate immune response, involving effectors such as natural killer (NK) cells 
and IFNa/ß. These are postulated to effectively control viral replication at the lymph 
node draining the inoculation site in the first 2-4 days of infection. The early control of 
virus infection is postulated to enable an effective anti-viral adaptive immune response 
to develop, for which cytotoxic T-cells (CTLs) are critical in virus control and clearance 
(Best 1998; Best and Kerr 2000). Reduction in permissivity of lymphoid cells to
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myxoma virus replication, no matter how small, will reduce viral replication and will 
aid the host in controlling and clearing the virus.
Although Best and Kerr (2000) did examine permissivity of lymphoid cells from 
susceptible and resistant rabbits to myxoma virus replication and found no difference, 
these experiments were not done with the attenuated Ur strain of myxoma virus and 
were not done with mitogen stimulation. The results in this chapter show that the use of 
an attenuated virus and mitogen stimulation did increase the sensitivity of the assay as a 
significant difference between lymphocytes from laboratory and wild rabbits were 
observed. This will be discussed further in the next section.
3.3.2 The Effect of Stimulation on the Permissivity of Lymphoid 
Cells to Myxoma Virus Replication
The T-cell mitogen, Con A, was used to stimulate lymphoid cell cultures. Con A 
induces extensive crosslinking of cell membrane proteins by binding a-D-mannose and 
a-D-glucose, which are part of the glycosaminoglycans (GAGs) that are commonly 
linked to membrane glycoproteins (Smith and Goldstein 1967). Crosslinking of cell 
membrane proteins mimics receptor activation and initiates multiple cell signaling 
pathways resulting in T-cell activation and proliferation (Smith and Goldstein 1967). It 
has previously been reported that, generally, isolated rabbit T-cells respond to Con A 
whereas rabbit B-cells do not (Sell 1979). A T-cell specific mitogen was used because 
T-cells are considered critical for myxoma virus pathogenesis. Myxoma virus antigen is 
detected in T-cell zones of the lymph node of infected rabbits (Best et al., 2000) and 
myxoma virus replicates in the rabbit CD4+ T-cell line, RL-5 (see Section 1.7). 
However, myxoma virus has also been shown to infect monocytes and macrophages
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(Macen et al., 1996; Mossman et al., 1996; Everett et al., 2000). T-cells have been 
shown to be important in the pathogenesis of other Leporipoxviruses. For example, 
malignant rabbit virus (MRV), which is a recombinant between myxoma virus and 
Shope fibroma virus, grows best in T-cells, moderately in B-cells, and least efficiently 
in adherent cells, such as monocytes and macrophages (Strayer et al., 1987).
Results in this chapter show stimulation of lymphoid cell cultures with Con A 
significantly increased lymphocyte permissivity to myxoma virus replication. The 
increase in permissivity of lymphoid cells to myxoma virus replication due to Con A 
may be due to interactions at one or more levels. These include virion entry, viral DNA 
and protein synthesis, virion assembly and maturation and virion egress. As discussed in 
the previous section, infected cells were detected by binding of a monoclonal antibody 
specific for a myxoma virus late protein. More cells expressed this late viral protein in 
stimulated cell cultures compared to unstimulated cell cultures, indicating the actions of 
Con A on virus replication must occur prior to late protein expression. It is postulated 
that Con A increases virion entry into the cell. The reasons for this are discussed below.
Poxviruses exist in two infectious forms, intracellular mature virion (IMV) and 
extracellular enveloped virion (EEV), which have different cell entry mechanisms 
(Moss 2001). The virus stocks used in this thesis consisted primarily of IMV, as 
intracellular free virus was released from infected cells by freeze/thawing and 
sonication. Studies of vaccinia virus have shown that vaccinia IMV entry into a cell 
requires activated signaling pathways (Locker et al., 2000). Locker et al. (2000) also 
showed that tyrosine kinase activity was involved in these signaling pathways. Tyrosine 
kinases play a key signaling role during the T-cell activation process and are more than 
likely activated by Con A (Fraser et al., 1993; Isakov 1993; Isakov et al., 1994).
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Tyrosine kinases have also been shown to be critical for permissive and productive 
myxoma virus infection (Lalani et al., 1999; Masters et ah, 2001). Thus in a simple 
model, Con A may increase the activity of specific tyrosine kinase signaling pathways 
that are critical for the infection of lymphocytes with myxoma virus.
However, lymphocytes were also successfully infected with myxoma virus in the 
absence of Con A stimulation. This result may be accounted for by either a proportion 
of cells in unstimulated cell cultures appropriately activated without the need for an 
external stimulus, or infection of cells with the EEV form of myxoma virus. In vaccinia 
virus, the EEV form of virion does not require activated cell signaling pathways for 
infection (Locker et al., 2000). However, it is not known whether the EEV form of 
myxoma virus uses a similar process for infection. It is unlikely that there were large 
amounts of EEV in the infecting virus stocks (~1% reviewed in Moss 2001). Therefore, 
it can be concluded that in the unstimulated cell cultures there were probably cells 
appropriately activated that could be preferentially infected by myxoma virus.
3.3.3 The Sub-population of Lymphoid Cells Permissive for 
Myxoma Virus Replication
The observation that only 60-80% of cells were permissive for myxoma virus 
replication suggests that there are particular sub-population(s) in primary lymph node 
cultures susceptible to myxoma virus infection. Previous studies have identified 
lymphocytes (Fenner et al., 1953), and in particular T-cells (Best and Kerr 2000), as 
critical for myxoma virus infection. Results from this thesis suggest that activated T- 
cells are the main cell sub-population in rabbit lymphoid cell cultures that are 
permissive for myxoma virus infection. This is because a T-cell mitogen significantly
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increased virus replication and the proportion of cells infected and higher levels of late 
protein were detected in the large cell sub-population, which are activated T-cells. T- 
cells account for -57% of the lymph node population (reviewed in Mage 1998). 
Therefore, there must be other cells in lymph node cell cultures permissive for myxoma 
virus infection.
These other cells could be B-cells or cells of the monocytic lineage. Preliminary studies 
in vitro of myxoma virus infection of spleen cells, which have a higher proportion of B- 
cells than lymph nodes, showed a smaller population of infected cells when examined 
by flow cytometry compared to lymph node preparations (data not shown). This 
suggests that B-cells are not a major target for myxoma virus infection although they are 
able to be infected. Supporting this, MRV preferentially replicates in T-cells, although it 
can also replicate in B-cells (Strayer et al., 1987). However, these results do not rule B- 
cells out as playing a role in myxoma virus infection. Monocytes and macrophages are 
also permissive for myxoma virus infection and also play a role in myxoma virus 
dissemination in vivo (Macen et al., 1996; Mossman et al., 1996; Everett et al., 2000), 
but were not examined in this thesis. Strayer et al. (1987) have shown that MRV 
replicates less efficiently in adherent cells such as monocytes and macrophages then it 
does in B-cells. If this is also the case for myxoma virus then it can be concluded that 
monocytes and macrophages do not play as important a role as T-cells in myxoma virus 
pathogenesis.
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3.3.4 Does Myxoma Virus Affect the Response of Rabbit 
Lymphoid Cells to T-cell Mitogens?
Although mitogen stimulation significantly enhanced myxoma virus replication in 
lymphocytes, paradoxically myxoma virus inhibited some features associated with 
lymphocyte activation, such as an increase in cell size and cell proliferation. Abrogation 
of proliferation is associated with arrest of the cell cycle at one of two cell cycle 
checkpoints, G1 or G2. The fact that the increase in cell size (FSC) and replication of 
cellular DNA ( H-T incorporation) are both inhibited suggests that myxoma virus is 
arresting the lymphocytes in the G1 stage of the cell cycle. The effect of myxoma virus 
infection on the cell cycle is investigated in chapter 4.
The results from this chapter indicate that the viral mechanism for inhibition of cell 
proliferation is independent of the signaling pathways that increase myxoma virus 
replication. This is because myxoma virus infection at a low moi completely abrogated 
proliferation but virus could still spread from cell to cell, as seen by the increase in 
proportion of cells expressing late protein and increase in virus replication. This is 
highlighted in the low moi, where peak infections were observed after 36-48 h but 
proliferation was inhibited after 24 h (see Figure 3.3). The fact that infection with the 
low moi also potently suppressed lymphocyte proliferation at a similar time to infection 
with the high moi indicates that virus replication is not required for the anti-proliferative 
effect. Inhibition of T-cell proliferation may be due to either binding of non-infectious 
virions, which are present in the virus preparations, to the cell surface, or due to the 
action of a potent anti-proliferative factor either derived from an early viral gene 
product or secreted by lymphoid cells immediately or shortly after virus binding and 
entry into the cell.
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The presence of secreted factors, either of viral or cellular origin, which halt 
lymphocyte proliferation has been suggested by previous studies. Strayer et al. have 
shown that infection with MRV suppressed T-cell proliferation (Strayer et al., 1988; 
Strayer et al., 1983; Strayer et al., 1986; Strayer et al., 1988), possibly due to a T-cell- 
derived factor that activated T-cell suppression mechanisms. As MRV virus is similar to 
myxoma virus, it could be assumed that similar mechanisms are operating in the 
suppression of lymphocyte proliferation. At this stage, it is difficult to make a 
convincing argument for either a T-cell-derived factor inducing suppression or 
suppression being induced by viral particles binding to cell surfaces, as the 
hypothesized anti-proliferative MRV protein has not been characterised. In addition, 
attempts to replicate the anti-proliferative effect of T-cell supernatants described by 
Strayer et al (1988) have not been consistent (Cartledge 1995). However, any anti-
proliferative factor would have to have potent inhibitory activity or would have to be 
secreted in sufficient concentrations to inhibit lymphocyte proliferation regardless of the 
moi, as myxoma virus infection with both low and high moi completely abrogated 
lymphocyte proliferation by 24 h.
The most likely explanation for the inhibition of lymphocyte proliferation is the 
presence of high amounts of non-infectious particles in the virus stocks that bind to T- 
cells and impede proliferation signals or stimulate inhibitory signals. High levels of 
non-infectious virus particles are typically present in stocks of virus with large DNA 
genomes, such as myxoma virus.
From these results, it can be hypothesized that the ability of myxoma virus to increase 
production of infectious progeny in vivo during cell activation but inhibit cell 
proliferation will cause severe disease in European rabbits. This is because during an
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immune response, cells proliferate and differentiate in response to activation signals. 
Myxoma virus replication and infection will be enhanced by these activated cell 
signaling pathways, but the virus will abrogate proper T-cell functioning by inhibiting 
proliferation and activation. This will disrupt the immune response and potentially lead 
to immunosuppression while still allowing myxoma virus amplification and 
dissemination in lymphocytes. Differences between virulent and attenuated virus strains 
may be related to other interactions between virus and host, such as dissemination. 
Results from this chapter that may shed light on this are discussed in the next section.
3.3.5 Is Attenuation of Ur Associated with a Reduced Ability to 
Productively Infect Lymphocytes?
In this chapter, three major differences were observed between SLS and Ur infection of 
rabbit lymphoid cell cultures. The first was the difference in viral titre/infected cell in 
lymphoid cell cultures. Analysis of titre/infected cell showed that the increase in 
replication of the attenuated Ur strain of myxoma virus in rabbit lymphoid cell cultures 
stimulated with Con A was a result of an increase in the number of cells infected. This 
was because the number of infectious virus particles produced for every infected cell 
was greater in unstimulated cell cultures compared to stimulated cell cultures. In 
contrast, the increase in virus titres observed in virulent SLS infections was due to an 
increase in the number of infectious particles produced per SLS-infected cell.
The difference in titre/infected cell between the virulent and attenuated myxoma virus 
strains when cells were activated may have consequences in vivo. Activation of T-cells 
is an important part of the immune response (reviewed in Sloan-Lancaster and Allen 
1996; Hollsberg 1999; Bi and Altman 2001; Sims and Dustin 2002) and requires
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specific stimulatory and co-stimulatory signals. In the lymph node this is usually 
provided by dendritic cells (Jenkins et al., 2001). In this thesis the T-cell mitogen, Con 
A, was used to mimic T-cell activation. Con A cross-links cell surface proteins and as 
such initiates signaling through many pathways. Although Con A stimulation may not 
be an accurate representation of events in vivo, as a variety of cell signaling pathways 
are activated that may not necessarily be activated during in vivo activation, it is 
probable that at least one of the pathways that Con A activates is that which is involved 
in in vivo activation of T-cells. The non-specific nature of Con A, with regards to the 
cell signaling pathways activated, does not enable detailed examination of which 
signaling pathways are required for myxoma virus infection, but rather enables 
examination of the broad effect of T-cell activation on virus infection.
During the following discussion it must be remembered that lymphocytes will only play 
a role in myxoma virus pathogenesis once the virus reaches the lymph node draining the 
inoculation site. So the differences observed in this chapter in the ability of SLS and Ur 
to replicate in activated T-cells will not affect the early events in myxoma virus 
pathogenesis which occur in the skin, but rather will impact on events after 24 h when 
myxoma virus has reached the lymph node draining the inoculation site as detected by 
immunofluorescence (Best and Kerr 2000).
In the case of SLS, T-cell activation in vitro leads to more cells becoming infected and 
an increase in virus replication in every infected cell. This potentially increases the 
chances of SLS “surviving” in vivo as there is more virus able to infect new cells. T-cell 
activation also leads to more cells infected with Ur in vitro but, unlike SLS infections, 
Ur replication within individual infected cells is not enhanced. Thus, potentially not as 
many infectious progeny will be produced in vivo once the virus reaches the lymph node
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draining the inoculation site, leading to a lower probability of infection of new cells. 
This may lead to better virus control and clearance by the host at the lymph node 
draining the inoculation site or at other lymphoid tissues, based simply on a reduced 
number of infectious Ur virions produced per infected cell. Studies of myxoma virus 
infection have shown that titres of Ur in lymph nodes draining the inoculation site and 
in distal tissues tend to be lower when compared to SLS (Best and Kerr 2000). 
Although one reason for this may be that the ability of Ur to replicate is lower in vivo as 
supported by the results just described, it could also be due to an enhanced anti-viral 
immune response by the host that inhibit virus replication.
The second difference between SLS and Ur was in their ability to replicate in stimulated 
lymphocytes from wild rabbits, which was discussed in Section 3.3.1. However, it must 
be remembered that lymphoid cells from wild rabbits exhibit resistance to myxoma 
virus replication and it may be the resistance of lymphocytes rather than attenuation of 
Ur (or a combination of both) that is responsible for this finding. As previously noted, 
permissivity to myxoma virus replication can be impeded at a number of levels. In 
lymphoid cell cultures from wild rabbit both SLS and Ur had a similar proportion of 
cells infected as measured by staining for a late virus protein, but the amount of 
infectious virus particles produced in lymphoid cell cultures from wild rabbits infected 
with Ur was significantly less than in cultures infected with SLS. These results indicate 
that the difference between SLS and Ur is operating after late protein expression in 
events late in the virus life cycle, such as virion assembly and maturation or egress. As 
discussed previously, any problems in virion egress would not be seen as the cells were 
sonicated to release virions prior to determination of titres by plaque assay. This 
suggests that Ur virions have a reduced ability to assemble or mature in lymphoid cells 
from wild rabbits compared to SLS.
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Alternatively, attenuation of Ur may involve increased cell death in cell cultures from 
wild rabbits initiated after late protein expression. Increased cell death late in infection 
may also be responsible for the significant drop at 72 h in the proportion of cells 
infected with Ur compared to SLS. The dramatic decrease in proportion of cells infected 
with Ur was the third major difference observed between SLS and Ur. Cell death 
pathways are induced on cell cycle arrest, which occurs when cell proliferation is 
abrogated. It is expected that these pathways are activated after infection with both SLS 
and Ur, but as only Ur showed a drop in proportion of cells infected at 72 h, it could be 
postulated that SLS is more effective at inhibiting the induction of cell death at cell 
cycle checkpoints than Ur. The possibility that a difference in cell death is involved in 
myxoma virus attenuation is examined experimentally in the next chapter.
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p values for chapter 4
Proportion of Cells in Sub Gl
Con A significantly increased the proportion of events classified as Sub Gl in mock- 
infected cultures over the 72 h time period. The p values for lymphoid cell cultures 
from susceptible and resistant rabbits are <0.02 and <0.001 respectively.
The proportion of Sub Gl events was less in stimulated SLS-infected cell cultures 
compared with stimulated mock-infected cell cultures in cell cultures from both rabbit 
types, but this difference was only significant in lymphoid cell cultures from wild 
rabbits (p value <0.03).
Compared to SLS-infected cell cultures, Ur-infected cell cultures had significantly 
higher proportion of events classified as Sub Gl 72 h posit infection in lymphoid cell 
cultures from both rabbit types. For cell cultures from susceptible rabbits the p value 
is <0.05 and for cell cultures from resistant rabbits, the p value is <0.04.
Proportion of Cells in G1/G0
When mock-infected cultures were stimulated with Con A, the proportion of cells in 
G1/G0 significantly decreased over the 72 h time course. For cell cultures from 
susceptible rabbits the p value is <0.01 and for cell cultures from resistant rabbits, the 
p value is <0.0005.
When cell cultures infected with SLS were stimulated with Con A, there was a 
significantly greater proportion of events in G1/G0 at 48 h (cell cultures from 
laboratory rabbits only) and 72 h (cell cultures from wild rabbits only) post infection 
compared to mock-infected cell cultures, and a significantly greater proportion of 
events in G1/G0 at 72 h compared to Ur-infected cell cultures (both rabbit types). The 
p values for this are shown in the table below._______________________________
Significance betw een Con A stim ulated Ml and SLS-infected cultures,
48 h pi p value
Cell c u ltu re s  from  su sc e p tib le  rab b its < 0 .02
Cell c u ltu re s  from  re s is ta n t  rabb its
not
sign ifican t
Significance between Con A stim ulated Ml and SLS-infected cultures,
72 h pi p value
Cell c u ltu re s  from  su sc e p tib le  rab b its
not
sign ifican t
Cell c u ltu re s  from  re s is ta n t rabb its < 0 .03
Significance between Con A stim ulated SLS and Ur-infected cultures,
72 h pi p value
Cell c u ltu re s  from  su sc e p tib le  rabb its < 0 .05
Cell c u ltu re s  from  re s is ta n t rabb its < 0 .05
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4.1 Intr od u cti on
There was a dramatic drop in the proportion of cells infected with Ur after 48 h in 
stimulated lymphoid cell cultures (chapter 3). The decrease in proportion of cells 
infected with Ur was observed in cell cultures from both rabbit types, but was not 
observed when cell cultures were infected with SLS. This result clearly differentiated 
virulent SLS myxoma virus from attenuated Ur myxoma virus. Chapter 3 also showed 
that both SLS and Ur abrogated lymphocyte proliferation, as measured by 3H-T 
incorporation and the CellTitre assay. Inhibition of proliferation is associated with arrest 
of the cell cycle at one of the cell cycle checkpoints (described in Section 1.6.1.3). 
failure of a cell to pass a cell cycle checkpoint can induce programmed cell death 
(apoptosis) (Shi et al., 1994; Meikrantz and Schlegel 1996; Yao et al., 1996; Evan and 
Littlewood 1998; Guo and Hay 1999). Differences between SLS and Ur in their ability 
to inhibit apoptosis induced by cell cycle arrest may account for the differences in 
proportion of cells infected at late time points.
Therefore, it could be hypothesized that the drop in proportion of Ur-infected 
lymphocytes at late time points in vitro is due to removal of these cells by apoptosis or 
other forms of cell death. Further, Ur fails to inhibit cell death pathways that are 
induced on cell cycle arrest. The inability of Ur to maintain lymphocyte viability in vivo 
would lead to a lower proportion of infected cells, which would limit Ur dissemination 
and amplification and lead to a milder clinical disease. In contrast, it is postulated that 
SLS is able to maintain the viability of infected lymphocytes after cell cycle arrest at 
late time points in vitro. If SLS was also able to maintain lymphocyte viability in vivo, it 
would lead to more efficient virus replication and dissemination and more severe 
clinical disease compared to Ur infection. These hypotheses can be investigated by
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examining and comparing lymphocyte viability in cell cultures infected with SLS and 
Ur.
Previous studies have shown that recombinant myxoma viruses with genes deleted that 
are essential for replication in lymphocytes are attenuated in vivo and induce apoptosis 
in lymphocytes in vitro (Opgenorth et al., 1992a; Macen et ah, 1996; Barry et ah, 1997). 
Shope fibroma virus also induces apoptosis in lymphoid cells in vitro, fails to replicate 
in lymphocytes and is attenuated in vivo. These studies suggest attenuation, at least in 
some cases, is associated with apoptosis of lymphocytes. Thus, it could be postulated 
that Ur has a lesion that alters production or function of proteins involved in apoptosis 
or related processes. These changes result in the failure of Ur to maintain lymphocyte 
viability after cell cycle arrest and contribute to Ur attenuation.
This chapter addresses the following questions;
1) Is there a difference between SLS and Ur in their ability to maintain lymphocyte 
viability after cell cycle arrest?
2) Can any difference in lymphocyte viability that is observed, be attributed to 
genetic differences in anti-apoptotic or host-range genes between SLS and Ur?
These questions were addressed using flow cytometric analysis of lymphocytes 
prepared from susceptible laboratory and resistant wild rabbits, infected in vitro with 
virulent SLS or attenuated Ur strain of myxoma virus. Propidium iodide staining of 
cellular DNA enabled analysis of cell viability and identification of cell cycle stages. To 
determine whether genetic differences exist between the SLS and Ur strains of myxoma 
virus, 10 viral genes implicated in inhibition of apoptosis, host-range or 
immunomodulation by Cameron et al. (1999) were sequenced.
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4.2 Resul t s
4.2.1 Cell Viability and Cell Cycle Analysis of Infected Rabbit 
Lymphocytes
4.2.1.1 Experimental Approach
Cells that are viable (in G1/G0 and G2/M stages of the cell cycle) can be distinguished 
from non-viable cells, cell fragments and debris using flow cytometry, based on 
intensity of propidium iodide (PI) staining of cellular DNA (Figure 4.1 A). This is 
because the amount of genomic DNA in a cell in G2/M will be twice that of a cell in 
G1/G0 as, by G2/M the genomic DNA has replicated but cytokinesis has not been 
completed. The flow cytometer counts and analyses ‘events’, which can be either a 
viable cell, apoptotic body or necrotic cell, cell fragment or cell debris (Becton 
Dickinson Immunocytometry Systems Reference Manual). Because there is twice as 
much DNA in cells in G2/M than G1/G0, more PI will bind to these cells, increasing the 
fluorescence intensity that is measured for that event. Apoptotic or necrotic cells, which 
have fragmented DNA, and cell fragments containing DNA will have less DNA per 
event measured than cells in G1/G0 and will therefore have lower fluorescence levels 
(Becton Dickinson Immunocytometry Systems). In this thesis, the term ‘Sub G1 phase 
of the cell cycle’ is used to describe these non-viable apoptotic and necrotic cells and 
cell fragments. The term ‘viable’ is used to describe cells in G1/G0 and G2/M.
Cells were assayed for viability by trypan blue exclusion immediately prior to setting up 
all experiments and only preparations with greater than 95% of cells excluding trypan 
blue were used. These cell cultures, with greater than 95% viability, were mock-infected 
or infected with SLS or Ur at a moi of 3 and analysed 4, 24, 48 and 72 h post infection
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for stage of cell cycle by PI staining of cellular DNA. Cell cultures prepared from three 
individual laboratory and three individual wild rabbits were used.
To confirm the flow cytometric gating of cells according to viability, the proportion of 
events detected as viable cells after cell cultures were incubated for 48 h was compared 
to that calculated using trypan blue exclusion. Results showed 79% of events (of 10,000 
counted) were classified as viable after 48 h by flow cytometry and 84% of cells (of 
approximately 200 counted) were classified as viable by trypan blue exclusion. The 
higher proportion of non-viable events when samples were examined by flow cytometry 
(21% compared to 16%) is possibly explained by the presence of cell fragments in the 
non-viable cell gate, which would not be counted in the trypan blue exclusion assay. 
This indicates that analysis of cell viability by flow cytometry is more powerful than 
that of trypan blue exclusion. Furthermore, flow cytometry also enables more than one 
cellular feature to be examined at a time. For example, myxoma virus infection can be 
examined concurrently with cellular DNA content to analyse whether cells infected with 
virus are in a particular stage of the cell cycle. This gives flow cytometry an advantage 
over trypan blue exclusion when examining the effects of myxoma virus infection on 
rabbit lymphoid cells.
The flow cytometer was calibrated such that events corresponding to the G1/G0 sub- 
population had a fluorescence intensity greater than 10 units and events classified as 
Sub G1 had a fluorescence intensity between 10 and 10 units (Figure 4.IB). Using this 
method, distinct viable (G1/G0 and G2/M) and non-viable (Sub Gl) cell sub-
populations were identified. Cell culture debris had a fluorescence intensity less than 
10l units and so was not included. CellQuest software was used to gate sub-populations 
from density plots of cell size versus PI staining, into Sub Gl (non-viable), G1/G0 and
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Apoptotic or 
necrotic cells 
and cell 
fragments
G1/G0
SubGl
G2/M
DNA Content
Figur e  4.1. Method  Used  to  An al yz e  Cel l  Via bil it y  an d  Cell  Cycl e  Stag es  
(A) The cell cycles through G1/G0 where the cell has one copy of DNA, and S phase (DNA 
replication) to G2/M phase where the cell has two copies of DNA. The flow cytometer identifies 
and analyses ‘events’. As there is twice as much DNA in G2/M than G1/G0, more propidium 
iodide (PI) will bind per event, shifting the fluorescence intensity peak to the right in the 
histogram plots. Cells undergoing apoptosis or necrosis and cell fragments will be detected as 
events, these sub-populations will have fragmented DNA and so will bind less DNA per event. 
Hence a shift to the left in fluorescence intensity will occur. (B) Cells were gated into Sub Gl, 
G1/G0 and G2/M based on PI staining of DNA. The proportion of cells in each of these sub-
populations was calculated using CellQuest software. These proportions are graphed in 
subsequent figures.
G2/M phases and to calculate the proportion of events in each. The density plots of cell 
size versus DNA content (Figure 4.IB) were graphed as a histogram plot.
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4.2.1.2 Proportion of Events Classified as Sub G1 (Non-viable cells)
There was no significant difference at the 95% confidence interval (Cl) between 
unstimulated and Con A-stimulated mock-infected cultures in the proportion of events 
classified as Sub G1 (fluorescence intensity lO'-lO2 units) over the 72 h time period. 
However, there was a significant difference in the proportion of events classified as Sub 
G1 in Con A-stimulated mock-infected cell cultures from both laboratory and wild 
rabbits when the duration of stimulation was examined (ANOVA, p<0.05) (Figure 4.2). 
For example, the proportion of events in Sub G1 in stimulated lymphoid cell cultures 
from laboratory rabbits was 23% 4 h post mock-infection, and 43% 72 h post mock- 
infection. In wild rabbit cell cultures, 14% of events were in Sub G1 at 4 h post mock- 
infection compared to 58% at 72 h post mock-infection. This illustrates that stimulation 
of cell cycling by a T-cell mitogen is sufficient to induce cell death in uninfected rabbit 
lymphocytes. In unstimulated mock-infected cell cultures the proportion of Sub G1 
events did not significantly change over the time course.
The high proportion (15-35%) of non-viable events in mock-infected cultures 
(stimulated and unstimulated) after 4 h indicates that the process of mock-infection is 
responsible for some of the Sub G1 sub-population, as all cultures had greater than 95% 
of cells viable by trypan blue exclusion prior to setting up the experiment.
The proportion of events in Sub G1 in SLS-infected cell cultures did not differ 
significantly at the 95% Cl with different periods of Con A stimulation. This sub-
population was also not significantly different in SLS-infected cell cultures compared to 
mock-infected cell cultures at 4, 24 or 48 h post infection (95% Cl). At 72 h post 
infection, however, the proportion of Sub G1 events was less in stimulated SLS-infected 
cell cultures compared with stimulated mock-infected cell cultures in cell cultures from
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Figur e  4.2. Pro po r tio n  of  Eve n ts  Cl a s s if ie d  as  Sub  G1 in  Ra bb it  Lymp ho id  
Cell  Cu lt ur es  Mo ck -Inf ec te d  or  In f ec te d  w it h  SLS o r  Ur
Laboratory and wild rabbit lymphoid cell cultures were mock-infected or infected with SLS or 
Ur at a moi of 3, in the presence or absence of Con A. Samples were analysed at *4, ®24, 48
and 5872 h post infection for PI staining of DNA. The proportion of events classified as Sub G1 
was calculated as shown in Figure 4.1. Infections were repeated for lymphoid cell cultures 
prepared from three laboratory and three wild rabbits, the mean of which is shown here. Error 
bars represent one standard error.
both rabbit types, but this difference was only significant in lymphoid cell cultures from 
wild rabbits (p<0.05) (Figure 4.2).
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Compared to SLS-infected cell cultures, Ur-infected cell cultures had significantly 
higher proportions of events classified as Sub G1 72 h post infection in lymphoid cell 
cultures from both rabbit types (p<0.05). There was no significant difference between 
SLS- and Ur-infected cell cultures at earlier time points. Comparison of unstimulated 
and stimulated Ur-infected cell cultures at each time point showed Con A stimulation 
did not significantly change the proportion of Sub G1 events in these cultures (p<0.05). 
The Sub G1 sub-population in Ur-infected cell cultures was not significantly different 
from that in mock-infected cell cultures at 72 h, however it did tend to be greater in Ur- 
infected cell cultures (Figure 4.2).
In conclusion, SLS maintained lymphocyte viability significantly above that of mock- 
infected and Ur-infected cell cultures at late time points (p<0.05).
4.2.1.2.1 Viability of Infected RL-5 Cells
To determine whether Ur also induced cell death compared to SLS in the rabbit T-cell 
line, RL-5, RL-5 cells were mock-infected or infected with SLS or Ur at a moi of 3 and 
analysed 72 h post infection as detailed in Figure 4.1. Histogram overlays of DNA 
content in mock-infected and infected RL-5 cells are shown in Figure 4.3 for three 
independent experiments. In cell cultures infected with Ur, the mean proportion of 
viable cells was 49% at 72 h. This was significantly less than in mock-infected or SLS- 
infected cell cultures where 78% of events in SLS-infected RL-5 cell cultures and 82% 
of events in mock-infected cell cultures were classified as viable (p<0.05) (Figure 
4.3B). These results show that Ur is also unable to maintain lymphocyte viability in 
infected RL-5 cells. However, in these RL-5 cell cultures there was no significant 
difference in proportion of events classified as viable between mock-infection and SLS- 
infection.
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Fig ur e  4.3. Via bility  of  RL-5 Cells  In f ec te d  w it h  SLS or  Ur
(A) RL-5 cells were mock-infected (black line) or infected with either SLS (green line) or Ur 
(blue line) at a moi of 3. Cell viability was determined by propidium iodide (PI) staining of 
DNA and was analyzed by flow cytometry, where events with a fluorescence intensity between
101 and 102 units were classified as the non-viable sub-population and events with a 
fluorescence intensity above 10“ units were classified as viable cells. A fluorescence intensity of
102 units is shown as a vertical black line. Cell viability was examined in three cultures, 
represented by I, II, III. The histogram overlays were generated using the CellQuest software.
(B) The mean proportion of viable cells in mock-infected and SLS- and Ur-infected RL-5 cell 
cultures was calculated.
4.2.1.3 Proportion of Lymphocytes in G1/G0 Stage of the Cell Cycle
There was no significant difference (p<0.05) in the proportion of unstimulated mock- 
infected lymphocytes in G1/G0 phase of the cell cycle over the 72 h time course with 
60% and 77% at 4 h in cell cultures from laboratory and wild rabbits respectively to 
56% and 64% respectively at 72 h (Figure 4.4). However, when mock-infected cell 
cultures were stimulated with Con A, the difference in proportion of lymphocytes in 
G1/G0 was significant (p<0.05) over the 72 h time course, with 65% and 73% of events 
in G1/G0 at 4 h post infection in cell cultures from laboratory and wild rabbits 
respectively, and 49% and 39% of events respectively at 72 h post infection.
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Laboratory Rabbit Cultures
mrvnr
MI+ConA I SLS SLS+ConAl Ur Ur+ConA
Wild Rabbit Cultures
Figur e  4.4. Pro por ti o n  of  Cel ls  in  G1/G0 Stage  of  t he  Cell  Cycle  in  
Ra b b it  Lymp hoid  Cell  Cult ur es  Mo c k -Inf ec te d  or  Inf ec te d  with  SLS or  Ur
Laboratory and wild rabbit lymphoid cell cultures were mock-infected or infected with SLS or 
Ur at a moi of 3, in the presence of absence of Con A. Samples were analysed at *4, *24, 48
and *72 h post infection for propidium iodide (PI) staining of DNA. The proportion of cells in 
G1/G0 was calculated as shown in Figure 4.1. Infections were repeated for lymphoid cell 
cultures prepared from three laboratory and three wild rabbits, the mean of which is shown here. 
Error bars represent one standard error.
When cell cultures were infected with either SLS or Ur in the absence of mitogen, the 
proportion of cells in G1/G0 was not significantly different to those in mock-infected 
cell cultures at the same time points (p<0.05). However, cell cultures infected with Ur 
tended to have lower proportions of events in G1/G0 compared to SLS-infected and 
mock-infected cell cultures (Figure 4.4).
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When cell cultures infected with SLS were stimulated with Con A, there was a 
significantly greater proportion of events in G1/G0 at 48 h (cell cultures from laboratory 
rabbits only) and 72 h (cell cultures from wild rabbits only) post infection compared to 
mock-infected cell cultures, and a significantly greater proportion of events in G1/G0 at 
72 h compared to Ur-infected cell cultures (both rabbit types) (p<0.05) (Figure 4.4). 
There was no difference between Ur- and mock-infected cell cultures (stimulated and 
unstimulated) in the proportion of events in G1/G0 at any time point (p<0.05), however 
the proportion of cells in G1/G0 in Ur-infected cultures was less than that in mock- 
infected cultures at 48 and 72 h.
In conclusion, there were a significantly higher proportion of cells in Gl/GO in SLS- 
infected cell cultures compared to mock-infected and Ur-infected cell cultures. This is 
reflected by the lower proportion of Sub G1 events in SLS-infected cell cultures 
compared to mock-infected and Ur-infected cell cultures as described in Section 4.2.1.2.
4.2.1.4 Proportion of Lymphocytes in G2/M Stage of the Cell Cycle
Con A stimulation more than doubled the proportion of cells in G2/M stage of the cell 
cycle in mock-infected rabbit lymphoid cell cultures (Figure 4.5). However, the 
proportion of cells in G2/M (mostly about 5%) was much lower generally than those in 
Gl/GO (mostly about 60%). The peak in proportion of cells in G2/M in cell cultures 
infected with myxoma virus was 4-24 h post infection with generally lower proportions 
compared with mock-infected cultures after this time. No significant difference in 
proportion of events in G2/M was observed between infections using SLS or Ur or 
infections of cultures from laboratory or wild rabbits for any time point (p<0.05).
175
Chapter 4- Cell Viability and Cell Cycle Following Infection
Laboratory Rabbit Cultures
Wild Rabbit Cultures
Figur e  4.5. Pro por tio n  o f  Cel ls  in  G2/M Stage  of  the  Cell  Cycl e  in  Ra bb it  
Lym ph o id  Cell  Cul t ur es  Moc k -In f ec te d  or  Inf e c t e d  w it h  SLS or  Ur  
Laboratory and wild rabbit lymphoid cell cultures were mock-infected or infected with SLS or 
Ur at a moi of 3, in the presence of absence of Con A. Samples were analysed at U 4 ,  ^24, 48
and *72 h post infection for propidium iodide (PI) staining of DNA. The proportion of cells in 
G2/M was calculated as shown in Figure 4.1. Infections were repeated for lymphoid cell 
cultures prepared from three laboratory and three wild rabbits, the mean of which is shown here. 
Error bars represent one standard error.
The fact that some cells in myxoma virus-infected cultures are in G2/M early in the time 
period suggests that the mechanism used by myxoma virus to inhibit cell proliferation is 
initiated in the middle to late stages of the virus life cycle. These results appear to 
conflict with those in chapter 3 which showed no increase in either H-T or absorbance 
(CellTitre assay). However, the JH-T assay detects replicating DNA as 3H-T is
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incorporated into the replicating DNA strands, whereas propidium iodide is an 
intercalating agent and as such is incorporated into existing DNA strands. Therefore, the 
two results can both exist.
4.2.1.5 Summary of Cell Viability and Cell Cycle
The Sub Gl sub-population was present 72 h post infection in infected lymphoid cell 
cultures from both laboratory and wild rabbits and infected RL-5 cells. In primary 
lymphocyte cell cultures the proportion of events in Sub Gl was increased by Con A 
stimulation. However, the Sub Gl sub-population was statistically significantly greater 
in Ur-infected cultures. This indicates that Ur is unable to maintain lymphocyte viability 
at late time points compared to SLS. In contrast, SLS maintained cell viability at late 
time points even when cell cultures were stimulated with Con A. The maintenance of 
viability in stimulated SLS-infected cell cultures appeared to be strongly related to cells 
in G1/G0, as stimulation of SLS-infected cell cultures led to significantly more cells in 
G1/G0 than mock-infected controls (p<0.05) but similar proportions of cells in G2/M at 
72 h. Therefore, the ability of SLS to maintain the viability of cells appears to be linked 
to G1/G0 arrest. This supports the results from chapter 3, which show SLS (and Ur) 
inhibit 3H-T incorporation indicating cells are not progressing into S phase.
4.2.2 Analysis of Myxoma Virus Antigen in Events Classified 
as Sub G t  G1/GQ and G2/M
In chapter 3 it was shown that cells stimulated with Con A were more permissive for 
infection than unstimulated cells. Con A stimulation of lymphocytes will generate sub-
populations of activated cells and of dividing cells which could not be differentiated in 
chapter 3. This section examines which stage of the cell cycle infected cells are in and
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also examines the permissivity of dividing cells (those lymphocytes in the G2/M stage 
of the cell cycle) for myxoma virus replication.
4.2.2.1 Experimental Approach
Cell cultures were stimulated with Con A for 48 h prior to infection with SLS or Ur for 
24 h. Cells were gated as Sub Gl, G1/G0 or G2/M on a density plot of cell size versus 
DNA content as shown in Figure 4.1. Each of these sub-populations was analyzed for 
binding of the anti-myxoma virus monoclonal antibody, 3b6e4, by plotting side scatter 
(SSC- light scattered 90° to direction of incident laser) versus virus infection (Figure 
4.6). From the density plots of cell granularity versus virus infection, histogram plots of 
virus infection were generated. The proportion of cells expressing viral antigen and 
therefore infected, were calculated from the histogram plots.
To compensate for the fact that G1/G0 events constitute the major sub-population 
present in rabbit lymphoid cell cultures, the probability that an event in a particular 
stage of the cell cycle would also stain positive for viral antigen was calculated. This 
was done by dividing the proportion of events in each sub-population that were 
expressing viral antigen by the total number of events in that sub-population. Analysis 
of data in this way showed there was a higher probability that an event, if classified as 
G2/M, will express viral antigen after 24 h of infection compared to events in G1 /GO or 
Sub G1 (Table 4.1). Interestingly, lymphoid cell cultures from wild rabbits had a lower 
probability of staining positive for viral antigen after 24 h than those in laboratory rabbit 
cell cultures (Table 4.1). This may indicate a lower permissivity of lymphocytes from 
wild rabbits to myxoma virus replication and supports the finding in chapter 3, where 
significantly lower virus titres were produced in lymphocytes from wild rabbits 
compared to lymphocytes from laboratory rabbits (chapter 3, Figure 3.1).
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Fig ur e  4.6. Met h o d  Us ed  t o  Ana ly ze  Vira l  Ant ig en  in  Eve n ts  Cla ss if ie d  as  
Sub  Gl G1/G0 o r  G2/M
Rabbit lymphoid cells were analyzed for stage of the cell cycle in conjunction with virus infection. 
Two examples are shown in this figure to illustrate the methodology used. Con A-stimulated 
laboratory rabbit lymphoid cell cultures were (A) mock-infected or (B) infected with SLS. Density 
plots of cell size versus DNA content were generated for all infections. Events were gated, based 
on DNA content, as either in Sub Gl, G1/G0 or G2/M as shown in Figure 4.1. Each of these sub-
populations was then analyzed for expression of a myxoma virus antigen (circled regions) by 
plotting cell granularity versus virus infection. A histogram plot (inset) of virus antigen expression 
is also shown.
179
Chapter 4- Cell Viability and Cell Cycle Following Infection
T a b l e  4.1. P r o b a b i l i t y  t h a t  a n  E v e n t  i n  Su b  Gl, G1/G0 o r  G2/M w i l l  S t a i n  
P o s i t i v e  f o r  V i r a l  A n t i g e n
Laboratory Rabbit Lymphoid 
Cultures
Wild Rabbit Lymphoid Cultures
S u b G l G1/G0 G2/M S u b G l G1/G0 G2/M
SLS 40%* 70% 86% 16% 46% 68%
rep licates = rep licates = rep licates = rep licates = rep licates = rep lica tes =
4 6 ,3 7 ,  &  37% 71 , 73 , &  66% 75 , 9 3 , &  91% 2 3 , 12, &  14% 4 5 , 58 , &  34% 75 , 6 8 , & 61%
Ur 32% 71% 84% 18% 37% 62%
rep licates - rep licates = rep licates = rep licates = rep licates = rep lica tes =
1 5 ,3 6 ,  &  43% 72 , 71 , &  69% 8 8 ,9 2 ,  &  72% 3 0 ,1 7 ,  &  6% 4 6 ,2 8 ,  &  36% 6 6 , 5 3 , &  67%
* Probabilities were calculated by dividing the proportion o f infected cells 24 h post infection in each 
sub-population by the total number o f cells in that sub-population. Figures are the means o f cultures 
from three laboratory or three wild rabbits. Probabilities for individual replicate cultures are also 
shown.
4.2.Z2 Detection of Viral Antigen Stages of Cell Cycle
To analyse in more detail the stage of the cell cycle where viral antigen was detected, 
the median fluorescence intensity corresponding to viral antigen was calculated and 
averaged for lymphoid cell cultures stimulated with Con A prior to infection for 24 h for 
each group of three rabbits. Cultures stimulated for 4, 24, 48 or 72 h prior to infection 
were examined. Analysis of mean median fluorescence intensity gives a more accurate 
idea of what is happening in terms of myxoma virus infection in each of the sub-
populations without data being skewed by outliers. However, the absolute values of 
mean medium fluorescence intensity cannot be compared between groups as they reflect 
concentration of viral antigen rather than the total amount in each sub-population.
Table 4.2 shows the difference in late protein expression, as measured by mean median 
fluorescence intensity, between mock-infected and virus-infected rabbit lymphoid cells. 
The results were obtained by calculating the difference in mean median fluorescence
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intensity of events in Sub Gl, G1/G0 or G2/M, between mock-infected and SLS- or Ur- 
infected cell cultures.
The mean median fluorescence intensity in cell sub-populations in lymphoid cell 
cultures from laboratory rabbits generally increased the longer the cells were stimulated 
prior to infection, supporting previous evidence that stimulation of cells increases their 
permissivity for virus replication (Table 4.2). This was a function of stimulation and not 
infection, as all cell cultures were analyzed after 24 h of infection. The greatest 
differences between mock-infected and virus-infected lymphocyte cell cultures from 
laboratory rabbits were observed when cell cultures were stimulated for either 48 or 72 
h prior to infection. This contrasts to infections of lymphoid ceil cultures from wild 
rabbits, where there is a decrease in fluorescence intensity in all sub-populations when 
cell cultures were stimulated with Con A for 48 h prior to infection compared to those 
stimulated for 24 or 72 h (Table 4.2). This decrease in mean median fluorescence 
intensity at this time point in cell cultures from wild rabbits was also noted in chapter 3 
(Table 3.1).
In all infections of lymphoid cell cultures (laboratory and wild rabbit) stimulated for 4, 
24 or 48 h, events in G2/M had a mean median fluorescence intensity difference greater 
than that of events in G1/G0 or Sub G1 (Table 4.2). This suggests that either more virus 
protein is being produced in cells in this sub-population or that virus protein 
accumulates in cells in G2/M by 24 h post infection. The increased production or 
accumulation of viral antigen may be related to increased virus replication in cells with 
activated signaling pathways, as shown in chapter 3, and as would be found in 
lymphocytes in G2/M stage of the cell cycle.
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4.2 Results
4.2.3 Summary of Cell Viability and Cell Cycle Examined by 
Flow Cytometry
The previous sections examined cell viability and cell cycle in rabbit lymphoid cell 
cultures infected with myxoma virus. In Ur-infected cultures there was a significant 
decrease in the number of viable cells 72 h post infection compared to cultures infected 
with SLS. In contrast, SLS maintained cell viability in infected cultures significantly 
above that of mock-infected cultures. These results support the hypothesis that the 
decrease at 72 h in the proportion of Ur-infected stimulated rabbit lymphoid cells 
observed in chapter 3, is due to the inability of Ur to completely inhibit cell death 
pathways, whereas SLS is able to inhibit cell death.
Cells in G2/M were more permissive for infection. Cells in G2/M would have activated 
signaling pathways because they are dividing. This is consistent with the results in 
chapter 3 that show activated cells were more permissive for infection. However, 
infection of cells in G1/G0 would probably play a larger role in mxyoma virus 
pathogenesis, as G1/G0 constitutes the major cell sub-population in lymphoid cell 
cultures.
4.2.4 Sequence Analysis of Anti-Apoptotic and Host-Range 
Genes
The results in the previous Section clearly differentiated the attenuated Ur and virulent 
SLS strains of myxoma virus. One cause of these differences may be mutations in the 
viruses’ anti-apoptotic or host-range genes as potential mechanisms for Ur attenuation. 
Myxoma virus encodes a wide variety of anti-apoptotic and host-range proteins that 
facilitate virus-host interactions and help maintain lymphocyte viability. The increase in
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Sub G1 events in Ur-infected cell cultures 72 h post infection may be attributable to 
changes in one of these genes.
4.2.4.1 Selection of Genes to be Sequenced
Nucleotide and amino acid sequence homology of anti-apoptotic, host-range or 
immunomodulatory ORFs between the two Leporipoxvirus species with published 
genome sequences, the virulent Lu strain of myxoma virus and attenuated SFV, were 
examined to determine which genes were least conserved and therefore may be 
associated with Leporipoxvirus attenuation. Homology was determined for all putative 
anti-apoptotic, host-range or immunomodulatory ORFs identified by Cameron et al 
(1999).
The majority of genes were between 70-80% homologous between Lu and SFV in 
nucleotide identity regardless of putative function (data not shown). The ORF with the 
least homology between Lu and SFV, M077, putatively encodes a structural protein. 
The wide variation in homology between the Lu and corresponding SFV ORF, 
particularly the structural and housekeeping genes which tend to be more conserved 
across poxvirus species, indicated that nucleotide and amino acid homologies were not 
useful as a basis for identifying genes potentially involved in Leporipoxvirus 
attenuation. Selection of the ten immunomodulatory, anti-apoptotic and host-range 
genes for sequencing was thus based primarily on putative gene product function and 
only partly on homology between ORF sequence in SFV and Lu.
Ten genes that were identified by Cameron et al (1999) as having potential 
immunomodulatory, anti-apoptotic or host-range function were selected for sequencing 
based primarily on gene product function. The ten anti-apoptotic, host-range and
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immunomodulatory genes selected for sequencing were M002, M004, M005, M062, 
M063, M064, M128, M151, M152 and M156. Table 4.3 lists these genes and the 
putative properties of their protein products.
Table  4.3. The  ORF Seque nce d  an d  the  Fu n ct io ns  of  the ir  Prot ein  
Produ ct s
ORF Gene Product Function(s) Reference
M002 -T N F  recep to r h o m o lo g  
-b lo ck s ap o p to s is
-d e le tio n  v iru s in d u ces ap o p to s is  in n o n -ad h e ren t 
leu k o cy tes
M acen  e t al. (1996)
M004 -d e le tio n  v iru s h as red u ced  in v ivo  v iru len ce  and 
d issem in a tio n
-d e le tio n  v iru s has red u ced  p rim ary  les io n s
B arry  e t al. (1997)
M005 -d e le tio n  v iru s in h ib its  cell and  v ira l p ro te in  sy n th esis  
-d e le tio n  v iru s h as red u ced  in  v ivo  v iru len ce  and 
d issem in a tio n
-d e le tio n  v iru s fa ils  to  in itia te  ce llu la r im m une resp o n se  
in  ly m p h o id  organs
M o ssm an  et al. (1996)
M062 -u n k n o w n
-p u ta tiv e  h o st ran g e / v iru len ce  fac to r
C am ero n  e t al. (1999)
M063 -ap o p to s is  reg u la to r
-d o m ain  h o m o lo g y  to  F as-b in d in g  dea th  asso c ia ted  
p ro te in
C am ero n  e t al. (1 9 9 9 )
M064 -u n k n o w n
-p u ta tiv e  h o st ran g e / v iru len ce  fac to r
C am ero n  e t al. (1999)
M128 -C D 4 7  h o m o lo g  (in teg rin -a sso c ia ted  p ro te in )
C am ero n  et al. (1 9 9 9 )
M151 -S E R P -2
-b in d s h u m an  IC E
-p rev en ts  p ro cess in g  o f  p ro - IL - lß  to  I L - lß  
-in h ib its  g ran zy m e B
-d e le tio n  v iru s  p ro d u ces m ild e r d isease  sy m p to m s
-d e le tio n  v iru s cau ses red u ced  seco n d ary  lesions
-d e le tio n  v iru s lo w ers ra b b it m o rta lity
-d e le tio n  v iru s e lev a tes  lev e ls o f  ap o p to s is  in lym ph
n o d es d ra in in g  in o cu la tio n  site
-d e le tio n  v iru s in creases in flam m ato ry  resp o n se  a t the
v ascu la r level
M essu d -P e tit e t al. (1998) 
P e tit e t al. (1996)
M152 -S E R P -3
-d e le tio n  v iru s h as red u ced  v iru len ce  an d  p ro d u ces 
m ild e r d isease  sy m p to m s
-d e le tio n  v iru s cau ses rap id  in flam m ato ry  resp o n se  
-d e le tio n  v iru s d oes n o t cau se  s ig n ifican t ap o p to s is  
-d e le tio n  v iru s d o es no t p ro d u ce  seco n d ary  lesions in 
ly m ph  no d e  d ra in in g  in o cu la tio n  site
G u erin  e t al. (2001)
M156 -e IF 2 a  h o m o lo g
-p u ta tiv e  ro le  in in te rfe ro n  res is tan ce  and  R N A  b in d in g
C am ero n  e t al. (1 9 9 9 )
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4 .2.4.2 Sequence of Selected Immunomodulatory, Anti-Apoptotic and 
Host-Range Genes in SLS and Ur
The strategy followed was that each of these ORFs was sequenced in the Ur strain of 
myxoma virus. If these Ur sequences differed from that of the published Lu strain of 
myxoma virus then the same ORFs in the Lu and SLS strains of myxoma virus were 
sequenced. Each ORF was sequenced separately from three independent PCR 
amplifications.
Results of sequencing the ten genes are shown in Table 4.4. The M002, M004, M062, 
M063, M064, M128, M l51 and M l56 ORFs were identical between Ur and the 
published Lu sequences. Differences were observed between the Ur sequence of M005 
and Ml 52 and the published Lu sequences, hence sequencing of these genes in SLS and 
Lu was undertaken. These results are discussed in detail in the following sections.
Ta b l e  4.4. Sequencing  Resu lt s
ORF in Lu Strain of 
Myxoma Virus
Difference between Lu 
and Ur
Difference between Lu 
and SLS
Difference between Ur 
and SLS
M002 N O  D IF F E R E N C E - -
M004 N O  D IF F E R E N C E - -
M005 T 3 3 —»C t 33̂ c
Insertion  o f  C 34 
Insertion  o fC 35 
G 2 9 3 —>A
Insertion  o f  C 34 
G 292—»A
Insertion  o f  C 35
M062 N O  D IF F E R E N C E - -
M063 N O  D IF F E R E N C E - -
M064 N O  D IF F E R E N C E - -
M128 N O  D IF F E R E N C E - -
M151 N O  D IF F E R E N C E - -
M152 Gi96
Aö25 Ĝ
A684- Ĝ
D eletion  o f T 778
G l 9 6 —>A 
A625—>G
Aö84 ^G 
D eletion  o f T 778
M156 N O  D IF F E R E N C E - -
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4.2.5 Sequence Analysis of MQ05
4.2.5.1 Mutations in the M005 ORF
In the M005 ORF, there were three nucleotide differences in SLS compared to Lu and 
four nucleotide differences in Ur compared to Lu (three of which are the changes found 
in the SLS strain). The first difference from Lu was a change of T33 in Lu to C33 in SLS 
and Ur (Figure 4.7). The second difference was an insertion in both SLS and Ur with 
respect to Lu, of a C at position 34. Ur had an insertion of a second C at this point 
compared to SLS (Figure 4.7). The final mutation in the M005 ORF was downstream of 
these insertion(s) and was from G291 in Lu to A292 and A293 in SLS and Ur respectively 
(Figure 4.8).
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Lu SLS Ur
t a c g c c U c g Ma t
T
u
T A C G C C C C C C G  T AT
i
u
T A C G C C C C C C G  T AT
Figur e  4.7. Nuc le o ti de  Dif f e r e n c e s  33-35 Nuc le oti des  fro m  the  Fir st  ATG 
in  th e  M005 ORF
Three sequence traces of the 27-3 8bp region of M005 ORF in Lu, SLS and Ur. The first difference 
in sequence was 33 nucleotides from the start codon, with a T in Lu and a C in SLS and Ur. There 
was also an insertion of a C after nucleotide 34 in the SLS strain and an insertion of two Cs in the 
Ur strain, with respect to Lu. The positions of these differences are indicated by the arrows. The 
M005 ORF was sequenced in all three virus strains from three independent PCR amplifications as 
shown.
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Lu SLS Ur
AGCC ÄA CG TC
AG CC AA CGTN
AG C C  A A C G  T C
>  298bp
AG CC A ACG T C
AGCC A ACGT C
A G C O A A C G T
> 296bp
A G C C G  A C G T  C
A G C C G  ACG T C
A G C C G  A C G T  C
> 296bp
Figure  4.8. Nu c l eo ti de  Dif f er en c es  287-298 Nuc le o ti des  From  th e  first  ATG 
in  th e  M005 ORF
Three sequence traces of the 287-298bp region of M005 ORF in Lu, SLS and Ur. The difference 
was G291 in Lu and A292 and A293 in SLS and Ur respectively (indicated by an arrow). The M005 
ORF was sequenced in all three virus strains from three independent PCR amplifications as shown.
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A.2.5.2 Implications of Nucleotide Mutations for M005 Protein
Expression
The insertion of C at position 34 in SLS compared with Lu results in a frameshift from 
the 11th codon, such that the protein encoded, when starting at the putative start codon in 
the Lu sequence, is only 78 amino acids long (red sequence in Figure 4.9A). In Ur, the 
protein encoded when this start site is used is 22 amino acids long before a stop codon is 
reached (red sequence in Figure 4.9B). Therefore, if M005 translation in SLS and Ur 
starts at the same start codon as in Lu, only truncated proteins will be produced from the 
ORF. To identify any other potential translation start codons all possible ORFs were 
translated for the SLS and Ur M005 sequences using MacVector. In the case of SLS, an 
ATG 17 nucleotides downstream from the Lu translation start site was found (green 
sequence Figure 4.9). Translation from this ATG in SLS would encode a protein 478 
amino acids in length that is identical to the Lu M005 protein except for the first ten 
amino acids of Lu M005, which, in SLS have been changed to five, non-homologous 
amino acids. After these five amino acids, the frameshift is rectified and the amino acid 
sequences between Lu and SLS are identical. If this ATG were to be used as the start of 
translation in Ur a 73 amino acid protein would be produced with no homology to either 
M005 from SLS or Lu (green sequence in Figure 4.9B). A 16 amino acid protein is 
produced from this ATG in Lu (data not shown).
In Ur, a protein identical to the Lu M005 C-terminal 382 amino acids would be 
produced if the ATG 303 nucleotides from the Lu M005 ATG were to be used. In this 
scenario, the first 101 amino acids of the M005 protein in Ur will have been lost.
An alignment of the homologous M005 amino acid sequences in Lu, SLS and Ur is 
shown in Figure 4.10. For SLS and Ur, translation needs to occur at the ATG 17 and
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A
10 20 30 40 50
ATG3ATCTATACGGGTATGTGTCGTGTACGCCCCCGTATCCGACACGATG
M D L Y G Y V S C T P P Y P T R C
M C R V R P R I R H D
60 70 80 90 100
TACTCGATGGTCTCTTGAACGTATACGACCCGGACGAACTATGTTCGCGG
T R W S L E R I R P G R T M F A
V L D G L L N V Y D P D E L C S R
110 120 130 140 150
GATACCCCCTTTCGCCTTTACCTAACGAGATACGACTGTACCCCGGAGGG
G Y P L S P L P N E I R L Y P G G
D T P F R L Y L T R Y D C T P E G
160 170 180 190 200
TTTACGTTTGTTTTTAACACGAGGCGCGGACGTCAACGGAGTTCGTGGTT
F T F V F N T R R G R Q R S S W F
K R K N K V R P A S T L P T R P
210 220  230  240 250
CTCGTACGTCTCCTCTGTGTACGGTCCTATCCAATAAAGATTTGG
S Y V S S V Y G P I Q  STOP 
E S R T S P L C T V L S N K  D-----
B
10
M
M
20 30 40 50
a t c t a t a c g g g t | t g t g t c g t g t a c g c c c c c c g t a t c c g a c a c g a t
D L Y G Y V S C T P P V S D T M
M C R V R P P Y P T R
60 70 80 90 100
GTACTCGATGGTCTCTTGAACGTATACGACCCGGACGAACTATGTTCGCG
Y S M V S STOP
C T R W S L E R I R P G R T M F A
110 120 130 140 150
GGATACCCCCTTTCGCCTTTACCTAACGAGATACGACTGTACCCCGGAGG
G Y P L S P L P N E I R L Y P G G
160 170 180 190 200
GTTTACGTTTGTTTTTAACACGAGGCGCGGACGTCAACGGAGTTCGTGGT 
F T  F V F N T R R G R Q R S S W
210  220 230  240  250
TCTCGTACGTCTCCTCTGTGTACGGTCCTATCCAATAAAGATTTGG
F S Y V S S V Y G P I Q  STOP
Figur e  4.9. Tran sl at io n  of  the  M005 ORF Fr om  SLS an d  Ur  Whe n  Read ing  
From  th e  Fir st  an d  Second  ATG
(A)  SLS and (B)  Ur nucleotide sequence and translation when the first (red) and second ATG 
(green) in the M005 ORT are used. Yellow shading indicates differences in nucleotide sequence 
between the virus strains.
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L u
SL S
U r
r n PRIRHDVLDGLLNVYDPDELCSRDTPFRLYLTRYDCTPEGLRLFLTRGAD 
’ "pR IR H D V LD G LLN VY DPD ELCSRDTPFRLY LTRY DCTPEG LRLFLTRG AD
: 60 
: 55
L u
SL S
U r
L u
SL S
U r
L u
SL S
U r
L u
SL S
U r
L u
SL S
U r
L u
SL S
U r
S: 120
: 115
: 175
: 240
: 23 5
: 139
: 300
: 295
: 199
: 360
: 355
: 259
53: 420
: 415H I  YD Y FRE FV D EC I RE RDAMKAD VLD AVS VFD TAFGLVARPRWKHVRI LSKYVRGVYi
[IYDYFREFVDECIRERDAMKADVLDAVSVFDTAFGLVARPRWKHVRILSKYVRGVYi
I  YD YFRE FVDE C I  RE RDAMKAD VLD AVS VFD TAFGLVARPRWKHVR I L  S KYVRGVY«
[GVRGSRTSPLCTVLSNKDLGNEAEALAKQLIDAGA7
(GVRGSRTSPLCTVLSNKDLGNEAEALAKQLIDAGA^
fAMAPDGRYPLLCLLENDRi:
FAMAPDGRYPLLCLLENDRi:
IAPDGRY PLLC LLEN D R i:
Q ISIN EQ NSLD FTPINY CVIH ND RRTFD YLLERG AD PNW N FLGN SCLD LA V LN GN ]
ISIN EQ N SLD FTPIN Y C V IH N D R R TFD Y LLER G A D PN W N FLG N SC LD LA V LN G N K
ISINEQN SLDFTPIN YCV IHN DRRTFDY LLERGA DPN W NFLG NSCLDLAV LNG N]
t a r f v r y m i d r g t s v y v r g t d g y g p v q t y i h s k n w l d t l r e l v r a g a t v h d p d k t y g :
TARFVRYMIDRGT SVYVRGTDGYGPVQT Y IH  SK N W LD TLR E LVRAGATVHD PDKT YG!
T ARFVRYMIDRGTSVYVRGTDGYGPVQT Y IH  SK N W LD  TLRE LVRAGATVHD PDKT YG:
iQCYMIAHVRSSNVQILRFLLRHGVDSSRGLHATVMFNTLERKISHGVFNRKVLDFIFT
,QC YMIAHVRS SNVQILRFLLRHGVD S SRGLHATVMFNTLE R K IS  H GVFNRKVLD F I  FT
.QCYM IAHVRSSNVQILRFLLRHGVDSSRGLHATVM FNTLERKISHGVFNRKVLDFIFT
H R L L R K T IT PD A Y T R A L N W N SN IY  S IK S  YGMSE FVKRHGTLYKALI RS FVKD S D R E I FT
H R L L R K T IT PD A Y T R A L N W N SN IY SIK S  YGMSE FVKRHGTLYKALIR S FV KD SDREI FT
[R LLR K TIT  PD A Y T R A L N W N SN IY  S I  KS YGMSE FVKRHGTLYKAL I  RS FVKD SDRE I  FT
RVKKILRSLHKRRFKTDRLVRRIADLCGPDGLW TRLPVEVRYSW DYLTDDEIHDL 
RVKKILRSLHKRRFKTDRLVRRIADLCGPDGLW TRLPVEVRYSW DYLTDDEIHDL 
RVKKILRSLHKRRFKTDRLVRRIADLCGPDGLW TRLPVEVRYSW DYLTDDEIHDL
L u
SL S
U r
483
478
382
Figur e  4.10. Alig nm en t  o f  M005 ORF Tra ns l at io n s  from  Lu , SLS an d  Ur  
St ra in s  of  Myxoma  Vir u s
The M005 ORF was sequenced from the Lu, SLS and Ur strains of myxoma virus. The 
nucleotide sequences were translated, aligned and shaded based on amino acid identity. The 
ORFs chosen were based on homology to Lu M005.
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303 nucleotides respectively downstream of the Lu M005 translation start site. Initiation 
of translation at these sites will generate a 478 and 382 amino acid protein in SLS and 
Ur respectively. It is unknown whether translation occurs from either of the initiation 
sites other than that proposed for Lu. However, it is presumed that SLS and Ur encode 
at least partial M005 homologs as infection with either of these strains does not lead to 
the high levels of apoptosis observed early in lymphocyte infection with the M005 
deletion virus (Mossman et al., 1996). The rest of this section will assume that the 478 
amino acid SLS M005 protein and the 382 amino acid Ur M005 protein are produced. 
Other possibilities are examined in the discussion of this chapter.
The final mutation in the M005 ORF was from G291 in Lu to A292 and A293 in SLS and 
Ur respectively. Assuming that translation of the M005 protein in SLS starts at the ATG 
17 nucleotides downstream from the Lu start site, the mutation at position 292 changes 
the 97th amino acid from aspartic acid in Lu, to asparagine in SLS. The change from 
aspartic acid to asparagine does not alter the predicted ankyrin repeat region. This 
amino acid is not present in the truncated M005 protein that is postulated to be encoded 
by Ur.
4.2.5.3 Analysis of the Putative Protein Products from the M005 ORF
4.2.5.3.1 Amino Acid Composition
The differences in the M005 ORF in SLS and Ur would change the expected molecular 
weight and isoelectric points (pi) of the putative M005 proteins, but would not affect the 
percent of non-polar, polar, acidic and basic amino acids. The predicted molecular 
weight of M005 in Lu is 55.5 kDa, and, if translation from the A 17TG for SLS and 
A303TG for Ur occurs, is 55 kDa and 44.4 kDa respectively. The differences in amino
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acid sequence would increase the estimated pi of M005 from 9.34 for Lu to 9.57 and 
9.65 for SLS and Ur respectively. However, all proteins would be composed of 
approximately 40% non-polar amino acids, 30% polar amino acids, 12% acidic amino 
acids and 18% basic amino acids. The conservation of amino acid composition may 
indicate conservation of the function of the putative translated proteins even though the 
complete N-terminal amino acid sequences are not retained.
4.2.5.3.2 Protein Domains in M005
Table 4.5 lists the domains found in M005, their consensus sequence and function and 
their position in Lu M005. The domains were identified using the PROSITE database. 
PROSITE searches and identifies amino acid patterns within protein sequences. M005 is 
predicted to have 7 ankyrin repeats and a RNase3 domain (Cameron et al., 1999). 
Figure 4.11 shows the position of these domains in the M005 amino acid sequence.
Using the PROSITE database, M005 in Lu contains, in addition to the two domains 
listed above, one tyrosine sulfonation site, one cAMP- and cGMP-dependent protein 
kinase phosphorylation site, eight protein kinase C phosphorylation sites, eight casein 
kinase II phosphorylation sites, one tyrosine kinase phosphorylation site and six N- 
myristoylation sites. The domain pattern of these latter sites is commonly found in 
proteins, and their predicted presence may thus be spurious. For example, the protein 
kinase C phosphorylation site, [ST]-x-[RK], only consists of three amino acids with a S 
or T separated from a R or K by any other amino acid. This pattern is commonly found 
in proteins, so the presence of a functional site must be experimentally determined.
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T a b l e  4.5. P u t a t i v e  P r o t e i n  D o m a i n s  i n  M005
Dom ain* C o n s en su s  S eq u en ce F unct ion Posit ion in Lu  
protein  seq u en ce
A n k y r in  R ep ea t - 3 3  amino acids and form ß- 
hairpin followed by two a-helices
• Protein-protein interactions ■ 105-140
• 250-282
• 283-315 
repeat region 
32-315
R N ase3  d o m a in [DEG]-[KRQT]-[LM]-E-[FYW]- 
[L V]-G-D-[S ARH]
• Digestion of  dsRNA and 
processing ribosomal RNA 
precursors
• 218-292
T yros in e  S u lfonat ion  
site
- • Regulation of  protein function • 461-475
c A M P -  and c G M P -  
d ep e n d en t  prote in  
kin ase
p h o sp h o ry la t io n  site
[RK ](2)-x - [ST ]
S or T = phosphorylation site
■ Regulation of  protein function • 223-226
Protein  k in a se  C 
p h o sp h o ry la t io n  site
[ST]-x-[RK ]
S or T = phosphorylation site
• Regulation of  protein function • 10-12
w a r n
■ 121-123
• 159-161
• 208-210
• 326-328
• 354-356
• 354-356
• 437-439
C ase in  k in a se  II [S T]-x (2 )- [D E ] • Regulation of  protein function 42-45
p h o sp h o ry la t io n  site ST = phosphorylation site 77-80
• 159-162
• 169-172
• 243-246
• 286-289
• 354-357
• 391-394 
■ 464-467
• 470-473
T y ro s in e  k in ase  
p h o sp h o ry la t io n  site
[RK]-x(2)-[DE]-x(3)-Y 
Y = phosphorylation site
• Regulation of  protein function • 456-463
N -m y r is to y la t io n  site G-{ED RK H PFY  W }-x(2)- • Site for addition o fC 1 4  fatty • 58-63
[STAGCN]-{P}
G = N-myristoylation site
acid to protein • 63-68
• 96-101
• 205-210 
•211-216
• 274-279
* Information on protein domains, their consensus sequence and function were obtained from 
PROSITE database
yellow shading indicates that this site is not present in SLS or Ur 
red shading indicates that this site is not present in Ur
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Lu M D L Y G Y V S C T P R I R H D V L D G L L N V Y D P D E L C g ^ ^ |^ ^ ^ ^ |f® ff i8 B H H B H H : 60
..........m c r v r pr i r h d v l d g l l n v y d pd e l c ^ S ^ M ^ H H H H M H H H b H): 55
Ur .................................................................. :
Lu
SLS
Ur
VNGVRGSRTSPLCTVLSNKDLGNEAEALAKQLIDAGADVNAMAPDGR5fPLLCLLENDRIN
VNGVRGSRTSPLCTVLSNKDLGNEAEALAKQLIDAGANVNAMAPDGRYPLLCLLENDRIN
......................................................................................
: 120  
: 115 
: 19
Lu
SLS
Ur
YMIDRGTSVYVRGTDGYGPVQTYIHSKNWLDTLRELVRAGATVHDPDKTYGFN : 180 
: 175 
: 79
Lu
SLS
Ur
VLQCYMIAHVRSSNVQILRFLLRHGVDSSRGLHA'j 240
235
139
Lu
SLS
Ur
LNGNKYMV
| l n g n k y m v
LNGNKYMV
: 300 
: 295 
: 199
Lu
SLS
Ur
HRLLRKTITPDA1
h r l l r k t i t p d a :
HRLLRKTITPDAYTr
l g |  ALNWNSNIYSIKSYGMSEFVKRHGTLYKALIRSFVKDSDREIFT: 360 
ALNWNSNIYSIKSYGMSEFVKRHGTLYKALIRSFVKDSDREIFT: 355 
IALNWNSNIYSIKSYGMSEFVKRHGTLYKALIRSFVKDSDREIFT:259
Lu YVHIYDYFREFVDECIRERDAMKADVLDAVSVFDTAFGLVARPRWKHVRILSKYVRGVYG:420 
SLS YVHIYDYFREFVDECIRERDAMKADVLDAVSVFDTAFGLVARPRWKHVRILSKYVRGVYG: 415 
Ur YVHIYDYFREFVDECIRERDAMKADVLDAVSVFDTAFGLVARPRWKHVRILSKYVRGVYG:319
Lu DRVKKILRSLHKRRFKTDRLVRRIADLCGPDGLWTRLPVEVRYSWDYLTDDEIHDLFVK:480 
SLS DRVKKILRSLHKRRFKTDRLVRRIADLCGPDGLWTRLPVEVRYSWDYLTDDEIHDLFVK:475 
Ur DRVKKILRSLHKRRFKTDRLVRRIADLCGPDGLWTRLPVEVRYSWDYLTDDEIHDLFVK: 37 9
Lu IHA: 483 
SLS IHA:478 
Ur IHA:382
Figur e  4.11. Put at iv e  Pro te in  Dom ai ns  in  M005
Putative domains of M005 in Lu, SLS and Ur were determined using the PROSITE database. 
PROSITE identified an ankyrin repeat region (blue shading), ankyrin repeats (black line) and 
RNase3 domain (red text). In Ur the ankyrin repeat domain is truncated.
Changes in the predicted SLS M005 protein deletes one of the protein kinase C 
phosphorylation sites, whereas the predicted Ur M005 protein has deletion of two 
protein kinase C phosphorylation sites, two casein kinase II phosphorylation sites and 
three N-myristoylation sites. In addition, the ankyrin repeat region is truncated in Ur 
M005 compared to Lu M005. The differences in Ur M005 are due to the deletion of the 
N-terminal amino acids of the putative M005 protein and not to differences in amino 
acid sequence.
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4.2.5.3.3 Secondary Structure
Secondary structure was predicted by combining the predictions using the Chou-Fasman 
(CF) method and Robson-Gamier (RG) method (MacVector). The CF method assigns 
each amino acid into one of the following categories- helix former, helix breaker, sheet 
former and sheet breaker. Secondary structure is predicted based on the clustering of 
amino acids in each group. The RG method examines neighbors of each amino acid and, 
as each amino acid exerts an effect on nearby amino acids, determines the probability 
that that amino acid will be part of a helix, sheet, turn or coil.
When examining the predicted secondary structure, by a combination of the CF and RG 
methods, there are five predicted heiix regions separated by sheet regions (data not 
shown). Ankyrin repeats are a section of approximately 33 amino acids that form a ß- 
hairpin followed by two a-helices. Therefore, the ankyrin repeats predicted in M005 
probably contribute to the secondary structure predicted.
4.2.6 Sequence analysis of M152
4.2.6.1 Mutations in the M152 ORF
Identical M l52 nucleotide sequences were obtained for SLS and Ur. However, there 
were four nucleotide differences in SLS and Ur compared to Lu. The first nucleotide 
difference was G196 in Lu, whereas in SLS and Ur, the nucleotide at this position was an 
adenine (Figure 4.12). The next nucleotide difference was Tö25 in Lu, which was C625 in 
SLS and Ur (Figure 4.13). This same difference (T to C) was also observed 684 
nucleotides downstream of the translation start site (Figure 4.14). The fourth difference 
observed between Lu and SLS and Ur was in the region T778-782. In Lu there were five 
Ts in this region but only four in SLS and Ur (Figure 4.15), suggesting either an
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Lu SLS Ur
G T ACG C AC AC
G T ACG CAC AC
GT  AC C A C  AC
201bp
GT ACACACAC
GT AC A CAC AC
GTACACACAC
»  201bp
G T ACACA CAC
g N a c ä c a c a
GT ACACACAC
>  201bp
Figure  4.12. Nuc l eo ti de  Dif f er en c es  196bp  From  the  First  ATG in  the  M152 
ORF
Three sequence traces of the 192-201 bp region of M l52 ORF in Lu, SLS and Ur. The first 
difference in sequence between Lu and SLS and Ur was found 196 nucleotides from the start 
codon, with a G in Lu and an A in SLS and Ur (indicated by arrows). The M005 ORF was 
sequenced in all three virus strains from three independent PCR amplifications as shown.
insertion in the Lu Ml 52 ORF or a deletion in SLS or Ur Ml 52 ORF. The lack of this T 
in SLS and Ur induces a frameshift that abrogates the M l52 stop codon. This results in 
the M l52 ORF from SLS and Ur being 96 nucleotides longer than in Lu. The extension 
of the Ml 52 ORF overlaps the first 63 nucleotides of the Ml 53 ORF.
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Lu SLS Ur
T G TG CGGG A
T GT  G C G G G A
TG T G C G G G  A
629bp <
T G T G  CGGG A
TG T G C G G G  A
T GT  G C G G G  A
629bp <
G G G G G  A
T G T G G G G A
N g t g G G G  A
629bp <
Figur e  4.13. Nu c l eo ti d e  Dif f er en c es  625bp From  t he  First  ATG in  M l52 ORF
Three sequence traces of the 621-629bp region of M l52 ORF in Lu, SLS and Ur. The second 
difference in sequence Lu and SLS and Ur (indicated by an arrow) was 625 nucleotides from the 
start site. The sequence trace shows this region on the 3’->5’ strand. In Lu this was a T and in SLS 
and Ur this was a C. The M l52 ORF was sequenced in all three virus strains from three 
independent PCR amplifications as shown.
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Lu
\
G C G G T T  G C G T
689bp^-----------------680bp
SLS
i
G C 6 6 T C G C 6 T
i
G C G G T C G C G T
üM
G C G G T ^ G C G  T
Ur
1
G C G G T  C GCGT
N c g g t c g  CG T 
G
is
g c N g t c g c g t
G
Fig ur e  4.14. Nuc le o ti de  Dif f er en c es  684bp  From  the  First  ATG in  M152 ORF 
Three sequence traces of the 680-689bp region o f M l 52 ORF in Lu, SLS and Ur. A difference in 
nucleotide sequence Lu and SLS and Ur (indicated by an arrow) was found 684 nucleotides from 
the start codon. The sequence trace shows this region on the 3’—>5’ strand. In Lu this was a T and 
in SLS and Ur this was a C. The M l52 ORF was sequenced in all three virus strains from three 
independent PCR amplifications as shown.
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Lu SLS Ur
C ' A A A A A G T  CT
C A A A A A G T C T
A A A A AG T C T
CfA A A^ GT C TA
C^AAA'G TOT A
CAA NAGTCT A
C A A A A G T C T A
V v V
C A A A A G T C T A
CA A A A G T C T A
Figure  4.15. Nu c l e o t id e  Dif fe ren ce s  778bp  From  the  Fir st  ATG in  M152 ORF
The M l52 ORF was sequenced three times in Lu, SLS and Ur. Differences were found in a region 
of T/A base pairs, 778-782 nucleotides from the start site in Lu. The sequence traces show this 
region (brackets) on the 3’->5’ strand, where, in Lu, this region has five As whereas SLS and Ur 
has four As. The M l52 ORF was sequenced in all three virus strains from three independent PCR 
amplifications as shown.
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4.2.6.2 Implications of Different Nucleotide Sequences for M152 
Protein Expression
The M l52 nucleotide sequences from Lu, SLS and Ur, were translated and aligned 
(Figure 4.16). The nucleotide differences change the amino acids at positions 65, 209 
and 261-266. In Lu these amino acids are A, T and LFMGKL respectively, whereas in 
SLS and Ur the amino acids at these positions are T, A and CLWGNS respectively. As 
stated in the previous section, the lack o f the T nucleotide in the 778-782 region in the 
SLS and Ur M l52 ORF abrogates the translation stop codon. This extends the M l52 
protein by 32 amino acids, as shown in Figure 4.16.
IFNHLNSINPRTRFCFSPVSVSYALSVCCTGNVPSDYVSSTVWKNKVYINAFKQSP^
IFNHLNSINPRTRFCFSPVSVSYALSVCCTGNVPSDYVSSTVWKNKVYINAFKQSP'V
IFNHLNSINPRTRFCFSPVSVSYALSVCCTGNVPSDYVSSTVWKNKVYINAFKQSP’S
TAYGCSNDRLYSYNEYAFSHLKQDRVKIIELPCDDDYSWLITHDSRSTITPDKVTGWL
TAYGCSNDRLYSYNEYAFSHLKQDRVKIIELPCDDDYSWLITHDSRSTITPDKVTGWL
TAYGCSNDRLYSYNEYAFSHLKQDRVKIIELPCDDDYSWLITHDSRSTITPDKVTGWli
t t r l r y v n v s l p k g s t e t g h n v t c l t p JJh v n l c h r c r i t i t k t g v d a t a f s c v d g d t c t
TTRLRYVNVSLPKGSTETGHNVTCLTPAHVNLCHRCRITITKTGVDATAFSCVDGDTCT 
TTRLRYVNVSLPKGSTETGHNVTCLTPAHVNLCHRCRITITKTGVDATAFSCVDGDTCT
Lu
SLS
Ur
i i L i J «  it i i  i i  i i n Ab S l f m S k l .....................................................................................................................................................
13; i i L i • ii V 7 • •
11 ir •  ii m A b 3j* W r t H f i i w * i : * f ! « V T jij e • • Y 1 * Ir
Fig ur e  4.16. Alig nm en t  of  M l52 ORF Tra ns l at io n s  fr om  Lu , SLS an d  Ur
The M l52 ORF was sequenced from the Lu, SLS and Ur strains of myxoma virus. The 
sequences were translated and aligned using Multalign, and shaded using BOXSHADE, based 
on amino acid identity.
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4.2.6.3 Analysis of the Putative Protein Products from the M152 ORF
4.2.6.3.1 Amino Acid Composition
The differences in the nucleotide sequence of M l52 between Lu, SLS and Ur, affects 
the expected molecular weight and pi of the M l52 protein. The expected molecular 
weight of M l52 from Lu is 30 kDa, whereas it increases to 33.5 kDa in SLS and Ur. 
The estimated pi for the M l52 protein is 9.21 for Lu and 9.69 for SLS and Ur. The 
nucleotide differences do not affect the percent of non-polar, polar, acidic and basic 
amino acids encoded. Approximately 32% of the amino acids in M l52 were non-polar 
compared to 42% polar, 9% acidic and 17% basic.
4.2.6.3.2 Protein Domains in M152
Table 4.6 lists each domain, its consensus sequence and function. M l52 is predicted to 
have a zinc finger and RNA binding site (Cameron et al., 1999). In addition, PROSITE 
identifies the following non-specific sites in Lu M l52; three N-glycosylation sites, one 
protein kinase C phosphorylation site, six casein kinase II phosphorylation sites, one 
tyrosine kinase phosphorylation site, four N-myristoylation sites, one microbodies C- 
terminal targeting signal and one threonine-rich region. The nucleotide difference at 
position 196, changing the amino acid from A in Lu to T in SLS and Ur, removes the 
predicted RNA binding site. The nucleotide differences at the C-terminus of Lu M l52 
remove the microbodies targeting signal. SLS and Ur also have a cAMP- cGMP- 
dependent protein kinase phosphorylation site, two extra protein kinase C 
phosphorylation sites, one extra N-myristoylation site and a cysteine-rich region created 
by the sequence changes compared to Lu. Figure 4.17 shows the main putative domains 
in M152.
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T a b l e  4 .6 . P u t a t i v e  P r o t e i n  D o m a i n s  i n  M 1 5 2
D o m a i n * C o n s e n s u s  S e q u e n c e F u n c t i o n P o s i t i o n  in  L u  
p r o t e i n  s e q u e n c e
N - g l y c o s y l a t i o n  s i t e N -{ P}- [ST ]-{ P}
N = g lycosy la t ion  site
• Site  fo r add i t ion  o f  
o l igosacchar ides
102-105
189-192
202-2 0 5
E u k a r y o t i c  R N A  
r e c o g n i t i o n  m o t i f
[ R K ] - G - { E D R K H P C G } -
[A G S C I] - [F Y ] - [L IV A ]-x -
[F Y L M ]
• B inds  s sR N A • 6 1 - 6 8
M i c r o b o d i e s  C -  
t e r m i n a l  t a r g e t i n g  
s i g n a l
[ S T A G C N ] - [R K H ]- [ L IV M  AFY] • T a rg e t  s ignal for  im p o r t  into 
m ic ro b o d ie s ,  small single  
m e m b ra n e  o rgane l le s  e.g. 
pe ro x iso m es ,  g ly o x y so m es ,  
g ly co so m es
• 2 6 4 - 2 6 6
P r o t e i n  k i n a s e  C  
p h o s p h o r y l a t i o n  s i t e
[S T ]-x - [R K ]
S or T = pho sp h o ry la t io n  site
• R egu la t ion  o f  p ro te in  func tion • 182-184
| 2 6 6 - 2 6 8
§ 2 7 0 - 2 7 2
C a s e i n  k i n a s e  II  
p h o s p h o r y l a t i o n  s i t e
[S T ]-x (2 )- [D E ]
ST = p h o s p h o ry la t io n  site
• R eg u la t io n  o f  p ro te in  func tion • 133-136
• 2 2 4 -2 2 7
• 2 3 2 -2 3 5
• 238-241  
■ 240 -2 4 3
• 2 5 6 -2 5 9
T y r o s i n e  k i n a s e  
p h o s p h o r y l a t i o n  s i t e
[R K ]-x (2 ) - [D E ]-x (3 ) -Y  
Y = phosp h o ry la t io n  site
• R eg u la t io n  o f  p ro te in  func tion • 75-83
N - m y r i s t o y l a t i o n  s i t e G - { E D R K H P F Y W  }-x(2)- 
[S T A G C N ]-{ P }
G = N -m y r i s to y l a t io n  site
• Site for addi t ion  o f  C 14 fatty 
acid to pro te in
• 33-38
• 6 2 -67
• 195-200
• 2 2 5 -2 3 0
1 2 5 7 - 2 6 2
T h r e o n i n e - r i c h  r e g i o n • R eg u la t io n  o f  p ro te in  func t ion • 170-256
c A M P -  a n d  c G M P -  
d e p e n d e n t  p r o t e i n  
k i n a s e
p h o s p h o r y l a t i o n  s i t e
[R K ](2 ) -x - [S T ]
S or  T = p h o s p h o ry la t io n  site
• R egu la t ion  o f  p ro te in  func t ion N o t  in  L u  
p o s i t i o n  2 6 7 -  
2 7 0  in  S L S  a n d
C y s t e i n e - r i c h  r e g i o n C - x - [ G N Q ] - x ( l  ,3 ) -G -x -C-x -C -  
x (2) -C -x-C
■ D o m a in  found in a varie ty  o f  
pro te ins ,  e g. g row th  factors , 
cy tok ine  recep tors ,  apop tosis-  
re la ted pro te ins ,  in tegrin s
N o t  in  L u  
p o s i t i o n  2 7 7 -  
2 9 4  in  S L S  a n d  
U r
* Information on protein domains, their consensus sequence and function were obtained from 
PRO SITE database
yellow shading indicates that this site is not present in SLS or Ur 
green shading indicates that this site is not present in Lu
4.2 Results
Lu MDIFNHLNSINPRTRFCFSPVSVSYALSVCCTGNVPSDYVSSTVWKNKVYINAFKQSPV:60 
SLS MDIFNHLNSINPRTRFCFSPVSVSYALSVCCTGNVPSDYVSSTVWKNKVYINAFKQSPV:60 
Ur MDIFNHLNSINPRTRFCFSPVSVSYALSVCCTGNVPSDYVSSTVWKNKVYINAFKQSPV:60
Lu
SLS
Ur
[TNDWHRLHKEVESYDVRFPIKSVNLDAVFLSINVTRVRLRWKIPLTEHNPY: 120 
RGTSYTHFTNDWHRLHKEVESYDVRFPIKSVNLDAVFLSINVTRVRLRWKIPLTEHNPY:120 
RGTSYTHFTNDWHRLHKEVESYDVRFPIKSVNLDAVFLSINVTRVRLRWKIPLTEHNPY:120
Lu QTAYGCSNDRLYSYNEYAFSHLKQDRVKIIELPCDDDYSWLITHDSRSTITPDKVTGWL:18 0 
SLS QTAYGCSNDRLYSYNEYAFSHLKQDRVKIIELPCDDDYSWLITHDSRSTITPDKVTGWL:180 
Ur QTAYGCSNDRLYSYNEYAFSHLKQDRVKIIELPCDDDYSWLITHDSRSTITPDKVTGWL:180
Lu RTTRLRYVNVSLPKGSTETGHNVTCLTPTHVNLCHRCRITITKTGVDATAFSCVDGDTCT:2 4 0 
SLS RTTRLRYVNVSLPKGSTETGHNVTCLTPAHVNLCHRCRITITKTGVDATAFSCVDGDTCT:24 0 
Ur RTTRLRYVNVSLPKGSTETGHNVTCLTPAHVNLCHRCRITITKTGVDATAFSCVDGDTCT:2 4 0
Lu EHDTTASTCTIIIKTTGLDFLFMGKL.................................:266
SLS ehdttastctiiikttgldfclwgnskklsikvnrl|khgycckhghcckpgrckpgg:298
Ur EHDTTASTCTIIIKTTGLDFCLWGNSKKLSIKVNRLCKHGYCCKHGHCCKPGRCKPGG:298
Figure  4.17. Put a ti v e  Prote in  Do m ai ns  of  M152
Putative domains o f M l 52 in Lu, SLS and Ur were determined using PROSITE. Domains 
shown are eukaryotic RNA recognition motif (blue shading), microbodies C-terminal targeting 
signal (green line) and threonine-rich region (red text). The elongation of the Ml 52 protein in 
SLS and Ur includes a cysteine-rich region (green shading). SLS and Ur do not have the 
eukaryotic RNA recognition motif the microbodies C-terminal targeting signal or the threonine- 
rich region.
4.2.6.3.3 Secondary Structure and Transmembrane Regions
Regardless of which secondary structure prediction method was used, M l52 was 
predicted to have a predominantly ß-sheet structure. Regions are similar in all virus 
strains. The extended C-terminus in SLS and Ur is predicted to be a turn region.
Lu M l52 is predicted to be an intracellular cytoplasmic protein (Cameron et al., 1999). 
No transmembrane domains were predicted using “DAS”; Transmembrane Prediction 
server confirms this prediction (data not shown). There is no predicted transmembrane 
domain within the elongated C-terminal of M l52 in SLS and Ur. Analysis of 
hydrophilicity shows the C-terminus of the Ml 52 protein in SLS and Ur is hydrophilic.
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4.2.7 Summary of Sequence Analysis
To identify if there was a genetic basis for the increase in proportion of non-viable cells 
in Ur-infected cell cultures detected in Section 4.2.1, ten genes with putative roles or 
known as having a role in apoptosis, were sequenced. M002, M004, M062, M063, 
M064, M128, M l51 and M l56 were identical between Ur and the published Lu 
sequence. Of the two that were not identical to the published Lu sequence, M005 and 
M l52, only M005 was different between SLS and Ur. The nucleotide differences in 
M005 potentially results in translation of similar proteins in SLS and Lu, but a truncated 
or even absent protein in Ur. The nucleotide differences in M l52 result in extension of 
the C-terminal end in SLS and Ur compared to Lu.
Chapter 4- Cell Viability and Cell Cycle Following Infection
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4.3 Dis c u s s io n
This chapter examined the hypothesis that a difference existed between SLS and Ur in 
their ability to maintain lymphocyte viability after cell cycle arrest. It was found that 
Ur-infected cell cultures had significantly lower proportions of cells in G1/G0 compared 
with SLS-infected and mock-infected cell cultures at 72 h post infection. In addition 
SLS-infected cell cultures had significantly greater proportions of G1/G0 events than 
mock-infected cell cultures at this time. These results together suggest that after cell 
cycle arrest caused by virus infection, cell death is induced. Ur is not able to inhibit 
these pathways leading to cell death, whereas SLS is able to inhibit these pathways. 
This result clearly differentiates SLS from Ur.
Sequence analysis of ten myxoma virus genes with putative anti-apoptotic, host-range 
or immunomodulatory functions was undertaken in order to identify genetic differences 
between SLS and Ur that may affect the ability of Ur to maintain lymphocyte viability. 
Analysis showed the M005 ORF in the Ur strain of myxoma virus had an insertion of 
one cytosine at position 34 compared to the SLS strain. This either truncates the M005 
protein or leads to its failure to be expressed. Failure to express M005 by myxoma virus
has been previously implicated in lymphocyte apoptosis (Mossman et ah, 1996) and so 
the difference in this ORF between SLS and Ur may contribute to the attenuation of Ur.
In addition, this chapter showed that cells in G2/M were more permissive for myxoma 
virus replication than cells in G1/G0. This may be due to the cell signaling pathways 
that are activated during cell division.
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4.3.1 Cell Cycle Arrest and Induction of Apoptosis
Both SLS and Ur abrogate lymphocyte proliferation and therefore have the ability to 
arrest the cell cycle in lymphocytes (chapter 3). Results in chapter 3 showed the arrest 
was due to a blockage in transition from G1 to S stage of the cell cycle based on the 
failure of lymphocytes to incorporate H-T and the inhibition of cell enlargement. The 
results in this chapter support this as the proportion of cells in G2/M did not increase 
over 72 h in virus-infected cultures, suggesting cells were not accumulating in this stage 
of the cell cycle. This is in contrast to MRV infection of RK13 cells where cells arrested 
in the G2/M stage of the cell cycle (Wali and Strayer 1996). This difference between 
myxoma virus and MRV will be discussed in more detail below. Even though cells in 
cultures infected with myxoma virus did not appear to accumulate in G2/M, a small 
number of events expressing high levels of viral protein and classified as G2/M were 
observed. The high levels of viral protein detected are presumably due to the enhanced 
virus replication that takes place in cells with activated cell signaling pathways, as 
would be the case when stimulated with mitogen.
Cell cycle progression involves numerous regulatory proteins and mechanisms that are 
highly conserved among eukaryotes (reviewed in Gregory 2001; Kohn 1999; Morgan 
1997). Proliferation is largely controlled during the G1 stage of the cell cycle where 
cells must accumulate a specific level of protein synthesis to be able to transit from G1 
to S stages. Cell division is inhibited if cell growth is halted, indicating there is a 
requirement for cell growth prior to DNA replication (Neufeld and Edgar 1998; 
Polymenis and Schmidt 1999). Cell growth is linked to DNA replication by coupling of 
the expression of cell cycle regulator(s), such as cyclins, to the rate of biosynthesis in a 
cell (reviewed in Neufeld and Edgar 1998). Cyclin E has been identified as the potential 
rate-limiting component of Gl-S progression in eukaryotic cells (reviewed in Stocker
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and Hafen 2000). Myxoma virus infection may inhibit the translation or increase the 
degradation of cell cycle regulators, such as cyclin E, in lymphocytes. This will lead to 
the failure of cell cycle regulators to accumulate in these cells and would arrest cells in 
the G1 stage of the cell cycle.
Cell cycle arrest can activate cell death pathways (Guo and Hay 1999) and proteins 
involved in cell cycle progression have been shown to mediate cell death (reviewed in 
Xaus et ah, 1999). One example is p53, which can cause G1 cell cycle arrest when DNA 
is damaged and is involved in some apoptotic pathways (reviewed in Stewart and 
Pietenpol 2001). The level of p53 expression may determine the stage of the cell cycle 
in which arrest occurs or may determine whether cells remain viable or undergo 
apoptosis during virus infection. For example, one study with Epstein-Barr virus 
showed that low levels of p53 in infected cells led to cell cycle arrest at G2/M, medium 
levels of p53 led to G1 arrest but without apoptosis, and high levels of p53 during 
Epstein-Barr virus infection induced apoptosis (Chen et al., 1998).
p53 has also been shown to be up-regulated after infection of the RK13 rabbit kidney 
cell line with malignant rabbit virus (MRV). MRV abrogates proliferation of RK13 cells 
in the G2/M stage of the cell cycle (Wali and Strayer 1996). As discussed in the 
previous chapter, the close relationship between myxoma virus and MRV makes it 
reasonable to assume that SLS and Ur may also increase p53 expression. Results from 
this chapter showed that SLS and Ur abrogate proliferation in the G1/G0 stage of the 
cell cycle. While it is formally possible that myxoma virus may induce greater levels of 
p53 than MRV and thus induce G1/G0 arrest similarly to Epstein-Barr virus, it is likely 
that the stage of the cell cycle arrest may be a function of the cell type studied as G2/M
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arrest was observed in infected RK13 cells, whereas this thesis examined rabbit 
lymphoid cells.
As Ur does not maintain lymphocyte viability late in infection, whereas SLS does, it 
may be postulated in a simple model, that both SLS and Ur infection increase p53 
expression to levels that arrest the cell cycle in Gl, but p53 builds up over time in Ur- 
infected cells such that by 72 h there is enough p53 to induce cell death. In contrast, 
SLS may be able to limit p53 levels or stop it from reaching its site of action, so that by 
72 h post infection levels are not sufficient to induce apoptosis. This could be tested be 
examining p53 levels in lymphocytes infected with SLS or Ur.
4.3.2 Implication for Differences in Lymphocyte Viability In Vivo
The difference between SLS and Ur in maintaining lymphocyte viability and therefore 
inhibiting cell death pathways, clearly differentiated the virulent and attenuated strains 
of myxoma virus. SLS maintained the viability of lymphocytes significantly above that 
of mock-infected and Ur-infected cell cultures indicating that SLS can effectively 
inhibit cell death pathways in lymphocytes. The ability of SLS to inhibit lymphocyte 
death may help prolong the period SLS has available for replication in vivo. As 
lymphoid cells are predicted to be the major cell type involved in systemic 
dissemination of myxoma virus in vivo (Fenner and Woodroofe 1953; Best and Kerr 
2000), maintaining the viability of these cells may enhance SLS spread. In contrast, Ur 
failed to inhibit cell death pathways late in infection. The inability to keep infected 
lymphocytes alive potentially decreases the time available for production of infectious 
progeny and would restrict the extent of virus dissemination in vivo. This will be 
discussed further in chapter 7.
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4.3.3 Genetic Differences in the MQ05 ORF Between SLS and 
Ur
The difference in ability of SLS and Ur to maintain lymphocyte viability suggested that 
the genetic lesion in Ur was associated with anti-apoptotic or host-range genes. Ur was 
isolated in early 1953, two years after the release of SLS in the summer of 1950-1951. 
SLS was the only strain of myxoma virus released in Australia at this time, therefore Ur 
is derived genetically from SLS. The high degree of genetic conservation between SLS 
and Ur (Saint et ah, 2001) indicates that the genetic differences between the virus strains 
are likely to be minor and in genes, or their regulatory sequences, that are associated 
with virulence in rabbits. The results in this chapter are the first demonstration of a 
difference associated with attenuation of Ur that is measurable in vitro.
The insertion of a C at position 34 in the M005 ORF and subsequent frameshift in Ur 
compared to SLS, may explain the different abilities of SLS and Ur to maintain 
lymphocyte viability. M005 is a critical virulence factor for myxoma virus and has been 
postulated to promote lymphocyte survival, as replication of a recombinant myxoma 
virus with M005 deleted was identical to wild type virus in RK13 cells but reduced in 
RL-5 cells and primary peripheral blood mononuclear leukocytes (Mossman et ah, 
1996). M005 inhibits apoptosis in infected lymphocytes by an unknown mechanism 
and, in the absence of M005, apoptosis occurs within 2 h of infection. In addition, host 
and viral protein synthesis is inhibited early after infection of RL-5 cells with the M005 
deletion virus (Mossman et ah, 1996).
As SLS is able to maintain lymphocyte viability, it is postulated that SLS has a 
complete set of functioning anti-apoptotic and host-range genes, including M005. 
However, the insertion of a C at position 34 in the SLS M005 ORF relative to the Lu
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M005 ORF, leads to a frameshift in the ORF that will code for a truncated protein if the 
Lu M005 translation start codon is used. However, translation from a second AUG 
codon, 17 nucleotides downstream from the Lu M005 translation start codon, is 
predicted to produce a protein that is identical to Lu M005 except for the first five 
amino acids.
Leaky scanning by the eukaryote translation machinery (which consists of the 40S and 
60S ribosomal subunits, tRNA molecule and initiation factors) may allow translation of 
SLS M005 to start from this second AUG codon. Leaky scanning involves the 
eukaryote translation machinery binding to the 5’ mRNA cap and scanning the mRNA 
for an AUG translation start codon (reviewed in Pestova et al., 2001). For reasons, such 
as secondary RNA structures, the first AUG translation start codon may not be easily 
recognised and the machinery will skip to the second or third AUG translation start 
codon (reviewed in Pestova et al., 2001). If this second site is not used in SLS then a 
protein with homology to Lu M005 will not be produced. As M005 is essential for 
replication of myxoma virus in lymphocytes, the lack of this protein will lead to cell 
death. Even if only a small proportion of M005 transcripts are translated from the 
second AUG translation start codon, this may be enough to maintain lymphocyte 
viability. Because lymphocyte viability is maintained in SLS infections in vitro it must 
be assumed that either some functional M005 is being produced or that its function has 
been replaced by another protein.
It is interesting to note that the C insertion in SLS creates a run of five Cs at this 
position. This may indicate an area of increased mutation in the SLS genome as the 
machinery replicating the viral genome may have a tendency to stutter at this point. This
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stutter may be the reason for the additional C at this site in Ur and may account for the 
generation of Ur in the field.
In Ur, the M005 ORF has an insertion of a C at position 34 compared to the M005 ORF 
in SLS, and an insertion of two Cs compared to the M005 ORF in Lu. These insertions 
produce a run of six Cs. The frameshift induced by these nucleotide insertions can be 
rectified 303 nucleotides downstream from the Lu M005 start codon. At this point there 
is an in-frame AUG translation start codon that will generate a protein with complete 
homology to the C-terminal sequence of Lu M005. It is presumed that Ur encodes at 
least a partial homolog of M005 as Ur infection does not lead to the high levels of 
apoptosis early in infection, observed in lymphocytes infected with the M005 deletion 
virus.
There are three potential scenarios for M005 expression in Ur infection: Firstly, that Ur 
expresses a truncated M005 protein that is partially functional and this serves to 
maintain lymphocyte viability at early times after infection but not beyond 48 h. A 
second possibility is that the C-terminal domain is sufficient for the anti-apoptotic 
action, but the protein is simply not produced in sufficient amounts from this 
downstream AUG to maintain cell viability at late time points after infection. 
Alternatively, it is also possible that the truncated protein is unstable and since M005 is 
produced as an early protein (Mossman et al., 1996) it does not survive in high enough 
concentrations to maintain cell viability beyond 48 h.
The third and, perhaps at first glance, most obvious possibility for M005 expression is 
that no M005 is produced during Ur infections. However, if this is assumed, then there 
must be some compensatory mechanism in the Ur genome that is not present in the Lu
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genome, replacing M005 function sufficiently to maintain lymphocyte viability to 48 h. 
This logic stems from the fact that inactivation of M005 in Lu induced lymphocyte cell 
death within 2 h. In this scenario there is also no need for SLS to produce M005 because 
it would also have the compensatory mechanism as it is genetically similar. However, 
because SLS is able to maintain lymphocyte viability beyond 72 h we must hypothesize 
that Ur also has a mutation in the putative compensatory gene that leads to cell death in 
infected lymphocytes at late time points. At this point the argument becomes much 
more complex than either of the first two possibilities. Additionally, complete absence 
of M005 expression may have made Ur too attenuated to be transmitted in the field. The 
simplest conclusion is that it is more probable that the truncated M005 is produced but 
is not sufficient to maintain lymphocyte viability beyond 48 h.
Translation of the truncated Ur M005 may be explained by the mRNA transcripts being 
spliced or by the presence of internal ribosome entry sites (IRES) in the mRNA 
transcripts. Both these mechanisms would move ribosome binding sites spatially closer 
to the start codon. However, these scenarios are considered unlikely as poxvirus mRNA 
is precluded from the host cell splicing machinery which is housed in the nucleus (Moss 
2001) and poxviruses have short 5’ untranslated regions which would not permit 
formation of secondary RNA structures that are required for an IRES (reviewed in 
Martinez-Salas et al., 2001; Pestova et al., 2001). There is the possibility that translation 
may be able to start mid-way down the mRNA transcript due to a yet unidentified 
ribosome binding site, as happens in prokaryote polycistronic mRNA transcripts or in 
translation of Caulimoviridae virus gene products (Ryabova et al., 2002). In addition, 
leaky scanning may occur, but the probability that the eukaryote translation machinery 
will pick up a start codon 303 nucleotides downstream is unknown. Translation of both
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SLS and Ur M005 will need to be confirmed by analysis of M005 expression in infected 
cells. This analysis was beyond the scope of this thesis.
The truncated form of M005 postulated for Ur will lack the N-terminal section of the 
ankyrin repeat region. Ankyrin domains are involved in protein-protein interactions and 
are generally associated with host-range. The absence or expression of a truncated 
M005 protein may abolish or disrupt protein-protein interactions between virus and 
host, leading to the inability of Ur to inhibit cell death pathways at late time points after 
infection. As postulated in Section 4.3.2, this may be due to a failed interaction between 
M005 and a host apoptotic factor, such as p53.
The M005 ORF is situated in the terminal inverted repeats (TIR) of the myxoma virus 
genome and so there are two copies of this gene. If disruption of the M005 ORF is the 
mechanism of Ur attenuation, then the mutation observed in the M005 gene must be 
present in both ORFs. As distinctive, clean peaks were observed in sequence traces 
from three independent PCR amplifications of the Ur M005 ORF, this suggests that 
both copies of the M005 ORF are identical. An alternative explanation to this is that 
mutations have occurred in one of the viral DNA binding sites used by the primer for 
PCR amplification of the M005 ORFs in one of the TIRs. This may result in either no 
PCR product being produced or PCR products of different sizes being produced. Similar 
to any postulated sequence changes in one copy of the M005 ORF, this is considered 
unlikely as, by definition, the mechanism of replication of poxvirus genomes leads to 
the TIRs being identical (reviewed in Moss 1996). There is also the formal possibility 
that the TIR boundaries are altered in Ur leading to rearrangements of the M005 genes, 
however, restriction mapping shows that there are no major genetic rearrangements 
between SLS and Ur including no change in the location of the TIR boundary (Russell
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and Robbins 1989; Saint et al., 2001). Since the completion of this thesis, the sequences 
of M005 at both ends of the genome have been shown to be identical for Lu, SLS and 
Ur (Labudovic et al., unpublished data).
4.3.4 Genetic Changes in M152 (Serp-3)
The changes found in the M l52 ORF were identical between SLS and Ur but different 
from Lu. The predicted M l52 protein in SLS and Ur had two amino acid differences 
and a frameshift that abolishes the stop codon and results in the protein in SLS and Ur 
being extended by 32 amino acids.
M l52 has been classified as a serpin as it contains conserved serpin motifs (Guerin et 
al., 2001). Serpins are involved in regulation of extracellular matrix remodeling, 
inflammatory responses, apoptosis, fibrinolysis, blood coagulation and complement 
activation (Rubin 1996; Church et al., 1997). A recombinant myxoma virus with M l52 
deleted has similar replicative ability both in vivo and in vitro to wild type virus (Guerin 
et al., 2001). In addition, deletion of Ml 52 does not induce apoptosis in vivo. Hence, the 
changes in this ORF are not considered to be related to Ur attenuation. However, as the 
sequence in SLS and Ur are identical, but different from Lu, it may be postulated that 
M l52 contributes to the different pathologies between the virus strains in vivo. The 
nucleotide changes in the SLS and Ur strains compared to the Lu strain do not affect the 
regions considered essential for serpin-like activity. They may, however, affect 
expression of M l53 as the extension of the M l52 ORF overlaps with the M l53 ORF 
and, as both M l52 and M l53 are putatively expressed under the control of an early 
promotor (Cameron et al., 1999), the transcription machinery for M l52 may interfere 
with the machinery for M l53, or may interfere with M l53 promotor or other regulatory 
elements. The function of Ml 53 is not known (Cameron et al., 1999).
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4.3.5 The Sub-population of Lymphoid Cells Permissive for 
Myxoma Virus Replication
This chapter showed that cells in G2/M could be considered more permissive for 
myxoma virus replication than cells in G1/G0, based on cells in G2/M had higher levels 
of late protein. Cells in G2/M would have activated signaling pathways as they are in 
the process of dividing. This supports the hypothesis from chapter 3 that activated T- 
cells were the main cell sub-population in rabbit lymphoid cell cultures that were 
permissive for myxoma virus infection. Further analysis of cell cycle stage with cell size 
showed that effectively all the cells in G2/M were large and the majority of cells in 
G1/G0 were large (data not shown). This indicates that cells in both G1/G0 and G2/M 
would have activated signaling pathways as they have responded to Con A. Cells in 
G2/M may be more permissive for virus replication than cells in G1/G0 because there 
may be more activated signaling pathways or the signaling that myxoma virus requires 
for replication may be increased or only active when cells are actively dividing. 
However, it must be remembered that infection of cells in G1/G0 would play a larger 
role in mxyoma virus pathogenesis as G1/G0 constitutes the major cell population in 
lymphoid cell cultures (—60%) compared to cells in G2/M (~5%).
Results from chapter 3 showed that myxoma virus infection abrogated replication of 
cellular DNA. In those experiments lymphoid cells were infected prior to mitogen 
stimulation. In contrast, the experiments discussed above were activated prior to 
infection, which allowed myxoma virus to infect lymphoid cells that were actively 
dividing.
217
Chapter 4- Cell Viability and Cell Cycle Following Infection
4.3.6 Conclusion
The mutation in the M005 ORF of Ur is potentially the first identified naturally 
occurring mechanism of myxoma virus attenuation. Genetic analysis presented in this 
chapter showed an insertion in the Ur M005 ORF that induces a frameshift relative to 
both SLS and Lu M005 ORF and either truncates the M005 protein or abolishes 
expression of M005. M005 has been implicated as critical for lymphocyte survival as 
deletion of M005 leads to lymphocyte apoptosis (Mossman et al., 1996). If the genetic 
change in the Ur strain of myxoma virus reduces M005 translation or generates a 
truncated protein it may account for the lymphocyte death observed in Ur-infected cell 
cultures late in infection. This can be tested by insertion of an intact copy of the Lu 
M005 gene into Ur. Expression of a functional M005 protein by SLS, even though the 
M005 ORF has an insertion relative to Lu M005 ORF, may account for the maintenance 
of cell viability observed in SLS-infected cell cultures. The maintenance in viability of 
SLS-infected lymphocytes may aid in vivo amplification and dissemination and thus 
contribute to its greater virulence compared to the Ur strain of myxoma virus.
As the proportion of viable cells for each infection was similar between laboratory and 
wild rabbit cell cultures irrespective of mitogen stimulation, resistance to myxoma virus 
does not appear to be related to the ability of cells from resistant rabbits to alter kinetics 
of virus-induced cell death. The mechanism of resistance to myxoma virus will be 
investigated further in chapter 5 by examining the difference in expression of cell 
surface proteins involved in T-cell activation and immune responses.
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5.1 In t r o d u c t io n
Earlier results in this thesis have shown that the activation state of lymphoid cells plays 
an important role in myxoma virus infection. This was because lymphocytes stimulated 
with Con A were significantly more permissive for myxoma virus replication than 
unstimulated lymphocytes. Results also showed that myxoma virus preferentially 
infected activated T-cells and that myxoma virus infection abrogated critical aspects of 
lymphocyte activation, such as cell proliferation and the increase in cell size. When 
considering the significance of these results in an in vivo context, it may be postulated 
that myxoma virus replication and subsequent propagation would be enhanced during 
an immune response as lymphocytes would be activated. However, the replication of 
myxoma virus will suppress the activity of infected lymphocytes leading to suppression 
of the anti-viral immune response, which in turn would aid survival of myxoma virus in 
vivo.
A key part of lymphocyte activation is the up-regulation of specific cell surface 
markers, such as MHC-I (Nussenzweig and Allison 1997). It has previously been shown 
that infection of the rabbit CD4+ RL-5 T-cell line with the Lu strain of myxoma virus 
caused down-regulation of the surface expression of MHC-I and CD4 (Barry et al., 
1995). In addition, infection of other cell types, such as BGMK cells, with myxoma 
virus also induced down-regulation of MHC-I from the cell surface (Boshkov et al., 
1992). Based on these results in cell lines and on the fact that myxoma virus abrogated 
the activation of infected lymphocytes as shown in chapter 3 of this thesis, it may be 
possible that infection with myxoma virus has altered expression of some of these 
markers on the surface of infected primary lymphocytes. This chapter examines the 
expression of particular cell surface proteins in primary rabbit lymphoid cell cultures 
during myxoma virus infection.
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The differential expression of cell surface proteins may contribute to rabbit resistance to 
myxoma virus. For example, resistance of rabbits to myxomatosis may be associated 
with lymphocytes from wild rabbits expressing higher levels of proteins critical for the 
anti-viral immune response or may be associated with the ability of lymphocytes from 
wild rabbits to prevent myxoma virus-induced down-regulation of some of these critical 
proteins. Higher levels of these critical cell surface proteins could enable the resistant 
rabbit immune response to function sufficiently to control and clear the virus. In 
susceptible rabbits, on the other hand, the lower levels of these critical proteins could 
prevent an effective or efficient immune response leading to the inability of the 
susceptible rabbit to control and clear the virus.
Similarly, attenuation of myxoma virus may reflect an altered ability to modify 
expressed levels of specific cell surface markers, For example, if an attenuated strain of 
myxoma virus is unable to induce down-regulation of key immunoregulatory proteins 
from the surface of myxoma virus-infected cells, the infected rabbit may be able to 
more efficiently and effectively control the virus compared to a virus strain that is able 
to down-regulate expression of key immunoregulatory proteins.
In this chapter, expression of CD4 and MHC-I on the surface of infected primary rabbit 
lymphoid cells was examined to determine whether the down-regulation observed in 
RL-5 and BGMK cell lines also occurred in primary rabbit lymphocytes. Unlike 
immortalized cell lines, primary lymphoid cells can be activated and so the expression 
of these cell surface proteins can be examined in both unstimulated and Con A- 
stimulated cell cultures. Previous chapters have shown that myxoma virus abrogated 
proliferation induced by Con A and so other cell surface proteins involved in T-cell 
activation were also investigated. CD25, the IL-2 receptor a-chain, is inducibly
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expressed after T-cell activation and is essential for T-cell proliferation, and so the 
expression of CD25 was examined to determine whether virus inhibition of lymphocyte 
proliferation involved altered levels of this cell surface protein. The anti-rabbit MHC-II 
antibody, which recognizes activated T-cells in addition to B-cells (reviewed in Mage 
1998), and the KEN-5 antibody, which recognizes an unidentified rabbit T-cell specific 
marker (called KEN-5 in this chapter and reviewed in Mage 1998), was used to examine 
the effects of myxoma virus on rabbit lymphocytes. The expression of CD43 and CD45 
on primary lymphoid cells were used as control markers as it has been shown that 
expression of these proteins on the surface of RL-5 cells is not altered by myxoma virus 
infection (Barry et al., 1995).
Specifically, this chapter investigates the following questions:
1) Do differences exist between unstimulated and Con A-stimulated lymphocytes 
from susceptible and resistant rabbits in the cell surface expression of CD25, 
CD4, CD43, CD45, KEN-5, MHC-I or MHC-II?
2) Does infection with the virulent SLS or attenuated Ur strains of myxoma virus 
alter the expression of CD25, CD4, CD43, CD45, KEN-5, MHC-I or MHC-II on 
the surface of unstimulated or Con A-stimulated lymphocytes from susceptible 
and resistant rabbits?
To address these questions, lymphoid cell cultures from laboratory and wild rabbits 
were mock-infected or infected with SLS or Ur and were examined for expression of 
CD25, CD4, CD43, CD45, KEN-5, MHC-I and MHC-II using flow cytometry. The 
choice of proteins examined was restricted by the limited range of antibodies specific 
for rabbit cell surface markers. Cultures were incubated in the presence or absence of
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Con A. For comparison, expression of these proteins on the surface of RL-5 cells 
infected with SLS or Ur was also examined.
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5.2 Resu l t s
5.2.1 Characteristics of the Cell Surface Markers Examined
Table 5.1 lists the cell surface proteins examined in this chapter, the cell type that 
expresses them, and their function and natural ligand.
Ta b l e  5.1. C e l l  Su r f a c e  P r o t e in s
Cell
Surface
Protein
Common
Name(s)
Cell Type in 
rabbits
Protein Function Natural
Ligand
CD25 -IL-2 receptor 
a-chain
-activated T-cells 
-pre-B-cells
-involved in T-cell growth 
and proliferation
IL-2
CD4 -subset of T-cells 
(CD4+)
-co-stimulatory protein 
involved in antigen 
recognition and presentation
MIIC-II
CD43 -Leukosialin
-gpH5
-T-cells 
-thymocytes 
-progenitor B-cells
-hematopoietic progenitor 
cell proliferation
ICAM-I
(CD54)
CD45 -Leukocyte
common
antigen
-leukocytes -protein phosphatase
-accessory molecule 
involved in cell signaling in 
T- and B-cells
CD22
KEN-5 - -T-cells -unknown unknown
MHC-I -all nucleated cells -presentation of antigen 
derived from intracellular 
environment
TCR complex 
specific for 
antigen in 
association 
with CD8
M HC-n -B-cells 
-macrophages 
-monocytes 
-subset of activated 
T-cells
-presentation of antigen 
derived from extracellular 
environment
TCR complex 
specific for 
antigen in 
association 
with CD4
Information obtained from Kuby (1997).
5.2.2 Method used to Examine Cell Surface Marker Expression
In this chapter, expression of cell surface proteins is measured using flow cytometry and 
antibodies specific for each cell surface protein. The results are presented in three ways, 
each giving different information about the data. The first is density plots of cell size
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versus protein expression. Plots were divided into ‘low’ (fluorescence intensity less than 
10 units) and ‘high’ (fluorescence intensity greater than 10 units) antibody binding and 
the mean proportion of cells in each sub-population from cultures from three laboratory 
and three wild rabbits was determined using CellQuest software. These plots are used to 
show the proportions of cells expressing high and low levels of protein and to show the 
relationship between cell size and the specific protein. This latter relationship will be 
examined in Section 5.2.4. In the second method, results are presented as histogram 
overlays of plots of number of cells versus protein expression. This enables direct 
comparison between infections with SLS and Ur.
The third way cell surface proteins are examined is by calculation of the mean median 
fluorescence intensity. This was calculated using CellQuest software from three 
replicate experiments. As previously stated, the mean median fluorescence intensity is a 
quantitative measure of protein expression on individual cells and is not likely to be 
skewed by very high or low antibody binding in a minor cell sub-population. Mean 
median fluorescence intensity is presented in column graphs. The first two ways of data 
presentation show results for individual rabbits whereas the third way shows mean 
results from lymphoid cell cultures from three laboratory and three wild rabbits. 
Statistical analysis was only undertaken on the mean median fluorescence intensity data 
because this data was considered the most accurate.
Preliminary experiments were undertaken to optimize antibody binding to CD43 and 
MHC-I, as representative cell surface proteins. Expression of these markers was 
examined in mock-infected lymphoid cell cultures after 24 and 48 h of Con A 
stimulation. Figure 5.1 shows CD43 and MHC-I antibody binding as histogram plots 
and calculated median fluorescence intensity for each plot. The greater level of antibody
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Figur e  5.1. Exp re s s io n  of  CD43 an d  MHC-I o n  Ra b b it  Lym ph o cy te s  
Preliminary experiments to determine the incubation time for analysis of antibody binding to cell 
surface proteins was undertaken. Lymphoid cell cultures from wild rabbits were incubated for 24 
or 48 h with and without Con A stimulation. The cell surface expression of (A) CD43 and (B) 
MHC-I was analysed using flow cytometry. Histogram plots of lymphoid cells from one rabbit are 
shown, but are typical of those obtained. Numbers within the histogram plot indicate units of 
median fluorescence intensity for each sample.
binding for both markers was observed after 48 h, hence all subsequent experiments of 
primary lymphoid cells were analysed after 48 h incubation. Due to innate differences in 
the level of the cell surface expression of particular proteins and the differences in 
affinity of the monoclonal antibodies for their cognate antigen, different flow cytometer 
thresholds were used for each antibody to obtain a clear peak. This means that the 
absolute values of mean median fluorescence intensity cannot be compared between 
different cell surface markers.
5.2.3 Cell Surface Protein Expression in Unstimulated and Con
A-Stimulated Mock-Infected Rabbit Lymphoid Cell Cultures
The expression of CD25, CD4, CD43, CD45, KEN-5, MHC-I and MHC-II on the 
uninfected rabbit lymphocyte cell surface was first examined using mock-infected rabbit 
lymphoid cells. This was done using histogram overlays of antibody binding for
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unstimulated and Con A-stimulated cells and by calculating the median fluorescence 
intensity using CellQuest software. Each experiment was repeated three times and the 
mean median fluorescence intensity of the three replicates was calculated. Statistical 
analysis of cell surface marker expression was undertaken by ANOVA, with a p  value 
<0.05 deemed significant.
Figure 5.2A shows histogram overlays of each cell surface marker in both unstimulated 
and stimulated lymphoid cell cultures. An increase in expression of the marker is seen 
as a shift to the right of the curve. These results were typical of those seen. Figure 5.2B 
shows the calculated mean median fluorescence intensity for the three replicates and 
statistical significance of the increased expression was calculated using ANOVA. Con 
A stimulation significantly increased the expression of CD25, MHC-I and MHC-II in 
mock-infected cell cultures (ANOVA, p<0.05). For example, the mean median 
fluorescence intensity for CD25 in lymphoid cell cultures from laboratory rabbits 
increased from 29 units to 133 units with Con A stimulation (Figure 5.2B).
The increase in CD25 and MHC-II expression observed when cell cultures were 
stimulated was expected as CD25 is the IL-2 receptor a-chain and is inducibly 
expressed on T-cell activation and activated rabbit T-cells have been shown to express 
MHC-II (reviewed in Mage 1998). The increase in MHC-I expression has not been 
reported before. It is interesting to note that the mean median fluorescence intensity of 
MHC-I in stimulated lymphoid cell cultures from wild rabbits, although not statistically 
significant at the 95% Cl, tended to be higher than that in cell cultures from laboratory 
rabbits. This may reflect an important difference in the immune responses of these 
rabbits and will be explored in the discussion to this chapter.
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There was a biphasic distribution of CD4 and CD43 expression on cells in unstimulated 
mock-infected rabbit lymphoid cell cultures (shaded regions Figure 5.2A). CD4 
expression tended to be higher in unstimulated lymphoid cell cultures from wild rabbits 
than unstimulated cultures from laboratory rabbits with a mean median fluorescence 
intensity of 133 and 87 units respectively, but this was not statistically significant at the 
95% Cl (Figure 5.2B). However, the differences in CD4 expression may have some 
biological significance (see the Discussion to this chapter). The greater levels of CD4 
expression on the surface of wild rabbit lymphocytes may improve MHC-II engagement 
and signaling through the T-cell receptor after encountering antigen in vivo. The 
difference in CD4 expression between lymphoid cell cultures from laboratory and wild 
rabbits was not evident after Con A stimulation with a mean median fluorescence 
intensity of 113 and 111 respectively (Figure 5.2B).
CD43 expression was significantly higher overall in unstimulated lymphoid cell cultures 
from wild rabbits compared to laboratory rabbits, with mean median fluorescence 
intensities of 295 and 103 units respectively (p<0.05) (Figure 5.2B). The greater levels 
of CD43 may enhance T-cell activation in vivo in wild rabbits by stabilizing the 
interaction between T-cells and antigen presenting cells (reviewed in Ostberg et ah, 
1998). CD43 expression fell after stimulation in mock-infected lymphoid cell cultures 
from both laboratory and wild rabbits (Figure 5.2B). The decrease in CD43 expression 
was almost 10 fold greater in cell cultures from wild rabbits than those from laboratory 
rabbits, but was not statistically significant at a 95% Cl.
CD45 and KEN-5 expression were not significantly altered by Con A stimulation with 
the mean median fluorescence intensity remaining between 30-38 units for the KEN-5 
antibody and between 45-56 units for the CD45 antibody. No difference was observed
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in the levels of CD45 or KEN-5 between lymphoid cell cultures from laboratory and 
wild rabbits.
5.2.3.1 Summary of Cell Surface Protein Expression in Mock-Infected 
Lymphoid Cell Cultures
Con A stimulation significantly increased the expression of CD25, MHC-I and MHC-II 
in mock-infected cell cultures, but did not alter the expression of KEN-5 or CD45. 
Lymphoid cells from wild rabbits had significantly greater expression of CD43 on the 
cell surface compared to lymphocytes from laboratory rabbits in the absence of Con A. 
Lymphoid cells from wild rabbits also had greater CD4 expression, although the 
difference was not statistically significant. When cultures were stimulated, there were 
greater levels of MHC-I and CD43 on the surface of lymphoid cells from wild rabbits 
compared to laboratory rabbits.
5.2.4 Expression of Cell Surface Proteins in Unstimulated and 
Con A-Stimulated Rabbit Lymphoid Cell Cultures infected with 
Myxoma Virus
To determine the effect of myxoma virus infection on the expression of proteins on the 
surface of lymphocytes, cell cultures were infected with SLS or Ur at a moi of 0.1 and 3 
and the expression of CD25, CD4, CD43, CD45, KEN-5, MHC-I and MHC-II was 
examined. Cell cultures were incubated in the presence or absence of Con A and were 
analysed 48 h post infection. The experiments with mock-infected cell cultures 
described in Section 5.2.2 were undertaken in parallel with myxoma virus infected-cell 
cultures, and will be compared in this section to virus-infected cell cultures. In some 
cases, a different individual rabbit is shown in the histogram overlays to the one shown
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in Figure 5.2. Flowever, the proportions of the cells expressing high and low levels of 
the cell surface markers shown represent the mean value calculated from cultures from 
all three laboratory or three wild rabbits. For some proteins, changes in the level of 
expression of some proteins are not statistically significant. However, they are discussed 
as it was considered that the changes, although small, may have some biological 
significance.
5.2.4.1 Expression of CD25
Figure 5.3 shows CD25 expression in unstimulated and Con A-stimulated lymphoid cell 
cultures from laboratory and wild rabbits that were either mock-infected or infected 
with SLS or Ur. The previous section showed Con A stimulation significantly increased 
CD25 expression on rabbit lymphoid cells (p<0.05). This can also be seen in the density 
plots (Figure 5.3A), where only 8% of cells in mock-infected cell cultures from 
laboratory rabbits expressed high levels of CD25 in the absence of stimulation, but 55% 
of cells expressed high levels of CD25 after stimulation. These density plots also show 
that cells expressing high levels of CD25 are those with a large cell size. The 
differential expression of cell surface proteins on large and small cells will be examined 
in detail in Section 5.2.4.
In infected cell cultures from laboratory rabbits, 15% of cells in cultures infected with 
SLS at a moi of 3, and 18% infected with Ur at a moi of 3, had high CD25 antibody 
binding after stimulation with Con A. The proportion of cells with high CD25 
expression was significantly less in stimulated virus-infected cultures compared to 
stimulated mock-infected cultures (p<0.05). The inhibition of the Con A-induced 
increase in CD25 expression by both SLS and Ur is also shown in the histogram plots 
(Figure 5.3B) and the graph of mean median fluorescence intensity (Figure 5.3C).
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Fig ur e  5.3. Exp re ss io n  o f  CD25 in  Ra b b it  Lym ph oid  Cell  Cul t ur es  Infec ted  
wi th  SLS or  Ur , Wi t h  an d  Without  Con  A Stim ula tion
Expression of CD25 was analysed in lymphoid cell cultures from laboratory and wild rabbits and 
is presented as (A) density plots of CD25 antibody binding versus cell size and (B) histogram 
overlays of CD25 antibody binding. Cultures were mock-infected (MI)B or infected with SLS, at 
a moi of 0.1 * or 3*, or infected with Ur, at a moi of 0.1 or 3*. Infections were undertaken in 
parallel with and without Con A stimulation. The experiment was repeated three times with only 
one typical replicate shown here. Plots were divided such that cells with a fluorescence intensity 
greater than 102 units were classified as having high CD25 expression and cells with a 
fluorescence intensity less than 102 units were classified as having low CD25 expression. Numbers 
in the density plots represent the mean percentage of cells in each sub-population from three 
experiments. (C) The mean median fluorescence intensity corresponding to CD25 expression in 
lymphoid cultures from three laboratory and three wild rabbits was calculated and plotted on a 
column graph. Error bars represent one standard error.
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A similar significant inhibition of the CD25 increase was observed in lymphoid cell 
cultures from wild rabbits (p<0.05). Neither strain of myxoma virus significantly altered 
CD25 expression in unstimulated rabbit lymphoid cell cultures.
The inhibition of the Con A-induced increase in CD25 expression by myxoma virus was 
moi-dependent, as 24% and 26% of lymphoid cell cultures from laboratory rabbits 
bound high levels of CD25 antibody after Con A stimulation when infected with SLS or 
Ur respectively at a moi of 0.1. This was also significantly lower than the 55% of cells 
in mock-infected lymphoid cell cultures from laboratory rabbits that expressed high 
levels of CD25 (p<0.05). The difference between moi can also be seen in the histogram 
plots of lymphoid cell cultures from wild rabbits, where the curves for the low moi are 
between those of mock-infected cell cultures and cell cultures infected with a moi of 3 
(Figure 5.3B) and in mean median fluorescence intensity graphs (Figure 5.3C). The 
observation that CD25 expression was inhibited by myxoma virus in a moi-dependent 
manner when cell cultures were stimulated directly contrasts with the inhibition of cell 
proliferation observed in chapter 3, which did not appear to be moi-dependent.
5.2.4.2 Expression of CD4
Neither strain of myxoma virus significantly altered CD4 expression in unstimulated 
cell cultures (p<0.05), with the proportion of cells with high CD4 expression between 
41% and 46% for a moi of 0.1 and 3 in lymphoid cell cultures from laboratory rabbits 
irrespective of virus strain and between 47% and 52% in lymphoid cell cultures from 
wild rabbits (Figure 5.4). However, when cell cultures were stimulated with Con A, cell 
cultures that were infected with either SLS or Ur at a moi of 3 had a lower proportion of 
cells binding high levels of CD4 antibody than those in mock-infected cell cultures. For 
example, the proportion of cells binding high levels of CD4 antibody was 53% in
234
5.2 Results
A Laboratory Rabbit Cultures
^ s tim u la te d  Cultures ^Stimulated Cultures
56%
# " f 5 r ' t t 2 ’’ iorr 'io*
44%
s i
59%
- js?
15 41%
,ld'?or W T « 4
58%
: f;
________ 42%
io^'*io'w? "io3 "io4
8h
C/5
"<5 r
54%
i
4?.
^46%
u
B
56%
ir ;
§ v . .
*  44%
, 36%
i :'" * » y 45% 
u r  io1 h t  u r kt
§i 66%
\:ih
- -  <v
s it"
‘ 34%
CD4 Expression
Wild Rabbit Cultures
^ s tim u la te d  Cultures s tim u la ted  Cultures
48%
M
E-
_ '52®/'
l l
I 1
2
48%
]*
ML.
10°  10
h
52%1
49%
.
51%
<D u
______ , 44;%
^ToO'ToO
§1
10° I01 1C2 H T 0 4
CD4 Expression
68%
* r
> t 0’ ?0o
Figur e  5.4. Ex pr e s s io n  o f  CD4 in  Rab b it  Lym ph o id  Cell  Cul t ur es  Infe cted  
w it h  SLS or  Ur , With  and  With out  Co n  A Sti mu la tio n
Expression of CD4 was analysed in lymphoid cell cultures from laboratory and wild rabbits and is 
presented as (A) density plots of CD4 antibody binding versus cell size and (B) histogram 
overlays of CD4 antibody binding. Cultures were mock-infected (MI)* or infected with SLS, at a 
moi of 0.1* or 3*, or infected with Ur, at a moi of 0.1 or 3*. Infections were undertaken in 
parallel with and without Con A stimulation. The experiment was repeated three times with only 
one typical replicate shown here. Plots were divided such that cells with a fluorescence intensity 
greater than 102 units were classified as having high CD4 expression and cells with a fluorescence 
intensity less than 102 units were classified as having low CD4 expression. Numbers in the density 
plots represent the mean percentage of cells in each sub-population from three experiments. (C) 
The mean median fluorescence intensity corresponding to CD4 expression in lymphoid cultures 
from three laboratory and three wild rabbits was calculated and plotted on a column graph. Error 
bars represent one standard error.
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stimulated mock-infected lymphoid cell cultures from laboratory rabbits and 36% and 
34% when infected with SLS or Ur at a moi of 3 (Figure 5.4A). These proportions were 
even lower than that in unstimulated mock-infected cell cultures, which had 44% of 
cells binding high levels of CD4. This result suggests either myxoma virus infection can 
induce removal of pre-existing CD4 molecules off the surface of the cell, can inhibit 
CD4 transport to the cell membrane or can decrease the population of cells expressing 
high levels of CD4 (i.e. by inducing apoptosis). Statistical analysis of mean median 
fluorescence intensity showed that the decrease in levels caused by both SLS and Ur 
was significant in lymphocytes from wild rabbits but not in those from laboratory 
rabbits (p<0.05).
The down-regulation of CD4 appeared to be dependent on moi when analysed on the 
density and histogram plots. In Figure 5.4A, there were 46% and 45% of cells 
expressing high levels of CD4 when stimulated lymphoid cell cultures from laboratory 
rabbits were first infected with SLS or Ur respectively, at a moi of 0.1 compared to 36% 
and 34% when infected with a moi of 3. However, a difference between moi was not 
observed when mean median fluorescence intensity was examined. One explanation for 
this could be that CD4 down-regulation is linked to myxoma virus replication and in 
low moi myxoma virus may not have replicated to titres sufficient for down-regulating 
CD4 to similar levels as higher moi. However, it was shown in chapter 3 that by 48 h 
virus in low moi had replicated to similar proportions as virus in high moi. 
Alternatively, reducing CD4 expression may not be dependent on virus replication per 
se, but may be due to infection with the lower moi not abrogating activation to as great 
an extent as infection with the high moi. This would lead to a greater proportion of 
activated cells and thus a greater expression of CD4. Similar results were obtained for 
lymphoid cell cultures from wild rabbits, particularly with Ur-infected cells.
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5.2.4.3 Expression of CD43
CD43 expression in unstimulated or Con A-stimulated lymphoid cell cultures from 
laboratory rabbits was not significantly altered by myxoma virus infection when 
examined on a density plot of cell size versus protein expression (95% Cl). For 
example, in lymphoid cell cultures from laboratory rabbits, the mean proportion of cells 
expressing high levels of CD43 ranged between 36-49% without Con A stimulation and 
between 44-52% with Con A stimulation (Figure 5.5A). In lymphoid cell cultures from 
wild rabbits, the proportion of cells expressing high levels of CD43 was also not 
significantly altered by myxoma virus infection (95% Cl). The apparent exception to 
this was in lymphoid cell cultures from wild rabbits that were infected with Ur at a moi 
of 3 and stimulated with Con A. In these cell cultures, only 51% of cells bound high 
levels of CD43 antibody compared to 68% in mock-infected cell cultures. This result is 
due to the small but distinct sub-population of cells, which can be seen in histogram 
plots with the peak in median fluorescence intensity at approximately 101 units. When 
this sub-population was further examined, it corresponded to the non-viable cell sub-
population (data not shown). This sub-population was not present in the other replicates 
of this experiment but was observed after 48 h in some samples from experiments 
investigating cell viability during myxoma virus infection (chapter 4).
The mean median fluorescence intensity did not change significantly but a decrease in 
CD43 expression in virus-infected unstimulated lymphoid cell cultures from wild 
rabbits was observed (Figure 5.5C). This decrease was not observed in stimulated 
cultures from wild rabbits, or in lymphoid cell cultures from laboratory rabbits. A 
decrease in mean median fluorescence intensity suggests CD43 expression is decreased 
on individual cells.
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>
« § 
s i
'S g
s ?
E 8
r r o ' - i
CD43 Expression
ln° 1o' 102 to3 104
►
Figure  5.5. Expr ess ion  of  CD43 in  Ra b b it  Lym ph oid  Cell  Cult ure s  Inf ec te d  
with  SLS or  Ur , Wi t h  and  Wit h o ut  Co n  A Sti mu la tio n
Expression of CD43 was analysed in lymphoid cell cultures from laboratory and wild rabbits and 
is presented as (A) density plots of CD43 antibody binding versus cell size and (B) histogram 
overlays of CD43 antibody binding. Cultures were mock-infected (MI)B or infected with SLS, at 
a moi of 0.1 * or 3>, or infected with Ur, at a moi of 0.1 or 3>. Infections were undertaken in 
parallel with and without Con A stimulation. The experiment was repeated three times with only 
one typical replicate shown here. Plots were divided such that cells with a fluorescence intensity 
greater than 102 units were classified as having high CD43 expression and cells with a 
fluorescence intensity less than 102 units were classified as having low CD43 expression. Numbers 
in the density plots represent the mean percentage of cells in each sub-population from three 
experiments. (C) The mean median fluorescence intensity corresponding to CD43 expression in 
lymphoid cultures from three laboratory and three wild rabbits was calculated and plotted on a 
column graph. Error bars represent one standard error.
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5.2.4.4 Expression of CD45
Myxoma virus infection did not significantly alter CD45 expression in unstimulated 
lymphocyte cultures (95% Cl) (Figure 5.6). However, cell cultures stimulated with Con 
A, generally had a lower proportion of lymphocytes expressing high levels of CD45 in 
myxoma virus-infected cultures than mock-infected cultures (Figure 5.6A). For 
example, 17% of cells in mock-infected cultures expressed high levels of CD45 
compared to 10% in cultures infected with either SLS or Ur at a moi of 3. The 
difference in CD45 expression on individual cells between stimulated mock-infected 
and stimulated myxoma virus-infected cultures was not significant at the 95% Cl 
(Figure 5.6C). In addition, the mean median fluorescence intensity in myxoma virus- 
infected cell cultures stimulated with Con A was similar to that in mock-infected cell 
cultures that had not been stimulated. This suggests that the lower CD45 expression in 
stimulated cell cultures infected with SLS or Ur was due to the virus inhibiting 
lymphocyte activation. This is further supported by closer examination of the density 
plots (Figure 5.6A), where the cells expressing high levels of CD45 are predominantly 
the larger cells in the culture. It has previously been shown that myxoma virus inhibits 
the increase in cell size associated with Con A activation. Hence, it may be postulated 
that cells in myxoma virus-infected cultures generally have a lower level of CD43 
expression because the virus inhibits the increase in cell size associated with 
lymphocyte activation.
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Figure  5.6. Expr ess ion  of  CD45 in  Ra b b it  Lym ph oid  Cell  Cul tu res  Inf ect ed  
w it h  SLS o r  Ur , Wit h  and  Wit h o ut  Co n  A Sti mu la tio n
Expression of CD45 was analysed in lymphoid cell cultures from laboratory and wild rabbits 
and is presented as (A) density plots of CD45 antibody binding versus cell size and (B) 
histogram overlays of CD45 antibody binding. Cultures were mock-infected (MI)B or infected 
with SLS, at a moi of 0.1 ® or 3 ■, or infected with Ur, at a moi of 0.1 or 3 ■. Infections were 
undertaken in parallel with and without Con A stimulation. The experiment was repeated three 
times with only one typical replicate shown here. Plots were divided such that cells with a 
fluorescence intensity greater than 102 units were classified as having high CD45 expression and 
cells with a fluorescence intensity less than 102 units were classified as having low CD45 
expression. Numbers in the density plots represent the mean percentage of cells in each sub-
population from three experiments. (C) The mean median fluorescence intensity corresponding 
to CD45 expression in lymphoid cultures from three laboratory and three wild rabbits was 
calculated and plotted on a column graph. Error bars represent one standard error.
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5.2.4.5 Expression of KEN-5
The protein that the KEN-5 antibody recognizes is unknown, but the antibody is T-cell 
specific (reviewed in Mage 1998). The proportion of cells binding either high or low 
levels of KEN-5 antibody remained effectively unchanged, ranging from 3-14%, 
regardless of Con A stimulation or infection with myxoma virus infection (Figure 5.7). 
This is supported by the mean median fluorescence intensity of KEN-5 (Figure 5.7C) 
where the mean median fluorescence intensity in cultures infected with myxoma virus 
were not significantly different to that in mock-infected cultures (95% Cl).
5.2.4.6 Expression of MHC-I
Figure 5.8A shows that in mock-infected laboratory rabbit lymphoid cell cultures 
stimulated with Con A, 75% of cells bound high levels of MHC-I antibody. These cells 
also had increased cell size. If these cell cultures were first infected with SLS or Ur at a 
moi of 3 prior to stimulation, only a mean of 53% and 52% of cells respectively, bound 
high levels of MHC-I antibody. This is a similar proportion to unstimulated mock- 
infected lymphoid cell cultures (Figure 5.8A) and therefore suggests that infection with 
either SLS or Ur inhibits the MHC-I up-regulation induced by Con A stimulation. The 
inhibition of MHC-I expression by myxoma virus was dependent on moi as 63% and 
62% of lymphoid cell cultures from laboratory rabbits infected with SLS or Ur 
respectively at a moi of 0.1 bound high levels of MHC-I antibody. Similar results were 
observed after analysis using histogram plots (Figure 5.8B). The mean median 
fluorescence intensity analysis also shows that both SLS and Ur abrogated the increase 
in MHC-I expression associated with Con A stimulation as the levels of mean median 
fluorescence intensity were similar to those from unstimulated mock-infected cultures 
(Figure 5.8C). However, statistical analysis shows that the decrease in mean median 
fluorescence intensity in MHC-I antibody binding between mock-infected and myxoma
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Figure  5.7. Exp res sio n  of  KEN-5 in  Ra b b it  Lymp ho id  Cell  Cul tu res  Inf ec te d  
with  SLS o r  Ur , Wi t h  an d  Wit h o u t  Co n  A Sti mu la tio n
Expression of KEN-5 was analysed in lymphoid cell cultures from laboratory and wild rabbits and 
is presented as (A) density plots of KEN-5 antibody binding versus cell size and (B) histogram 
overlays of KEN-5 antibody binding. Cultures were mock-infected (MI)B or infected with SLS, at 
a moi of 0.1 ■ or 3«, or infected with Ur, at a moi of 0.1 or 3*. Infections were undertaken in 
parallel with and without Con A stimulation. The experiment was repeated three times with only 
one typical replicate shown here. Plots were divided such that cells with a fluorescence intensity 
greater than 102 units were classified as having high KEN-5 expression and cells with a 
fluorescence intensity less than 102 units were classified as having low KEN-5 expression. 
Numbers in the density plots represent the mean percentage of cells in each sub-population from 
three experiments. (C) The mean median fluorescence intensity corresponding to KEN-5 
expression in lymphoid cultures from three laboratory and three wild rabbits was calculated and 
plotted on a column graph. Error bars represent one standard error.
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Figure  5.8. Exp re ss io n  of  MHC-I in  Rabb it  Lymp ho id  Cell  Cultu res
Infect ed  with  SLS or  Ur , Wit h  an d  With out  Co n  A Sti mu la tio n
Expression of MHC-I was analysed in lymphoid cell cultures from laboratory and wild rabbits and
is presented as (A) density plots of MHC-I antibody binding versus cell size and (B) histogram 
overlays of MHC-I antibody binding. Cultures were mock-infected (MI)B or infected with SLS, at 
a moi of 0.1« or 3*, or infected with Ur, at a moi of 0.1 or 3*. Infections were undertaken in 
parallel with and without Con A stimulation. The experiment was repeated three times with only 
one typical replicate shown here. Plots were divided such that cells with a fluorescence intensity 
greater than 102 units were classified as having high MHC-I expression and cells with a 
fluorescence intensity less than 102 units were classified as having low MHC-I expression. 
Numbers in the density plots represent the mean percentage of cells in each sub-population from 
three experiments. (C) The mean median fluorescence intensity corresponding to MHC-I 
expression in lymphoid cultures from three laboratory and three wild rabbits was calculated and 
plotted on a column graph. Error bars represent one standard error.
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virus-infected stimulated cultures was not significant. The reason for this is probably the 
large standard errors for some of the samples. Similar results were also observed in 
lymphoid cell cultures from wild rabbits. Thus, overall myxoma virus down-regulated 
MHC-I expression.
5.2.4.7 Expression of MHC-I I
Neither SLS nor Ur infection significantly altered the proportion of cells expressing 
high levels of MHC-II in unstimulated lymphoid cell cultures from laboratory or wild 
rabbits when examined by any of the three methods used (p<0.05) (Figure 5.9).
Based on the density plots, myxoma virus infection did not alter MHC-II expression in 
stimulated lymphoid cultures from laboratory rabbits (Figure 5.9A). In stimulated 
lymphoid cultures from wild rabbits, cultures infected with Ur at a moi of 3 had a lower 
proportion of cells expressing high levels of MHC-II compared to mock-infected and 
SLS-infected cultures (Figure 5.9A). However, detailed examination of MHC-II 
expression per cell by using mean median fluorescence intensity, showed that both SLS 
and Ur infection decreased MHC-II expression in stimulated lymphocytes from both 
rabbit types, though this was only significant at the 95% Cl for Ur infection of 
lymphoid cells from wild rabbits (Figure 5.9C). This apparent contradiction can be 
readily resolved by the fact that MHC-II is not only expressed on rabbit B-cells but also 
on activated T-cells (reviewed in Mage 1998) and thus levels of antibody binding will 
increase in lymphoid cell cultures when T-cells are activated. Hence, the down- 
regulation of MHC-II in cultures infected with myxoma virus is most likely due to 
inhibition of T-cell activation, which would decrease the proportion of activated cells 
and therefore the proportion of cell expressing high levels of MHC-II.
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Figur e  5.9. Expr ess ion  of  MHC-n in  Rab b it  Lym ph oid  Cell  Cul tures  
Inf ect ed  with  SLS or  Ur , Wit h  and  Without  Co n  A Sti m ul a ti o n  
Expression of MHC-II was analysed in lymphoid cell cultures from laboratory and wild rabbits 
and is presented as (A) density plots of MHC-II antibody binding versus cell size and (B) 
histogram overlays of MHC-II antibody binding. Cultures were mock-infected (MI)* or 
infected with SLS, at a moi of 0.1* or 3*, or infected with Ur, at a moi of 0.1 or 3*. 
Infections were undertaken in parallel with and without Con A stimulation. The experiment was 
repeated three times with only one typical replicate shown here. Plots were divided such that 
cells with a fluorescence intensity greater than 102 units were classified as having high MHC-II 
expression and cells with a fluorescence intensity less than 102 units were classified as having 
low MHC-II expression. Numbers in the density plots represent the mean percentage of cells in 
each sub-population from three experiments. (C) The mean median fluorescence intensity 
corresponding to MHC-II expression in lymphoid cultures from three laboratory and three wild 
rabbits was calculated and plotted on a column graph. Error bars represent one standard error.
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5.2.4.8 Summary of Expression of Cell Surface Proteins In Cultures 
Infected with SLS or Ur
The major results from Section 5.2.3 which will be discussed further in Section 5.3 are 
as follows:
1. SLS and Ur inhibited the Con A-induced increase in CD25 and appeared to 
inhibit MHC-I expression, though this was not statistically significant.
2. SLS and Ur generally down-regulated CD4 and MHC-II molecules from the 
lymphocyte surface in cultures that were stimulated with Con A.
3. CD43, CD45 and KJEN-5 expression were not substantially altered by myxoma 
virus infection.
5.2.5 Expression of Cell Surface Proteins in Large and Small 
Cell Sub-Populations
The previous sections have shown that myxoma virus infection can alter the expression 
of some proteins on the surface of lymphocytes from cultures stimulated with Con A. 
Addition of Con A to primary rabbit lymphoid cell cultures was shown in chapter 3 to 
induce a sub-population of activated T-cells which could be distinguished from the rest 
of the cell culture by an increase in cell size as determined by FSC. The generation of 
this activated T-cell sub-population was inhibited by myxoma virus infection, with 
approximately 15% of cells classified as large at the 48 h time point compared to 
approximately 50-60% in mock-infected cultures. Activated T-cells have been shown to 
express different levels of cell surface proteins to quiescent T-cells (Nussenzweig and 
Allison 1997). Thus, it may be hypothesised that myxoma virus infection inhibits the 
overall expression in the lymphocyte culture of specific cell surface proteins by 
inhibiting T-cell activation. This hypothesis can be investigated by examining the
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median fluorescence intensity of large and small cell sub-populations. For some 
proteins, changes in the level of expression of some proteins are not statistically 
significant. However, they are discussed as it was considered that the changes, although 
small, may have some biological significance.
Consider the following hypothetical example where the entire stimulated culture (large 
and small cells combined) has a median fluorescence intensity of a particular protein of 
75 units, 50% of cells in the stimulated culture are large and have a median fluorescence 
intensity of 100 units and the small cell sub-population has a median fluorescence 
intensity of 50 units. If the cells are infected with myxoma virus prior to stimulation 
then the large cell sub-population may only contain 10% of the cells in the culture, as it 
has been documented in previous chapters that myxoma virus inhibits the increase in 
lymphocyte size associated with Con A stimulation. Virus infection may result in the 
median fluorescence intensity of the entire culture dropping to 55 units as there are a 
greater proportion of small cells. Without examining the median fluorescence intensity 
in discrete sub-populations it may be assumed that myxoma virus down-regulates cell 
surface expression of the particular protein in stimulated cultures. However, myxoma 
virus may just be decreasing the proportion of cells in the large sub-population, which 
reduces the overall median fluorescence intensity.
Examination of the median fluorescence intensity in large and small cell sub-
populations will determine whether myxoma virus is modulating expression of the 
particular proteins either directly or by inhibiting T-cell activation. Continuing with the 
hypothetical example started above, if the median fluorescence intensity of the gated 
large cell sub-population in infected cultures is also 100 units, then it can be concluded 
that myxoma virus does not alter the level of protein expression, rather just the
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proportion of cells in that sub-population. However, if the median fluorescence intensity 
of the large cell sub-population is 50 units then it can be concluded that myxoma virus 
down-regulates expression of that protein on the cell surface.
Therefore if the mean median fluorescence intensity of antibody binding in the large (or 
small) cell sub-population is the same both before and after myxoma virus infection, 
then it can be concluded that myxoma virus inhibits the expression of specific cell 
surface proteins by inhibiting T-cell activation. Alternatively, if the mean median 
fluorescence intensity of antibody binding is different in discrete cell sub-populations 
before and after infection then it can be concluded that myxoma virus infection is 
directly affecting cell surface protein expression.
This section re-examines the data from Section 5.2.3 by gating large and small cell sub-
populations in cell cultures mock-infected or infected with myxoma virus, determining 
the median fluorescence intensity for each rabbit and then calculating the mean median 
fluorescence intensity of antibody binding for the three rabbits in each group as before. 
Figure 10 shows how this was done, using CD25 expression as an example.
5.2.5.1 Protein Expression on Large and Small Cells
5.2.5.1.1 Expression of CD25 and MHC-I in Large and Small Cell Sub- 
Populations
Figure 5.11 and Figure 5.12 show that mock-infected large cells expressed greater 
amounts of CD25 and MHC-I than did small cells. This can be seen as a greater mean 
median fluorescence intensity in the large cell sub-population compared to the small cell 
sub-population (Figure 5.11 and Figure 5.12). Although not statistically significant at
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Cu l t u r e s
The cell surface expression of CD25 was examined on unstimulated and Con A-stimulated 
laboratory rabbit lymphoid cells that had been mock-infected and analysed 48 h later. The large 
and small cell sub-populations were gated on density plots of cell size versus granularity and 
plotted as histograms of protein expression. The median fluorescence intensity for each cell sub-
population was determined (numbers in histograms) and in subsequent figures is plotted on a 
column graph as a mean of three experiments.
the 95% Cl, Con A stimulation increased the mean median fluorescence intensity of 
CD25 and MHC-I in the large cell sub-population, indicating that generally the 
expression of CD25 and MHC-I on each large cell was increased and not just the 
proportion of large cells. In the small cell sub-population, Con A stimulation did not 
significantly alter the mean median fluorescence intensity of CD25 or MHC-I (95% Cl).
Infection with either SLS or Ur inhibited the Con A-induced increase in expression on 
large cells of CD25 (Figure 5.11) and MHC-I (Figure 5.12). The mean median 
fluorescence intensity of CD25 and MHC-I in infected stimulated cultures was similar 
to that in mock-infected unstimulated cultures, suggesting that that myxoma virus
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Figur e  5.11. CD25 Ex pr e s s io n  o n  Large  an d  Sma ll  Cells  in  Ra b b it  Lymp ho id  
Cell  Cul t u r e s
The mean median fluorescence intensity corresponding to CD25 antibody binding was 
determined in lymphoid cell cultures from three laboratory and three wild rabbits. Cultures were 
mock-infected* or infected with either SLS, at a moi of 0.1* or 3*, or Ur, at a moi of 0.1 or 
3*. Con A was added after cultures were infected. CD25 expression was analyzed in large and 
small cell sub-populations as outlined in Figure 5.10. Error bars represent one standard error.
Laboratory Rabbit Lyrrphoid CeP Cultures VWId Rabbit Lyrrphoid Cell Cultures
Stimulated Cultures, Large Cells
Laboratory Rabbit Lymphoid Cell Cultures Wld Rabbit Lymphoid Cell Cultures
Stimulated Cultures, Small Cells
Laboratory Rabbit Lyrrphoid CeP Cultures VUId Rabbit Lyrrphoid CeP Cultures
Fig ur e  5.12. MHC-I Exp re ss io n  on  La r g e  and  Small  Cells  in  Rab b it  
Ly m ph o id  Cell  Cultures
The mean median fluorescence intensity corresponding to MHC-I antibody binding was 
determined in lymphoid cell cultures from three laboratory and three wild rabbits. Cultures 
were mock-infected* or infected with either SLS, at a moi of 0.1 * or 3*, or Ur, at a moi of 
0.11 or 3*. Con A was added after cultures were infected. MHC-I expression was analyzed in 
large and small cell sub-populations as outlined in Figure 5.10. Error bars represent one 
standard error.
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infection is down-regulating CD25 and MHC-I expression on large cells by inhibiting 
T-cell activation. Small cells bound low levels of CD25 and MHC-I antibodies. These 
levels were not significantly altered by infection with myxoma virus or by Con A 
stimulation.
5.2.5.1.2 Expression of CD4 in Large and Small Cell Sub-Populations
CD4 was expressed at higher levels on mock-infected large cells compared with small 
cells (Figure 5.13). CD4 expression was higher overall, but not significantly so, in 
unstimulated mock-infected large lymphocytes from wild rabbits (mean median 
fluorescence intensity of 214 units) compared to those from laboratory rabbits (mean 
median fluorescence intensity of 162 units) (Figure 5.13). In stimulated mock-infected 
lymphoid cell cultures from wild rabbits there were lower levels of CD4 expression on 
the surface of small and large cells compared to unstimulated cells. This was not 
statistically significant at the 95% Cl. Stimulation did not significantly change CD4 
expression in mock-infected large cells from laboratory rabbits at the 95% Cl.
Myxoma virus infection did not significantly alter mean median fluorescence intensity 
of CD4 on large or small lymphoid cells from laboratory rabbits or wild rabbits in the 
absence of Con A (95% Cl) (Figure 5.13). For small cells, the mean median 
fluorescence intensity ranged from a minimum of 76 units to a maximum of 94 units in 
lymphoid cell cultures from laboratory rabbits, and ranged from a minimum of 115 units 
and a maximum of 131 units in lymphoid cell cultures from wild rabbits (Figure 5.13).
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Figure  5.13. CD4 Exp re ss io n  on  Large  an d  Sma ll  Cell s  in  Rab b it  Lym ph o id  
Cell  Cul tu res
The mean median fluorescence intensity corresponding to CD4 antibody binding was 
determined in lymphoid cell cultures from three laboratory and three wild rabbits. Cultures were 
mock-infected* or infected with either SLS, at a moi of 0.1 ® or 3*, or Ur, at a moi of 0.1 - or 
3*. Con A was added after cultures were infected. CD4 expression was analyzed in large and 
small cell sub-populations as outlined in Figure 5.10. Error bars represent one standard error.
However, infection with either strain of virus generally decreased CD4 expression on 
large cells in stimulated lymphoid cell cultures from both rabbit types (Figure 5.13). 
This decrease, although not statistically significant at the 95% Cl, was apparent even at 
low moi and levels were lower than in unstimulated mock-infected large cells. This 
supports the hypothesis that CD4 is either actively down-regulated from the surface of 
infected, stimulated cells or that CD4 transport to the cell surface is inhibited by 
myxoma virus infection. The mean median fluorescence intensity of CD4 in small cells 
in stimulated lymphoid cell cultures from both rabbit types was greater in cultures 
infected with myxoma virus compared to mock-infected cultures. These results show 
that myxoma virus infection induced CD4 down-regulation only on large cells.
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5.2.5.1.3 Expression of CD43 in Large and Small Cell Sub-Populations
Large cells in mock-infected cultures expressed greater levels of CD43 than small cells 
(Figure 5.14). Con A stimulation decreased CD43 expression on large and small cells in 
cultures from both rabbit types. This was significant only in small cells in lymphoid cell 
cultures from wild rabbits (p<0.05). Myxoma virus infection down-regulated CD43 
expression on large cells in unstimulated lymphoid cell cultures from laboratory and 
wild rabbits (Figure 5.14). This decrease in CD43 expression, was not statistically 
significant at the 95% Cl but inversely correlated with moi and was more apparent in 
lymphoid cell cultures from wild rabbits. The mean median fluorescence intensity of 
CD43 in the small cell sub-population was not significantly altered by myxoma virus 
infection in unstimulated lymphoid cell cultures from laboratory rabbits. In 
unstimulated mock-infected lymphoid cell cultures from wild rabbits, the mean median 
fluorescence intensity of CD43 expression was 292 units. In cultures infected with SLS 
or Ur the mean median fluorescence intensity was 212 and 222 units respectively 
(Figure 5.14).
Con A stimulation of cell cultures infected with SLS or Ur, led to a significant increase 
in CD43 expression in the small cell sub-population compared to levels in stimulated 
mock-infected cultures (p<0.05) (Figure 5.14). There was no statistically significant 
difference in CD43 expression on large cells between mock-infected and myxoma 
virus-infected cultures in either rabbit type. However, CD43 expression was increased 
by approximately 50 units by SLS infection in large cells from stimulated cultures from 
wild rabbits.
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Figur e  5.14. CD43 Exp re ss io n  o n  Lar ge  and  Sma l l  Cell s  in  Ra b b it  Lymphoid  
Cell  Cult ur es
The mean median fluorescence intensity corresponding to CD43 antibody binding was 
determined in lymphoid cell cultures from three laboratory and three wild rabbits. Cultures 
were mock-infectedB or infected with either SLS, at a moi of 0.1 ■ or 3*, or Ur, at a moi of 
0.1 or 3B. Con A was added after cultures were infected. CD43 expression was analyzed in 
large and small cell sub-populations as outlined in Figure 5.10. Error bars represent one 
standard error.
The results presented in this section are in contrast to the results shown for the mean 
median fluorescence intensity in the entire cell culture, which did not show any 
difference in CD43 expression between mock-infected and virus-infected cell cultures 
(Section 5.2.3.3). However, it must be remembered that examination of large and small 
cell sub-populations is more sensitive than examination of the entire cell culture as the 
large and small cell sub-populations represent defined subsets of cells and that large and 
small cells constitute different proportions of the total culture.
5.2.5.1.4 Expression of CD45 in Large and Small Cell Sub-Populations
Large cell sub-populations had a greater mean median fluorescence intensity of CD45 
antibody binding compared to small cell sub-populations (Figure 5.15). Infection of cell
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cultures with either SLS or Ur did not significantly alter CD45 expression on cell sub-
populations in unstimulated cell cultures (95% Cl) (Figure 5.15). Stimulation of 
infected cell cultures with Con A did not significantly alter CD45 expression on large 
and small cells in lymphoid cell cultures from laboratory or wild rabbits compared to 
stimulated mock-infected cell cultures (95% Cl) (Figure 5.15).
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Fig u re  5.15. CD45 Ex pr e s s io n  o n  Lar g e  and  Sma l l  Cells  in  Ra b b i t  Lymp ho id  
Cell  Cult ur es
The mean median fluorescence intensity corresponding to CD45 antibody binding was determined 
in lymphoid cell cultures from three laboratory and three wild rabbits. Cultures were mock- 
infectedB or infected with either SLS, at a moi of 0.1 ■ or 3■, or Ur, at a moi of 0.U or 3■. Con 
A was added after cultures were infected. CD45 expression was analyzed in large and small cell 
sub-populations as outlined in Figure 5.10. Error bars represent one standard error.
5.2.5.1.5 Expression of KEN-5 in Large and Small Cell Sub-Populations
Large cells in rabbit lymphoid cell cultures generally expressed higher levels of KEN-5 
than small cells (Figure 5.16). The level of KEN-5 expression in the large or small cell 
sub-population was not altered significantly between rabbit types or stimulation.
255
Chapter 5- Expression o f Cell Surface Proteins
I
<D
§
<Ds
T T T T T
Laboratory Rabbit Lymphoid Ceil Cultures VUltd Rabbit Lymphoid Cell Cultures Laboratory Rabbit Lymphoid CeH Cultures VUId Rabbit Lymphoid Cell Cultures
Figur e  5.16. KEN-5 Exp res sio n  o n  Lar g e  an d  Sma l l  Cel ls  in  Ra b b it  
Lym ph o id  Cell  Cultu res
The mean median fluorescence intensity corresponding to KEN-5 antibody binding was 
determined in lymphoid cell cultures from three laboratory and three wild rabbits. Cultures were 
mock-infected■ or infected with either SLS, at a moi of 0.1 * or 3*, or Ur, at a moi of 0.1 or 
3*. Con A was added after cultures were infected. KEN-5 expression was analyzed in large and 
small cell sub-populations as outlined in Figure 5.10. Error bars represent one standard error.
5.2.5.1.6 Expression of MHC-II in Large and Small Cell Sub-Populations
Examination of mean median fluorescence intensity in mock-infected large and small 
cell sub-populations showed large cells had significantly higher expression of MHC-II 
than small cells (p<0.05) (Figure 5.17) For comparison, the mean median fluorescence 
intensity graphs for the entire cell culture (shown in Figure 5.9) are also shown with the 
same scale. This gives an indication that MHC-II expression on individual cells may not 
impact greatly on events within the entire lymphoid cell cultures.
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Figur e  5.17. MHC-II Expr ession  on  Lar g e  an d  Sma ll  Cells  in  Rabb it  
Lym ph o id  Cell  Cultures
The mean median fluorescence intensity corresponding to MHC-II antibody binding was 
determined in lymphoid cell cultures from three laboratory and three wild rabbits. Cultures were 
mock-infected* or infected with either SLS, at a moi of 0.1 B or 3B, or Ur, at a moi of 0.1 or 
3B.  Con A was added after cultures were infected. MHC-II expression was analyzed in large and 
small cell sub-populations as outlined in Figure 5.10. The mean median fluorescence intensity in 
the entire culture from Figure 5.9C are also plotted with the same scale as for large and small cell 
sub-populations. Error bars represent one standard error.
Infection of rabbit lymphoid cell cultures with SLS or Ur at a moi of 3 increased MHC- 
II levels on large cells in unstimulated cell cultures relative to mock-infected cell 
cultures (Figure 5.17). For instance, the mean median fluorescence intensity of MHC-II 
expression in mock-infected cultures from laboratory rabbits was 370 units. This 
increased to 956 and 543 units for SLS and Ur respectively. This was not statistically 
significant due to the wide variation in MHC-II expression levels in cultures infected
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with myxoma virus. Similar results were observed in lymphoid cell cultures from wild 
rabbits.
Con A stimulation of these cell cultures partially inhibited the increase in MHC-II 
expression in infected cell cultures, however MHC-II expression was still greater than 
that in mock-infected cell cultures as Con A reduced MHC-II expression on large cells. 
The increase in MHC-II expression tended to be greater in cell cultures infected with 
SLS compared to cell cultures infected with Ur. The mean median fluorescence 
intensity in small cell sub-populations was not greater than 90 units in any infection.
The discrepancy between MHC-II levels in the entire cell culture and on large cells can 
be accounted for by the small proportion of large cells (approximately 15%). When the 
entire cell culture is considered, this minor population will not greatly affect results 
when a median is calculated.
5.2.5.1.7 Summary of Expression of Cell Surface Proteins in Large 
and Small Cell Sub-populations
The main results in this section are:
1. SLS and Ur inhibited the Con A-induced increase in CD25 and MHC-I 
expression on large cells.
2. SLS and Ur did not significantly alter CD4 expression on large or small cells in 
unstimulated cultures. CD4 expression on large cells was down-regulated by 
both virus strains when cultures were stimulated.
3. CD43 expression was down-regulated on large cells in the absence of 
stimulation. There was no change in CD43 expression on large cells when
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cultures were stimulated, however, CD43 expression was significantly increased 
in the small cell sub-population when cultures were stimulated.
4. Overall, CD45 and KEN-5 expression was not altered substantially in either cell 
sub-population when cultures were infected with myxoma virus.
5. MHC-II expression on large cells increased dramatically with myxoma virus 
infection.
5.2.6 Expression of Cell Surface Proteins in Rabbit Lymphoid 
Cell Cultures Stimulated with Con A Prior to Infection with 
Myxoma Virus
Chapter 3 showed that myxoma virus inhibited lymphocyte proliferation induced by 
Con A. During the anti-viral immune response, however, some cells would be 
stimulated prior to their being infected with virus. As chapter 3 showed that cells 
already stimulated are the predominant sub-population infected with myxoma virus, the 
ability of the virus to alter cell surface expression of specific proteins in cell cultures 
activated prior to infection was examined. To determine whether myxoma virus could 
alter the activation state of lymphoid cells by altering cell surface expression of CD25 
or MHC-I, cell cultures were stimulated with Con A for 4, 24 or 48 h and then mock- 
infected or infected with SLS or Ur at a moi of 3. These experiments also allow better 
comparison with previously published studies examining the expression of cell surface 
markers during myxoma virus infection of constantly replicating cell lines. Cell cultures 
were examined 24 and 48 h after infection. These are the same samples used in chapter 
3 for analysis of cell size. Samples were analysed by density plots of cell size versus 
protein expression and histogram overlays of protein expression. Cell cultures 
stimulated with Con A for 24 h prior to infection are not shown as these results are
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intermediate between results from cultures stimulated for 4 or 48 h prior to infection. 
Similarly, results from cultures infected for 24 h after Con A stimulation for 4 or 48 h 
are not shown, because results from virus-infected cultures can not be as clearly 
distinguished from mock-infected cultures as that in cultures infected for 48 h.
CD25 and MHC-I expression were decreased at 24 and 48 h after infection in rabbit 
lymphoid cell cultures that had been stimulated with Con A for 4 h prior to infection 
with SLS or Ur (Figure 5.18 and 5.19). This was more apparent after 48 h of infection 
compared to 24 h post infection (data not shown).
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Fig ur e  5.18. Cell  Sur fa ce  Ex pr e s s io n  of  CD25 in  Ra b b it  Lymphoid  Cell  
Cult ur es  Sti mu la ted  w it h  Co n  A Pr io r  t o  Inf ec ti o n  w it h  SLS or  Ur  
Lymphoid cell cultures from laboratory and wild rabbits were incubated with Con A for (A) 4 h or 
(B) 48 h and then were either mock-infected (MI)B or infected with SLSB or UrB, at a moi of 3, 
for an additional 48 h. CD25 expression was analysed by flow cytometry. The experiment was 
undertaken using lymphoid cells isolated from three laboratory and three wild rabbits (one shown 
here). Data is presented as density plots of cell size versus CD25 expression, and histogram 
overlays of CD25 expression. Cells with a fluorescence intensity greater than 102 units were 
classified as expressing high levels of CD25, whereas cells with a fluorescence intensity less than 
102 units were classified as expressing low levels of CD25. Numbers are mean proportions of cells 
in sub-populations expressing high and low CD25 levels from the three experiments.
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Figure  5.19. Ce ll  Sur fa ce  Ex pr e s s io n  of  MHC-I in  Ra b b i t  Lym ph o id  Cell  
Cu lt ur es  Sti m ul a te d  w it h  Co n  A Pr io r  to  In f ec ti o n  w it h  SLS or  Ur
Lymphoid cell cultures from laboratory and wild rabbits were incubated with Con A for (A) 4 h 
or (B) 48 h and then were either mock-infected (MI)* or infected with SLS* or Ur*, at a moi of 
3, for an additional 48 h. MHC-I expression was analysed by flow cytometry. The experiment 
was undertaken using lymphocytes isolated from three laboratory and three wild rabbits (one 
shown here). Data is presented as density plots of cell size versus MHC-I expression, and 
•- histogram overlays of MHC-I expression. Cells with a fluorescence intensity greater than 102 
units were classified as expressing high levels of MHC-I, whereas cells with a fluorescence 
intensity less than 102 units were classified as expressing low levels of MHC-I. Numbers are 
mean proportions of cells in sub-populations expressing high and low MHC-I levels from the 
three experiments.
The longer cell cultures were stimulated with Con A prior to infection, the less the 
decrease in CD25 and MHC-I expression following infection. This can be seen by the 
similar proportions of cells from laboratory rabbits expressing high levels of CD25 
(Figure 5.18) or MHC-I (Figure 5.19) between mock-infected and myxoma virus- 
infected cell cultures when stimulated for 48 h prior to infection and in the histogram 
overlays where similar curves were observed in mock-infected and virus-infected
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cultures stimulated for 48 h prior to infection. Similar results were observed in wild 
rabbit cultures.
These results suggest that myxoma virus inhibits CD25 and MHC-I expression by 
inhibiting cell activation because CD25 and MHC-I expression were not affected if cells 
were activated prior to infection. This hypothesis is supported by analysis of mean 
median fluorescence intensity which shows the ability of myxoma virus to decrease 
CD25 (Figure 5.20) and MHC-I (Figure 5.21) antibody binding is reduced the longer 
cell cultures were stimulated prior to infection. Mock-infected cultures stimulated with 
Con A for 48 h had lower levels of MHC-I expression compared to cultures stimulated 
for shorter periods, suggesting that in cultures stimulated for 48 h, MHC-I was either 
actively taken off the surface of the cell or the production of new molecules was 
reduced. The expression of CD25 and MHC-I on small cells was not altered by Con A 
stimulation or by myxoma virus infection in cell cultures from either type of rabbit.
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Figure  5.20. Me an  Medi an  Fluo re sc en ce  Int e ns it y  Corr es po nd in g  to  CD25 
Exp re ss io n  in  Ra bb it  Lym ph o id  Cel l  Cult ur es  Sti mu la te d  w it h  Con  A Prior  
t o  Infec ti on  with  SLS or  Ur
The mean median fluorescence intensity corresponding to CD25 expression was determined in 
cell cultures stimulated with Con A for 4 or 48h prior to infection for 48h. CD25 expression 
was analysed in large and small cell sub-populations in lymphoid cell cultures from laboratory 
and wild rabbits. Cultures were mock-infected* or infected with SLS* or Ur® at a moi of 3. 
Error bars represent one standard error.
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Figure  5.21. Me an  Med ian  Fl u o re s ce nc e  Int e ns it y  Co rr es po nd in g  t o  MHC-I
Exp re ss io n  in  Ra b b it  Lym ph oid  Cell  Cul t u r e s  St im ul a te d  w it h  Co n  A Prior  
t o  Inf e c t i o n  w it h  SLS or  Ur
The mean median fluorescence intensity corresponding to MHC-I expression was determined in 
cell cultures stimulated with Con A for 4 or 48h prior to infection for 48h. MHC-I expression was 
analysed in large and small cell sub-populations in lymphoid cell cultures from laboratory and 
wild rabbits. Cultures were mock-infected* or infected with SLS* or Ur* at a moi of 3. Error 
bars represent one standard error.
265
Chapter 5- Expression o f Cell Surface Proteins
5.2.7 Expression of Cell Surface Proteins on RL-5 Cells 
Infected with SLS or Ur
Infection with myxoma vims has previously been shown to decrease CD4 and MHC-I 
expression on RL-5 cells, but not affect CD43 or CD45 expression . Myxoma vims 
infection has also been shown to decrease MHC-I on the primate kidney cell line, 
BGMK (Boshkov et al., 1992). These experiments were undertaken using the Lu strain 
of myxoma vims. To investigate if SLS and Ur could also decrease CD4 and MHC-I 
expression on RL-5 cells, analysis of cell surface protein expression on RL-5 cells 
infected with SLS and Ur was undertaken in a similar manner to that done for primary 
lymphocytes. The effects of SLS and Ur infection on expression of the other cell surface 
proteins examined in this chapter were also investigated. Protein expression is presented 
as density plots of cell size versus protein expression, histogram overlays and mean 
median fluorescence intensity. MHC-II expression was not analyzed as preliminary 
examination of MHC-II expression, by staining cells with normal mouse ascites fluid or 
with anti-MHC-II monoclonal antibody, showed RL-5 cells did not express MHC-II 
(data not shown).
Results presented here confirm and extend the results of Barry et al. (1995) in that 
myxoma vims caused a decrease in CD4 and MHC-I expression and no change in CD43 
and CD45 expression on RL-5 cells. Infection with either SLS or Ur decreased CD4 
expression, with 90% of cells expressing high levels of CD4 in mock-infected cultures, 
but only 73% and 75% in cultures infected with SLS or Ur respectively (Figure 5.22). 
The concurrent decrease in mean median fluorescence intensity was not statistically 
significant at the 95% Cl. Similarly, a decrease in the proportion of cells expressing 
high levels of MHC-I was observed (Figure 5.23); the concurrent decrease in mean
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Figur e  5.22. Ex pr e s s io n  of  CD4 on  th e  Surf ace  of  RL-5 Cells  Inf ec te d  Wit h  
SLS OR UR
RE-5 cells were mock-infected (MI)* or infected with SLS* or Ur* at a moi of 3, for 24 h. 
Expression of CD4 was analysed by flow cytometry. The experiment was undertaken on three 
separate occasions (one shown here). Data is presented as (A) density plots of cell size versus 
protein expression and (B) histogram overlays of protein expression. A black line has been 
drawn to distinguish sub-populations expressing high and low levels of CD4. (C) The mean 
median fluorescence intensity corresponding to CD4 for each infection was calculated for the 
three separate occasions.
median fluorescence intensity was greater, decreasing from 205 units in mock-infected 
cultures to 110 and 140 units in SLS- and Ur-infected cultures respectively.
Neither SLS nor Ur infection significantly altered CD43 (Figure 5.24) or CD45 (Figure 
5.25) expression with differences in mean median fluorescence intensity between mock- 
infected and myxoma virus-infected cell cultures less than 10 units.
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Fig ur e  5.23. Exp re s s io n  of  MHC-I o n  t he  Surface  of  RL-5 Cells  Infect ed  
With  SLS o r  Ur
RL-5 cells were mock-infected (MI)B or infected with SLS* or Ur* at a moi of 3, for 24 h. 
Expression of MHC-I was analysed by flow cytometry. The experiment was undertaken on three 
separate occasions (one shown here). Data is presented as (A) density plots of cell size versus 
protein expression and (B) histogram overlays of protein expression. A black line has been 
drawn to distinguish sub-populations expressing high and low levels of MHC-I. (C) The mean 
median fluorescence intensity corresponding to MHC-I for each infection was calculated for the 
three separate occasions.
Neither expression of CD25 nor expression of the KEN-5 marker has been previously 
examined in cell lines infected with myxoma virus. Infection with SLS or Ur decreased 
CD25 expression on the surface of RL-5 cells (Figure 5.26). This can be seen in the 
density plots for CD25 expression, where 51% of mock-infected RL-5 cells express 
high levels of CD25 compared to 30% and 34% of RL-5 cells infected with SLS or Ur 
respectively. The decrease in CD25 expression on RL-5 cells was also observed on the 
histogram plots and after analysis of mean median fluorescence intensity (Figure 5.26B 
and 5.26C), but was not statistically significant at the 95% Cl.
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F i g u r e  5.24. Ex pr e s s i o n  o f  CD43 o n  t h e  Su r f a c e  o f  RL-5 Ce l l s  In f e c t e d  
W i t h  SLS o r  Ur
RL-5 cells were mock-infected (MI)* or infected with SLS* or Ur* at a moi of 3, for 24 h. 
Expression of CD43 was analysed by flow cytometry. The experiment was undertaken on three 
separate occasions (one shown here). Data is presented as (A) density plots of cell size versus 
protein expression and (B) histogram overlays of protein expression. A black line has been drawn 
to distinguish sub-populations expressing high and low levels of CD43. (C) The mean median 
fluorescence intensity corresponding to CD43 for each infection was calculated for the three 
separate occasions.
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Figure  5.25. Exp re ss io n  of  CD45 on  the  Surf ace  of  RL-5 Cells  Inf ec te d  
With  SLS o r  Ur
RL-5 cells were mock-infected (MI)* or infected with SLS* or Ur* at a moi of 3, for 24 h. 
Expression of CD45 was analysed by flow cytometry. The experiment was undertaken on three 
separate occasions (one shown here). Data is presented as (A) density plots of cell size versus 
protein expression and (B) histogram overlays of protein expression. A black line has been drawn 
to distinguish sub-populations expressing high and low levels of CD45. (C) The mean median 
fluorescence intensity corresponding to CD45 for each infection was calculated for the three 
separate occasions.
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Fig u re  5.26. Ex pre s s io n  of  CD25 on  the  Surf ace  of  RL-5 Cel ls  Inf ect ed  
Wi t h  SLS or  Ur
RL-5 cells were mock-infected (Ml)* or infected with SLS* or Ur* at a moi of 3, for 24 h. 
Expression of CD25 was analysed by flow cytometry. The experiment was undertaken on three 
separate occasions (one shown here). Data is presented as (A) density plots of cell size versus 
protein expression and (B) histogram overlays of protein expression. A black line has been 
drawn to distinguish sub-populations expressing high and low levels of CD25. (C) The mean 
median fluorescence intensity corresponding to CD25 for each infection was calculated for the 
three separate occasions.
A decrease in KEN-5 expression on the surface of RL-5 cells by SLS and Ur infection 
was only evident when mean median fluorescence intensity was calculated (Figure 
5.27). However, this decrease was not significant at the 95% Cl.
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Figure  5.27. Exp res sio n  of  KEN-5 o n  th e  Sur f ac e  of  RL-5 Cells  Inf e c t e d  
Wit h  SLS or  Ur
RL-5 cells were mock-infected (MI)* or infected with SLS* or Ur* at a moi of 3, for 24 h. 
Expression of KEN-5 was analysed by flow cytometry. The experiment was undertaken on three 
separate occasions (one shown here). Data is presented as (A) density plots of cell size versus 
protein expression and (B) histogram overlays of protein expression. A black line has been 
drawn to distinguish sub-populations expressing high and low levels of KEN-5. (C) The mean 
median fluorescence intensity corresponding to KEN-5 for each infection was calculated for the 
three separate occasions.
5.2.8 Sub-popuiation of Lymphoid Cells Responding to Con A
Chapter 3 showed distinct large and small cell sub-populations after Con A stimulation. 
Section 5.2.1 and Section 5.2.4 showed the large and small cell sub-populations 
expressed different levels of the one protein. However, the analysis in this thesis so far 
has not considered how the sub-population of lymphoid cells in a culture change with 
Con A activation. Therefore cell surface protein expression in large and small cell sub-
populations was investigated in mock-infected cell cultures to determine the sub-
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population that responded to Con A. Density plots of cell size versus protein expression 
for lymphoid cell cultures are shown in Figure 5.28. The results obtained were similar 
between lymphoid cell cultures from laboratory and wild rabbits and are only shown for 
laboratory rabbits.
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Fig ure  5.28. Sub -po pu la tio n  of  Lym ph o id  Cells  t h at  Respon ded  to  Co n  A 
Lymphoid cell cultures from laboratory rabbits were mock-infected and incubated with or 
without Con A stimulation. (A) Samples were divided into quadrants based on cell size and level 
of cell surface protein expression. Cell size was plotted against binding of (B) CD25, (C) CD4, 
(D) CD43, (E) CD45, (F) KEN-5, (G) MHC-I and (H) MHC-II antibodies. Expression was 
analysed through flow cytometry and the plots generated using CellQuest software. The 
experiment was repeated three times with one replicate shown here. Numbers represent the 
mean percentage of cells in each quadrant from the three experiments.
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Identical quadrants were drawn on density plots of cell size versus protein expression, to 
define four sub-populations; (l) large cells expressing high levels of protein, (2) large 
cells expressing low levels of protein, (3) small cells expressing high levels of protein 
and (4) small cells expressing low levels of protein (Figure 5.28A). For protein 
expression, cells with a fluorescence intensity greater than 10 units were classified as 
expressing high levels of protein and cells with a fluorescence intensity less than 102 
units were classified as expressing low levels of protein. For cell size, the cut off for 
large and small cells was set at 250 units. These gates appeared to reasonably divide the 
four populations.
From these results it could be hypothesized that the large cell sub-population following 
Con A stimulation of lymphoid cell cultures is derived from small cells expressing high 
levels of CD4 and CD43. The proportion of all cells with low levels of CD4 expression 
in unstimulated cell cultures (56%) was similar to that when cultures were stimulated 
(47%) (Figure 5.28C). Likewise, the proportion of all cells with low CD43 expression 
was 62% in unstimulated cultures and 52% in stimulated cultures. Overall, the 
proportion of cells expressing high levels of CD4 was not greatly altered by Con A 
stimulation with 44% and 53% of cells expressing high levels of CD4 in unstimulated 
and stimulated cultures respectively. This indicates that cells with high levels of CD4 
expression are not altering the level of CD4 expression, rather they are just altering their 
size. In a similar manner, an argument for cells with high levels of CD43 expression 
being the sub-population that responded to Con A can be made (Figure 5.28D). This 
indicates that the large cells have higher levels of CD4 and CD43 compared to the small 
cells and that the large cell sub-population induced by Con A stimulation is mostly 
derived from the small cell sub-population that expresses high levels of CD4 and CD43,
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although some of these cells are also derived from cells in the small sub-population that 
express low levels of CD4.
As shown previously, the large, and thus high CD4 and CD43 expressing cells, also had 
increased expression of CD25 (Figure 5.28B) and MHC-I (Figure 5.28G). CD45 and 
KEN-5 were not expressed on any specific sub-population in mock-infected cell 
cultures. However, cells in cultures examined for CD45 or KEN-5 expression did 
respond to Con A as shown by the increase in cell size in these samples (Figure 5.28E 
and 5.28F).
Antibodies specific for rabbit MHC-1I recognize B-cells and activated T-cells (reviewed 
in Mage 1998). B-cells were not removed from the primary lymph node preparations 
used for the experiments and are not expected to respond to Con A. It is therefore 
reasonable to assume the small, high MHC-II expressing cells (lower right quadrant) in 
unstimulated cell cultures are most likely B-cells. The proportion of cells in this sub-
population was similar both before (28%) and after (20%) Con A stimulation but was 
less than the estimated proportion of B-cells in rabbit lymph node preparations of 37% 
(Mage 1998). The large cell sub-population, which increased in number with the 
addition of the T-cell specific mitogen, Con A, was expected to be predominantly 
activated T-cells. The density plot of cell size versus MHC-II expression showed that 
approximately 38% of cells are large and bind high levels of the MHC-II antibody 
(Figure 5.28H).
In conclusion, these results thus suggest that small cells expressing high levels of CD4 
and CD43 respond to Con A by increasing their cell size and expression of CD25, 
MHC-I and MHC-II.
275
Chapter 5- Expression o f Cell Surface Proteins
5.3 Dis c u s s io n
This chapter describes the expression of cell surface proteins in primary rabbit 
lymphocytes infected with myxoma virus. The first aim of this chapter was to 
investigate if differences existed in the cell surface expression of CD25, CD4, CD43, 
CD45, KEN-5, MHC-I and MHC-II between unstimulated and stimulated lymphocytes 
from susceptible and resistant rabbits. Unstimulated lymphocytes from wild rabbits had 
greater expression of CD4 and CD43 than those from laboratory rabbits and stimulated 
lymphocytes from wild rabbits had greater MHC-I expression than those from 
laboratory rabbits. This differentiated lymphocytes from the two rabbit types. When 
mock-infected cell cultures were stimulated with Con A, expression of CD25 
(lymphocytes from both rabbit types), MHC-I (lymphocytes from laboratory rabbits), 
and MHC-II (lymphocytes from wild rabbits) was significantly increased on the surface 
of activated lymphocytes.
The second aim was to examine the effects of myxoma virus infection on expression of 
these cell surface proteins. Myxoma virus infection down-regulated CD25 and MHC-I 
expression in primary rabbit lymphoid cell cultures and in RL-5 cell cultures. Further 
analysis showed that this was significant on large cells in primary cultures. Myxoma 
virus also down-regulated pre-existing CD4 molecules on large cells when cultures 
were stimulated with Con A and on the surface of RL-5 cells. Infection with myxoma 
virus did not alter expression of CD25 or MHC-I on the surface of lymphocytes 
activated prior to infection. There was no difference between SLS and Ur in their ability 
to alter cell surface marker expression.
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5.3.1 Experimental Approach
Three methods of analysis were used to examine cell surface protein expression in 
rabbit lymphocytes. The first of these was density plots of cell size versus protein 
expression. These plots were useful as they allowed a clear overview of the broad sub-
populations that exist within lymphoid cell cultures, with respect to cell size and protein 
expression. The second method of analysis was by histogram overlays. Overlaying 
histograms of protein expression from different infections on the one graph allowed 
direct comparison of the different infections. An advantage of this method of analysis 
was being able to immediately see that both SLS and Ur had similar effects on the 
expression levels of proteins.
The final method for analysis of cell surface proteins was mean median fluorescence 
intensity. The median fluorescence intensity gives an estimate of protein expression on 
individual cells. This method has been essential for determining expression levels in cell 
sub-populations that only constituted a minor proportion of the entire culture. Unlike the 
first two methods, this analysis averages results over a group of three rabbits. By 
combining these three methods a thorough examination of protein expression on the cell 
surface was undertaken.
5.3.2 Expression of Specific Markers on the Lymphocyte 
Surface
Lymphocytes can be differentiated based on cell surface expression of specific proteins. 
Experiments in this thesis utilized lymphoid cells prepared from rabbit lymph nodes. 
Rabbit lymph nodes contain approximately 57% T-cells and 37% B-cells (reviewed in 
Mage 1998). Cultures prepared from lymph nodes also contain phagocytic cells as well
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as some stromal and endothelial cells. However, in this thesis, the majority of these cells 
were removed from the lymphoid cell cultures prior to all experiments. Thus, the cell 
preparations used in experiments were primarily composed of T- and B-cells.
Cells that responded to the T-cell mitogen, Con A, as shown by an increase in cell size, 
were those that initially had high levels of CD4 and CD43. CD4 expression defines a 
subset of T-cells and CD43 is expressed on T-cells and thymocytes (reviewed in Mage 
1998). Thus, the fact that cells with high expression levels of these proteins responded 
to the T-cell mitogen, Con A, was not unexpected. The proportion of cells in activated 
cultures expressing high levels of CD4 (53%) was not too dissimilar to the expected 
proportion of T-cells (57%). This suggests that most of the T-cells in popliteal lymph 
node preparations may be CD4+ T-cells as opposed to CD8f T-cells. Alternatively, 
some CD8+ T-cells may also express high levels of CD4, although current hypotheses of 
T-cell differentiation deem this unlikely (reviewed in Germain 2002), or more likely the 
proportion of B-cells in the culture may not be as high as the previous estimates of 37%. 
From this thesis, if all cells in unstimulated lymphoid cell cultures expressing MHC-II 
are presumed to be B-cells, then B-cells constituted approximately 28% of the culture.
A subset of activated T-cells in the cell culture also had increased expression of CD25, 
MHC-I and MHC-II. CD25, the IL-2 receptor a-chain, is one of the key markers of T- 
cell activation. The MHC-II antigen is also expressed on activated T-cells (reviewed in 
Mage 1998). Hence, it was not surprising to find high levels of CD25 and MHC-II 
expression on the activated T-cell sub-population. Small cells did not have substantially 
altered cell surface marker expression irrespective of stimulation or virus infection.
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The increase in MHC-I expression when cells were stimulated may be postulated to lead 
to enhanced antigen presentation of intracellular-derived antigen simply due to a greater 
numbers of MHC-I molecules on the cell surface. This may lead to greater killing of 
infected lymphocytes and thus less chance for virus to replicate and disseminate. 
Alternatively, it may be postulated that the higher levels of MHC-I may be required to 
prevent NK cell targeting. In a simple model, NK cells trigger apoptosis in cells that 
express abnormally low MHC-I levels (reviewed in Parkin and Cohen 2001). A 
quiescent T-cell will express a particular level of MHC-I. If this cell is activated then it 
will increase its size. For the MHC-I levels to remain constant per unit volume and 
thereby minimizing the chance of NK cell attack, then expression of MHC-I must also 
be increased. In this model, the infected cell will not be targeted for killing and will thus 
be able to disseminate the virus. Obviously in this model there will be other 
considerations, for example, the involvement of membrane rafts, which may not 
distribute MHC-I molecules across the lymphocyte surface (Carrie Miceli et al., 2001; 
Goot and Harder 2001).
5.3.3 Implications of Different Levels of Lymphocyte Surface 
Proteins for the Immune Response
The mechanism of T-cell activation is different depending on the history of the 
particular T-cell. For example, naive T-cells (T-cells that have not been exposed to a 
specific pathogen) require high levels of antigen, sustained signaling and co-stimulation 
for effective activation (reviewed in Lanzavecchia and Sallusto 2000; Guermonprez et 
al., 2002). In contrast, T-cells that have previously been exposed to antigen require only 
short periods of stimulation and low levels of antigen. The sustained signaling needed to 
prime naive T-cells requires continuous engagement of the T-cell receptor and 
MHC/peptide complex (reviewed in Lanzavecchia and Sallusto 2000; Guermonprez et
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al., 2002). The time available for sustained signaling is dependent on adhesion 
molecules and co-stimulatory interactions. If adhesion is increased between the cells 
then a stable interaction will be formed leading to a potentially longer signaling time. 
Similarly, an increase in co-stimulation will decrease the time required for activation.
The higher levels of cell surface expression of CD4, CD43, in the absence of Con A, 
and MHC-I in the presence of Con A, in lymphoid cell cultures from wild rabbits when 
compared to cultures from laboratory rabbits, may have important consequences for 
activation of naive T-cells in vivo. For instance, CD4 is a co-stimulatory molecule and 
an increase in its expression increases the sensitivity of T-cells to antigen presented in 
association with MHC-II (reviewed in van Parjis and Abbas 1998). An elevated level of 
CD4 expression may thus help reduce the time required for priming of naive T-cells by 
increasing the opportunities for co-stimulation. CD43, on the other hand, is involved in 
cell adhesion during the interaction between T-cells and antigen presenting cells 
(reviewed in Ostberg et al., 1998). Increased CD43 levels on the surface of T-cells may 
help the formation of stable cell-cell interactions, again decreasing the time required for 
T-cell activation and increasing the probability of effective and sufficient signaling.
Taken together, the increase in expression of CD4 and CD43 in lymphoid cell cultures 
from wild rabbits compared to laboratory rabbits may allow a more effective and 
efficient immune response against myxoma virus. The greater expression of MHC-I on 
the surface of activated lymphocytes from wild rabbits may increase presentation of 
viral antigen on the surface of infected cells. These results may contribute to resistance 
of rabbits against myxoma virus.
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5.3.4 CD25 Expression in Myxoma Virus Infection
Previous chapters have shown myxoma virus inhibited T-cell activation in two ways: 
inhibition of the increase in cell size and inhibition of cell proliferation by G1/G0 cell 
cycle arrest. Signaling through the IL-2 receptor is essential for T-cell proliferation and 
activation and IL-2 receptor signaling mediates the transition from G1/G0 into S phase 
(Cantrell and Smith 1984). Therefore, the down-regulation of CD25 expression in 
primary cultures, and RL-5 cells, infected with myxoma virus may curtail signaling 
through the IL-2 receptor leading to the cell cycle arrest observed. Thus down- 
regulation of CD25 may be a key mechanism by which myxoma virus inhibits T-cell 
activation.
5.3.5 Cell Surface Protein Expression During Myxoma Virus 
Infection
This thesis examined the differences between cell surface marker expression in the RL- 
5 cell line and in primary lymphoid cell cultures. Myxoma virus has been previously 
shown to down-regulate CD4 and MHC-I on RL-5 cells (Barry et al., 1995) and MHC-I 
on BGMK cells (Boshkov et al., 1992). These cell lines are continuously activated and 
proliferating. Results from this chapter show myxoma virus can also down-regulate 
CD4 and MHC-I proteins in primary rabbit lymphoid cell cultures. CD4 expression on 
large cells was only down-regulated when cell cultures were activated, suggesting that 
activated cell signaling pathways and their down-stream effects may be essential for this 
process. Alternatively, enhanced myxoma virus replication, which is increased after 
activation of T-cells, may be responsible for the CD4 down-regulation. The experiments 
undertaken in this thesis were not able to differentiate between these possibilities.
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The down-regulation of CD4 on large cells in primary cell cultures may have important 
consequences in vivo. For instance, high levels of CD4 expression on activated T-cells 
will enable more effective co-stimulation to occur as it will increase the sensitivity of T- 
cells to antigen presented in association with MHC-II (van Parjis and Abbas 1998). It 
has previously been postulated that the down-regulation of CD4 on lymphocytes 
infected with myxoma virus would cause the T-cells to become less capable of 
responding to exogenously produced antigen (Barry et ah, 1995). This may suppress the 
anti-viral immune response.
Recently, a model has been proposed for the myxoma virus infection-induced down- 
regulation of CD4 and MHC-I (Mansouri et al., 2003). CD4 and MHC-I are synthesised 
in the endoplasmic reticulum and travel through the Golgi apparatus to be presented on 
the cell surface. However, in myxoma virus-infected cells, once these proteins are at the 
cell surface they are internalised and sorted to intracellular vesicles. This internalisation 
was proposed to be induced by the myxoma virus protein, MV-LAP (Mansouri et al., 
2003). This is contrary to the results observed in primary cells in this thesis, where SLS 
and Ur inhibited the up-regulation of MHC-I induced by Con A stimulation, but could 
not down-regulate pre-existing MHC-I molecules if the cells had been stimulated prior 
to infection.
As both SLS and Ur were shown in chapter 4 to have nucleotide sequences for MV- 
LAP (M l53 ORF) identical to the published Lu sequence, one explanation for the 
difference is that experiments in this thesis were not sensitive enough to detect down- 
regulation of MHC-I by SLS and Ur. Alternatively, the differences may be due to the 
activation state of the cells. For instance, stimulation of primary cells was required for 
the down-regulation of CD4. Furthermore, in agreement with published results (Barry et
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al., 1995), down-regulation of CD4 and MHC-I was detected in RL-5 cells, which are 
continuously proliferating. This thesis also provides evidence that cell lines act 
differently to primary cells. For instance, RL-5 cells maintain a uniform size, whereas 
primary cells increase their size depending on their activation state. The findings of 
Mansouri et al. (2003) were based on studies using cell lines, which may account for the 
differences observed.
The results presented in this chapter have demonstrated that myxoma virus modulates 
cell surface expression of lymphocyte proteins critical for T-cell activation and the 
immune response and is the first demonstration of this in primary rabbit lymphocytes. 
Changing the expression levels of cell surface proteins could significantly disrupt or 
enhance the anti-viral immune response and may be involved in resistance of rabbits to 
myxomatosis. Another way in which myxoma virus may modulate the immune 
response is through altering the profile of cytokine expression. The effects of myxoma 
virus infection on the cytokine expression will be further examined in chapter 6.
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6.1 Introduction
6.1 Int r od u ct io n
The results in the previous chapters have shown that myxoma virus can alter the 
activation of lymphocytes, including inhibition of lymphocyte proliferation and 
modulation of the cell surface expression of proteins involved in regulation of the 
immune response. These actions will potentially disrupt T-cell function. T-cells have 
been shown to be critical in the immune response to other poxvirus infections. For 
example, in mice infected with ectromelia virus, both CD4+ and CD8+ T cells are 
critical for effective control and clearance of virus (Karupiah et al., 1996; Karupiah 
1998). In ectromelia virus infection, induction of an effective cell-mediated immune 
response depended on the profile of cytokines produced and in particular, expression of 
the Th I -inducing cytokines, IFNy and IL-2. Expression of the T^-inducing cytokines, 
such as IL-4 without the co-expression of Th I cytokines, was associated with a failure 
to clear virus infection in this model (Karupiah 1998).
One common method used to measure cytokine levels is to examine mRNA expression. 
Analysis of mRNA expression is particularly useful in tissues, and is possible in rabbits 
as the cytokines have been cloned and sequenced. However, Karupiah (1998) reported 
that mRNA levels of IL-2, IFNy and TNFa in lymphoid organs did not reflect the levels 
of protein seen using immunocytochemistry. This suggested that post-transcriptional 
regulation of these cytokines occurs in vivo, and so mRNA levels are not representative 
of changes in cytokine expression in mice. Post-translational regulation of other 
cytokines, for example IL-12 (Carra et al., 2000), has also been shown previously.
The alternative to measurement of cytokine mRNA expression is to assay cytokine 
protein levels. To do this, antibodies that are specific for the cytokine under
287
Chapter 6- Production and Characterisation o f Antibodies
examination are required. Unfortunately, antibodies directed to rabbit cytokines are not 
commercially available and so a similar analysis can not be readily undertaken.
The aim of the work described in this chapter is to produce and characterize antibodies 
to rabbit IL-2 and IFNy, as representative Th I cytokines, and rabbit IL-4, IL-6 and IL- 
10, as representative Th2 cytokines. The cDNAs for these rabbit cytokines have been 
cloned and sequenced (Perkins et al., 2000) and so can be used to design synthetic 
peptides for antibody production or, alternatively, cloned into protein expression vectors 
for production of protein for use in antibody preparation. In this study, synthetic 
peptides corresponding to potential epitopes on these cytokines, were designed from the 
published sequence data. Rats (and chickens for the IL-2 synthetic peptides) were 
inoculated with the synthetic peptides conjugated to the immunogenic carrier protein 
mariculture keyhole limpet hemocyanin (mcKLH). The specificity of the anti-peptide 
sera generated was examined by immunofluorescence and immunoblot assays, using 
rabbit cytokines produced in a mammalian expression system as antigen. In addition, 
recombinant myxoma viruses expressing rabbit cytokines previously constructed in this 
laboratory were tested to confirm cytokine production from these viruses.
The application of the antibodies produced for analysis of cellular localization of 
cytokine expression during myxoma virus infection was investigated by flow cytometric 
analysis of RL-5 cells and by immunohistochemical analysis of lymph node sections 
from laboratory and wild rabbits infected with myxoma virus. The results reported here 
demonstrate that the antibodies generated in this work provide the basis for more 
extensive and detailed studies characterizing cytokine expression during myxoma virus 
infection of rabbits.
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6.2 Resul t s
6.2.1 Production of Anti-Peptide Sera Specific for Rabbit 
Cytokines
6.2.1.1 Identification of Peptides with Potential Immunogenicity
Cloning and sequencing of rabbit IL-2, IL-4, IL-6, IL-10 and IFNy (accession numbers 
gi:2804256, gi:4432961, gi:230694) have been previously described (Perkins et al., 
2000). The predicted rabbit amino acid sequence was compared to cytokine sequences 
from other species and the 3-dimensional human model for each cytokine was examined 
in order to identify at least two potentially immunogenic regions (12-20 amino acids) 
for each cytokine (Dr H. Perkins, School of Biochemistry and Molecular Biology, 
ANU). These regions were selected so as to have as little homology as possible to the 
amino acid sequence of other species. Potential immunogenic regions were either linear 
surface exposed regions of the protein, such as a loop, or the surface of an exposed helix 
that would be likely to have its secondary structure retained in the peptide.
Figure 6.1 A shows the amino acid alignment of rabbit, rat, chicken and human IL-2 and 
the regions corresponding to the selected peptide sequences. The predicted 3- 
dimensional model of human IL-2 is shown (Figure 6. IB) with the locations of the helix 
B and C/D loop synthetic peptides identified. The peptides are both exposed regions on 
the molecule. Similarly, alignments of rabbit, rat and human cytokine amino acid 
sequence and modeling of the synthetic peptide sequence on 3-dimensional models of 
human IL-4 (Figure 6.2), IL-6 (Figure 6.3), IL-10 (Figure 6.4) and IFNy (Figure 6.5) 
were undertaken. A list of the synthetic peptide sequences selected for synthesis and 
antibody production is shown in Table 6.1.
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A
Rabbit -MYKVQLLSCIALTLALLTSSAPTSSS---TKETQEQLDQLLLDLQVLLKGVNDYKNSKL 56
Rat -MYSMQLASCVALTLVLLVNSAPTSSP---AKETQQHLEQLLLDLQVLLRGIDNYKNLKL 56
Chicken MMCKVLIFGCISVAMLMTTAYGASLSS---- AKRKPLQTLIKDLEILEN-------- 1 4 6
Human -MYRMQLLSCIALILALVTNSAPTSSSTKKTKKTQLQLEHLLLDLQMILNGINNYKNPKL 59
Rabbit SRMLTFKFYMPKKVTELKH— LQCLEEELKPLEEVLNLAQGKNSHGGNTRESISNINVTV 114 
Rat PMMLTFKFYLPKQATELKH— LQCLENELGALQRVLDLTQSKSFHLEDAGNFISNIRVTV 114 
Chicken KNKIHLELYTPTETQECTQQTLQCYLGEWTLKKETEDDTEIKEEFVTAIQNIEKNLKSL 106 
Human TRMLTFKFYMPKKATELKQ— LQCLEEELKPLEEVLNLAQSKNFHLR-PRDLISNINVIV 116
Rabbit LKLKGSE-TFMCEY-DETVTIVEFLNRWITFCQSIISASSS 153
Rat VKLKGSENKFECQFDDEPATWEFLRRWIAICQSIISTMTQ 155
Chicken TGLNHTGSECKICEANNKKKFPDFLHELTNFVRYLQK---- 143
Human LELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT- 156
B
Figure  6.1. Seque nce  Align men t  and  Mo de l  of  IL-2
(A) The amino acid sequence alignment o f rabbit, rat, chicken and human IL-2, with the helix B 
peptide sequence in green and the C/D loop peptide sequence in blue. (B) A 3D model o f human 
IL-2 shows the location of these peptides, with the helix B peptide in green and the C/D loop 
peptide in blue. Sequences and model were obtained from Genbank.
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A
Rabbit MGLPAQLPVTLLCLLAGTAHFIQGRRGDIILPEVIKTLNILTERKTPCTKLMIADALAVP 60 
Rat MGLSPHLAVTLFCFLICTGNGIHGCN-DSPLREIINTLNQVTEKGTPCTEMFVPDVLTAT 59 
Human MGLTSQLLPPLFFLLACAGNFVHGHKCDITLQEIIKTLNSLTEQKTLCTELTVTDIFAAS 60
Rabbit KNTTEREAVCRAATALRQFYLHHK--------VSWCFKEHGELGDLRLLRGLDRNLCSMA 112
Rat RNTTENELICRASRVLRKFYFPRD--------VPPCLKNKSGV--LGELRKLCRGVSGLN 109
Human KNTTEKETFCRAATVLRQFYSHHEKDTRCLGATAQQFHRHKQL— IRFLKRLDRNLWGLA 118
Rabbit KLSNCPGKEARQTTLEDFLDRLKTAMQEKYSK-RQS—  147 
Rat SLRSCTVNESTLTTLKDFLESLKSILRGKYLQSCTSMS 147 
Human GLNSCPVKEANQSTLENFLERLKTIMREKYSK-CSS-- 153
Fig ur e  6.2. Se q u e n c e  Ali gnm ent  and  Model  of  IL-4
(A) An amino acid sequence alignment of rabbit, rat, and human IL-4. The helix C peptide 
sequence is shown in green and the helix A peptide sequence in blue. (B) A 3D model of human 
IL-4 shows the location of these peptides. Sequences and model were obtained from Genbank.
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A
Rabbit MNSFTSALRPGPLGCSLALLLWATAFPTSAPVREDSNTKAS--PDKTLTPPGRTIESIR 58 
Rat MKFLS-ARDFQPVAF-LGLMLLTATAFPTSQVRRGDFTEDTT--HNRPVYTTSQVGGLIT 56 
Human MNSFS-TSAFGPVAFSLGLLLVLPAAFP-APVPPGEDSKDVAAPHRQPLTSSERIDKQIR 58
Rabbit SILETIKELRKEMCDHDVNCMNRKEALAEVNLHLPRLIEEDGCFPPAVNNETCLLRITSG 118 
Rat YVLREILEMRKELCNGNSDCMNSDDALSENNLKLPEIQRNDGCFQTGYNQEICLLKICSG 116 
Human YILDGISALRKETCNKSNMCESSKEALAENNLNLPKMAEKDGCFQSGFNEETCLVKIITG 118
Rabbit LMEFRMYLEHLQAKFRSDEENTRVSMVLKNIQHLIKTLRPKVKNLNEEATLKPAVAVSLM 178 
Rat LLEFRFYLEFVKNNLQ-DNKKDKARVIQSNTETLVHIFKQEIKDSYKIVLPTPTSNALLM 175 
Human LLEFEVYLEYLQNRFE-SSE-EQARAVQMSTKVLIQFLQKKAKNLDAITTPDPTTNASLL 176
Rabbit ENLQQKNQWLKTTTIHFILRGLTNFLEFTLRAVDLMECGCPCLRNFMGSASHGQNTPSCP 238
Rat EKLESQKEWLRTKTIQLILKALEEFLKVTMRSTRQT------------------------  211
Human TKLQAQNQWLQDMTTHLILRSFKEFLQSSLRALRQM------------------------  212
Rabbit LD 240
Rat
Human
Fig ure  6.3. Seq ue nce  Al ig n m en t  and  Model  o f  IL-6
(A) An amino acid sequence alignment of rabbit, rat and human IL-6. The helix E peptide 
sequence is shown in blue and the tail peptide sequence is shown in green. (B) A 3D model of 
human IL-6 shows the location of the helix E peptide. The tail peptide (green) is not shown as 
this is contained in a region of the C-terminus of rabbit IL-6 that is not present in human IL-6. 
Sequences and model were obtained from Genbank.
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A
Rabbit MLSSALLCCLVFLGGTGASRGQDTPAENSCIHFPGGLPHMLRELRAAFGRVKTFFQSKDQ 60 
Rat MLGSALLCCLLLLAGVKTSKGHSIRGDNNCTHFPVSQTHMLRELRAAFSQVKTFFQKKDQ 60 
Human MHSSALLCCLVLLTGVRASPGQGTQSENSCTHFPGNLPNMLRDLRDAFSRVKTFFQMKDQ 60
Rabbit LNSMLLTESLLEDLKGYLGCQALSEMIQFYLKDVMPQAENHSPAIREHVNSLGENLKTLR 120 
rat LDNIVLTDSLLQDFKGYLGCQALSEMIKFYLVEVMPQAENHGPEIKEHLNSLGEKLKTLW 120 
Human LDNLLLKESLLEDFKGYLGCQALSEMIQFYLEEVMPQAENQDPDIKAHVNSLGENLKTLR 120
Rabbit LRLRQCHRFLPCENKSKAVEQVKSAFSKLQEEGVYKAMSEFDIFINYIETYMTMKIKS 178 
Rat IQLRRCHRFLPCENKSKAVEQVKNDFNKLQDKGVYKAMNEFDIFINCIEAYVTLKMKN 178 
Human LRLRRCHRFLPCENKSKAVEQVKNAFNKLQEKGIYKAMSEFDIFINYIEAYMTMKIRN 178
Fig u re  6.4. Seque nce  Ali gnm ent  an d  Mo de l  of  IL-10
(A) The amino acid sequence alignment of rabbit, rat and human IL-10. The N-term peptide 
sequence is shown in green and the C/D-hD peptide sequence in blue. (B) A 3D model of human 
IL-10 shows the location of these peptides. Sequences and model were obtained from Genbank.
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A
Rabbit  MSYTSYILAFQLCLILGSYGCYCQDTLTRETEHLKAYLKANTSDVANGGPLFLNILR 57
Rat  MSATRRVLVLQLCLMALS-GCYCQGTLIESLESLKNYFNSSSMDAMEGKSLLLDIWR 56
Human  MKYTSYILAFQLCIVLGSLGCYCQDPYVKEAENLKKYFNAGHSDVADNGTLFLGILK 57
Rabbit NWKEESDNKIIQSQIVSFYFKLFDNLKDHEVIKKSMESIKEDIFVKFFNSNLTKMDDFQN 117
Rat NWQKDGNTKILESQIISFYLRLFEVLKDNQAISNNISVIESHLITNFFSNSKAKKDAFMS 116
Human NWKEESDRKIMQSQIVSFYFKLFKNFKDDQSIQKSVETIKEDMNVKFFNSNKKKRDDFEK 117
Rabbit LTRISVDDRLVQRKAVSELSNVLNFLSPKSNLKKRKRSQTLFRGRRASKY 167
Rat IAKFEVNNPQIQHKAVNELIRVIHQLSPESSLRKRKRSRC---------- 156
Human LTNYSVT DLNVQRKAIHE LIQVMAEL S PAAKTGKRKRSQML FRGRRAS Q- 166
Figure  6.5. Sequ e nc e  Al ig n m en t  an d  Model  of  IFNy
(A) The amino acid sequence alignment of rabbit, rat and human IFNy, with the hB-B/C peptide 
sequence in green and the helix D peptide sequence in blue. (B) A 3D model of human IFNy 
shows the location of these peptides. Sequences and model were obtained from Genbank.
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Tabl e  6.1. Syn t he ti c  Pept ide  Seq ue nc es
Synthetic
Peptide
Sequence
IL-2 helix B C L E E E L K P L E E V L N
IL-2 C/D loop C E Y D E T V T I V E F L N
IL-4 helix A L P E V I K T L N I L T E R K T P C
IL-4 helix C C F K E H G E L G D L R L L R G L D R N
IL-6 helix E L K P A V A V S L M E N L Q Q K N Q W
IL-6 tail L R N F M G S A S H G Q N T P S C
IL-10 C/D-hD P Q A E N H S P A I R E H V N S
IL-10 Nterm S R G Q D T P A E N S C
IFNy helix D K K S M E S I K E D I F V K
IFNy hb-B/C L F L N I L R N W K E E S D N K
6.2.1.2 Conjugation of Synthetic Peptides to mcKLH
Each synthetic peptide was obtained as a dry powder from the Biomolecular Resource 
Facility (JCSMR, Canberra, Australia). For conjugation to the immunogenic carrier 
protein mcKLH, the peptides needed to be solubilised and so various solvents were 
tested. IL-6 tail, IL-10 C/D-hD, IL-10 N-term and IFNy helix D peptides were soluble in 
the conjugation buffer supplied with the Imject® Maleimide Activated mcKLH kit. The 
IL-2 helix B and IFNy hb-B/C peptides were dissolved in a 1:10 dilution of 7 M 
guanidine in conjugation buffer. The IL-6 helix E and IL-2 C/D loop peptides were 
partially dissolved in 7 M guanidine and the IL-4 helix A peptide were dissolved in 5 M 
guanidine. The IL-4 helix C peptide was only soluble in 20% DMSO.
The peptide solutions were conjugated to mcKLH and rats were inoculated with each 
conjugate. Sera was collected from all rats except those inoculated with the IL-4 helix C 
peptide conjugate that was fatal for inoculated rats. This may have been due to traces of 
DMSO in the inoculation.
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6.2.1.3 Testing Rat Sera for Cytokine Specific Antibodies
The presence of cytokine-specific antibodies in the rat sera was tested by 
immunofluorescence assay of Vero cell monolayers transfected with pcDNA3.1 
expressing each specific rabbit cytokine. Expression of the cytokine gene from 
pcDNA3.1 was under the control of the IE1 cytomegalovirus promotor, which allows 
expression of genes that have been put under the control of this promoter, in 
mammalian tissue culture systems. Each cytokine had been cloned into the plasmid in 
frame with a six Histidine tag (His-tag) at the C-terminus. Detection of the His-tag, 
using an anti-His monoclonal antibody, confirmed that the cytokines were being 
expressed in the tissue culture system.
Figure 6.6 shows the results of immunofluorescence assays screening for the presence 
of anti-rabbit cytokine antibodies. All pictures were taken with the same exposure time. 
Fluorescence was observed for sera from all rats inoculated with IL-4 helix A, IL-6 
helix E, IL-6 tail, IFNy helix D or IFNy hb-B/C, indicating the sera contained cytokine- 
specific antibodies (only serum from one rat for each synthetic peptide is shown in 
Figure 6.6). Only one rat inoculated with IL-10 C/D-hD tested positive for rabbit IL-10- 
specific antibodies. No antibodies were detected in rats immunized with either of the IL- 
2 peptide conjugates or with the IL-10 N-term peptide conjugate. Variation was 
observed between transfections of pcDNA3.1 expressing different cytokines. To allow 
for this during testing of the rat sera the binding of each sera was compared to the anti- 
His positive control for that transfection. Anti-His positive controls were done for every 
transfection, but only the positive control for pcDNA3.1 IL-6 is shown in Figure 6.6.
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Fig ure  6.6. Det ect ion  by  Im m u n o f l u o r e s c e n c e  of  Ra b b it  Cy t o k in e -Spec ific  
Ant ib o di es  in  Ra t  Se r a
Sera from rats immunised with the IL-2 helix B, IL-2 C/D loop, IL-4 helix A, IL-6 helix E, IL-6 
tail, IL-10 C/D-hD, IL-10 N-term, IFNy helix and IFNy hb-B/C were tested for antibodies to the 
specific cytokine from which the peptide was derived, by immunofluorescence assay on Vero cell 
monolayers transfected with plasmids expressing each rabbit cytokine. Anti-His C-terminal 
antibody was used as a positive control in pCDNA3.1-IL-6 transfected cells. Anti-rat Ig-FITC (no 
primary antibody) and normal rat sera were used to determine non-specific binding. Anti-mouse 
IL-2 and anti-mouse IL-10 were used to determine species cross-reactivity of the anti-sera. 
Binding of antibodies was detected by a secondary antibody conjugated to FITC (anti-rat Ig- 
FITC). Pictures were taken using the 40x objective.
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Monoclonal antibodies to mouse IL-2 and IL-10 were obtained from Dr A. Ramsay, 
(JCSMR, Canberra, Australia) to test for cross reactivity to rabbit cytokines. Anti-
mouse IL-2 and anti-mouse IgM IL-10 (Figure 6.6) and anti-mouse IgG IL-10 (data not 
shown) did not show fluorescence with rabbit IL-2 and IL-10. As no cross-reactivity 
was seen for IL-2 and IL-10, which are the cytokines with the most conserved amino 
acid sequences, antibodies raised to cytokines from other species were not tested on the 
rabbit cytokines.
6.2.1.4 Inoculation of Chickens with IL-2 Peptide/KLH Conjugate and 
Testing Sera for Anti-Peptide Antibodies
One potential reason for the sera from rats inoculated with either of the IL-2 peptide 
conjugates being negative for IL-2-specific antibodies was that the synthetic peptide is 
too similar to the same region of rat IL-2. In this scenario, the rat immune system will 
not recognize the rabbit IL-2 peptides as foreign and will not generate an immune 
response against the peptides. Rat IL-2 has 63% amino acid identity to rabbit IL-2 (53% 
and 57% identity over the IL-2 C/D loop and helix B peptide regions respectively). In 
contrast, chicken IL-2 only shares 22% amino acid identity to rabbit IL-2 
(approximately 27% and 21% identity over the IL-2 C/D loop and helix B peptide 
regions respectively). Therefore, in an attempt to produce antibodies to rabbit IL-2, 
chickens were inoculated with the conjugated synthetic peptides.
Chicken sera was tested for the presence of anti-rabbit IL-2 antibodies by 
immunofluorescence on Vero cell monolayers infected with a recombinant myxoma 
virus expressing rabbit IL-2. The recombinant virus was prepared by Mr S. Junankar 
(School of Biochemistry and Molecular Biology, ANU). The pattern of cells infected 
with the recombinant myxoma virus can be clearly seen in the positive control cells,
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under UV light only and UV together with visible light (Figure 6.7A and 6.7B). No 
antibodies that recognised rabbit IL-2 were detected in chicken sera (Figure 6.7E and 
6.7F). The cells incubated with the test chicken sera show the fluorescence is 
generalized and spread across the entire field of view. The immunofluorescence 
observed in chickens inoculated with IL-2 C/D loop conjugate is associated with cell 
debris and not infected cells.
6.2.1.5 DNA Immunisation of Rats with pM agio IL-2
As immunization of either rats or chickens with IL-2 synthetic peptides did not generate 
IL-2-specific antibodies, rats were immunized with DNA vaccine expressing IL-2 and 
boosted with the IL-2 peptides in a further attempt to raise antibodies to rabbit IL-2. 
Analysis by immunofluorescence of sera from rats immunized with pMagic-IL-2 did 
not detect any rabbit IL-2-specific antibodies (data not shown).
6.2.2 Characterisation of Anti-Peptide Sera Specific for Rabbit 
Cytokines
6.2.2.1 Titration of Anti-Peptide Rat Sera on Cells Transfected with 
Plasmids Expressing Rabbit Cytokines
Rat sera were titrated on Vero cell monolayers transfected with pcDNA3.1 expressing 
the appropriate rabbit cytokine genes under control of the CMV IE1 promotor. Sera 
were tested at l:20, l:40, 1:100 and 1:500 dilutions.
Sera from rats inoculated with IL-4 helix A showed strong fluorescence at a dilution of 
1:500 (Figure 6.8). Both the IL-6 tail sera (Figure 6.9) and the IL-6 helix E sera (Figure 
6.10) had fluorescence at the 1:100 dilutions, but not at the 1:500 dilutions. Only one rat
300
6.2 Results
Anti-myxoma virus antibody
UV light UV + white light
Normal chicken sera No primary antibody
IL-2 helix B
IL-2 C/D loop
C hicken 1 Im ken
Fig u re  6.7. Detec ti on  by  Im m u n o f l u o r e s c e n c e  of  Ra bb it  IL-2-Speci fi c  
Antibodies  in  Chicke n  Se r a
Sera from chickens were tested for antibodies to rabbit IL-2by immunofluorescence of Vero cell 
monolayers infected with recombinant myxoma virus expressing rabbit IL-2,. (A, B) Anti-
myxoma virus antibody was used as a positive control and (C) normal chicken sera and (D) anti-
chicken Ig-FITC were used to determine non-specific binding. Chickens were immunised with 
(E) IL-2 helix B or (F) IL-2 C/D loop. Binding of antibodies was detected by a secondary 
antibody conjugated to FITC. Pictures were taken at 40x magnification.
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Fig u re  6.8. Titrat ion  o f  an t i-IL-4 (he lix  A) Rat  Se r a
Sera from rats immunised with the IL-4 helix A peptide were titrated at 1:20, 1:40, 1:100 and 
1:500 against Vero cell monolayers transfected with pcDNA3.1 plasmid expressing rabbit IL-4. 
Results from each of the two rats immunised with the helix A peptide are shown. Anti-His C- 
terminal antibody was used as a positive control, and anti-rat Ig-FITC in the absence of primary 
antibody, and normal rat sera as the primary antibody, were used to determine non-specific 
binding. Pictures were taken at 40x magnification.
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Figur e  6.9. Titration  o f  an t i-IL-6 (t a i l ) Rat  Se ra
Sera from rats immunised with the IL-6 tail peptide were titrated at 1:20, 1:40, 1:100 and 1:500 
against Vero cell monolayers transfected with pcDNA3.1 plasmid expressing rabbit IL-6. Results 
from each of the two rats immunised with the IL-6 tail peptide are shown. Anti-His C-terminal 
antibody was used as a positive control, and anti-rat Ig-FITC in the absence of primary antibody, 
and normal rat sera as the primary antibody, were used to determine non-specific binding. Pictures 
were taken at 40x magnification.
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Fig u r e  6.10. Titration  of  an t i-IL-6 (he lix  E) Ra t  Se r a
Sen from rats immunised with the IL-6 helix E peptide were titrated at 1:20, 1:40, 1:100 and 
1:5)0 against Vero cell monolayers transfected with pcDNA3.1 plasmid expressing rabbit IL-6. 
Remits from each of the two rats immunised with the helix E peptide are shown. Anti-His C- 
terninal antibody was used as a positive control, and anti-rat Ig-FITC in the absence of primary 
antbody, and normal rat sera as the primary antibody, were used to determine non-specific 
binling. Pictures were taken at 40x magnification.
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Figure  6.11. Titr ati on  of  an t i-IL-10 (CD-h /D) Rat  Se r a
Sera from rats immunised with the IL-10 CD-h/D peptide were titrated at 1:20, 1:40, 1:100 and 
1:500 against Vero cell monolayers transfected with pcDNA3.1 plasmid expressing rabbit IL- 
10. Only serum from one rat had IL-10 specific antibodies, thus only results from that rat are 
shown. Anti-His C-terminal antibody was used as a positive control, and anti-rat Ig-FITC in the 
absence of primary antibody, and normal rat sera as the primary antibody, were used to 
determine non-specific binding. Pictures were taken at 40x magnification.
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Sera from rats inoculated with synthetic peptides derived from IFNy showed 
fluorescence at a dilution of 1:100 (Figure 6.12 and Figure 6.13) and one rat inoculated 
with IFNy hb-B/C showed fluorescence at 1:500 dilution (Figure 6.12). Non-specific 
binding was not observed at these dilutions as shown by the cells stained with normal 
rat serum and the cells stained in the absence of primary antibody. However, some non-
specific background binding was present at 1:20 and 1:40 dilutions. As in the initial 
screening, the anti-His C-terminus antibody was used as the positive control and 
showed that the cytokine protein was expressed from the pcDNA3.1 constructs in all 
transfections.
6.2.2.2 Immunoblot Analysis of Anti-Peptide Rat Sera
The rat sera were tested to see if they bound the appropriate cytokine by immunoblot. 
Antigen samples were prepared as either secreted cytokines from recombinant myxoma 
viruses expressing one of the cytokines in mammalian cell culture and in some cases, 
expression of cytokines from plasmid DNA transfected into mammalian cells.
6.2.2.2.1 Analysis of Samples from Virus-Infected Cells
RK13 cells were infected with recombinant myxoma virus expressing one of rabbit IL- 
4, IL-6, IL-10 or IFNy (obtained from Dr H. Perkins and Ms B. Inglis, School of 
Biochemistry and Molecular Biology, ANU). Supernatants or cell extracts were 
collected, supernatants were concentrated by acetone precipitation, and run on a SDS- 
PAGE gel under reducing or non-reducing conditions. Gels were either Coomassie blue 
stained and silver stained to visualize total protein in the gel, or used for transfer of 
protein to a PDVF membrane and subsequent analysis by immunoblotting using 
enhanced chemiluminescence (ECL) detection.
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Fig u re  6.12. Titration  o f  an t i-IFNy  (h b-B/C) Ra t  Se ra
Sera from rats immunised with the IFNy hb-B/C peptide were titrated at 1:20, 1:40, 1:100 and 
1:500 against Vero cell monolayers transfected with pcDNA3.1 plasmid expressing rabbit IFNy. 
Results from each of the two rats immunised with the IFNy hb-B/C peptide are shown. Anti-His 
C-terminal antibody was used as a positive control, and anti-rat Ig-FITC in the absence of 
primary antibody, and normal rat sera as the primary antibody, were used to determine non-
specific binding. Pictures were taken at 40x magnification.
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Figu re  6.13. Titration  of  a n t i -IFNy  (Helix  D) Rat  Se r a
Sera from rats immunised with the IFNy helix D peptide were titrated at 1:20, 1:40, 1:100 and 
1:500 against Vero cell monolayers transfected with pcDNA3.1 plasmid expressing rabbit IFNy . 
Results from both rats immunised with the helix D peptide are shown. Anti-His C-terminal 
antibody was used as a positive control, and anti-rat Ig-FITC in the absence of primary antibody, 
and normal rat sera as the primary antibody, were used to determine non-specific binding. Pictures 
were taken at 40x magnification.
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More proteins were visualized on silver stained reduced gels than Coomassie stained 
reduced gels due to the increased sensitivity of the former staining method (Figure 
6.14A and B). No bands corresponding to the particular cytokine, based on molecular 
weight, were observed by staining with Coomassie blue or silver stain. Detection of 
viral proteins by the anti-myxoma polyclonal serum (Figure 6.14C) showed that the 
cells were successfully infected.
The IL-4 helix A rat sera was able to detect IL-4 (molecular weight of approximately 16
>
kDa) in the supernatant of cells infected with myxoma virus expressing IL-4 when 
samples were run on a reduced gel (Figure 6.14D). Interestingly, the IL-10 C/D-hD rat 
sera was able to detect IL-10 (molecular weight of approximately 20 kDa) in both the 
supernatant and in the cell extract of cells infected with myxoma virus expressing IL-10 
(Figure 6.14G). No IL-6 or IFNy was detected in supernatants or cell extracts from cells 
infected with myxoma virus expressing IL-6 and IFNy. The background using ECL was 
high when IL-6 (Figure 6.14E and H) or IFNy helix D (Figure 6.141) rat sera were used 
as the primary antibody. This may have masked specific IL-6 or IFNy antibody binding. 
Further analysis with shorter exposure times, nitrocellulose membrane and different 
detection methods (e.g. DAB/NiCl) did not decrease this background (data not shown).
Rat sera non-specifically bound to cellular and/or viral proteins. This non-specific 
binding can be seen in blots probed with IL-4 helix A sera, IL-10 C/D-hD sera and IFNy 
hb-B/C sera (Figure 6.14D, G and H). In these blots, the non-specific binding is 
observed in lanes containing cell extracts from cells infected with any of the 
recombinant viruses.
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Fig u re  6.14. Immu no b lo t  Anal ys is  of  Ra t  Se r a  Specific  Fo r  Rab b it  
Cyto kines  on  Reducing  SDS-PAGE
Supernatants and cell extracts from cells infected with recombinant myxoma viruses expressing 
one of rabbit IL-4, IL-6, IL-10 or IFNy were run on a SDS-PAGE gel under reducing conditions in 
the following lane order; supernatants from myxoma virus expressing (1) IL-4, (2) IL-6, (3) IL-10 
or (4) IFNy and cell extracts from myxoma virus expressing (5) IL-4, (6) IL-6, (7) IL-10 or (8) 
IFNy and (9) molecular weight markers. Gels were stained with (A) Coomassie or (B) silver stain 
or used for analysis by immunoblot. The primary antibodies using in immunoblot analysis were 
(C) polyclonal anti-myxoma virus serum, (D) IL-4 helix A rat sera, (E) IL-6 helix E rat sera, (F) 
IL-6 tail rat sera, (G) IL-10 C/D-hD rat sera, (H) IFNy hb-B/C rat sera or (T) IFNy helix D rat sera. 
Bands corresponding to IL-4 (16.2 kDa) and IL-10 (20 kDa) are indicated in panel (D) and (G) 
respectively.
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A possible reason why bands were not seen for IL-6 and IFNy is that reducing 
conditions break disulphide bonds and therefore may disrupt the secondary protein 
structure. The secondary structure may be important for the antibody to recognize the 
native protein. To try and maintain the secondary protein structure, some of the samples 
were analyzed under non-reducing conditions (Figure 6.15). Interestingly, IL-4 was not 
detected with the IL-4 helix A rat sera (Figure 6.15D), in spite of IL-4 being able to be 
detected under reducing conditions. IL-6 and IFNy were also not detected by any rat 
sera under non-reduced conditions (data not shown). Analysis of IL-10 C/D-hD under 
non-reducing conditions was not performed.
A Coomassie blue stain B
SOkOa 
30kDa 
25kDa
l5kDa
Silver stain
c Anti-myxoma virus serum D IL-4 helix A sera
Fig u re  6.15. Im mu nob lot  Ana l ys is  of  Ra t  Se r a  Specific  Fo r  Ra b b it  
Cyto kines  o n  Non -red ucing  SDS-PAGE
Supernatants and cell extracts from cells infected with recombinant myxoma virus expressing 
one of rabbit IL-4, IL-6, IL-10 or IFNy were run on a SDS-PAGE gel under non-reducing 
conditions in the following lane order; supernatants from myxoma virus expressing (1) IL-4, (2) 
IL-6, (3) IL-10 or (4) IFNy and cell extracts from myxoma virus expressing (5) IL-4, (6) IL-6, 
(7) IL-10 or (8) IFNy and molecular weight markers. Gels were stained with (A) Coomassie or 
(B) silver stain or used for analysis by immunoblot. The primary antibodies using in 
immunoblot analysis were (C) polyclonal anti-myxoma virus serum and (D) IL-4 helix A rat 
sera.
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In conclusion, by immunoblot, the rat anti-rabbit IL-4 helix A anti-sera and IL-10 C/D- 
hD anti-sera were shown to bind their respective cytokines secreted by recombinant 
myxoma viruses. The IL-6 and IFNy anti-sera did not detect cytokines secreted by 
recombinant myxoma virus-infected cells using immunoblotting.
To further examine whether the IL-6 and IFNy anti-sera could detect their respective 
cytokines by immunoblotting, COS-7 cells, which are routinely used for expression of 
mammalian proteins, were transfected with pcDNA3.1 containing either rabbit IL-6 or 
IFNy, and the supernatants and cell monolayers were tested for IL-6 and IFNy 
expression. Immunofluorescence assay of transfected cells, using the anti-His antibody, 
showed that both these plasmids had successfully been transfected and were expressing 
protein (data not shown). However, expression of neither IL-6 nor IFNy could be shown 
by immunoblotting of cell supernatants or cell extracts (data not shown). Analysis of 
samples concentrated using centricon units and large sample volumes did not change the 
lack of detection of the cytokines by the rat sera (data not shown). This suggests that 
either not enough protein was produced in the transfection for detection or that the rat 
sera do not recognize these proteins by immunoblot. As both IL-6 and IL-10 were 
detected using the anti-sera by immunofluorescence staining of cells transfected with 
pcDNA3.1 encoding these cytokines, the epitopes must be altered by the 
immunoblotting procedure. Interestingly, similar backgrounds to Section 6.2.2.2.1 were 
observed with ECL when rat sera with antibodies specific for IL-6 or IL-10 were used 
as the primary antibody. This suggests that a high background is a property of the sera 
itself rather then the source of antigen.
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6.2.3 Use of Anti-Peptide Sera for Detection of IL-4 and IFNy
Analysis of cytokine expression during myxoma virus infection was undertaken in two 
ways. Firstly, expression of IFNy in RL-5 cells was examined by flow cytometry. RL-5 
cells constitutively express IFNy mRNA and presumably IFNy protein (Seto et al., 
1997). The rat sera specific for IFNy hb-B/C were used to test for the expression of 
IFNy by RL-5 cells. Secondly, IFNy and IL-4 expression in tissue sections from rabbits 
infected with either SLS or Ur were examined by immunofluorescence (Section 
6.2.3.2).
6.2.3.1 Aniibody Detection of IFNy by Fiow Cytometry
6.2.3.1.1 Detection of IFNy Expressed by RL-5 Cells
To determine if IFNy protein was expressed by RL-5 cells, cells were incubated with 
Brefeldin A (Bref A) and examined by flow cytometry, for IFNy expression using the 
rat sera specific for IFNy,. Bref A interrupts secretion of proteins from the cell by 
interfering with the Golgi apparatus. As IFNy is a secreted protein, Bref A was used to 
sequester protein inside the cell. Con A, although not affecting the proliferation of RL-5 
cells, may activate cell signaling pathways involved with IFNy expression. Hence, 
experiments were also done in the presence and absence of Con A.
Figure 6.16 shows that addition of Bref A to RL-5 cultures increased the detection of 
IFNy compared to cells without Bref A. This indicates that Bref A was inducing 
sequestration of IFNy and that the cells are secreting IFNy in the absence of Bref A. No 
further increase in IFNy expression was detected in cells stimulated with Con A. It is 
interesting to note that IFNy could not be detected by immunoblot (Section 6.2.2), but
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Figure  6.16. IFNy Exp re ss io n  in  RL-5 Cell s
RL-5 cells were incubated with or without Bref A and with or without Con A. Binding of 
normal rat sera (black) or IFNy hb-B/C rat sera (red) to RL-5 cells was detected by flow 
cytometry following incubation with anti-rat-FITC. Results are presented as histogram overlays 
of the number of cells versus IFNy antibody binding.
could be detected in cells expressing IFNy in culture. This supports the idea that IFNy 
antibody epitopes are altered when cells are examined after immunoblotting.
6.2.3.1.2 Detection of IFNy in RL-5 Cells Infected with SLS or Ur
RL-5 cells were infected with SLS or Ur at a moi of 3 to examine whether myxoma 
virus infection altered IFNy expression. In this experiment, IFNy was also detected in 
RL-5 cells in the absence of Bref A. However, this result was not repeatable in some 
experiments, hence subsequent experiments were undertaken using Bref A.
Infection with either strain of myxoma virus increased the non-specific binding of 
normal rat serum in RL-5 cultures such that fluorescence intensities were similar to 
those corresponding to IFNy in mock-infected cell cultures (Figure 6.17). This was
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Fig ure  6.17. IFNy Exp re ss io n  in  RL-5 Cel ls  Inf ec te d  w it h  SLS or  Ur
RL-5 cells were infected with SLS or Ur at a moi of 3 and incubated (A) with or (B) without 
Bref A. Cells were analysed as histogram overlays of number of cells versus IFNy hb-B/C 
antibody binding in mock-infected (red), SLS- (green) or Ur-infected (blue) cultures. Non-
specific binding of normal rat sera in each infection is shown in black. (C) The fluorescence 
intensity due to normal rat sera in mock-infected (black), SLS-infected (green) and Ur-infected 
(blue) RL-5 cells were overlaid on the one histogram.
independent of addition of Bref A. The non-specific binding of normal rat serum 
precluded any comparison of the effects of infection with SLS and Ur. Attempts to 
overcome this problem by using different fixation solutions (Figure 6.18), such as 
ethanol and buffered formaldehyde acetone (BFA), and pre-incubating cells with fetal 
calf serum or BSA (Figure 6.19) to block non-specific binding sites, did not decrease 
non-specific binding. In fact, in uninfected cell cultures, fixation with ethanol or BFA.
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Fig ure  6.18. Exa mi na ti o n  of  Per m ea bi li sa ti o n  Solu ti o ns  f o r  IFNy Det ec t io n  
in  Infect ed  RL-5 cells
RL-5 cells were mock-infected (black) or infected with SLS (green) at a moi of 3 and incubated 
with Bref A. Cells were permeabilised by (A) methanol:acetone, (B) ethanol or (C) buffered 
formaldehyde acetone (BFA) and analysed as histogram overlays of number of cells versus 
binding of normal rat serum.
and the use of 3% BSA in cell cultures permeabilised with methanol:acetone, increased 
the non-specific binding of normal rat serum (Figure 6.19). To remove non-specific 
binding of antibodies, sera was adsorbed to infected cells prior to use in 
immunofluorescence but this also had no effect on non-specific binding (data not 
shown). In conclusion, IFNy was detected in RL-5 cells by flow cytometry using anti- 
IFNy anti-sera. However, problems with increased non-specific binding of normal rat 
serum to cells infected with myxoma virus hampered analysis of IFNy expression 
during myxoma virus infection.
6.2.3.2 Immunostaining of Rabbit Tissue Sections for IFNy and IL-4
To determine whether the anti-peptide sera could be used for staining tissue sections, 
frozen sections of lymph node from uninfected rabbits or four days post infection with 
either SLS or Ur, were tested with anti-IFNy or anti-IL-4 rat sera. Detection of IL-4 and 
IFNy was undertaken using IL-4 helix A and IFNy hb-B/C rat sera respectively. The 
anti-rabbit-CD43 monoclonal antibody and normal rat serum were used as positive and
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Fig ur e  6.19. Blo ck in g  Non -Speci fic  Binding  w it h  Fetal  Ca l f  Serum  an d  BSA 
RL-5 cells were mock-infected (black) or infected with SLS (green) at a moi of 3 and incubated
with Bref A. Cells were permeabilised by (A) methanol:acetone, (B) ethanol or (C) buffered 
formaldehyde acetone (BFA) and blocked with fetal calf serum (FCS). The percentage of BSA in 
all solutions was also used at 1% and 3%. Cells were analysed as histogram overlays of number of 
cells versus binding of normal rat sera.
negative controls respectively. CD43 is expressed on T-cells and thymocytes (Ostberg 
et ah, 1998) and may cross-react with progenitor rabbit B-cells (reviewed in Mage 
1998), thus it should bind to rabbit lymph node sections. Figure 6.20 shows the 
detection of CD43, IL-4 and IFNy in lymph node sections from an uninfected rabbit. 
Fluorescence was observed with antibodies to each of these proteins.
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The confocal images shown in Figure 6.21 A and 6.2IB suggest that both SLS and Ur 
infection could increase expression of IFNy in the lymph node draining the inoculation 
site of both laboratory and wild rabbits compared to lymph nodes from uninfected 
rabbits as shown in Figure 6.20. IL-4 expression also appeared greater in rabbits 
infected with Ur than in rabbits infected with SLS (Figure 6.2IB and 6.2ID). However 
these results will need to be repeated. Interestingly, staining of virus-infected sections 
did not appear to increase non-specific background, suggesting the problem of non-
specific binding seen in immunoblots does not occur on tissue sections.
Although a comprehensive study of cytokine expression was outside the scope of this 
thesis, the results obtained strongly suggest that the anti-IFNy and anti-IL-4 anti-sera 
will be useful in future studies of detection of expression of these cytokines by 
immunofluorescence in tissue sections.
329
Chapter 6- Production and Characterisation o f Antibodies
330
6.2 Results
Figure  6.21. Immu no fl uo re sc en ce  of  Rabb it  Cy to k in es  in  Tiss ue  Se ct io ns  
from  the  Lymph  Nod e  of  a  Ra bb it  Inf ect ed  w it h  SLS or  Ur  
The lymph node draining the inoculation site from a laboratory rabbit infected with (A) SLS or 
(B) Ur and a wild rabbit infected with (C) SLS or (D) Ur, 4 days post infection were sectioned 
and analysed by immunofluorescence for expression of IL-4 (IL-4 helix A rat sera) and IFNy 
(IFNy hb-B/C rat sera). CD43 expression was used as a positive control and normal rat sera 
were used as a negative control. Magnification is shown as a 50um bar on each oicture.
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6.3 Dis c u s s io n
This chapter detailed the production and preliminary characterization of anti-peptide rat 
sera specific for rabbit IL-4, IL-6, IL-10 and IFNy. Antibodies to IL-4, IL-6, IL-10 and 
IFNy were generated after immunization of rats with synthetic peptides conjugated to an 
immunogenic carrier protein, mcKLH. Production of anti-peptide sera to rabbit IL-2 
was attempted but was unsuccessful.
Each of the sera from rats (with the exception of IL-2) recognized the specific cytokine 
in mammalian cells transfected with pcDNA 3.1 containing the cytokine gene. In 
addition, anti-IL-10 sera detected IL-10 by immunoblotting, anti-IFNy sera detected 
IFNy in tissue sections and in uninfected cells transformed with pcDNA3.1 and anti-IL- 
4 sera detected IL-4 in immunoblotting and tissue sections. The different ability to 
detect cytokines under different experimental conditions indicates that some of the 
antibodies may be highly sensitive to a specific structure on the expressed protein.
The aim of producing antibodies to the rabbit Th I and Th2 cytokines was to detect 
expression of these cytokines during myxoma virus infection, particularly infection of 
lymphoid cells in vitro. The antibodies bound specifically to their cognate cytokine 
expressed in mammalian cells and anti-IFNy antibodies bound IFNy in uninfected RL-5 
cells. This indicates that the regions chosen for the synthetic peptides were 
immunogenic for the intact native protein. However, problems occurred with these 
antibodies when analysis of virus-infected cells was attempted. The major obstacle in 
the in vitro analysis was the non-specific binding of rat sera to cells that had been 
infected with myxoma virus. The normal rat sera bound strongly to viral plaques on cell 
monolayers (data not shown). This binding could not be blocked by pre-incubation with
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fetal calf serum or by increasing the concentration of BSA. The non-specific binding of 
normal rat sera to cell monolayers increased when cells were infected with myxoma 
virus and was observed by immunoblot. The source of the non-specific binding by 
normal rat sera was not further investigated.
Examination of IL-4 and IFNy expression in vivo in tissue sections from rabbits infected 
with myxoma virus did not produce high background when viewed by confocal 
microscopy. This indicated that these antibodies are likely to be useful as a tool for 
analyzing tissue expression of cytokines during the immune response to myxoma virus 
infection. At this stage, the use of IL-6 and IL-10 in tissue sections has not been 
examined.
The limitations of using synthetic peptides for antibody production were highlighted by 
the fact that antibodies specific for rabbit IL-2 were not able to be produced. The lack of 
IL-2 antibody production may be because the regions of IL-2 chosen for the synthetic 
peptide may not be immunogenic or may be too similar to the host cytokine amino acid 
sequence. It is interesting to note that DNA immunization of rats was also not 
successful in generation of IL-2 antibodies.
In conclusion, this chapter described the production and characterization of a group of 
antibodies specific for rabbit cytokines. The antibodies produced will enable future 
investigation of the role of cytokine expression in the attenuation of myxoma virus and 
genetic resistance to myxoma virus. Their most useful role is likely to be in 
immunostaining in tissue sections rather than in immunostaining of infected cultures.
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7.1 Introduction
7.1 In t r o d u c t i o n
The interaction between myxoma virus and the European rabbit is one of the best 
documented natural models of host/ virus co-evolution. However, in spite of extensive 
studies having been done documenting the emergence of rabbits resistant to 
myxomatosis and the development of attenuated myxoma virus strains in the field, the 
cellular and molecular mechanisms behind the co-evolution are not clear.
The interactions between myxoma virus and the host rabbit ultimately determine the 
outcome of virus infection. This interaction is complex and involves the host rabbit 
innate and adaptive immune responses and the many immunomodulatory proteins 
encoded by myxoma virus.
In this thesis, resistance and attenuation have been examined using the same 
experiments, but analysis of results has been from a different perspective. For instance, 
examination of resistance of rabbits to myxomatosis primarily focused on experimental 
differences between lymphoid cells from wild and laboratory rabbits, whereas 
examination of attenuation of myxoma virus primarily focused on experimental 
differences between SLS and Ur. Results from this thesis were also examined to 
determine whether the use of an attenuated strain of myxoma virus could be used to 
model rabbit resistance and conversely whether the use of rabbits with some resistance 
to myxomatosis could be use to model virus attenuation.
This thesis focused on the role of lymphoid cells in the interaction between myxoma 
virus and the European rabbit as these cells have been previously identified as important 
for myxoma virus pathogenesis and have been implicated in resistance of rabbits to
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myxomatosis and in the pathogenesis of attenuated strains of myxoma virus (discussed 
in chapter 1). The interaction between myxoma virus and rabbit lymphoid cells in vivo 
is complicated by other factors, such as the immune response initiated in the skin on 
infection. To characterize the effects of myxoma virus infection on lymphocytes without 
other in vivo factors, impacting on the results, this study was performed in vitro. 
Lymphoid cells were isolated from lymph nodes from susceptible and resistant rabbits 
and infected in vitro with either SLS or Ur. Infection was compared both before and 
after activation of T-cells, to mimic the in vivo situation during the anti-myxoma virus 
immune response. Presumably in vivo some T-cells would be activated prior to infection 
or become activated after infection due to signals generated as a result of the anti-viral 
immune response. The results of the in vitro analysis have been discussed in the earlier 
chapters. This final discussion chapter will therefore extend the in vitro results by 
testing against an in vivo model. This chapter will also present models for rabbit 
resistance and attenuation of the Ur strain of myxoma virus.
7.2 Res is t a nc e  to  Myxo ma t o s is
This thesis examined resistance of rabbits to myxomatosis by infecting primary rabbit 
lymphoid cells from resistant and susceptible rabbits with attenuated and virulent strains 
of myxoma virus. Differences in the response of lymphocytes from these two rabbit 
types identified potential mechanisms for rabbit resistance. Specifically, a small but 
statistically significant reduction was observed in the permissivity for myxoma virus 
replication in lymphocytes from resistant rabbits, compared to lymphocytes from 
susceptible rabbits (chapter 3). This was clearest when using an attenuated strain of 
myxoma virus. In addition, lymphocytes from resistant rabbits also had an increase in 
the expression of specific cell surface proteins that could enhance the early immune
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response to the virus (chapter 5). These changes may enable resistant rabbits to more 
effectively control and clear myxoma virus infection compared to susceptible rabbits. 
Previously, resistance of rabbits to myxomatosis has been compared to the 
murine/ectromelia virus model (Best and Kerr 2000). Resistance of inbred mice to 
ectromelia virus infection has been primarily associated with an enhanced immune 
response generated by the host, with an increased CTL-mediated immune response 
(O'Neill and Brenan 1987) and early enhanced non-specific host defenses, involving 
NK cells and IFNa/ß (Jacoby et al., 1989) correlating to resistance. Induction of a Th I 
cytokine response has also been shown to correlate with resistance of mice to ectromelia 
virus, whereas induction of Th2 cytokine response in ectromelia virus infection leads to 
failure to control ectromelia virus replication and death of the infected mouse (Karupiah 
1998).
The role of the immune response in resistance of rabbits to myxomatosis has not been 
examined in detail due to the paucity of rabbit-specific reagents. However, Best et al. 
(2000) showed that there were gross differences in pathology of the lymph node 
draining the inoculation site when rabbits were infected with virulent SLS. In lymph 
nodes from susceptible rabbits infected with SLS there was an absence of lymphocytes 
and an infiltration of polymorphs, whereas resistant rabbits infected with SLS, mostly 
retained a normal lymphocyte population in the lymph node draining the inoculation site 
(Best et al., 2000).
Studies by Best and Kerr (2000) also showed differences in virus pathogenesis between 
the two rabbit types as virus dissemination was delayed and replication was lower in 
distal tissues in resistant rabbits compared to susceptible rabbits. When this difference 
in virus replication was examined in vitro, no difference was observed in replication of
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the virulent SLS strain in lymphocyte cultures from the two rabbit types, suggesting that 
there was no difference between lymphocytes from susceptible and resistant rabbits in 
their permissivity for myxoma virus replication (Best and Kerr 2000). There was also no 
difference observed in the ability of SLS to replicate in primary fibroblast cells isolated 
from resistant and susceptible rabbits. However, this study did not test the attenuated Ur 
strain for its ability to replicate in vitro and the lymphoid cells were not activated (Best 
and Kerr 2000). As shown in this thesis, the use of the attenuated strain of myxoma 
virus and lymphocyte activation did highlight differences between lymphocytes from 
resistant and susceptible rabbits. These results illustrated that an attenuated strain of 
myxoma virus could be used to model some resistance factors.
As well as the lack of difference in cell permissivity, Best and Kerr (2000) did not find 
any differences in antibody titres between susceptible and resistant rabbits, suggesting 
that antibodies were not crucial but that CTLs probably were. However, since 
differences in virus replication were observed early in infection in vivo, it was 
postulated that innate factors were also involved. From the results described above, and 
based on the model for resistance of mice to ectromelia virus infection, Best and Kerr 
(2000) hypothesized that resistant rabbits had an enhanced early innate immune 
response, compared to susceptible rabbits, and that this limited virus replication enough 
in key tissues for an effective, specific cell-mediated anti-viral immune response to 
develop.
This thesis challenges the notion that the permissivity of lymphocytes to myxoma virus 
replication does not contribute to resistance, as lymphocytes from resistant rabbits were 
significantly less permissive for myxoma virus replication than lymphocytes from 
susceptible rabbits. This was clearest in infection of activated lymphocytes from
340
7.2 Resistance to Myxomatosis
resistant rabbits with the Ur strain of myxoma virus, where Ur did not reach a mean titre 
greater than 5 pfu/input cell over the 72 h. In comparison, Ur was able to replicate in 
activated lymphocytes from susceptible rabbits with greater than 10 pfu/input cell 
reached after 24 h (chapter 3).
Lymphocytes would be activated in the lymph node draining the virus inoculation site 
as an immune response against the virus will have been initiated by the rabbit on 
infection. Thus the observation that virus titres are reduced in activated cultures from 
resistant rabbits (chapter 3), particularly with infection using an attenuated myxoma 
virus strain, suggests that myxoma virus replication in vivo in the lymph node draining 
the inoculation site could also be reduced. It is therefore reasonable to assume that in 
vivo, myxoma virus replication in lymph nodes from resistant rabbits will not be as 
efficient as its replication in lymph nodes from susceptible rabbits.
Due to the dynamic interaction between host and virus, any small difference in virus 
replication may potentially have a great effect on the outcome of disease. The 
permissivity of lymphocytes for myxoma virus replication will be particularly important 
for myxoma virus pathogenesis as lymphocytes are considered one of the primary cells 
for in vivo amplification and dissemination. The reduced replication of myxoma virus in 
resistant rabbit lymphocytes will decrease the production of infectious progeny and 
limit virus-induced immunosuppression. This would enable greater control of the virus 
at the lymph node by the host, which will prevent virus dissemination and reduce 
pathology and may enable a specific cell-mediated anti-viral immune response to 
develop in sufficient time to control virus replication in distal tissues.
The reduced ability of myxoma virus to replicate in lymphoid cells from resistant
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rabbits may also enable a greater number of lymphocytes to function appropriately 
during the anti-viral immune response. This, combined with the increased expression of 
proteins critical for the immune response such as CD4 and CD43 on resting 
lymphocytes from resistant rabbits and MHC-I on activated lymphocytes from resistant 
rabbits, would enable a more effective immune response in the resistant rabbit that 
would help control virus replication in distal tissues. This has been discussed in detail in 
chapter 5. Further examination of the rabbit immune response using rabbit cytokine- 
specific antibodies, similar to those described in chapter 6 of this thesis, will help 
elucidate whether the immune response generated after myxoma virus infection of 
resistant rabbits is more effective than that of susceptible rabbits.
The genetic basis for rabbit resistance to myxomatosis has not been investigated. 
However, resistance of mice to ectromelia virus is multigenic with the main genetic 
component in gene(s) within the natural killer gene complex (Delano and Brownstein 
1995). It would not be unreasonable to assume that resistance to myxomatosis is also 
multigenic, especially in light of the results from this thesis that show resistant rabbit 
lymphocytes have increased cell surface expression of multiple proteins as well as 
decreased permissivity for virus replication, which may be discretely controlled.
7.2.1 Summary of Experimental Results Pertaining to Resistance
The two main results from this thesis that provide the basis for the model outlined in 
Section 7.2.2 are as follows:
1. Lymphoid cells from resistant rabbits were significantly less permissive for 
myxoma virus replication than lymphoid cells from susceptible rabbits. This was 
enhanced when cultures were infected with Ur and were activated; and
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2. Resting lymphoid cells from resistant rabbits had greater expression of CD4 and 
CD43 and activated lymphoid cells had greater expression of MHC-I compared 
to lymphoid cells from susceptible rabbits.
7.2.2 Proposed Model for Resistance to Myxomatosis
Taking the results presented in this thesis together with the pathogenesis studies of Best 
and Kerr (2000) and Best et al. (2000) and the model proposed in these studies by the 
authors, the following model of resistance of rabbits to myxomatosis is presented 
(Figure 7.1). Myxoma virus infects susceptible and resistant rabbits and reaches the 
lymph node draining the inoculation site in susceptible rabbits at a similar time to that in 
resistant rabbits (Best and Kerr 2000). A non-specific anti-viral immune response in the 
skin is generated by the rabbit. To combat the anti-viral immune response, myxoma 
virus produces a number of immunomodulatory proteins. The interaction between the 
rabbit immune response induced in the skin and those viral immunomodulatory proteins 
results in soluble factors that activate T-cells in the lymph node draining the inoculation 
site.
From the skin, myxoma virus is transported to the lymph node draining the inoculation 
site by MHC-II+ dendritic-like cells (Best and Kerr 2000). Once at the lymph node, 
myxoma virus targets T-cells, especially activated T-cells, for infection and replication. 
As reported in this thesis, myxoma virus abrogates the proliferation, and presumably 
subsequent activity, of infected T-cells. However, the T-cell activation signals that 
would be present as a result of the anti-viral immune response increases virus 
replication in these cells. T-cells from resistant rabbits have a lower permissivity for 
myxoma virus replication especially in the presence of stimulatory signals as shown in
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Fig u re  7.1. Prop ose d  Model  f o r  Re s is ta nc e  of  Rab b it s  t o  My xo ma t o sis
Results from this thesis are shown in red. Myxoma virus infects a resistant rabbit. Resistant 
rabbits have increased expression of CD4 and CD43 on the surface of resting lymphoid cells and 
MHC-I on the surface of activated lymphoid cells. This enables a more effective and efficient 
early immune response against the virus. The virus that reaches the lymph node draining the 
inoculation site is not able to replicate as efficiently in T-cells as these cells are less permissive 
for virus replication. This, along with the enhanced immune response, which would also be 
acting in the draining lymph node, reduces the production of infectious virus and limits virus 
dissemination to distal tissues. This reduces disease and prolongs rabbit survival time.
chapter 3 of this thesis. This leads to the reduced viral titres in lymphoid tissues 
compared to infected susceptible rabbits reported by Best and Kerr, (2000). The lower 
level of virus replication in resistant rabbits compared to susceptible rabbits, reduces
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virus dissemination to distal tissues as previously shown (Best and Kerr 2000). The 
lower levels of myxoma virus replication in resistant rabbit lymphocytes also leads to 
reduced production of viral immunomodulatory proteins and therefore a lower ability of 
myxoma virus to suppress the immune response at the level of the lymph node. In 
addition to this, the increased cell surface expression of CD4 and CD43 on resting 
lymphocytes from resistant rabbits, as described in chapter 5, may generate a faster and 
more effective immune response early in infection. The immune response may be 
enhanced once the lymphocytes are activated by the increased expression of MHC-I on 
lymphocytes from resistant rabbits compared to lymphocytes from susceptible rabbits.
The lower virus replication and subsequent immunosuppression together with the 
increased ability of the resistant rabbit lymphocytes to participate in the anti-viral 
immune response (due to the increase in expression of certain cell surface proteins) 
enable more effective and efficient control and clearance of virus from the resistant 
rabbit, reduced clinical disease and increased rabbit survival when compared to 
susceptible rabbits. It must be noted that the resistant rabbit is not able to reduce the 
replication of virulent SLS to as great an extent as it is for the attenuated virus strains 
such as Ur, but is still able to reduce replication to levels lower than those in susceptible 
rabbits. This gives resistant rabbits an advantage over susceptible rabbits in clearing 
myxoma virus infection.
In susceptible rabbits, myxoma virus is able to effectively replicate in tissues distal to 
the skin. Lymphocytes from susceptible rabbits also have lower levels of CD4, CD43 
and MHC-I on resting lymphocytes relative to resistant rabbits. It is therefore predicted 
that lymphocytes from susceptible rabbits are not able to respond to infection as quickly 
or effectively as lymphocytes from resistant rabbits. This leads to susceptible rabbits not
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being able to control myxoma virus replication and dissemination and replication in 
distal tissues to as great an extent as in resistant rabbits, often resulting in death.
7.3 At t e n u a t io n  of  My xo ma  V iru s
This thesis is the first report of a potential mechanism for attenuation of a naturally- 
derived strain of myxoma virus. Attenuation of the Ur strain of myxoma virus was 
examined by comparing infection of lymphoid cells with the virulent SLS and 
attenuated Ur strain of myxoma virus. A difference between the two strains of myxoma 
virus was observed in that SLS was more able to maintain lymphocyte viability after 
cell cycle arrest than Ur (chapter 4). The genetic mechanism for this difference was 
investigated by sequencing genes whose products have putative anti-apoptotic or host- 
range function. A lesion was detected in the M005 ORF which is potentially responsible 
for the inability of Ur to maintain lymphocyte viability. The genetic mechanism of 
attenuation of naturally derived strains of myxoma virus has not previously been 
investigated.
Attenuation of a virus, in a particular host species, must be accompanied by changes in 
its genetic sequence. Most genetic studies of myxoma virus have examined the effects 
of experimentally deleting genes on myxoma virus pathogenesis. These studies have 
shown that the deletion of one of a number of genes (e.g. M011, M002, M004 and 
M005 ORFs) leads to an attenuated disease phenotype in vivo (Macen et al., 1996; 
Mossman et al., 1996; Opgenorth et al., 1992; Barry et al., 1997). Flowever, it is 
unlikely that Ur attenuation is due to deletion of an entire gene as, in the field, the 
transmission of any myxoma virus strain that has a deletion of a virulence gene will 
most likely be compromised. The deletion mutants that are attenuated have limited
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replication and are quickly controlled by the host immune response. This will result in 
the virus not being able to remain in the skin at titres sufficient for transmission. The 
virus strain will not be able to transmit to a new host and will rapidly die out (Fenner 
and Kerr 1994; Fenner and Ratcliffe 1965).
Experiments have shown the postulated mechanism of attenuation of these recombinant 
myxoma viruses with any one of M011, M002, M004 or M005 deleted is the induction 
of lymphocyte death, as has been demonstrated in vitro (Macen et al., 1996; Mossman 
et ah, 1996; Opgenorth et ah, 1992; Barry et ah, 1997). Lymphocytes are important for 
virus amplification and dissemination in vivo, so the inability of the deletion viruses to 
replicate in lymphocytes will reduce virus replication and dissemination and enable 
effective control of the virus by the rabbit. Control of virus replication will reduce 
pathology and disease and enhance rabbit survival.
However, all of these deletion mutant viruses could replicate in fibroblast cells as 
efficiently as wild type virus. The ability of myxoma virus to replicate in fibroblast and 
other skin cells is essential for transfer of virus between hosts. This is because myxoma 
virus is passively transmitted between hosts on the mouthparts of biting arthropods. In 
its natural host, S. brasiliensis, myxoma virus replicates in the skin and so the virus can 
propagate between hosts. Virus does not infect lymphocytes and does not disseminate 
systemically where it could cause disease and potentially death of the host. Such a 
scenario would reduce the time period the virus has available to produce infectious 
progeny. Thus in its natural host, it could be considered that myxoma virus has evolved 
to have the maximum opportunity for replication.
In O. cuniculus, which was immunologically naive to myxoma virus prior to the virus’
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introduction into wild rabbit populations, myxoma virus can infect lymphocytes, does 
disseminate systemically and often causes death of the infected rabbit. This suggests 
that as well as the ability of myxoma virus to replicate in lymphocytes being critical for 
virulence it may also be critical in an evolutionary sense.
The pathogenesis of virulent and attenuated myxoma virus strains has previously been 
examined (Best and Kerr, 2000; Best et al, 2000). In wild rabbits Ur titres are reduced at 
the lymph node draining the inoculation site and dissemination to distal tissues from this 
site is delayed compared to SLS (Best and Kerr 2000). This supports the hypothesis in 
this thesis that the ability of specific naturally-attenuated strains of myxoma virus to 
replicate in lymphocytes is a determinant of myxoma virus virulence. Further work on 
other attenuated strains of myxoma virus is required to determine whether the inability 
to replicate in lymphoid cells is a common phenotype of these strains. To explain the 
reduced titres and delayed dissemination of Ur, Best and Kerr (2000) suggested three 
possibilities: either Ur disseminates less efficiently in vivo than SLS; the lymph node 
draining the inoculation site controls virus replication thereby preventing dissemination; 
or there is an enhanced immune response in rabbits infected with Ur that controls virus 
replication in distal tissues. These possibilities are potentially inter-linked.
Results from this thesis support all three of these hypotheses. Firstly, both strains of 
myxoma virus inhibited cell proliferation before S phase of the cell cycle (chapter 3). 
However, SLS and Ur differed in their ability to maintain lymphocyte viability after cell 
cycle arrest (chapter 4). For instance, in Ur-infected cultures there was a reduction in 
lymphocyte viability, presumably due to the failure of Ur to inhibit cell death pathways 
that were initiated on cell cycle arrest. In contrast, SLS was able to maintain lymphocyte 
viability. Genetic analysis undertaken in this thesis is the first identification of a genetic
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lesion that may alter the effect of the virus on lymphocyte viability.
Sequencing of the M005 ORF in Ur found an insertion of a cytosine relative to the 
M005 ORF in SLS (chapter 4). The insertion of this cytosine induces a frameshift, 
potentially resulting in production of a truncated M005 protein. M005 has been 
previously implicated in lymphocyte survival (Mossman et al., 1996), so this lesion may 
be responsible for the reduction in lymphocyte viability observed in Ur-infected cultures 
at late time points (discussed in chapter 4). The failure of Ur to maintain lymphocyte 
viability may limit virus dissemination in vivo as Ur infection will kill the cell. 
However, it is unclear whether this lesion is responsible for the reduced ability of Ur to 
replicate in lymphocytes from wild rabbits compared to laboratory rabbits as observed 
in chapter 3. Whether the lesion in M005 is responsible for attenuation of Ur could be 
examined by creating a recombinant Ur strain of myxoma virus that has the SLS M005 
gene inserted, and testing for its ability to maintain lymphocyte viability or whether its 
virulence in rabbits is increased.
Overall, activation of T-cells significantly increased both the viral titres produced in 
infected lymphoid cell cultures and the proportion of lymphocytes infected with 
myxoma virus (chapter 3). The increase in SLS titres observed after activation of rabbit 
lymphocytes was due to an increase in virus production in every infected cell. For Ur 
infection, however, the increase in titres observed with Con A stimulation, which was 
only detected in lymphoid cell cultures from laboratory rabbits, was due to an increase 
in the number of infected cells. These results illustrated that the use of resistant rabbits 
in experiments examining myxoma virus attenuation may highlight some factors 
involved in attenuation.
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Lymphocytes will be activated during an immune response and are presumably 
activated in the lymph node draining the inoculation site due to the immune response 
being initiated in the skin. The results in this thesis suggest that Ur replication in 
activated lymphocytes in the rabbit lymph node will not be as efficient as SLS. The 
lower replication of Ur will enable greater control of the virus at the lymph node 
draining the inoculation site, which will reduce virus dissemination and 
immunosuppression and enhance virus clearance.
The third possibility presented by Best and Kerr (2000) was that there was an enhanced 
innate immune response in rabbits infected with Ur that controlled virus replication 
sufficiently for a T-cell response to develop. This T-cell response subsequently controls 
virus replication in distal tissues. This thesis showed that both strains of myxoma virus, 
although preferentially replicating in activated T-cells, completely abrogated features of 
T-cell activation, such as cell proliferation, increase in cell size and up-regulation of 
CD25, CD4 and MHC-I on the lymphocyte surface. This effect was observed in 
lymphoid cell cultures that were activated after myxoma virus infection, but not in 
cultures activated prior to infection.
The reduced ability of Ur to replicate in lymphoid cells may allow a greater number of 
lymphocytes to function appropriately in vivo. This, combined with the reduced 
dissemination of Ur and the lower ability of Ur to replicate in activated cells, as 
discussed in the previous paragraphs, will enable a more effective immune response that 
will help control virus replication in distal tissues. The greater number of lymphocytes 
that function appropriately may also account for the observation of Best et al. (2000) 
that the lymph nodes in susceptible rabbits infected with SLS are effectively 
depopulated of lymphocytes, but in Ur infection, there is no net loss of lymphocytes that
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is visible histologically.
7.3.1 Summary of Experimental Results Pertaining to Attenuation
The main results from this thesis that provide the basis for the model outlined in Section
7.3.2 are as follows:
1. Ur was not able to maintain lymphocyte viability late in infection, whereas SLS 
was able to maintain lymphocyte viability late in infection;
2. Ur had a genetic lesion in M005 compared to SLS, which may be responsible for 
the inability of Ur to inhibit cell death pathways; and
3. Ur-infected lymphocytes generated lower titres of virus per cell when activated 
compared to lymphocytes infected with SLS.
7.3.2 Proposed Model for Ur Attenuation
In conclusion, this thesis proposes the following model for Ur attenuation (Figure 7.2). 
Infection of a rabbit with SLS or Ur induces an inflammatory response in the skin, 
which activates cells in the lymph node. Both SLS and Ur reach the lymph node 
draining the inoculation site at similar times and infect T-cells. Both strains abrogate T- 
cell proliferation as shown in this thesis. However, Ur cannot replicate as effectively as 
SLS as shown by the differences in viral titre per infected cell (chapter 3), and fails to 
maintain lymphocyte viability after cell cycle arrest (chapter 4). This may explain the 
decreased titres in the lymph node draining the inoculation site observed in wild rabbits 
by Best and Kerr (2000). Although Best and Kerr (2000) did not observe reduced Ur 
titres at the draining lymph node in susceptible rabbits, it is postulated, based on results 
from chapter 3 of this thesis that Ur will not replicate as efficiently as SLS in the lymph
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F ig u r e  7.2. P r o p o s e d  M o d e l  f o r  A t t e n u a t io n  o f  M y x o m a  V i r u s
Results from this thesis are shown in red. Both SLS and Ur reach the lymph node draining the site 
of infection at similar times. Here they infect T-cells which, along with monocytes and 
macrophages, disseminate the virus to distal tissues. Ur can not maintain the viability of T-cells 
late in infection possibly due to the lesion in the M005 gene, so limited Ur dissemination occurs. 
This reduces Ur in distal tissues and therefore Ur replication in these tissues. The reduced 
dissemination and replication of Ur at these sites leads to reduced disease and pathology and 
increased rabbit survival. In contrast SLS is able to replicate and disseminate in T-cells. SLS also 
maintains lymphocyte viability late in infection. This may allow greater virus replication in the 
distal tissues causing pathology and severe clinical disease in the rabbit.
node draining the inoculation site in these rabbits.
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The failure of Ur to maintain lymphocyte viability is potentially due to the mutation in 
the M005 ORF. A decrease in viability of infected lymphocytes may reduce the ability 
of Ur to disseminate to distal tissues. This would lead to lower levels of virus present in 
distal tissues and, coupled with the lower levels of Ur replication per cell in these tissues 
compared with SLS, would enable easier control and clearance of virus.
The lower levels of Ur replication would lead to reduced production of 
immunomodulatory proteins and lower ability of Ur to suppress the immune response 
which also favors development of an effective cell-mediated immune response. This, 
together with the enhance control and clearance due to reduced Ur titres would explain 
the decrease in the clinical disease in Ur-infected rabbits and increase in rabbit survival.
As SLS is able to maintain lymphocyte viability, SLS would be able to disseminate and 
would potentially have greater chance to replicate to high numbers. The increase in viral 
replication in lymphocytes and the maintenance of lymphocyte viability would 
contribute to the systemic dissemination, severe pathology and reduced rabbit survival 
observed with SLS infection.
It has been previously shown that SLS induces apoptosis in lymphocytes from the 
lymph node draining the inoculation site early in infection (Best et al., 2000). This was 
hypothesized to be due to either the lymphocytes being primed for apoptosis prior to 
expression of late viral proteins, significant external factors (cytokines or ligand 
interactions) that induce apoptosis in uninfected cells, partial activation of antigen- 
specific cells or the production of a virus-induced factor that induces apoptosis in 
uninfected cells. Results from this thesis are not able to determine which of these is the 
mechanism for the early apoptosis observed. However, experiments in this thesis
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were done in isolation from external in vivo factors and found that lymphoid cell 
cultures infected with SLS had less cell death than those infected with Ur, suggesting 
that significant external factors generated outside the lymph node are required either 
directly or indirectly for the induction of bystander apoptosis.
7.4 Conclusion
This thesis has identified a putative mechanism for resistance of rabbits to 
myxomatosis. Based on results obtained, resistance to myxomatosis is postulated to be 
due to a combination of a reduced permissivity of lymphocytes from resistant rabbits for 
virus replication and an increase in expression on naive T-cells of certain cell surface 
proteins critical for the immune response.
This thesis is also the first report of a naturally occurring mechanism for attenuation of 
myxoma virus. Based on flow cytometric analysis of infected lymphocyte cultures and 
of sequencing, attenuation of the Ur strain of myxoma virus is postulated to be due to a 
lesion in the M005 gene that reduces the ability of this strain to maintain lymphocyte 
viability after cell cycle arrest.
This thesis also showed that the use of an attenuated strain of myxoma virus could be 
used to model some aspects of rabbit resistance and conversely the use of rabbits with 
some resistance to myxomatosis could be use to model some aspects of virus 
attenuation.
In conclusion, this thesis indicates that the interactions between myxoma virus and T- 
cells may be critical for determining the outcome of infection and do indeed play a
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major role in the pathogenesis of myxoma virus in resistant rabbits and of attenuated 
strains of virus. Future studies applying these in vitro findings to in vivo experiments 
will extend our understanding of the genetic mechanism of resistance of rabbits to 
myxomatosis and also of the attenuation of myxoma virus in the field.
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Appendix 1
Appe n d ix  1. 3H-T inc o r po r a t io n  o f  Ly mph o id  Cells  fr o m 
La b o r a t o r y  o r  W ild  Ra bb it s  Inf ec t ed  w it h  SLS o r  Ur
Lymphoid cell proliferation was measured by 3H-T incorporation. Lymphoid cells were 
isolated from (A) laboratory and (B) wild rabbits and mock-infected (MI) or infected 
with SLS or Ur at a concentration of 0.1 or 3 pfu/input cell, for one hour prior to Oh 
time point. Con A was added at Oh. 3H-T was added at OB, 24B, 48 and 72h^ and the 
cells pulsed for 18h. Values were adjusted such that H-T incorporation of MI cultures 
at Oh was equal to 1. Reactions were done in triplicate and repeated for three laboratory 
and three wild rabbits (labeled 1, 2 and 3). Error bars represent standard errors. Due to 
the variability observed with this technique, graphs have different scales.
Graphs from all rabbit cultures are shown here in addition to the graph of rabbit #1 
which is shown in the body of the thesis (Figure 3.4).
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Appe nd ix  2. Pr o l if e r a t io n  o f  Ra b b it  Ly mph o id  Cell s  fr o m 
La b o r a t o r y  o r  W ild  Ra b b it s  a nd  Inf ec t ed  w it h  SLS o r  Ur
The proliferation of lymphoid cells from (A) laboratory and (B) wild rabbits was 
measured using the CellTitre 96® AQueous One Solution Cell Proliferation Assay 
using the MTS reagent. Lymphoid cells were mock-infected (MI) or infected with SLS 
or Ur at a moi of 0.1 or 3 pfu/input cell, for one hour prior to the Oh time point. Con A 
was added at Oh. The MTS reagent was added at OB, 24B, 48 and 72h® post 
infection. Absorbance was read at 490nm after a 4h incubation with the MTS reagent. 
Values were adjusted such that the absorbance of MI samples at Oh was equal to 1. 
Reactions were done in triplicate and repeated using cultures from three laboratory and 
three wild rabbits (labelled 1, 2 and 3). Error bars represent standard errors.
All graphs from all rabbits are shown here in addition to the graph of rabbit #1 which is 
shown in the body of the thesis (Figure 3.5).
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Append ix  3. Pr o l if e r a t io n  of  t he  Ra b b it  T-c e l l  Lin e , RL-5, 
Infe c te d  w it h  SLS o r  Ur
RL-5 proliferation was measured by tritiated thymidine incorporation and the CellTitre 
96® AQueous One Solution Cell Proliferation Assay, using the MTS reagent. RL-5 
cells were mock-infected (MI) or infected with SLS or Ur at a moi of 0.1 or 3 pfu/input 
cell, for one hour prior to Oh time point. 3H-T or MTS reagent was added at OB, 24 *,
48 and 72h® post infection. The cells were pulsed for 4h with 3H-T or MTS reagent. 
Values were adjusted such that the 3H-T incorporation or absorbance of MI samples at 
Oh equaled 1. Reactions were done in triplicate and repeated three times (represented by 
1, 2 and 3). Error bars represent standard errors. Due to the variability observed with 
this technique, graphs may have different scales.
All graphs are shown here in addition to the graphs shown in the body of the thesis 
(Figure 3.6).
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